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Leptospirosis is an underappreciated cause of human illness and livestock 
production loss in the tropics. Our understanding of the burden of disease, 
reservoirs and sources of human infection, and the performance of point-
of-care diagnostic tests is limited in African countries. To fill data gaps, we 
recruited patients presenting with fever to two hospitals in Moshi, northern 
Tanzania, during 2012-2014 and at Endulen Hospital during 2016-17. We 
tested participants for leptospirosis using microscopic agglutination testing 
(MAT), Leptospira culture, and in a subset, polymerase chain reaction 
(PCR) and IgM point-of-care tests and evaluated test accuracy. We 
conducted a case-control study to identify risk factors for acute 
leptospirosis and conducted a survey of community livestock owners 
across northern Tanzania. We estimated leptospirosis incidence from the 
prevalence in Moshi Rural and Moshi Urban Districts by using multipliers 
derived from a health-care utilisation survey and calculated disability 
adjusted life years (DALYs). We compared MAT serogroup reactivity and 
Leptospira species detected in people with those detected in animals. To 
assess potential animals hosts of Leptospira serogroups and species we 
conducted a systematic review of all typed isolations and PCR detections 
of Leptospira from animals. We estimated the incidence of leptospirosis in 
several districts in northern Tanzania using a model that predicted an 
individual’s probability of leptospirosis based on their risk factors and the 
presence of recent fever. We estimated the annual leptospirosis incidence 
in Moshi Rural and Moshi Urban Districts as 11-18 cases per 100,000 
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people and 169 DALYs lost annually. Annual incidence in surrounding 
Districts was up to 85 per 100,000 persons. At our Moshi and Endulen 
sites the most commonly reactive serogroups were Australis and 
Djasiman. The systematic review found that serovars from the Australis 
serogroup have been isolated in Africa from field rats, multi-mammate 
rats, and cattle. Serovars of the Djasiman serogroup have not been 
isolated in Africa but have been isolated from dogs and small mammals in 
South America, Asia, and Europe. Using PCR, we identified L. 
borgpetersenii, L. interrogans, and L. kirschneri in the serum of patients 
with fever. Working in rice fields (odds ratio [OR] 14.6, 95% confidence 
intervals [CI] 2.9-59.5), cleaning cattle waste (OR 4.3, CI 1.2-12.9), 
feeding cattle (OR 3.9, CI 1.3-10.3) and being a farmer (OR 3.3, CI 1.3-
8.2) were risk factors for acute leptospirosis. Increasing cumulative cattle 
urine exposure (OR 2.3, CI 1.1-4.7) and rodent urine exposure (OR 1.7, CI 
1.1-2.8) were associated with leptospirosis on bivariable but not 
multivariable logistic regression. Working in rice fields (OR 3.6, 95% CI 
1.5-9.0), slaughtering goats (OR 2.3, 95% CI 1.0-4.8), working as a farmer 
(OR 1.8, 95% CI 1.3-2.5), and frequently seeing rodents in the kitchen 
(OR 1.5, 95% CI 1.1-2.1) were risk factors for Leptospira seropositivity. All 
IgM point-of-care assays had low sensitivity compared with MAT. 
Leptospirosis causes substantial morbidity in northern Tanzania. 
Prevention of Leptospira infection in livestock is likely to reduce the burden 
of human leptospirosis. Clinicians should suspect leptospirosis in patients 
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with fever who are rice workers or exposed to cattle urine, however IgM 
point-of-care tests are insufficiently accurate for clinical use.  
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Chapter 1. Existing knowledge 
about leptospirosis in northern 
Tanzania 
1.1 MICROBIOLOGY OF LEPTOSPIROSIS 
Leptospirosis is caused by spirochete bacteria from the genus Leptospira.  
Within the family Leptospiraceae, there are 3 genera of which one genus, 
Leptospira contains multiple pathogenic species that are the aetiologic 
agents of leptospirosis, as well as non-pathogenic species. Separate 
classification schemes classify Leptospira into serovars based on 
serological differences, or species based on deoxyribonucleic acid (DNA) 
relatedness. Both schemes have an important role when investigating the 
epidemiology of leptospirosis. 
 
1.1.1 Serovar 
Serovar classification is based on agglutinating antibodies against the 
lipopolysaccharide O antigens of the Leptospira outer membrane (1). Two 
Leptospira strains are considered to be of different serovars if after cross-
absorption with adequate amounts of heterologous antigen, they have at 
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least 10% of the homologous titre of antisera remaining in at least one of 
the strains (2). There are over 250 pathogenic serovars of Leptospira 
identified (3, 4). The serovar classification has epidemiologic and biologic 
meaning as although the difference in outer membrane lipopolysaccharide 
between serovars is only one of many phenotypic differences between 
them, variability in the lipopolysaccharide is important as it is partially 
responsible for the ability of Leptospira to establish chronic infection in the 
kidney of maintenance hosts (5). Serovars are organised into serogroups, 
although these have no taxonomical standing, but facilitate laboratory 
testing. Serogroups contain serovars with shared, cross-agglutinating 
antigens. Consequently, when performing micro-agglutination serology, 
antigen panels contain serovars that represent serogroups relevant to the 
population being tested (3).   
 
1.1.2 Species 
In addition to classification by serovar, Leptospira are also classified into 
species based upon genetic relatedness. Species should have more than 
70% DNA-DNA relatedness and with thermal stability difference 
≤5°Celcius (6). The standard technique for determining DNA relatedness 
is DNA-DNA hybridisation (6, 7). Species can be clustered according to 
pathogenicity. Currently 10 pathogenic species and 5 species of 
intermediate pathogenicity have been described (8).  
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The relationship between Leptospira species and serovar is complex. 
Several serovars may comprise a single species, but it has been shown 
that a single serovar can contain strains that belong to two species. There 
are currently 12 serovars that contain strains from multiple species. The 
Leptospira serovars and associated species are listed in Table 1.1, 
modified from Levett (9). The complex relationship between serovar and 
species is of particular importance to the epidemiology of leptospirosis in 
Africa, where several novel Leptospira species-serovar combinations have 
been reported among isolates (10).  One explanation for the presence of 
isolates from a single serovar being found within multiple species is the 
horizontal transfer of lipopolysaccharide gene sequences between 
species. However, the frequency of such exchange and its mechanism is 
unknown (11, 12). 
 
 
Table 1.1 Leptospira serovars that belong within ≥2 species 
Serovar Species 
Bataviae L. interrogans, L. santarosai 
Bulgarica L. interrogans, L. kischneri 
Fugis L. interrogans, L. kischneri 
Grippotyphosa L. interrogans, L. kischneri 
Hardjo L. borgpetersenii, L. interrogans, L. meyeri 
Icterohaemorrhagiae L. interrogans, L. inadai 
Kremastos L. interrogans, L. santarosai 
Mwogolo L. interrogans, L. kischneri 
Paidjan L. interrogans, L. kischneri 
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Pomona L. interrogans, L. noguchii 
Pyrogenes L. interrogans, L. santarosai 
Szajizak L. interrogans, L. santarosai 
Valbuzzi L. interrogans, L. kischneri 
 
1.1.3 Leptospira transmission cycle 
The transmission pathway of Leptospira is shown in Figure 1.1. Leptospira 
are maintained by animal hosts (13). Although individual serovars are 
often associated with individual animal species (13), there can be 
transmission between animal species. Animals may develop an acute 
illness, but if the Leptospira serovar is well adapted to the renal tract of the 
infected animal, chronic infection with leptospiruria may develop. Humans 
are incidental hosts, who are thought rarely to develop chronic infection. 
Transmission occurs through contact with urine, blood or other body fluids 
from an infected animal, or soil or water contaminated by infected urine. 
 
 
Figure 1.1 Transmission pathway of leptospirosis, indicating 
potential sources of human infection 
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1.2 HEALTHCARE IN TANZANIA  
Tanzania has a population of approximately 50 million people with a gross 
domestic product of US$936 per capita in 2017 (14). The expenditure on 
healthcare in 2014 was US$52 per capita, 5.6% of gross domestic 
product. Up to 13% of people have either state or private health insurance.  
There were 6734 health facilities operating in 2015 and 66.5% of people 
lived within 5 km of a health facility (15). However there is an uneven 
distribution of health facilities across the country, with many rural areas 
underserved. The majority of health facilities are dispensaries, where 
treatment including antimicrobials can be bought without prescription. Up 
to 32% of antimicrobials are bought without prescription, and overuse of 
over-the-counter antimicrobials is thought to be high (16). Patients with 
febrile illness often challenges accessing care including transport to 
hospital and accessing funds for care (17,18). 
 
1.3 LEPTOSPIROSIS IN ANIMALS 
Leptospirosis is a zoonotic disease, with humans incidentally infected 
hosts. It is thought that any serovar or species of Leptospira can infect any 
animal species, but that a limited number of serovars and species 
predominate in any particular location (13).  Therefore, in a region, 
comparison of which serovars and species infect non-human animals with 
those that infect human beings may identify potential reservoirs and 
sources of human infection. 
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In Tanzania, there is limited information currently on Leptospira infection in 
animals. Existing data can be subdivided into livestock and domestic 
animals, and wildlife groupings. 
 
1.3.1 Livestock and domestic animals 
Leptospira infection of cattle appears to be common. Leptospira have 
been isolated from the urine or renal tract of cattle repeatedly over more 
than a decade (19-22). Isolations have included a new serovar, L. 
kirschneri serovar Sokoine (19), as well as L. interrogans serovar 
Grippotyphosa, and L. borgpetersenii serovar Hardjobovis (21, 22). Sero-
reactivity of cattle to Leptospira has also been commonly found over an 
extended period. A sero-survey of dairy and abattoir cattle in several parts 
of Tanzania including northern Tanzania, published in 1997, identified 6% 
sero-positivity to serovar Hardjo, and 2% to serovar Pyrogenes (20). A 
2004 survey of abattoir cattle in Tanga found 29% sero-reactive to serovar 
Hardjo, and 18% to serovar Tarassovi (23). A survey of cattle in the Katavi 
region in southern Tanzania found 30% of cattle seropositive (24). Finally, 
a recent survey of abattoir cattle in Moshi found sero-reactivity in 48% of 
sampled cattle, with cattle most commonly having the highest titres 
against serogroup Mini (22). There are few published studies on the 
impact of leptospirosis among livestock, and none that come from Africa. 
However, leptospirosis is known to cause livestock illness, death, and 
reproductive losses (13). A recent study estimated that the median annual 
cost of leptospirosis through lost livestock production in New Zealand from 
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2001-14 was NZ$11.31 (95% probability intervals 5.50–22.29) million (20). 
Although it has yet to be measured, it is likely that leptospirosis among 
livestock also causes substantial cost to Tanzanian farmers. 
 
There are also data indicating that Leptospira infection has been present 
in livestock other than cattle. Leptospira belonging to the previously 
unknown serovar Morogoro have been isolated from two pigs (21,26), and 
4% of pigs were seropositive. While there have been no reported isolates 
from goats (21, 27), 9% were seropositive in the Katavi Region (24). Dogs 
too are a well-established reservoir host of several serovars of Leptospira 
(13). Leptospira have not been isolated from dogs in Tanzania, and 
although few attempts have been made to culture material from them, 
evidence of infection from a single study found 37% of dogs seropositive 
to serogroup Icterohaemorrhagiae, and <1% seropositive to serogroup 
Canicola (20). 
1.3.2 Wildlife 
Globally, rodents are a major reservoir host of Leptospira. There are many 
species of rodents within Tanzania, and the prevalence of Leptospira 
infection has varied between species. Despite being common hosts of 
Leptospira in many countries, Leptospira have not been isolated from 
either the black rat (Rattus rattus), or the Norwegian rat (Rattus 
norvegicus) in Tanzania. In a study of rodents trapped in Moshi, 
Leptospira was neither isolated by culture nor detected by polymerase 
chain reaction (PCR) in any of 326 black rats captured (22).  Serologic 
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data on Leptospira infection in Rattus spp. are sparse. In 1997, Machangu 
et al identified 10 (2%) of 537 rodents as seropositive, with 3 (denominator 
not reported) from Rattus species (20). A recent study from Katavi, 
identified one (50%) of two black rats seropositive (24).  
 
 Other species of rodents have been shown to be carriers of Leptospira 
including both the African giant pouched rat (Cricetomys gambianus), and 
the multimammate mouse (Mastomys natalensis). Leptospira serovars 
Sokoine, Kenya, Canicola, and Mwogolo have been isolated from the 
African giant pouched rat, and serovars Kenya and Lora from the 
multimammate mouse (21).  It is thought that both the African giant 
pouched rat and the multimammate mouse are ubiquitous agricultural 
pests that are more likely than black or Norwegian rats to play an 
important role in the ecology of leptospirosis in rural Tanzania (28).  
 
There are serologic data on leptospirosis in non-rodent wildlife, but no 
isolates. In the Katavi-Rukwa ecosystem over 19% of bats were 
seropositive to Leptospira serovar Sokoine. In Morogoro in central 
Tanzania 14 (29%) of 48 freshwater fish were seropositive against serovar 
Kenya, and 12 (25%) against serovar Sokoine. 
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1.4 LEPTOSPIROSIS IN HUMANS IN NORTHERN TANZANIA  
1.4.1 Leptospirosis as a cause of febrile illness 
Febrile illness is a common problem in tropical countries (29). Malaria is a 
major cause of febrile illness in Tanzania, but the incidence of malaria is 
declining (30), and there is increasing recognition that malaria is over 
diagnosed (31). Leptospirosis is among a number of infections that also 
cause a non-specific febrile illness and is a major cause of febrile illness 
worldwide, particularly in tropical countries with developing economies 
(32). It has been recently estimated that globally, there were nearly 1.03 
million cases of acute leptospirosis, 59,000 deaths, and 2.90 million 
disability-adjusted life years lost (DALYs) during 2015 (32,33).  
 
1.4.2 Prevalence and Incidence 
Until recently there have been sparse data on leptospirosis in Tanzania. 
However, in the last 10 years several papers have identified bacterial 
zoonoses in general, and leptospirosis in particular, to be diseases of 
public health importance. During a study of 870 patients admitted with a 
fever to hospital in Moshi, Tanzania, 8% were found to have either 
confirmed or probable leptospirosis during 2007 and 2008 (34). Biggs and 
colleagues were able to estimate incidence by combining this prevalence 
data with a healthcare utilisation survey in the districts surrounding Moshi. 
They estimated the incidence of leptospirosis to be between 75-102 cases 
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per 100,000 population per year (35). This ranks as one of the highest 
rates of endemic leptospirosis globally (32).  
Leptospirosis is a disease with a broad spectrum of severity. A recent 
meta-analysis estimated the case fatality rate of untreated leptospirosis to 
be 2.2% (range 0.0-39.7%) (36). However, many patients either will have 
such mild symptoms they will not seek health care or may be unable to 
access health care. This means that estimates of incidence rate may 
reflect only the portion of people with disease who are able to access the 
health system and the actual incidence of infection is likely to be higher. In 
the northern Tanzanian cohort reported by Biggs, 40% of all patients had 
serologic evidence of Leptospira exposure (34). Although the prolonged 
and variable persistence of antibodies against Leptospira (37) makes it 
impossible to make an accurate estimate of incidence based on 
prevalence of serological exposure, it does suggest many cases are 
undetected due to patients not presenting for assessment. The high 
prevalence of exposure to Leptospira has been replicated by another 
study investigating patients with febrile illness. In a study that involved 370 
patients in Kilosa District Hospital in central Tanzania, Chipwaza and 
colleagues identified 11.6% of patients with confirmed leptospirosis and a 
further 13% with presumptive leptospirosis (38). To reach the case 
definition for confirmed leptospirosis patients required an antibody titre 
≥160. As antibody titres decline slowly in endemic countries, a case 
definition of an antibody titre ≥160 is relatively non-specific, and a single 
high titre may indicate previous rather than current infection. As such, the 
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estimate by Chipwaza and colleagues may have overestimated the 
prevalence of acute leptospirosis, but nevertheless, the data suggest that 
human populations are highly exposed to Leptospira in Tanzania and that 
leptospirosis is a common cause of febrile illness. 
 
1.4.3 Clinical description of leptospirosis 
Biggs and colleagues described leptospirosis among 70 individuals in 
northern Tanzania, who were diagnosed using microscopic agglutination 
testing (MAT) performed at the US Centers for Disease Control and 
Prevention (34). In this cohort of patients from two referral hospitals, the 
clinical picture was one of a non-specific febrile illness that was difficult to 
distinguish from other causes of fever. They found that participants with 
leptospirosis presented a median of seven days after the onset of 
symptoms for adults and adolescents, and a median of three days for 
infants and children.  They were not able to identify any symptom or 
physical examination sign that distinguished adults or adolescents with 
leptospirosis from those with fevers due to other causes. Although 
adolescent and adult participants with leptospirosis were more likely to 
have thrombocytopenia than those without leptospirosis (odds ratio 3.5 for 
confirmed cases, and 2.2 for presumptive cases, 95% confidence intervals 
not reported), the magnitude of the association is insufficient on its own, 
for accurate diagnosis. Among infants and children, they found that 
lymphadenopathy was more common among those with leptospirosis than 
children with other causes of fever (odds ratio not reported). They did not 
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find an association between thrombocytopenia and leptospirosis among 
the 27 children included in the study (odds ratio not reported). That the 
clinical picture of leptospirosis is non-specific was highlighted by the failure 
of clinicians to diagnose any of the 70 cases of leptospirosis at 
presentation. All cases were diagnosed retrospectively from laboratory 
testing performed during the study. Of note, human immune deficiency 
virus infection (HIV) did not appear to be associated with leptospirosis or 
affect the clinical picture (39). 
 
The case fatality ratio of leptospirosis is uncertain. The best available 
estimate comes from a recent systematic review that reported a negligible 
case fatality ratio in young children that climbed to 60% among the elderly 
(36). In Tanzania, Biggs reported death in hospital for 7% (95% 
confidence intervals 2-16%) of those with leptospirosis (34). This estimate 
of case fatality has two causes of bias that are likely to operate in opposite 
directions. Firstly, as they recruited patients from referral hospitals there 
was likely a selection bias towards more serious illness, and hence inflate 
the case-fatality ratio. However, perhaps of greater influence is their 
reliance on a four-fold rise in antibody titres between paired serum 
samples to confirm cases, as this precludes most decedents from 
diagnosis and may lower estimates of the case-fatality ratio. 
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1.4.4 Diagnosis of leptospirosis 
Despite being a common cause for fever in Tanzania, clinical diagnosis of 
leptospirosis is rare (34). This is due partly to clinicians in northern 
Tanzania (40) having low awareness of zoonotic disease and to diagnostic 
tests being unavailable. In any setting, leptospirosis is difficult to diagnose 
with certainty, and as discussed in detail in Chapter 10 of this thesis, no 
single test performs well for clinicians (41).   
 
Leptospira culture is unable to diagnose patients in a clinically meaningful 
timeframe, as Leptospira doubling time is between 10 hours and a few 
days under optimal conditions and detecting growth may take up to 13 
weeks. In addition, as leptospiraemia is transient and present during only 
the first week of illness, culture is an insensitive method of diagnosis.  As 
an example, one estimate of the sensitivity of culture compared to 
serologic diagnosis and PCR, was 10% (95% confidence intervals 3–28%) 
(41). 
 
MAT using paired serum samples collected during both the acute illness 
and convalescence is the reference standard for the diagnosis of 
leptospirosis. The sensitivity of MAT is approximately 80% and the 
specificity is over 95% (41-43). However, if MAT is performed using only a 
single serum sample collected during the acute phase of illness the 
sensitivity is much lower, possibly less than 10% of those diagnosed by 
culture (43). The low sensitivity of MAT during the acute phase of illness, 
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which is when patients present to clinicians, is a major limitation for 
immediate patient management decisions. In addition to the technical 
limitations of the reference tests, there are practical limitations to 
diagnostic testing for leptospirosis in Tanzania. Between them, culture, 
PCR and MAT require specialised culture media, expensive instruments, 
and maintenance of live leptospiral cultures. None of these test modalities 
are readily available currently to clinicians in district, or even referral 
hospital laboratories in Tanzania.  
 
1.4.5 Serovar, serogroup, and species identified among humans 
There are no typed isolates of Leptospira spp. from humans in Tanzania. 
Although Mgode and colleagues cultured Leptospira spp. from abattoir 
workers, the isolates were contaminated and lost prior to identification 
(21).  
 
There have been several serologic studies of human leptospirosis in 
Tanzania, which are summarised in Table 1.2. The published studies have 
employed MAT to characterise the serogroups of Leptospira infecting the 
population. With MAT, the serogroup to which an infecting serovar belongs 
may be inferred by identifying which serovar a patient’s serum contains 
antibodies at the highest titre. Cross-reactivity between serovars of the 
same serogroup is common, and cross-reactivity can also occur between 
serovars from different serogroups (42). Therefore, in most ecosystems it 
is not possible to identify the infecting serovar from MAT, and even 
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inferring to which serogroup the infecting serovar belongs must be done 
cautiously (44-46). In northern Tanzania, Biggs and colleagues utilised a 
MAT panel of 20 serovars from 17 serogroups. They identified that the 
highest antibody titres were most commonly to the Mini and Australis 
serogroups (34). Chipwaza et al investigated seroreactivity to Leptospira 
using an MAT panel of six serovars from six serogroups among 
hospitalised febrile children. They identified that the predominant 
serogroups in the Kilosa region were Icterohaemorrhagiae, Ballum, 
Grippotyphosa, and Hebdomadis, with reactivity to serogroup Australis 
uncommon (38).  Of note is that serogroup Mini was not represented in 
their MAT panel. Assenga and colleagues investigated leptospirosis 
among healthy villagers in the Katavi-Rukwa ecosystem by testing serum 
using a MAT antigen panel of seven serovars covering seven serogroups 
(24). They identified serogroup Sejroe as the most common. Serogroups 
Icterohaemorrhagiae and Grippotyphosa were also common. Serogroup 
Mini was again not represented in their MAT antigen panel.  
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Table 1.2 Patterns of dominant MAT serogroup reactivity among patients with leptospirosis, from published studies 
in Tanzania, until 2015  
Study Number with  Population MAT panel Most common serogroup reactivity 
 leptospirosis    % (95% CI) 
Biggs  70 Patients with 
fever 
Australis (represented by L. interrogans serovar Australis, L. interrogans serovar 
Bratislava), Autumnalis (L. interrogans serovar Autumnalis), Ballum (L. borgpetersenii 
serovar Ballum), Bataviae (L. interrogans serovar Bataviae), Canicola (L. interrogans 
serovar Canicola), Celledoni (L. weilii serovar Celledoni), Cynopteri (L. kirschneri 
serovar Cynopteri), Djasiman (L. interrogans serovar Djasiman), Grippotyphosa (L. 
interrogans serovar Grippotyphosa), Hebdomadis (L. santarosai serovar Borincana), 
Icterohaemorrhagiae (L. interrogans serovar Mankarso, L. interrogans 
Icterohaemorrhagiae), Javanica (L. borgpetersenii serovar Javanica), Mini (L. 
santarosai serovar Georgia), Pomona (L. interrogans serovar Pomona), Pyrogenes (L. 
interrogans serovar Pyrogenes, L. santarosai serovar Alexi), Sejroe (L. interrogans 


















Chipwaza 26 Patients with 
fever 
Australis (L. interrogans serovar Lora), Ballum (L. borgpetersenii serovar Kenya), 
Grippotyphosa (L. kirschneri serovar Grippotyphosa), Hebdomadis (L. interrogans 

















Assenga 96 Healthy 
villagers 
Australis (L. interrogans serovar Lora), Ballum (L. borgpetersenii serovar Kenya), 
Canicola (L. interrogans serovar Canicola), Grippotyphosa (L. kirschneri serovar 
Grippotyphosa), Hebdomadis (L. santarosai serovar Hebdomadis) Icterohaemorrhagiae 























Across the studies referenced in the preceding paragraph, there have 
been diverse serogroups to which people have been seroreactive. The 
variation in results may reflect the different compositions of the MAT 
panels, cross reactivity between serogroups, or varied exposure to 
serovars in different geographical locations and time periods. Therefore, it 
is possible that technical limitations of MAT may account for some of the 
variation in predominant serogroup reactivity, but it is also likely that 
leptospirosis ecology in Tanzania is complex, within multiple dynamic 
ecosystems. 
 
1.4.6 Risk factors for human leptospirosis 
Globally, there is variation in ecological and behavioural risk factors for 
human leptospirosis (47). In north America and Europe leptospirosis is 
associated with recreational water exposure (48). In South America there 
have been epidemics associated with rodent contact, heavy rainfall, and 
urban slum living (49-52), but among rural dwellers there has also been 
evidence of endemic leptospirosis associated with livestock contact (53). 
In South and Southeast Asia, risk factors for leptospirosis have included 
exposure to flood waters (54,55), rice farming, and rodents (42). Contact 
with livestock has been inconsistently associated with leptospirosis in Asia 
(47,54,55). 
 
There is very limited data on risk factors for leptospirosis in Tanzania (27, 
47, 56).  In northern Tanzania, Biggs identified that rural living was 
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associated with increased risk of leptospirosis (34), while in West Africa 
increased risk of contracting leptospirosis has been associated with cocoa 
farming and working in kennels or in abattoirs (47).  In Uganda, skinning 
cattle has been associated with increased risk of being Leptospira 
seropositive (57). Identification of the major sources of human infection is 
challenging, as the available studies come from disparate parts of Africa, 
have looked at specific segments of society, or have not investigated risk 
factors. Therefore, although the main risk factors for human leptospirosis, 
and infection sources are unknown, there is a suggestion that livestock 
may play a role in transmission of leptospirosis to humans. 
 
1.5 CONCLUSION 
From the limited published reports, it appears that leptospirosis may be a 
common cause of fever in Tanzania. The incidence of leptospirosis among 
people during 2007-08 was very high by international standards. People 
with leptospirosis in northern Tanzania had highest antibody titres to 
serovars from the Australis, Icterohaemorrhagiae, and Mini serogroups 
during 2007-08, but in different regions of Tanzania, in different years 
there were markedly different patterns of sero-reactivity. In livestock, 
particularly cattle, antibodies against Leptospira are common; L. kirschneri 
Sokoine, L. interrogans Grippotyphosa, and L. borgpetersenii Hardjobovis 
have been isolated. Among rodents, Rattus spp. have shown a low 
prevalence of Leptospira antibodies and have not been shown to shed 
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Leptospira. In contrast other rodents, notably the African giant pouched rat 
and the multimammate mouse, have been shown to shed Leptospira in 
their urine.  
 
There remain large gaps in the knowledge of Leptospira epidemiology in 
Tanzania. First, there are large variations in estimates of prevalence, and 
it is unclear whether variations in prevalence are due to different 
prevalence in different regions or changing rates of infection over time. 
Second, the impact of leptospirosis in humans and in their livestock has 
not been quantified. Risk factors for human infection in Tanzania are 
unknown, as are the sources of human infection, and the relevant 
reservoir hosts.  
1.6 THESIS AIMS 
This thesis aims to fill in many of the knowledge gaps identified above. 
The aims included to: 
1. Estimate the burden of human leptospirosis in northern Tanzania, 
2. Identify specific risk factors and likely sources of human 
leptospirosis in northern Tanzania  
3. Identify prevention strategies for leptospirosis in northern Tanzania 
Specific objectives and the chapter in which they are addressed are 
described in Table 1.3. 
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Table 1.3 PhD thesis specific objectives 
Specific objective Chapter  
1. Assess potential reservoir hosts of human leptospirosis 
through serovar, serogroup and species associations. 
2, 3, 9 
2. Determine the prevalence of leptospirosis among febrile 
patients in northern Tanzania.  
3 
3. Estimate the incidence of leptospirosis northern Tanzania 
and assess changes over time. 
4, 7 
4. Assess the burden of human leptospirosis in northern 
Tanzania. 
5, 8 
5. Identify ecological and behavioural risk factors associated 
with leptospirosis infection.  
6, 7 
6. Evaluate the performance in northern Tanzania of available 
point-of-care diagnostic tests for leptospirosis. 
10,11 
7. To develop strategies, including biomedical, structural and 
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Chapter 2. Host range of 
Leptospira species and 
serovars 
2.1 INTRODUCTION 
2.1.1 Reservoirs of infection 
A reservoir of an infectious disease may be defined according to a defined 
target population (1). For Leptospira, the target population could be either 
humans or animal species. A reservoir for Leptospira could therefore be 
defined as epidemiologically connected populations or environments in 
which Leptospira can be permanently maintained and from which infection 
is transmitted to humans or animals (1).  Non-human animals are 
considered to be the reservoir hosts of Leptospira (2). Humans are 
considered an incidental host and it is unlikely that they act as a reservoir 
of infection (3, 4). Leptospira can persist in water and soil but it is unclear 
if they can act as a reservoir (5). 
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2.1.2 Is there host specificity of Leptospira species or serovars? 
There are 15 pathogenic or intermediate pathogenicity species and more 
than 250 pathogenic serovars within the genus Leptospira (6). The 
taxonomic classification of species and serovars of Leptospira has 
important epidemiologic implications for both human and animal infection. 
Some serovars are particularly associated with some animal hosts and 
can persist in the renal and reproductive tracts of specific animal hosts. 
Well adapted serovars produce few clinical symptoms in host animals and 
have prolonged urinary shedding. Often cited examples of serovar-host 
associations include L. borgpetersenii serovar Hardjobovis and L. 
interrogans serovar Hardjoprajitno in cattle (7), L. interrogans serovar 
Bratislava and L. interrogans serova Pomona in pigs (8, 9), and Leptospira 
interrogans serovar Icterohaemorrhagiae in Norwegian rats (2).  Among 
the serovars listed above, there has not been a recent study 
systematically testing the hypothesis that serovars are maintained by a 
limited number of animal hosts. In addition, there are few publications on 
the possible host range of the large number of remaining serovars.  
 
As discussed in Chapter 1, the classification of serovar and species is 
independent and there are multiple instances of Leptospira of a single 
serovar belonging to more than one species, and vice versa. Despite this, 
serovar and species often form unique combinations. The recognition of 
the lipopolysaccharide in the Leptospira outer membrane by Toll-like 
receptor 4 appears critical to the serovar classification, and this in turn is 
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mediated by factors such as genome reduction (10, 11). Many bacteria 
with reduced genomes and minimal genetic sequence diversity are 
thought to have a limited potential host range (12). L. borgpetersenii is one 
example of a serovar that has a genome that has been reduced and is 
~700kb shorter than the genome for L. interrogans (11). The shortened 
genome is thought to be responsible for the reduced persistence in 
aquatic environments of L. borgpetersenii compared to L. interrogans (11). 
The link between outer-membrane and genome raises the potential of host 
specificity for both species and serovar of Leptospira. 
 
In addition to possible restrictions in reservoir host of varying serovars, 
there may be geographic restrictions to some serovars and species.  For 
example, serovar Pomona-Kennewicki is an important serovar among 
cattle in North America and Australasia, but not present in Europe (2, 13).  
Additionally, as studies of animal Leptospira infection extend into Africa, 
novel combinations of species and serovar have been identified (14, 15), 
again raising the possibility of geographical ranges of individual serovars.  
 
There have been recent narrative reviews that document possible host 
specificity for a handful of serovars (2, 16), but there have not been 
systematic investigations. While the authors of the cited recent narrative 
reviews have included widely acknowledged experts, such as Prof. W.A. 
Ellis, Prof B. Adler, and Prof. A. de la Pena Moctezuma who have many 
years of accumulated knowledge relating to Leptospira, any non-
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systematic review is still subject to bias. The last published attempt to 
systematically document the host and geographic range of Leptospira 
serovars was compiled by Dr. Galton of the US Centers of Disease 
Control and Prevention (CDC) in 1966 (17), with an update by Dr. Sulzer, 
also of the CDC, in 1975 (18). There have been major developments since 
1975, including substantial changes to taxonomy, with the re-classification 
of species (19), and the addition of multiple newly recognised serovars (6). 
In addition, there have been many additional studies over 40 years, 
isolating Leptospira from animal hosts across the globe, including in 
African countries (20, 21). While the distribution lists of Galton and Sulzer 
remain useful, the developments over the last 40 years mean an update is 
needed. Revolutionary changes in information technology, and the 
development of systematic review methods may identify additional reports 
that were not included in the historic distribution lists. 
 
2.1.3 Potential utility of host specificity for human and animal public 
health 
Lists of the host and geographic range of Leptospira species and serovars 
might inform epidemiologic investigations of leptospirosis in multiple ways. 
First, through determining serovar composition of microscopic 
agglutination testing (MAT) antigen panels for particular locations. MAT 
antigen panels should include serovars circulating in the area where the 
patient became infected (22). Currently there is no resource that allows 
ready identification of serovars isolated from a country or region.  Second, 
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lists of the geographic and animal host range of serovars could inform 
investigations of endemic and epidemic leptospirosis by identifying known 
local animal hosts of the relevant isolates.  Geographic and host range 
lists could help veterinary scientists decide serovar composition of 
multivalent Leptospira vaccines. 
 
2.1.4 Knowledge of the host range of Leptospira serovars could 
inform research into the epidemiology of leptospirosis in Tanzania 
Identifying potential reservoir hosts of specific Leptospira serovars is an 
aim of our work in Tanzania. During 2007-08, 16 (40%) of 40 patients 
diagnosed with acute leptospirosis had their highest titres of sero-reactivity 
to serogroup Mini (represented in our MAT antigen panel by L. santarosai 
serovar Georgia) (23). Despite people demonstrating sero-reactivity to 
serogroup Mini, no serovar from serogroup Mini has been isolated in 
Tanzania (20). Serogroup Mini has been isolated from humans in Mayotte 
(24), but not from animals or humans in continental Africa (21). Exploration 
of known animal hosts outside of Africa would inform attempts to locate 
the Tanzanian reservoir host and to investigate potential risk factors for 
human infection. During 2007-08, 13 (32.5%) of 40 participants diagnosed 
with acute leptospirosis had their highest titres of sero-reactivity to 
serovars from serogroup Australis. The only known animals hosts of 
serogroup Australis serovars in Africa are grass rats (Arvicanthus 
niloticus) in Nigeria, and cattle (Bos taurus) in Zimbabwe (21). Attempts to 
identify the reservoir hosts in Tanzania could be informed by knowledge of 
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which animals have been identified globally as hosts of serovars from 
serogroup Australis. 
2.1.5 Study aim 
The aims of this study were: 
1. To identify all reported animal hosts of Leptospira globally, to 
determine the host and geographic range of pathogenic Leptospira 
species and serovars. 
2. To investigate the host specificity of Leptospira species and 
serovars  
3. To identify possible reservoir hosts of the Leptospira serogroups to 
which people in Tanzania are sero-reactive. 
 
2.2. METHODS 
2.2.1 Registration of a systematic review 
A systematic review was undertaken following Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The 
review could not be registered with the International Prospective Register 
of Systematic Reviews (PROSPERO), as reviews of animals’ studies are 
ineligible (25). 
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2.2.2 Search Terms 
I chose, in conjunction with a University of Otago Clinical Librarian (Sarah 
Gallagher), search terms to identify all reports of Leptospira sp. identified 
to species or serovar level in non-human animals. We placed no limits or 
refinements on the search which was over all years and not limited by 
language. The search terms we used in one database (PubMed) are 
included in Figure 2.1. We modified our search terms slightly for other 
databases in order to meet the requirements of each database. In most 
databases the search was run as one search but in Scopus, database 







animal* OR mammal* OR reptil* OR bird* OR avian OR amphibian*  
AND 
Abramis OR Agogo OR Aguaruna OR Alexi OR Alice OR Altodouro OR Andamana OR Anhoa OR Arborea OR 
Arenal OR Argentinensis OR Atchafalaya OR Atlantae OR Australis OR Autumnalis OR Babudieri OR Bafani OR 
Bajan OR Bakeri OR Balboa OR Balcanica OR Ballum OR Bangkinang OR Banna OR Bataviae OR Benjamini 
OR Beye OR Biggis OR Bim OR Bindjei OR Birkini OR Bogvere OR Borincana OR Brasiliensis OR Bratislava 
OR Bravo OR Broomi OR Buenos Aires OR Bulgarica OR Butembo OR Camlo OR Canalzonae OR Canicola 
OR Caribe OR Carimagua OR Carlos OR Castellonis OR Celledoni OR Ceylonica OR Chagres OR Claytoni OR 
Copenhageni OR Copenhageni OR Corredores OR Costa Rica OR Coxi OR Cristobali OR Cuica OR Cynopteri 
OR Dadas OR Dakota OR Darien OR Dehong OR Dikkeni OR Djasiman OR Djatzi OR Erinaceiauriti OR Evansi 
OR Fluminense OR Fortbragg OR Fugis OR Galtoni OR Gatuni OR Gem OR Gengma OR Georgia OR 
Geyaweera OR Goiano OR Gorgas OR Grippotyphosa OR Guangdong OR Guaratuba OR Guaricura OR 
Guidae OR Gurungi OR Haemolytica OR Hainan OR  Hamptoni OR Hardjo OR Hawain OR Hebdomadis OR 
Hekou OR Holland OR Hongchon OR Hualin OR Huallaga OR Huanuco OR Hurstbridge OR 
Icterohaemorrhagiae OR Istrica OR Jalna OR Javanica OR Jonsis OR Jules OR Kabura OR Kambale OR 
Kamituga OR Kanana OR Kaup OR Kenya OR Khorat OR Kisuba OR Kobbe OR Kremastos OR Kunming OR 
Kuwait OR Kwale OR Lai OR Lambwe OR Langati OR Lanka OR Lichuan OR Lincang OR Lora OR Losbanos 
OR Louisiana OR Luis OR Machiguenga OR Malaya OR Malaysia OR Mangus OR Manhao OR Manilae OR 
Mankarso OR Manzhuang OR Maru OR Medanensis OR Mengding OR Mengla OR Menglian OR Mengma OR 
Mengpeng OR Mengrun OR Menoni OR Mini OR Mogden OR Mooris OR Mozdok OR Muelleri OR Muenchen 
OR Mujunkumi OR Mwogolo OR Myocastoris OR Naam OR Nanla OR Navet OR Ndahambukuje OR Ndambari 
OR Nicaragua OR Nigeria OR Nona OR Nyanza OR Orleans OR Paidjan OR Panama OR Patoc OR Perameles 
OR Peru OR Peruviana OR Pina OR Pinchang OR Poi OR Polonica OR Pomona OR Portblairi OR Portlandvere 
OR Princestown OR Proechimys OR Pyrogenes OR Qingshui OR Rachmati OR Rama OR Ramisi OR Ranarum 
OR Ratnapura OR Recreo OR Ricardi OR Rio OR Rioja OR Robinsoni OR Roumanica OR Ruparupae OR 
Rushan OR Sanmartini OR Santarosa OR Saopaulo OR Sarmin OR Saxkoebing OR Schueffneri OR Sejroe OR 
Semaranga OR Sentot OR Shermani OR Sichuan OR Smithi OR Sofia OR Sokoine OR Sorexjalna OR 
Soteropolitana OR Srebarna OR Sulzerae OR Sumneri OR Szwajizak OR Tabaquite OR Tarassovi OR 
Tingomaria OR Tonkini OR Topaz OR Trinidad OR Tropica OR Tsaratsovo OR Tunis OR 
 Valbuzzi OR Vanderhoedeni OR Varela OR Vargonicas OR Varillal OR Vughia OR Waskurin OR Weaveri OR 
Weerasinghe OR Whitcombi OR Wolffi OR Worsfoldi OR Yaan OR Yeonchon OR Yunnan OR Yunxian OR 
Zanoni OR Zhenkang OR serovar* OR serogroup* OR serotype* 
 
 37 
Figure 2.1 Search terms used in PubMed to identify reports of 
detection or isolation of Leptospira from animals 
Footnote: The symbol * is a wildcard symbol enabling detection of any 
suffix.  
2.2.3 Databases  
The following databases were searched: Medline, Scopus, Web of 
Science, BIOSIS, CAB abstracts, Wildlife and Ecology Studies Worldwide, 
Proquest Agricultural Science Collection, Zoological Record, PubMed, 
Cabdirect (Cab Abstracts), which includes Aquaculture Compendium, 
CABI Full Text, Global Health and Leisure Tourism. In addition, we 
searched the Royal Dutch Tropical Institute (KIT) Leptospira strain library 
(now called the Amsterdam Medical Centre Leptospira library) for 
information on reference strain provenance (26). 
2.2.4 Winnowing Strategy 
All database hits were exported to Endnote X7.4 (Thomson Reuters, 
Toronto, Canada) for winnowing. To be considered eligible, papers were 
required to meet the following inclusion and exclusion criteria: 
 
Inclusion 
1. Be a report of Leptospira spp. infection in a non-human host. 
2. Utilise either culture or molecular diagnosis of Leptospira spp. 





1.  All papers in which animals have been experimentally infected. 
2.  All papers in which there is not a description of the methodology 
used to identify serovar or species. 
 
 
Methods that we considered acceptable for identifying serovar and 
species are shown in Table 2.1. I determined which criteria were 
acceptable by considering recommendations from reference texts and 
recent review articles (6, 27-34). Cross agglutination absorption testing 
(CAAT) is the reference standard test for distinguishing serovars and 
identifying novel serovars (29). Monoclonal antibody typing and factor 
analysis are both capable of distinguishing known serovars (35). 
Microscopic agglutination testing (MAT) is able to differentiate isolates to 
serogroup level but there is often cross-agglutination with serovars from 
within a serogroup (32). As MAT antigen panels usually contain only a 
limited number of serovars from a serogroup, I considered it insufficiently 
reliable for serovar determination.  No serologic technique is able to 
differentiate Leptospira species (32). Conversely DNA based techniques 
can differentiate species, but not serovar. DNA-based techniques that 
identify genetic differences to a high resolution can distinguish strains of 
Leptospira, and in appropriate circumstances serovar may be inferred. 
DNA-DNA hybridisation has been the reference standard for differentiating 
species, although it is now uncommonly used due to technological 
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advances (33). Pulsed-field gel electrophoresis (PFGE), and bacterial 
restriction endonuclease DNA analysis (BRENDA) are techniques that 
separate strains by comparing how bacterial DNA is digested by restriction 
enzymes, on agarose or acrylamide gels. They have been reliable at 
identifying most serovars, with some exceptions such as the inability of 
PFGE to distinguish serovar Icterohaemorrhagiae from serovar 
Copenhageni (36-38). BRENDA profiles can be simplified by use of 
southern blotting (34). Multi-locus sequence typing (MLST), and multi-
locus variable number of tandem repeats analysis (MLVA) is able to 
segregate strains and characterise relationships between strains. Three 
main MLST schemes are able to differentiate most Leptospira serovars 
(39-41). Insertion sequences vary considerably between species, and 
between serovars within the same species. As such they have been used 
successfully to distinguish serovars (42). Sequencing and phylogeny of 
single or multiple genes has been able to differentiate Leptospira species, 
and sometimes serovar (43, 44). Whole genome sequencing is capable of 
very high resolution of bacterial strains, and there are recent reports that it 
has been used to differentiate Leptospira species and serovar (45). As 
many reporting authors sent isolates to reference laboratories for 
characterisation, and were unable to report their methods, we included 
articles in which the authors did not report exact methods, but instead 
reported sending their isolates to reference laboratories that had 
themselves published Leptospira serovar or species determination using 
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acceptable methods. The reference laboratories included are also shown 
in Table 2.1. 
 
Eligibility was determined as a two-stage process. First, I reviewed all titles 
and abstracts and those titles and abstracts of papers that were possibly 
eligible were passed for full-text review. Full-text reviews were undertaken 
by two independent reviewers (one of Dr S. Cash-Goldwasser, Dr. B. 
Cossic, Dr. M. Carugati, Dr. E. Demeter, or Dr. N. Sulikhan, and I). Any 
papers with discrepant eligibility assessments were reviewed by a third tie-
breaking reviewer (Prof. J.A. Crump).  
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Table 2.1 Acceptable methods of determining serovar or species 
during systematic review of Leptospira host and geographic range, 
2015 
Classification Method 
Serovar Serological Methods 
 Cross-absorption agglutinin test 
 Monoclonal antibody typing 
 Serum factor analysis 
 Molecular Methods 
 Bacterial restriction-endonuclease DNA analysis (BRENDA) 
 Insertion sequence typing 
 Multi-locus sequence typing (MLST) 
 Multilocus variable number of tandem repeats analysis (MLVA) 
 Pulsed-field gel electrophoresis (PFGE) 
 Sequencing and phylogeny on rRNA encoding genes, secY or lfb1 
 Southern-blot hybridisation 
 Whole genome sequencing 
  
Species Molecular methods 
 DNA-DNA hybridisation 
 Genotyping: 16S, rpoB, flaB. 
 Insertion sequence (IS1500-1502), 
 Multi-locus variable number of tandem repeats analysis (MLVA) 
 Multi-locus sequence typing (MLST) 
 Pulsed-field gel electrophorsesis (PFGE) 
 Sequencing and phylogeny on rRNA encoding genes, secY or lfb1 
 Variable number of tandem repeats (VNTR)  




Identification by a listed reference laboratory 
 Central Veterinary Laboratory, Weybridge, United Kingdom 
 Komensky University Laboratory, Bratislava, Czechoslovakia 
 Leptospira Reference Laboratory, London School of Hygiene and 
Tropical Medicine, UK 
 National Vaccine Institute, Bucharest, Romania 
 Pan-American Zoonosis Institute, Buenos Aires, Argentina 
 Queensland Leptospirosis Reference Laboratory, Brisbane, 
Australia 
 Regional Medical Research Centre Leptospirosis Laboratory, Port 
Blair, India 
 Royal Dutch Tropical Institute, Amsterdam, Netherlands 
 Sent to Superior Institute of Health, Rome, Italy 
 The laboratory of Drs. Wolff and Borgpetersen, Copenhagen, 
Denmark 
 US Centres for Disease Control and Prevention, Atlanta, United 
States of America 
 US National Veterinary Laboratory, Ames, United States of America 
 Walter Reed Army Medical Institute, Washington, United States of 
America 
 WHO Collaborating Laboratory, Israel 
 WHO/FAO Leptospirosis Reference Laboratory, London, United 
Kingdom 
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2.2.5 Data Extraction 
Data were extracted into the online web database Airtable 
(www.airtable.com, San Francisco, United States of America) to record the 
year of collection; the country and other location data of the infected 
animal; the common name and scientific name of the infected animal; the 
number, age and health status of infected animals; the organ or body fluid 
from which the Leptospira was identified; the methods used for 
determination of species and serovar; and the Leptospira species and 
serovar. 
2.2.6 Analysis 
We generated summary tables of the data, divided by geographic area 
and serogroup. To be concise, in this thesis I have not also generated 
tables summarising serovars by animal species. Our goal is to make our 
database available online so that researchers can interrogate and filter the 
data by any variable. Within each serogroup table, serovars were listed 
alphabetically. Within each serovar sub-table, isolations are alphabetically 
ordered by the scientific name of the animal host. When only the scientific 
name of an animal was listed, or the animal common name varied from 
other publications, the animal common names listed in our tables were 
sourced from Wikipedia (www.wikpedia.org, Wikimedia Foundation, St 
Petersburg, United States of America). Animal scientific names were 
inferred from animal common names for livestock species, and for animal 
common names which describe a single species.  
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2.3 RESULTS 
2.3.1 Search results 
The database search was performed over two days on the 28th and 31st of 
August 2015.  We identified 24,855 articles, of which 8,546 were unique. 
The results of individual searches are recorded in Table 2.2. 
 
Table 2.2 Results of searches for reports of  Leptospira detection 
among non-human animals in medical, veterinary, and zoological 
scientific databases, 28 and 31 August 2015 
Date Database Results  
28Aug15  BIOSIS via Web of Science 4,216  
31Aug15 CAB Direct  1,851 
31Aug15 CAB: Abramas-Ballum 398 
31Aug15 CAB: Bangkinan-Butembo 245 
31Aug15 CAB: Camlo -Cynopteri 550 
31Aug15 CAB: Dadas-Hainan 363 
31Aug15 CAB: Hamtoni-Hurstbridge 410 
31Aug15 CAB: Icterohaemorrhagiae-Kwale 574 
31Aug15 CAB: Lai-Mankarso 184 
31Aug15 CAB: Manzhuang-Ndahambukuje 37 
31Aug15 CAB: Ndambari - Pyrogenes 606 
31Aug15 CAB: Qingshui- Semaranga 225 
31Aug15 CAB: Sentot-Tunis 198 
31Aug15 CAB: Valbuzzi-serotype* 1,457 
28Aug15 Medline  2,289 
28Aug15 Proquest Agricultural Science 1,113 
28Aug15 PubMed 2,704 
28Aug15 Scopus: Abramas-Ballum 465 
28Aug15 Scopus: Bangkinan-Caribe 136 
28Aug15 Scopus: Carimagua-Djatzi 13 
28Aug15 Scopus: Erinaceiauriti – Hainan 434 
28Aug15 Scopus: Hamptoni-Kenya 1,138 
28Aug15 Scopus: Khorat – Mankarso 200 
28Aug15 Scopus: Manzhuang – Ndahambukuje 62 
28Aug15 Scopus: Ndambari – Pyrogenes 881 
28Aug15 Scopus: Qingshui – Semaranga 237 
28Aug15 Scopus: Sentot – Tunis 219 
28Aug15 Scopus: Valbuzzi – serotype* 2,198 
28Aug15 Web of Science Core Collection 872 
28Aug15 Wildlife and Ecology Studies 194 
28Aug15 Zoological Record via Web of Science 385 
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2.3.2 Article winnowing 
The flow diagram of article winnowing is shown as Figure 2.2. Of 8,378 
articles, 1,486 (17.7%) passed title and abstract review and required full-
text review. Of 1,486 articles for full-text review, we completed review of 
1,317 (88.6%), with 79 (5.4%) articles unable to be located, and 90 (8.4%) 
of articles unable to be translated. The articles requiring full-text review 
were published between 1917 and 2015. The language in which the 





Figure 2.2 Flow diagram of the article review process for a 




Table 2.3 Written language of articles requiring full-text review during 
systematic review of host and geographic range of Leptospira, 2015 
 Number of articles for full-
text review  
Number of articles unable to be 
reviewed  
Language N=1486 N=166 
 n (%) n (%) 
Afrikaans 1 (0.1) 0 (2.4) 
Bulgarian 7 (0.5) 4 (0.0) 
Chinese 28 (1.9) 0 (0.0) 
Croatian 8 (0.5) 0 (4.2) 
Czech 7 (0.5) 7 (5.4) 
Dutch 10 (0.7) 9 (21.7) 
English 1037 (69.8) 36 (1.8) 
French 55 (3.7) 3 (1.2) 
German 47 (3.2) 2 (0.6) 
Hebrew 1 (0.1) 1 (1.2) 
Hungarian 3 (0.2) 2 (0.6) 
Italian 14 (0.9) 1 (1.8) 
Japanese 3 (0.2) 3 (1.2) 
Korean 2 (0.1) 2 (0.0) 
Norwegian 1 (0.1) 0 (4.2) 
Polish 8 (0.5) 7 (4.2) 
Portuguese 39 (2.6) 7 (1.8) 
Romanian 13 (0.9) 3 (10.2) 
Russian  87 (5.9) 17 (0.6) 
Serbian 4 (0.3) 1 (1.2) 
Slovakian  2 (0.1) 2 (9.0) 
Spanish 63 (4.2) 15 (0.6) 
Swedish 2 (0.1) 1 (0.0) 
Turkish 1 (0.1) 0 (0.6) 
Vietnamese 1 (0.1) 1 (25.3) 
Unknown 43 (2.9) 42 (2.4) 
 
2.3.3 Summary of included articles 
We included 490 articles, published from 1927 through August 2015, with 
data about serovar or species determination of 206 Leptospira serovars, 
and 11 species. These reports were from 176 animals where animal 
genus and species were identifiable, and an additional nine for which the 
genus only was recorded. The reports included data from 80 countries. In 
462 (94.3%) of 490 studies Leptospira serovar or species was determined 
from cultured isolates. In 28 (5.7%) studies serovar or species was 
determined by PCR product without culture. 
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2.3.3.1 Host and geographic range of pathogenic Leptospira species 
and serovars 
The host animal, and country of origin of each serovar, are grouped 
according to serogroup, and displayed in Tables 2.4 through 2.27. The 
host animal and country of origin for Leptospira species are shown in 
Tables 2.28 through 2.38. The Leptospira species tables contain 
information only on isolates that underwent species determination, and 
those with presumptive species identification based on serovar 
determination are not included. Figures 2.3 through 2.8 show the 
geographic distribution of Leptospira species, including those typed, and 
those with presumptive retrospective identification based on serovar 
determination. 
 
2.3.3.2 Application of the database to identifying potential reservoirs 
of Leptospira in Tanzania 
2.3.3.2.1 Hosts of serovars from Mini and Australis serogroups  
During previous studies of leptospirosis in northern Tanzania, people 
admitted with fever most commonly had their highest Leptospira antibody 
titres to serogroups Mini and Australis. Serovars from serogroup Mini have 
been isolated from 13 animal species, including livestock and rodents, and 
from nine countries, of which six were on the American continents or 
Caribbean (Brazil, Mexico, Panama, Peru, Trinidad, and the United States 
of America), and three were not (Australia, Bulgaria and Israel). The 
geographically closest isolations are from Israel, where serovar Swajizak 
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was isolated from hedgehog (Erinaceus europaeus), house mice (Mus 
musculus), and black rats (Rattus rattus). Serovars from Australis 
serogroup have been isolated from 47 animal species, including livestock, 
rodents, and amphibians. The isolations of serovars from serogroup 
Australis have occurred from animals in 40 countries. 
 
2.3.3.2.2 Typed isolations of Leptospira from Africa 
We identified 25 serovars that have been isolated from animals in Africa, 
including: Australis, Balcanica, Ballum, Canicola, Fugis, Grippotyphosa, 
Hardjo (sub-type not specified), Hardjobovis, Icterohaemorrhagiae, Kenya, 
Kuwait, Kwale, Lambwe, Marondera, Mhou, Mombe, Mozdok, Ngavi, 
Nigeria, Paidjan, Pomona, Pyrogenes, Ratnapura, Sokoine, and 
Zimbabwe. We found reports of detection of only three Leptospira species: 
L. borgpetersenii, L. interrogans, and L. kirschneri. Leptospira kirschneri 
was the most frequently detected species (10 reports), with L. 
borgpetersenii (nine), and L. interrogans (five) reported less commonly. 
Twenty-seven (64.3%) of 42 reports are of isolation of Leptospira from 
cattle, with five (11.9%) from Rattus species. There have been only single 
reports of isolation from pigs, and dogs, and no report of isolation of 
Leptospira from goats in Africa. The remaining Leptospira detections were 
in rodents other than Rattus species, including Arvicanthus niloticus, 
Cricetomys gambianus, Mus musculus, Rattus norvegicus, Rattus rattus 
Saccostomus campestris, Sus scrofa domesticus, and Tatera robusta. 
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Table 2.4 Animal host range of Leptospira serovars from the Australis serogroup from non-human animals published 
prior to 28-31 August 2015 
Australis 
Animal host Scientific name Countries References 
Brown field rat Arvicanthus niloticus Nigeria (46) 
Cattle Bos taurus Japan, Malaysia (47-51) 
Horse Equus caballus Philippines (52) 
Hedgehog Erinaceus europaeus Belgium, Italy, Israel (53-55) 
Indian mongoose Herpestes auropunctatus Guadeloupe (56) 
Northern brown bandicoot Isoodon macrourus Australia (57) 
House mouse Mus musculus Australia (57) 
Nutria Myocastor coypus Taiwan (58) 
South American water rat Nectomys squamipes Brazil (59) 
Pampas deer Ozotoceros bezoarticus Brazil (60) 
Long-nosed bandicoot Perameles nasuta Australia (57) 
Raccoon Procyon lotor USA (61, 62) 
Bush rat Rattus fuscipes Australia (57, 63) 
Cape York rat Rattus leucopus Australia (63) 
Muller's giant sunda rat Rattus muelleri Malaysia (64) 
Norwegian rat Rattus norvegicus American Samoa, United States of America (Hawai’i) (65, 66) 
Black rat Rattus rattus Australia (57) 
Canefield rat Rattus sordidus Australia (63) 
Dusky field rat Rattus sordidus conatus Australia (57) 
Rat species Rattus spp. Australia, Taiwan (58, 63, 67) 
Giant white-tailed rat Uromys caudimaculatus Australia (63) 
Giant naked-tailed rats Uromys spp. Australia (68) 
"Field rats" or "rodents" Not stated Australia, Poland, Thailand, United States of America (69-73) 
 
Bajan 
Animal host Scientific name Countries References 
Giant marine toad Bufo marinus Barbados (74) 





Animal host Scientific name Countries References 
Domestic dog Canis lupus familiaris Thailand (76) 
 
Bratislava 
Animal host Scientific name Countries References 
Yellow neck field mouse Apodemus avicollis Croatia (77) 
Woodmouse Apodemus sylvaticus Croatia (77) 
Domestic dog Canis lupus familiaris USA (78) 
Horse Equus caballus Austria, Germany, Italy, Luxembourg, the Netherlands, Northern 
Ireland, Portugal, Switzerland, United Kingdom (not specified) 
(79-84) 
Hedgehog Erinaceus europaeus England, Italy, Northern Ireland, the Netherlands, Wales (53, 83, 85, 86) 
European hedgehog Erinaceus europaeus roumanicus Bulgaria, Russia (87) 
Sheep Ovis aries England, Northern Ireland (83, 88) 
Norwegian rat Rattus norvegicus Northern Ireland (83) 





Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (15) 
 
Hawain 
Animal host Scientific name Countries References 
Bandicoot Echymipera kalabu Papua New Guinea (97) 
 
Jalna 
Animal host Scientific name Countries References 
Yellow necked woodmouse Apodemus flavicollis Bulgaria, Croatia, Czechoslovakia (87, 97, 98) 
Broad toothed field mouse Apodemus mystacinus Bulgaria (87) 
Woodmouse Apodemus sylvaticus Bulgaria, Croatia, Poland (87, 98, 99) 
European water vole Arvicola terrestris Poland (99) 
Common shrew Sorex araneus Poland (99) 





Animal host Scientific name Countries References 
Yellow necked woodmouse Apodemus flavicollis Bulgaria, Croatia (87, 100) 
Broad-toothed field mouse Apodemus mystacinus Georgia (101) 
Wood mouse Apodemus sylvaticus Bulgaria, Georgia (102, 103) 
Bank vole Clethrionomys glareolus Croatia (104) 
Horse Equus caballus 
Austria, Germany, Italy, Luxembourg, the Netherlands, Portugal, 
Switzerland, United Kingdom 
(82, 105) 
Common vole Microtus arvalis Bulgaria (87, 103) 
House mouse Mus musculus Bulgaria (103) 
Muskrat Ondatra zibethicus Netherlands (106) 
Black rat Rattus rattus Bulgaria (87) 
Domestic pig Sus scrofa domesticus Netherlands (107) 
 
Muenchen 
Animal host Scientific name Countries References 
Yellow-necked field mouse Apodemus avicollis Croatia, England (77, 83) 
Woodmouse Apodemus sylvaticus Croatia (77) 
Cattle Bos taurus Brazil (108) 
Domestic dog Canis lupus familiaris France (108) 
Bank vole Clethrionomys glareolus England (83, 109) 
Horse Equus caballus 
Austria, Germany, Italy, Luxembourg, the Netherlands, Northern 
Ireland, Portugal, United Kingdom  
(79, 110) 
Short tailed vole Microtus agrestis England (83, 109) 
Grey squirrel Sciurus carolinensis Wales (83) 
Domestic pig Sus scrofa domesticus England, Northern Ireland (83, 91-93, 111, 112) 
 
Nicaragua 
Animal host Scientific name Countries References 
Weasel Mustela nivalis Nicaragua (97, 113) 
 
Peruviana 
Animal host Scientific name Countries References 
Cattle  Bos taurus Peru (97) 





Animal host Scientific name Countries References 
Oriental fire-bellied toad Bombina orientalis China (97) 
 
Soteropolitana 
Animal host Scientific name Countries References 
Brazilian guinea pig Cavia aperea Brazil (115) 
Hairy tailed akodon Zygodontomys lasiurus Brazil  
 
Table 2.5 Animal host range of Leptospira serovars from the Autumnalis serogroup from non-human animals 
published prior to 28-31 August 2015 
Autumnalis 
Animal host Scientific name Countries References 
Japanese field mouse Apodemus speciosus Japan (47) 
Lesser bandicoot rat Bandicota bengalensis India, Thailand (116, 117) 
Cattle Bos taurus Japan (47, 48) 
Giant marine toad Bufo marinus Trinidad (114, 118) 
Raccoon Procyon lotor USA (119) 
Rat Not stated Thailand (69, 70, 72) 
Black rat Rattus rattus Barbados, India, Thailand (117, 120-122) 
 
Bim 
Animal host Scientific name Countries References 
Giant marine toad Bufo marinus Barbados (74, 123) 
Domestic dog Canis lupus familiaris Barbados (124) 
Whistling frog Eleutherodactylus johnstonei Barbados (74, 75) 
House mouse Mus musculus Barbados (125) 




Animal host Scientific name Countries References 
Black rat Rattus rattus mindanensis Taiwan (127) 
 
Carlos 
Animal host Scientific name Countries References 
Giant marine toad Bufo marinus Philippines (97) 
 
Erinaceiauriti 
Animal host Scientific name Countries References 
Hedgehog Erinaceus europaeus Russia (97) 
 
Fort Bragg 
Animal host Scientific name Countries References 
Lesser Indian mongoose Herpestes auropunctatus Barbados (121, 128) 
Norwegian rat Rattus norvegicus Barbados (121) 
Black rat Rattus rattus Barbados (121, 129) 
Black rat Rattus rattus frugivorus Barbados (121) 
Rat Rattus spp. Barbados (128) 
 
Lambwe 
Animal host Scientific name Countries References 
Unstriped grass rat Arvicanthus niloticus Kenya (130) 
 
Mooris 
Animal host Scientific name Countries References 
Black rat Rattus rattus mindanensis Taiwan (127) 
 
Mujunkumi 
Animal host Scientific name Countries References 
Long eared hedgehog Hemiechinus auritis Kazakhstan (97) 
 
Srebarna 
Animal host Scientific name Countries References 
Common shrew Sorex araneus Bulgaria (97) 
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Table 2.6 Animal host range of Leptospira serovars from the Ballum serogroup from non-human animals published 
prior to 28-31 August 2015 
Arborea 
Animal host Scientific name Countries References 
Wood mouse Apodemus sylvaticus Italy (97) 
Hedgehog Erinaceus europaeus Italy (53) 
House mouse Mus musculus Argentina, Azores, Barbados (125, 131-134) 
Algerian Mouse Mus spretus Portugal (131) 
Rat Rattus spp. Australia (135) 
Norwegian Rat Rattus norvegicus Argentina, Azores, Barbados, Portugal (126, 131, 134) 
Black Rat Rattus rattus Azores, Barbados, Israel (126, 131-133, 136) 





Animal host Scientific name Countries References 
Montane grass mouse Akodon arviculoides Brazil (137) 
Brown field rat Arvicanthus niloticus Nigeria (46) 
Short tailed shrew Blarina brevicauda brevicauda United States of America (138) 
Cattle Bos taurus Malaysia, New Zealand (50, 139) 
Domestic dog Canis lupus familiaris United States of America (140) 
Baretailed woolly opossum Caluromys philander trinitatis Trinidad (114, 118) 
Virginia opossum Didelphus virginiana United States of America (141, 142) 
Common Opossum Didelphis marsupialis United States of America (62, 143-145) 
Hedgehog Erinaceus europaeus Israel, New Zealand (146, 147) 
Wildcat Felis rufa United States of America (62) 
Small Indian mongoose Herpestes auropunctatus United States of America (148) 
Eastern hog-nosed snake Heterodon platyrhinus United States of America (144) 
Striped skunk Mephitis mephitis United States of America (62, 145, 149-152) 
Meadow vole Microtus pennsylvanicus United States of America (153) 
House mouse Mus musculus Brazil, Denmark, Guadeloupe, Mexico, New Zealand, Trinidad, 
United States of America 
(56, 59, 118, 142, 144, 146, 
148, 154-159) 
Deer mouse Peromyscus maniculatus United States of America (144) 
Oldfield mouse Peromyscus polionotus United States of America (156) 
Gray four-eyed opossum Philander opossum Brazil (59) 
Raccoon Procyon lotor United States of America (62) 
Polynesian rat Rattus exulans United States of America (148, 159) 
Norwegian rat Rattus norvegicus Israel, Italy, New Zealand, Puerto Rico, Spain, United States of 
America 
(146, 148, 155, 157, 160-
164) 
Black rat Rattus rattus Israel, Grenada, New Zealand, Trinidad, United States of America (114, 118, 136, 148, 155, 
157, 159, 163) 
Rat species Rattus spp. Canada, New Zealand (165, 166) 
Gray fox    





Animal host Scientific name Countries References 
Wood mouse Apodemus sylvaticus Spain (97) 
Cattle Bos taurus Chile (168) 
White eared opossum Didelphis albiventris Brazil (169) 
House mouse Mus musculus Barbados (121) 
Sheep Ovis aries Argentina (170) 
 
Guangdong 
Animal host Scientific name Countries References 
Lesser rice field rat Rattus losea China (97) 
 
Kenya 
Animal host Scientific name Countries References 
Giant pouched rat Cricetomys gambianus Tanzania (171) 





Table 2.7 Animal host range of Leptospira serovars from the Bataviae serogroup from non-human animals published 
prior to 28-31 August 2015 
Argentinensis 
Animal host Scientific name Countries References 
‘Peludo’ armadillo Choetophractus villotus Argentina (172-174) 
 
Balboa 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (113) 
 
Bataviae 
Animal host Scientific name Countries References 
Striped field mouse Apodemus agrarius Croatia (77) 
European water vole Arvicola terrestris Bulgaria (175) 
Big hairy "Peludo" armadillo Chaetophractus villosus Argentina (172) 
Domestic cat Felis catus Indonesia (176) 
Rat species Rattus spp. Philippines, Taiwan, Thailand (67, 177, 178) 
Rats' or 'rodents' Not stated Poland, Thailand (69-72) 
Muller's giant sunda rat Rattus muelleri Malaysia (179) 
Norwegian rat Rattus norvegicus Vietnam (180) 
Black Rat Rattus rattus Malaysia (181) 
Andaman rat Rattus sabanus Malaysia (179) 
Pig Sus scrofa domesticus Peru (182) 
 
Brasiliensis 
Animal host Scientific name Countries References 
Common opossum Didelphis marsupialis Brazil (183) 
Small Indian mongoose Herpestes auropunctatus Grenada (114) 





Animal host Scientific name Countries References 
Indian Mongoose Herpestes auropunctatus Puerto_Rico (160) 
House Mouse Mus musculus Puerto_Rico (160) 
Black rat Rattus rattus Puerto_Rico (160) 
 
Claytoni 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (113) 
 
Kobbe 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (184) 
Pig Sus scrofa domesticus Peru (185) 
 
Losbanos 
Animal host Scientific name Countries References 
Norwegian rat Rattus norvegicus Philippines (186) 
Asian house rat Rattus tanezumi Philippines (186) 
Rat Not stated Philippines (187) 
 
Paidjan 
Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (15, 188) 
‘Peludo’ armadillo Chaetophractus villosus Argentina (172, 174) 
Opossum Didelphis azarae Argentina (189) 
Nutria Myocastor coypus USA (190) 
 
Rioja 
Animal host Scientific name Countries References 




Table 2.8 Animal host range of Leptospira serovars from the Canicola serogroup from non-human animals published 
prior to 28-31 August 2015 
Benjimani 
Animal host Scientific name Countries References 
Polynesian rat Rattus exulans Malaysia (179) 
 
Bindjei 
Animal host Scientific name Countries References 
Fawn-footed mosaic-tailed rat Melomys cervinipes Australia (68) 
Papua grassland mosaic-
tailed rat 
Melomys lutillus Australia (57) 
 
Broomi 
Animal host Scientific name Countries References 
Northern brown bandicoot Isoodon macrourus Australia (57) 





Animal host Scientific name Countries References 
‘Peludo’ armadillo Akodon azarae Argentina (192) 
Cattle Bos taurus Argentina, Brazil, Iran, Malaysia, United States of America (49, 50, 193-199) 
Asiatic red bellied squirrels Callosciurus erythraeus Argentina (200) 
Iberian wolf Canis lupus Spain (201) 
Domestic dog Canis lupus familiaris Abkhazia, Argentina, Brazil, France, India, Indonesia, Italy, Japan, 
Netherlands, Russia, South Africa, Taiwan, United States of 
America 
(118, 202-224) 
Armadillo Chaetophractus villosus Argentina (174) 
Hog nosed skunk Conepatus semistriatus Nicaragua (225) 
White eared opossum Didelphis albiventris Argentina (195) 
Hedgehog Erinaceus europaeus Israel (55, 147) 
Domestic cat Felis catus Trinidad (118, 204) 
Long-eared hedgehog Hemiechinus auritus Israel (147) 
Small Indian mongoose Herpestes auropunctatus Trinidad (114, 118) 
Striped skunk Mephitis mephitis United States of America (150, 151, 226) 
Rat Rattus spp. Taiwan (67) 
Polynesian rat Rattus exulans Malaysia (179) 
Norwegian rat Rattus norvegicus Brazil (227, 228) 
Black rat Rattus rattus Egypt (229) 
Eastern spotted skunk Spilogale putorious Nicaragua (225) 
Domestic pig Sus scrofa domesticus Peru, South Africa, Sri Lanka, United States of America (219, 230-232) 
Gray fox Urocyon cinereoargenteus Nicaragua (225) 
Weasel Not stated Argentina (193) 
 
Galtoni 
Animal host Scientific name Countries References 
Cattle Bos taurus Argentina (233) 
 
Kuwait 
Animal host Scientific name Countries References 
Norwegian rat Rattus norvegicus Kuwait, Madagascar (97, 234) 





Animal host Scientific name Countries References 
Cattle Bos taurus Argentina (195) 
Domestic dog Canis lupus familiaris Argentina, Trinidad (118, 204, 205) 
 
Schuffneri 
Animal host Scientific name Countries References 
Bat Cynopterus spp. Indonesia (97) 
Polynesian rat Rattus exulans Malaysia (179) 
Red spiny rat Rattus rajah Malaysia (116) 
 
 
Table 2.9 Animal host range of Leptospira serovars from the Celledoni serogroup from non-human animals published 
prior to 28-31 August 2015 
Celledoni 
Animal host Scientific name Countries References 
Northern brown bandicoot Isoodon macrourus Australia (57, 68) 
Giant white-tailed rat Melomys cervinipes Australia (57) 
Rice-field rat Rattus argentiventer Malaysia (179) 




Table 2.10 Animal host range of Leptospira serovars from the Cynopteri serogroup from non-human animals 
published prior to 28-31 August 2015 
Cynopteri 
Animal host Scientific name Countries References 
Cattle Bos taurus Iran (194) 
Bat Cynopterys spp. Indonesia (97) 
 
Tingomaria 
Animal host Scientific name Countries References 
Common opossum Didelphis marsupialis Peru (191) 
Gray four-eyed opossum Philander opossum Peru (191) 
 
Table 2.11 Animal host range of Leptospira serovars from the Djasiman serogroup from non-human animals 
published prior to 28-31 August 2015 
Buenos Aires 
Animal host Scientific name Countries References 
Domestic dog Canis lupus familiaris Argentina (195, 235) 
 
Djasiman 
Animal host Scientific name Countries References 
Bower's white toothed rat Rattus bowersi Malaysia (179) 
European ground squirrel Spermophilus citellus Turkey (236) 
 
Huallega 
Animal host Scientific name Countries References 





Animal host Scientific name Countries References 
Asian palm civet Paradoxurus hermaphroditus Malaysia (179) 
 
Table 2.12 Animal host range of Leptospira serovars from the Grippotyphosa serogroup from non-human animals 
published prior to 28-31 August 2015 
Canalzonae 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (184) 
Opossum Philander opossum Panama (184) 
Spiny pocket mouse Liomys adspersus Panama (184) 
 
Dadas 
Animal host Scientific name Countries References 
Horse Equus caballus At least one of: Germany, Austria, Netherlands, Switzerland, Italy, 
Portugal, Luxembourg, United Kingdom* 
(82) 
Cattle Bos taurus Turkey (237) 
Yellow neck field mouse Apodemus avicollis Croatia (77) 
* Either Dadas or Ratnapura 
 
Grippotyphosa 
Animal host Scientific name Countries References 
Montane grass mouse Akodon arviculoides Brazil (137) 
Yellow neck field mouse Apodemus flavicollis Croatia, Slovakia (77, 238) 
Cattle Bos taurus Australia, Brazil, Iran, Mexico, Puerto Rico, Tunisia, United States 
of America 
(239-247) 
Domestic dog Canis lupus familiaris USA (140, 248, 249) 
Goat Capra aegagrus hircus Israel (250) 
Bank vole Clethrionomys glareolus Slovakia (238) 
Tick (obtained from cattle) Dermacentor marginatus Kazakhstan (251) 
Common opossum Didelphis marsupialis Brazil (137) 
Horse Equus caballus Germany, United States of America and at least one of: Austria, 
Germany, Netherlands, Switzerland, Italy, Portugal, Luxembourg, 
(82, 252-255) 
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United Kingdom  
Flying squirrel Glaucomys volans Japan (256) 
Long-eared hedgehog Hemiechinus auritus Israel (147) 
Northern brown bandicoot Isoodon macrourus Australia (68) 
Striped skunk Mephitis mephitis United States of America  (150) 
Field vole Microtus agrestis Russia (257) 
Common vole Microtus arvalis Netherlands, Poland, Slovakia (238, 258, 259) 
Root vole Microtus oeconomus Russia (260) 
Meadow vole Microtus pennsylvanicus United States of America (261) 
Pine vole Microtus subterraneus Slovakia (238) 
House mouse Mus musculus Egypt, Iran (262, 263) 
South American water rat Nectomys squamipes Brazil (137, 228) 
Brazilian pygmy rice rat Oligoryzomys eliurus Brazil (137) 
Muskrat Ondatra zibethicus France, Netherlands (106, 264) 
Sheep Ovis aries Iran, Spain (245, 265, 266) 
Quaestor hocicudo  Oxymycterus quaestor Brazil (137) 
Gray four-eyed opossum Philander opossum Brazil (59) 
Raccoon Procyon lotor USA (62, 141, 143) 
Muller's giant sunda rat Rattus muelleri Malaysia (116, 179) 
Black rat Rattus rattus Egypt, Israel (164, 229) 
Dusky field rat Rattus sordidus Australia (68) 
Western harvest mouse Reithrodontomys megalotis United States of America (143) 
Paraguayan rice rat Sooretamys angouya Brazil (137) 
Domestic pig Sus scrofa domesticus United States of America (267) 
Swamp rabbit Sylvilagus aquaticus United States of America (268) 
Cottontail rabbit Sylvilagus floridanus United States of America (268) 
Fringe-tailed gerbil Tatera robusta vicina Kenya (269) 
Blackish grass mouse Thaptomys nigrita Brazil (137) 
Grey fox Urocyon cinereoargenteus United States of America (61) 
Rodents Not stated Poland (71) 
Rotel Mice Not stated Slovakia (270) 
Opossum Not stated United States of America (271) 
Vagrant shrew Not stated United States of America (271) 





Animal host Scientific name Countries References 
Gray four-eyed opossum Philander opossum Peru (273) 
 
Muelleri 
Animal host Scientific name Countries References 
Mueller’s giant sunda rat Sundamys muelleri Malaysia (116) 
 
Ratnapura 
Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (274) 
Horse Equus caballus Austria, Germany, Italy, Luxembourg, Netherlands, Portugal, 
Switzerland, United Kingdom 
(110) 
Black rat Rattus rattus India (275) 
* Either Dadas or Ratnapura 
 
Valbuzzi 
Animal host Scientific name Countries References 
Black rat Rattus rattus India (275) 
 
Vanderhoeden 
Animal host Scientific name Countries References 





Table 2.13 Animal host range of Leptospira serovars from the Hebdomadis serogroup from non-human animals 
published prior to 28-31 August 2015 
Borincana 
Animal host Scientific name Countries References 
Rat Not stated Peru (277) 
Common opossum Philander marsuplialis Peru (277) 
Muskrat Ondrata zibethicus France (264) 
 
Goiano 
Animal host Scientific name Countries References 
Cattle Bos taurus Brazil (278) 
Pig Sus scrofa domesticus Peru (279) 
 
Hebdomadis 
Animal host Scientific name Countries References 
Yellow-necked mouse Apodemus flavicollis Romania (280) 
Woodmouse Apodemus sylvaticus Iran, Romania (281, 282) 
Cattle Bos taurus Japan (48) 
House mouse Mus musculus Romania (282) 
Steppe mouse Mus spicilegus Romania (282) 
Raccoon Procyon lotor Japan (283) 
Rat Rattus spp. Taiwan (67) 
Rat Not stated Vietnam (284) 
 
Iassy 
Animal host Scientific name Countries References 
House mouse Mus musculus Romania (285) 
 
Jules 
Animal host Scientific name Countries References 





Animal host Scientific name Countries References 
Cattle Bos taurus Iran, Japan, Peru (182, 194, 286) 
Northern brown bandicoot Isoodon macrourus Australia (57) 
Long-nosed bandicoot Perameles nasuta Australia (57) 
 
Maru 
Animal host Scientific name Countries References 
Crab-eating mongoose Herpestes urva Taiwan (287) 
Spiny rat Proechimys semispinosus Panama (184) 
 
Marondera 
Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (15, 288) 
 
Mhou 
Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (15, 288) 
 
Sanmartini 
Animal host Scientific name Countries References 




Table 2.14 Animal host range of Leptospira serovars from the Icterohaemorrhagiae serogroup from non-human 
animals published prior to 28-31 August 2015 
Bogvere 
Animal host Scientific name Countries References 
Black rat Rattus rattus Guadeloupe (289) 
 
Copenhageni 
Animal host Scientific name Countries References 
Cattle Bos taurus Brazil, New Zealand (139, 198, 290) 
Domestic dog Canis lupus familiaris 
Barbados, Brazil, Trinidad 
(118, 121, 124, 204, 223, 
290-292) 
Red deer Cervus elaphus New Zealand (293) 
Small Indian mongoose Herpestes auropunctatus Grenada (114) 
House Mouse Mus musculus Barbados (128) 
Nutria Myocastor coypus Netherlands (294) 
Muskrat Ondatra zibethicus France, Netherlands (106, 264) 
Pampas deer Ozotoceros bezoarticus Brazil (60) 
Guyenne spiny rat Proechimys guyannensis Trinidad (114, 118) 
Norwegian rat Rattus norvegicus 
Barbados, Brazil, Germany, Grenada, Japan, New Zealand, Peru, 
Trinidad, United States of America 
(114, 118, 121, 126, 128, 
155, 273, 279, 290, 295-
299) 
Black rat Rattus rattus 
Barbados, Brazil, French Guiana, Grenada, Trinidad 
(114, 118, 121, 126, 128, 
290, 300) 
Rat Rattus spp. Canary Islands, Romania, Romania, Trinidad (292, 301, 302) 





Animal host Scientific name Countries References 
Asiatic red bellied squirrels Callosciurus erythraeus Argentina (200) 
Horse Equus callabus Brazil (303) 
Hedgehog Erinaceus europaeus Azores (304) 
Capybara Hidrochaerys hidrochaerys Brazil (169) 
Raccoon Procyon lotor Japan (283) 
Black rat Rattus rattus Azores, Guadeloupe (289, 304) 
Rat Not stated Peru (277) 
*Serovar status determined by pulsed-field gel electrophoresis, which is unable to distinguish these two serovars 
 
Hongchon 
Animal host Scientific name Countries References 
Field mouse Apodemus agrarius Korea (305) 
 
Icterohaemorrhagiae 
Animal host Scientific name Countries References 
Cattle Bos taurus Brazil, India, Iran, Northern Ireland, United States of America (244, 306-309) 
Small vesper mouse Calomys lauchas Argentina (192) 
Iberian wolf Canis lupus Spain (310) 
Domestic dog Canis lupus familiaris Argentina, Italy, Netherlands, Puerto Rico, United States of 
America 
(160, 205, 209, 220, 224, 
311) 
Goat Capra aegagrus hircus Spain (265) 
Hamster Cricetinae spp. United States of America (311) 
Common opossum Didelphis marsupialis Brazil (137) 
Hedgehog Erinaceus europaeus Azores, Italy (53, 312) 
Lesser Indian mongoose Herpestes auropunctatus Guadeloupe, Puerto Rico, United States of America (56, 148, 159, 160) 
Egyptian mongoose Herpestes ichneumon Egypt (262) 
Rajah's spiny rat Maxomys rajah Malaysia (313) 
Striped skunk Mephitis mephitis United States of America (150, 151, 314) 
Japanese field vole Microtus montebelli Japan (315) 
House mouse Mus musculus Puerto Rico, United States of America (148, 159, 160, 314) 
Nutria Myocastor coypus Czech Republic, England, France (210, 316, 317) 
Muskrat Ondatra zibethicus France (210, 264) 
Sheep Ovis aries Spain (265) 
Masked palm civet Paguma larvata taivana Taiwan (127) 
Raccoon Procyon lotor United States of America (314) 
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Spiny rat Proechimys spp. Peru (318) 
Polynesian rat Rattus exulans United States of America (148, 159) 
Norwegian rat Rattus norvegicus Algeria, Argentina, Azores, Canada, Colombia, England, French 
Guiana, Japan, Israel, Malaysia, Puerto Rico, South Africa, Spain, 
Trinidad, Tunisia, United States of America,  
(118, 133, 136, 148, 159, 
160, 164, 179, 297, 312, 
319-332) 
Black rat Rattus rattus Azores, Colombia, Peru, Puerto Rico, Taiwan, Trinidad, Tunisia, 
United States of America,  
(118, 127, 133, 148, 159, 
160, 312, 323, 333, 334) 
Asian house rat Rattus tanezumi Philippines (186) 
Rat Rattus spp. Peru, Puerto Rico, Romania, Trinidad, United States (160, 211, 292, 302, 335, 
336) 
Muller's giant sunda rat Sundamys (Rattus) muelleri Malaysia (179, 313) 
Domestic pig Sus scrofa domesticus Argentina, Brazil, India, Scotland, United States of America (193, 195, 309, 337-339) 
Gray fox Urocyon cinereoargenteus United States of America (314) 
Red fox Vulpes vulpes niloticus Egypt (262) 
Fruit bat Not stated Peru (272) 
Rodents Not stated Poland (340) 
Opossum Not stated United States of America (167) 
Rat Not stated Argentina (193) 
 
Lai 
Animal host Scientific name Countries References 
Striped field mouse Apodemus agrarius China, South Korea (341-343) 
Oriental house rat Rattus tanezumi China (344) 
Mueller's giant sunda rat Sundamys muelleri Malaysia (313) 
Rat Not stated South Korea (345) 
 
Mankarso 
Animal host Scientific name Countries References 
Rat Rattus spp. Trinidad (292) 
Whitehead's spiny rat Rattus whiteheadi Indonesia (116) 
 
Sokoine 
Animal host Scientific name Countries References 





Animal host Scientific name Countries References 
Rat Not stated South Korea (345) 
 
Zimbabwe 
Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (15, 347) 
 
 
Table 2.15 Animal host range of Leptospira serovars from the Iquitos serogroup from non-human animals published 
prior to 28-31 August 2015 
Varillal 
Animal host Scientific name Countries References 
Cattle Bos taurus Iran (336) 
Norwegian rat Rattus norvegicus Peru (194) 






Table 2.16 Animal host range of Leptospira serovars from the Javanica serogroup from non-human animals 
published prior to 28-31 August 2015 
Ceylonica 
Animal host Scientific name Countries References 
Musk shrew Suncus caeruleus giganteus Sri Lanka (348) 
 
Dehong 
Animal host Scientific name Countries References 
Rat Not stated China (97) 
 
Fluminense 
Animal host Scientific name Countries References 
Field mouse Akodon arviculoides Brazil (97) 
 
Izatnagar 
Animal host Scientific name Countries References 





Animal host Scientific name Countries References 
Cattle Bos taurus India, Malaysia (49-51, 351) 
Domestic dog Canis lupus familiaris Sri Lanka (230) 
Domestic cat Felis catus Indonesia (176) 
House mouse Mus musculus India (352, 353) 
Nutria Myocastor coypus Taiwan (58) 
Sheep Ovis aries India (352, 354) 
Rice-field rat Rattus argentiventer Malaysia (179) 
Norwegian rat Rattus norvegicus India, Malaysia, Philippines 
(179, 181, 186, 351-353, 
355, 356) 
Black rat Rattus rattus India, Indonesia, Japan, Malaysia, Thailand 
(97, 120, 122, 179, 181, 
357, 358) 
Asian house rat Rattus tanezumi Philippines (186) 
Rat Rattus spp. Philippines, Taiwan, Thailand (58, 67, 177, 178) 
Rat Not stated Sri Lanka, Thailand, Vietnam (72, 230, 284) 
 
Menoni 
Animal host Scientific name Countries References 
Lesser bandicoot rat Bandicota bengalensis India (359) 
 
Sorexjalna 
Animal host Scientific name Countries References 
Hedgehog Erinaceus europaeus Netherlands (86) 
Shrew mouse Sorex araneus Czech Republic (97) 
Rodents Not stated Poland (71) 
 
Yaan 
Animal host Scientific name Countries References 
Water shrew Crocidura platycephala China (97) 
 
Zhenkang 
Animal host Scientific name Countries References 
House rat Rattus flavipectus China (97) 
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Table 2.17 Animal host range of Leptospira serovars from the Louisiana serogroup from non-human animals 
published prior to 28-31 August 2015 
Lanka 
Animal host Scientific name Countries References 
Mouse opossum Marmosa fuscata Trinidad (114, 118) 
Pouchless opossum Marmosa mitis Trinidad (114, 118) 




Animal host Scientific name Countries References 
Armadillo  Dasypus novemcinctus United States of America (360) 
 
Orleans 
Animal host Scientific name Countries References 





Table 2.18 Animal host range of Leptospira serovars from the Mini serogroup from non-human animals published 
prior to 28-31 August 2015 
Beye 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (113) 
 
Georgia 
Animal host Scientific name Countries References 
Cattle Bos taurus Peru (182) 
Domestic dog Canis lupus familiaris Trinidad (118, 204) 
Opossum Didelphis marsupialis United States of America (361) 
Striped skunk Mephitis mephitis United States of America (150, 361) 
Raccoon Procyon lotor United States of America (361) 
 
Hekou 
Animal host Scientific name Countries References 
Raccoon Procyon lotor United States of America (97) 
 
Mini 
Animal host Scientific name Countries References 
European water vole Arvicola terrestris Bulgaria (175) 
Cattle Bos taurus Mexico (242) 
Northern brown bandicoot Isoodon macrourus Australia (57) 
 
Perameles 
Animal host Scientific name Countries References 
Bandicoot Perameles narsuta Australia (97) 
 
Ruparupae  
Animal host Scientific name Countries References 
Common opossum Didelphis marsupialis Peru (191) 




Animal host Scientific name Countries References 
Cattle Bos taurus United States of America (362) 
Common opossum Didelphis marsupialis Brazil (137) 
Hedgehog Erinaceus europaeus Israel (55, 147, 164) 
House mouse Mus musculus Israel (55, 164) 
Black rat Rattus rattus Israel (55, 147, 164) 
 
Table 2.19 Animal host range of Leptospira serovars from the Panama serogroup from non-human animals published 
prior to 28-31 August 2015 
Cristobali 
Animal host Scientific name Countries References 
Didelpis opossum Didelphis spp. Panama (113) 
 
Mangus 
Animal host Scientific name Countries References 
White eared opossum Didelphis albiventris Brazil (59) 
Small Indian mongoose Herpestes auropunctatus Trinidad (118, 363) 
 
Panama 
Animal host Scientific name Countries References 





Table 2.20 Animal host range of Leptospira serovars from the Pomona serogroup from non-human animals published 
prior to 28-31 August 2015 
Altodouro 
Animal host Scientific name Countries References 
House mouse Mus musculus Portugal (364) 
 
Kunming 
Animal host Scientific name Countries References 
Chevrier's field mouse Apodemus chevrieri China (365) 
 
Mozdok 
Animal host Scientific name Countries References 
Striped field mouse Apodemus agrarius Croatia, Germany, Russia (77, 98, 366, 367) 
Yellow neck field mouse Apodemus flavicollis Croatia (77) 
Woodmouse Apodemus sylvaticus Croatia, Russia (77, 366) 
Cattle Bos taurus England, Germany, Russia, Zimbabwe (15, 366, 368, 369) 
Greater white toothed shrew Crocidura russula Portugal (131) 
Crab-eating mongoose Herpestes urva Taiwan (287) 
Field vole Microtus agrestis England (368) 
Common vole Microtus arvalis Russia (97) 
Major's pine vole Microtus majori Russia (366) 
House mouse Mus musculus Germany (367) 
Algerian Mouse Mus spretus Portugal (131) 
Hazel dormouse Muscardinus avellanarius Croatia (98) 





Animal host Scientific name Countries References 
Montane grass mouse Akodon arviculoides Brazil (59) 
Striped field mouse Apodemus agrarius Russia (371) 
European water vole Arvicola terrestris Bulgaria (175) 
Cattle Bos taurus Argentina, Brazil, Canada, Chile, Iran, Malaysia, Puerto Rico, 
Romania, Russia, South Africa, United States of America 
(50, 51, 193-196, 199, 244, 246, 
247, 366, 372-386) 
Plantain squirrel Callosciurus notatus Malaysia (313) 
Domestic dog Canis lupus familiaris Argentina, Brazil, United States of America (205, 223, 387) 
Goat Capra aegagrus hircus Spain (265) 
Pampas Cavy Cavia pamparum Argentina (388) 
Guinea pig Cavia porcellus Peru (182) 
White eared opossum Didelphis albiventris Brazil (59) 
Common opossum Didelphis marsupialis United States of America (149) 
Horse Equus caballus Canada, Northern Ireland, United States of America (80, 141, 252, 253, 255, 368, 372, 
389-392) 
Domestic or feral cat Felis catus Malaysia, United States of America (149, 179, 372, 393) 
Wild cat Felis rufa USA (62, 145) 
Ground hog Marmota monax Canada (326, 394) 
Striped skunk Mephitis mephitis USA (62, 141, 145, 149, 150, 261, 372) 
Skunk Mephitis spp. Canada (382, 392, 394) 
Northern elephant seal Mirounga angustirostris USA (395) 
House mouse Mus musculus Brazil (59) 
White tailed deer Odocoileus virginianus Canada, United States of America (396-398) 
Black footed pygmy rice rat Oligoryzomys nigripes Brazil (59) 
Sheep Ovis aries Argentina, Canada, Northern Ireland, Spain (88, 265, 368, 379, 382) 
Asian palm civet Paradoxurus hermaphroditus Malaysia (179) 
Raccoon Procyon lotor United States of America (62, 141, 372, 392) 
Norwegian rat Rattus norvegicus Colombia (328) 
Black rat Rattus rattus Brazil (59) 
Domestic pig Sus scrofa Argentina, Australia, Canada, Chile, Colombia, Hungary, 
New Zealand, Nicaragua, Peru, Sri Lanka, United States of 
America,  
(166, 193, 195, 230, 279, 320, 
333, 372, 379, 382, 385, 386, 
399-404) 
Red fox Vulpes vulpes Canada (405) 
California sea lions Zalophus californianus Canada, United States of America (386, 392, 406, 407) 
Deer Not stated New Zealand (408) 




Animal host Scientific name Countries References 
Common opossum Philander marsuplialis Peru (277) 
Spiny rat Proechimys semispinosus Panama (113) 
Rat Not stated Peru (277) 
 
Tropica 
Animal host Scientific name Countries References 
Spiny pocket mouse Liomys adspersus Panama (184) 
House mouse Mus musculus Brazil (59, 154, 410) 
Spiny rat Proechimys semispinosus Panama (184) 
 
Tsaratsovo 
Animal host Scientific name Countries References 
Striped field mouse Apodemus agrarius Croatia (100) 
Yellow-necked mouse Apodemus flavicollis Croatia (100) 
Horse Equus caballus Portugal (84) 
Harvest mouse Micromys minutus Bulgaria (97) 
 
Monjakov 
Animal host Scientific name Countries References 
Norwegian rat Rattus norvegicus Russia (366) 





Table 2.21 Animal host range of Leptospira serovars from the Pyrogenes serogroup from non-human animals 
published prior to 28-31 August 2015 
Abramis 
Animal host Scientific name Countries References 
Gray four-eyed opossum Philander opossum Nicaragua (225) 
 
Guaratuba 
Animal host Scientific name Countries References 
Gray four-eyed opossum Philander opossum Brazil (137) 
 
Kwale 
Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (14, 15) 
Tatera gerbil Tatera robusta Kenya (130) 
 
Manilae 
Animal host Scientific name Countries References 
Norwegian rat Rattus norvegicus Philippines (186, 411) 
Black rat Rattus rattus Philippines (411) 
Asian house rat Rattus tanezumi Philippines (186) 
Rat Rattus spp. Philippines (178) 
Rat Not stated Philippines (412) 
 
Mombe 
Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (14, 15) 
 
Myocastoris 
Animal host Scientific name Countries References 





Animal host Scientific name Countries References 
Cattle Bos taurus Nigeria, Zimbabwe (14, 15, 414) 
 
Pyrogenes 
Animal host Scientific name Countries References 
Cattle Bos taurus Nigeria (46) 
South American water rat Nectomys squamipes Brazil (228) 
Black rat Rattus rattus Egypt (229) 
Rat Rattus spp. Philippines, Thailand (177, 178) 
Domestic pig Sus scrofa domesticus Peru, Philippines (182, 415, 416) 
Field rat Not stated Thailand (69, 70, 72) 
 
Robinsoni 
Animal host Scientific name Countries References 
Dusky field rat Rattus sordidus conatus Australia (57) 
Giant white-tailed rat Uromys caudimaculatus Australia (57) 
 
Varela 
Animal host Scientific name Countries References 
Opossum Not stated Nicaragua (113) 





Animal host Scientific name Countries References 
Cattle Bos taurus Australia (417, 418) 
Northern brown bandicoot Isoodon macrourus Australia (57) 
Fawn-footed mosaic-tailed rat Melomys cervinipes Australia (68) 
Papua grassland mosaic-
tailed rat Melomys lutillus Australia 
(57) 
House mouse Mus musculus Australia (57) 
Bush rat Rattus fuscipes assimilis Australia (57) 
Norwegian rat Rattus norvegicus Australia (57) 
Black rat Rattus rattus Australia (57) 
Dusky field rat Rattus sordidus conatus Australia (57) 
Giant white-tailed rat Uromys caudimaculatus Australia (68) 
Rodent Not stated Australia (419) 
 
Table 2.22 Animal host range of Leptospira serovars from the Ranarum serogroup from non-human animals 
published prior to 28-31 August 2015 
Ranarum 
Animal host Scientific name Countries References 
Horse Equus caballus Brazil (420) 
Northern leopard frog Rana pipiens USA (421) 
Ranarum frog Ranarum nigromaculata China (422) 
 
Pinchang 
Animal host Scientific name Countries References 




Table 2.23 Animal host range of Leptospira serovars from the Sarmin serogroup from non-human animals published 
prior to 28-31 August 2015 
Cuica 
Animal host Scientific name Countries References 
Marsupial opossum Metachirus opossum Brazil (97) 
 
Machiguenga 
Animal host Scientific name Countries References 
Gray four-eyed opossum Philander opossum Peru (191) 
 
Rio 
Animal host Scientific name Countries References 
Black rat Rattus rattus Brazil (423) 
 
Waskurin 
Animal host Scientific name Countries References 
Bandicoot Echimipera kalabu Papua New Guinea (97) 
 
Weaveri 
Animal host Scientific name Countries References 




Table 2.24 Animal host range of Leptospira serovars from the Sejroe serogroup from non-human animals published 
prior to 28-31 August 2015 
Caribe 
Animal host Scientific name Countries References 
Norwegian rat Rattus norvegicus Trinidad (97) 
 
Dikkeni 
Animal host Scientific name Countries References 
Bandicoot Bandicota bengalensis India (97) 
 
Gorgas 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (113) 
 
Guaricura 
Animal host Scientific name Countries References 
Cattle Bos taurus Brazil (278) 
Domestic water buffalo Bubalus bubalis Brazil (424) 
 
Hardjo, subtype not determined 
Animal host Scientific name Countries References 
Cattle Bos taurus 
Argentina, Australia, Brazil, Canada, Colombia, England, Ireland, 
Germany, Malaysia, New Zealand, Northern Ireland, Portugal, 
Scotland, South Africa, United States of America, Wales 
(50, 51, 166, 243, 247, 
306, 309, 378, 381, 384, 
425-443) 
Red deer Cervus elaphus New Zealand (293) 
Peludo armadillo Chaetophractus villosus Argentina (174) 
Horse Equus caballus Argentina, Northern Ireland (81, 444) 
Steppe mouse Mus spicilegus Romania (280) 
Nutria Myocastor coypus England (445) 
Sheep Ovis aries Australia, New Zealand, Northern Ireland (166, 434, 446, 447) 
Raccoon Procyon lotor United States of America (141) 




Animal host Scientific name Countries References 
Cattle Bos taurus Australia, Brazil, Canada, Chile, England, Germany, Iran, Israel, 
Italy, Netherlands, New Zealand, Nigeria, Northern Ireland, 
Portugal, Puerto Rico, Scotland, Switzerland, United States of 
America, Zimbabwe 
(15, 194, 241, 246, 258, 
376, 380, 417, 418, 449-
458) 
Sheep Ovis aries Northern Ireland, Netherlands (456, 459) 
Deer Not stated New Zealand (408) 
 
Hardjoprajitno 
Animal host Scientific name Countries References 
Woodmouse Apodemus sylvaticus Romania (280) 
Cattle Bos taurus Brazil, Canada, Iran, Mexico, Northern Ireland, Scotland (194, 242, 451, 452, 454-
456, 460-462) 
Horse Equus caballus Northern Ireland (456) 
Domestic cat Felis catus United States of America (463) 
Sheep Ovis aries Brazil, Northern Ireland (456, 464) 
Pig Sus scrofa domesticus United States of America (89) 
 
Istrica 
Animal host Scientific name Countries References 
Yellow necked mouse Apodemus flavicollis Czech Republic  
House mouse Mus musculus Croatia (71) 
 
Medanensis 
Animal host Scientific name Countries References 
Dog Canis lupus familiaris Indonesia (97) 
Northern brown bandicoot Isoodon macrourus Australia (68) 





Animal host Scientific name Countries References 
European hedgehog Erinaceus europaeus roumanicus Poland (465) 
House mouse Mus musculus Romania (285) 
Black rat Rattus rattus Egypt (229) 
 
Recreo 
Animal host Scientific name Countries References 
Gray four-eyed opossum Philander opossum Nicaragua (113) 
 
Ricardi 
Animal host Scientific name Countries References 
Cattle Bos taurus Peru (185) 
Horse Equus callabus Austria, Germany, Italy, Luxembourg, Netherlands, Switzerland, 




Animal host Scientific name Countries References 





Animal host Scientific name Countries References 
Yellow necked fieldmouse Apodemus flavicollis Croatia, Denmark, England  (77, 98, 434, 466) 
Woodmouse Apodemus sylvaticus Croatia, England, Romania (77, 280, 434) 
Domestic dog Canis lupus familiaris England (434) 
Bank vole Clethrionomys glareolus England (434) 
Hedgehog Erinaceus europaeus Italy (53) 
Badger Meles meles England (433, 434) 
Field vole Microtus agrestis England, Germany, Scotland (433, 434, 467) 
Common vole Microtus arvalis Russia (468) 
Vole Microtus spp. England (433) 
House mouse Mus musculus Germany, Romania (285, 295) 
Steppe mouse Mus spicilegus Romania (280, 285) 
Red fox Vulpes vulpes England (434) 
Rodents Not stated Poland (71) 
Vole Not stated Wales (434) 
 
Sejroe 
Animal host Scientific name Countries References 
Cattle Bos taurus United Kingdom (469) 
Iberian wolf Canis lupus Spain (201) 
Domestic dog Canis lupus familiaris Italy (470) 
Goat Capra aegagrus hircus Spain (265) 
Lesser Indian mongoose Herpestes auropunctatus Guadeloupe, United States of America (56, 148, 159, 471) 
Sand lizard Lacerta agilis Slovakia (472) 
Common vole Microtus arvalis Poland (259) 
House mouse Mus musculus Denmark, Romania (97, 285) 
Steppe mouse Mus spicilegus Romania (280, 285) 
Nutria Myocastor coypus France (473) 
Sheep Ovis aries Spain (265) 





Animal host Scientific name Countries References 
Woodmouse Apodemus sylvaticus Romania (280) 
Cattle Bos taurus Brazil (378) 
House mouse Mus musculus Romania (282) 
Steppe mouse Mus spicilegus Romania (280, 282) 
 
Unipertama 
Animal host Scientific name Countries References 
Cattle Bos taurus Malaysia (50, 474) 
 
 
Table 2.25 Animal host range of Leptospira serovars from the Semeranga serogroup from non-human animals 
published prior to 28-31 August 2015 
Patoc 
Animal host Scientific name Countries References 
Cattle Bos taurus United States of America (475) 
Domestic cat Felis catus Egypt (229) 
 
Table 2.26 Animal host range of Leptospira serovars from the Shermani serogroup from non-human animals 
published prior to 28-31 August 2015 
Babudieri 
Animal host Scientific name Countries References 





Animal host Scientific name Countries References 
"Chucha" opossum Caluromys philander Colombia (476) 
 
Luis 
Animal host Scientific name Countries References 
Gray four-eyed opossum Philander opossum Peru (191) 
 
Shermani 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (113) 
 
 
Table 2.27 Animal host range of Leptospira serovars from the Tarassovi serogroup from non-human animals 
published prior to 28-31 August 2015 
Atchafalaya 
Animal host Scientific name Countries References 
Common opossum Didelphis marsupialis United States of America (152) 
Lesser Indian mongoose Herpestes auropunctatus Grenada (114) 
 
Atlantae 
Animal host Scientific name Countries References 
Common opossum  Didelphis marsupialis United States of America (97) 
 
Bakeri 
Animal host Scientific name Countries References 
Common opossum Didelphis marsupialis United States of America (152) 





Animal host Scientific name Countries References 
Spiny pocket mouse Liomys adspersus Panama (184) 
Spiny rat Proechimys semispinosus Panama (184) 
 
Chagres 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (113) 
 
Darien 
Animal host Scientific name Countries References 
Gray four-eyed opossum Philander opossum Panama (113) 
 
Gatuni 
Animal host Scientific name Countries References 
Spiny rat Proechimys semispinosus Panama (113) 
 
Guidae 
Animal host Scientific name Countries References 
Bandicoot Echymipera kalubu Papua New Guinea (477) 
Domestic pig Sus scrofa domesticus Romania, Spain (97, 478, 479) 
 
Kanana 
Animal host Scientific name Countries References 
Gerbil Tatera robusta Kenya  
 
Kaup 
Animal host Scientific name Countries References 
Bandicoot Echymipera kalabu Papua New Guinea (97) 
 
Navet 
Animal host Scientific name Countries References 





Animal host Scientific name Countries References 
Cattle Bos taurus Zimbabwe (15, 480) 
 
Ossetia 
Animal host Scientific name Countries References 
Domestic pig Sus scrofa domesticus Russia (478) 
 
Rama 
Animal host Scientific name Countries References 
Gray four-eyed opossum Philander opossum Nicaragua (225) 
 
Tarassovi 
Animal host Scientific name Countries References 
Yellow-necked mouse Apodemus flavicollis Romania (280) 
Woodmouse Apodemus sylvaticus var lauricus Romania (479) 
Cattle Bos taurus Mexico, Russia (242, 481) 
Domestic dog Canis lupus familiaris New Zealand (166) 
Common opossum Didelphis marsupialis United States of America (152) 
Rakali (Water rat) Hydromys chrysogaster Australia (152) 
Striped skunk Mephitis mephitis United States of America (150-152) 
Slider turtle Pseudemys scripta-elegans United States of America (482) 
Bower's white toothed rat Rattus bowersi Malaysia (179) 
Bush rat Rattus fuscipes assimilis Australia (57) 
Rat Rattus spp. Philippines (178) 
Muller's giant sunda rat Sundamys muelleri Malaysia (179) 
Domestic pig Sus scrofa domesticus Argentina, Australia, Chile, Cuba, India, New Zealand, Romania, 
Russia 
(97, 338, 478, 479, 483-
486) 




Animal host Scientific name Countries References 
Cattle Bos taurus Australia (487) 





Animal host Scientific name Countries References 
Domestic pig Sus scrofa domestica Tunisia (97) 
 
Vietnam 
Animal host Scientific name Countries References 
Domestic pig Sus scrofa domesticus Russia, Vietnam (481) 
 
Yunxian 
Animal host Scientific name Countries References 




Table 2.28 Animal host range of Leptospira borgpetersenii from non-human animals published prior to 28-31 August 
2015 
Animal host Scientific name Countries References 
Yellow neck field mouse Apodemus avicollis Croatia (77) 
Woodmouse Apodemus sylvaticus Croatia (77) 
Greater bandicoot  Bandicota indica Taiwan (489) 
Cattle Bos taurus Australia, Brazil, Chile, India, Iran, Israel, Italy, Netherlands, New 
Zealand, Northern Ireland, Portugal, Scotland, Switzerland, United 
States of America, Zimbabwe 
(15, 131, 194, 241, 258, 
351, 449, 451-453, 456, 
458) 
White eared opossum Didelphis albiventris Brazil (169, 490) 
Horse Equus caballus Northern Ireland (456) 
Ryukyu mouse Mus caroli Thailand, Lao PDR, Cambodia (491) 
House mouse Mus musculus Brazil, Croatia, Mexico (100, 492, 493) 
Mouse Mus spp. Canary Islands, Portugal (301, 494) 
Algerian Mouse Mus spretus Portugal (131) 
Grey red backed vole Myodes rufocanus bedfordiae Japan (489) 
Red backed vole Myodes rutilus mikado Japan (489) 
Sheep Ovis aries Netherlands, Northern Ireland (456, 459) 
Raccoon Procyon lotor United States of America (495) 
Polynesian rat Rattus exulans Taiwan (489) 
Norwegian rat Rattus norvegicus  Azores, India, Japan, Malaysia, Portugal,  
(131, 181, 289, 351, 355, 
356) 
Black Rat Rattus rattus Azores, Guadepoupe, Japan, Malaysia (131, 181, 289, 357) 
Rat Rattus spp. Australia (135) 




Table 2.29 Animal host range of Leptospira fainei from non-human animals published prior to 28-31 August 2015 
Animal host Scientific name Countries References 
Domestic pig Sus scrofa domesticus Australia (496) 
Tent making bat Uroderma bilobatum Peru (272) 
 
 
Table 2.30 Animal host range of Leptospira inadai from non-human animals published prior to 28-31 August 2015 
Animal host Scientific name Countries References 
Lesser bandicoot rat Bandicota bengalensis India (497) 
Greater bandicoot rat Bandicota indica India (497) 
Black rat Rattus rattus rufescens India (497) 
Black rat Rattus rattus wroughtoni hinton India (497) 




Table 2.31 Animal host range of Leptospira interrogans from non-human animals published prior to 28-31 August 
2015 
Animal host Scientific name Countries References 
Striped field mouse Apodemus agrarius China, Korea (341, 342, 499) 
Yellow neck field mouse Apodemus avicollis Croatia (77, 98, 100) 
Large Japanese field mouse Apodemus speciosus Japan (489, 500) 
Woodmouse Apodemus sylvaticus Croatia (77, 98) 
Dark fruit eating bat Artibeus obscurus Peru (272) 
Lesser bandicoot rat Bandicota bengalensis India (117) 
Greater bandicoot rat Bandicota indica Thailand, Lao PDR, Cambodia (491) 
Small white toothed rat Berylmys berdmorei Thailand, Lao PDR, Cambodia (491) 
Cow Bos taurus Argentina, Australia, Brazil, Canada, Chile, England, France, 
Germany, India, Iran, Mexico, Northern Ireland, Portugal, 
Scotland, Sri Lanka, Switzerland, United States of America, 
Zimbabwe 
(108, 193-195, 210, 242, 
277, 307, 372, 379, 385, 
386, 451, 456, 461, 462, 
501-505) 
Asiatic red bellied squirrels Callosciurus erythraeus Argentina (200) 
Plantain squirrel Callosciurus notatus Malaysia (313) 
Iberian wolf Canis lupus Spain (201) 
Domestic dog Canis lupus familiaris Argentina, Brazil, France, India, Iran, Japan, New Caledonia, 
United States of America 
(45, 78, 195, 205, 210, 
212, 235, 248, 341, 505-
508) 
European beaver Castor fiber Germany (509) 
Brazilian guinea pig Cavia aperea Brazil (510) 
Bank vole Clethrionomys glareolus Croatia (511) 
South American white-eared 
opossum 
Didelphis albiventris Argentina, Brazil (195, 512) 
Patagonian mara Dolichotis patagonum Portugal (494) 
Horse Equus caballus Austria, Brazil, Germany, Italy, Luxembourg, Netherlands, 
Northern Ireland, Portugal, United Kingdom, United States of 
America 
(79, 84, 105, 110, 141, 
252, 253, 255, 303, 372, 
392) 
Hedgehog Erinaceus europaeus Azores (131) 
Cat Felis catus United States of America (372, 463) 
Palla's long-tongued bat Glossophaga soricina Peru (272) 
Gaumer's spiny pocket mouse Heteromys gaumeri Mexico (513) 
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Capybara Hidrochaerys hidrochaerys Brazil (169) 
South American gray fox Lycalopex griseus Argentina (514) 
Red spiny rat Maximus surifer Cambodia, Lao PDR, Thailand (491) 
Rajah's spiny rat Maxomys rajah Malaysia (313) 
Striped skunk Mephitis mephitis United States of America (141, 372) 
Skunk Mephitis spp. Canada (386) 
Northern elephant seal Mirounga angustirostris United States of America (395) 
Ryukyu mouse Mus caroli Japan (489) 
Cook's mouse Mus cookii Lao PDR, Thailand (491) 
House mouse Mus musculus New Caledonia, Kenya (515, 516) 
Nutria Myocastor coypus Czechoslovakia, England (169, 317) 
Muskrat Ondatra zibethicus France (210) 
Big eared climbing rat Ototylomys phyllotis Mexico (513) 
Sheep Ovis aries Argentina, Brazil, Iran, Northern Ireland (379, 456, 464, 507) 
Pampas deer Ozotoceros bezoarticus Brazil (517) 
Common opossum Philander marsuplialis Peru (277) 
Raccoon Procyon lotor Japan, United States of America (141, 332, 372, 392, 495) 
Spiny rat Proechimys spp. Peru (318) 
Rice-Field rat Rattus argentiventer Cambodia, Lao PDR, Thailand (491) 
Polynesian rat Rattus exulans New Caledonia (491, 516) 
Bush rat Rattus fuscipes Australia (63) 
Cape York rat Rattus leucopus Australia (63) 
Lesser rice field rat Rattus losea Cambodia, Lao PDR, Taiwan, Thailand (489, 491) 
Norwegian rat Rattus norvegicus Azores, Brazil, Canada, Colombia, France, Japan, Madagascar, 
New Caledonia, Philippines, Taiwan, Vietnam 
(131, 186, 210, 332, 489, 
491, 505, 518-520) 
Black rat Rattus rattus Azores, Brazil, Colombia, Egypt, Guadeloupe, India, Madagascar, 
Mayotte, New Caledonia 
(117, 122, 131, 133, 181, 
229, 234, 289, 333, 505, 
516, 521) 
Canefield rat Rattus sordidus Cambodia, China, Lao PDR, Thailand (63) 
Oriental house rat Rattus tanezumi Cambodia, China, Lao PDR, Philippines, Thailand (186, 344, 491) 
Rat Rattus spp. Australia, Canary Islands, Japan, Peru, Portugal (63, 301, 336, 489, 494) 
Rusa deer Rusa timorensis New Caledonia (506) 
Asian house shrew Suncus murinus Japan, Taiwan (489) 
Mueller's giant sunda rat Sundamys muelleri Malaysia (313) 
Domestic pig Sus scrofa domesticus Argentina, Australia, Brazil, Canada, Chile, Colombia, Cuba, 
England, Nicaragua, United States of America, Vietnam 
(89, 90, 96, 193, 195, 333, 
372, 379, 385, 386, 400, 
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403, 417, 484, 498, 506, 
522) 
Tent making bat Uroderma bilobatum Peru (272) 
Giant naked-tailed rats Uromys spp. Australia (63) 
California Sea Lion Zalophus californianus Canada, United States of America (386, 392, 406, 523, 524) 
Deer Not stated New Zealand (408) 
Fox Not stated Canada (392, 409) 
Fruit bat Not stated Peru (272) 
Rat Not stated Argentina, England, Philippines, Peru, South Korea, Vietnam (187, 193, 277, 284, 345, 
498) 
Weasel Not stated Argentina (193) 
 
 
Table 2.32 Animal host range of Leptospira kirschneri from non-human animals published prior to 28-31 August 2015 
Animal host Scientific name Countries References 
Striped field mouse Apodemus agrarius Croatia (77, 98, 100) 
Yellow neck field mouse Apodemus flavicollis Croatia (77, 100) 
Woodmouse Apodemus sylvaticus Croatia (77) 
Cattle Bos taurus Brazil, Iran, Mexico, Sri Lanka, Tanzania, Zimbabwe 
(15, 188, 194, 241, 242, 
274, 346, 347, 504) 
Dog Canis lupus familiaris Brazil (525) 
Greater white toothed shrew Crocidura russula Portugal (131) 
Horse Equus caballus 
Austria, Germany, Italy, Luxembourg, Netherlands, Portugal, 
United Kingdom  
(82, 84) 
Flying squirrel Glaucomys volans Japan (256) 
Fawn coloured mouse Mus cervicolor Lao PDR, Thailand (491) 
Cook's mouse Mus cookii Lao PDR, Thailand (491) 
House mouse Mus musculus Kenya, Portugal (364, 515) 
Algerian Mouse Mus spretus Portugal (131) 
Hazel dormouse Muscardinus avellanarius Croatia (98) 
Greater spear-nosed bat Phyllostomus hastatus Peru (272) 
Black rat Rattus rattus Guadeloupe, Mayotte (289, 521) 
Domestic pig Sus scrofa domesticus Portugal (494) 
Fruit bat Not stated Peru (272) 
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Table 2.33 Animal host range of Leptospira licerasiae from non-human animals published prior to 28-31 August 2015 
Animal host Scientific name Countries References 
Cattle Bos taurus Iran (194) 
Norwegian rat Rattus norvegicus Peru (336) 
Black rat Rattus rattus Peru (336) 
 
 
Table 2.34 Animal host range of Leptospira noguchii from non-human animals published prior to 28-31 August 2015 
Animal host Scientific name Countries References 
Domestic dog Canis lupus familiaris Brazil (526) 
Sheep Ovis aries Brazil (527) 
Common opossum Philander marsuplialis Peru (277) 
Rat Not stated Peru (277) 
 
Table 2.35 Animal host range of Leptospira santarosai from non-human animals published prior to 28-31 August 2015 
Animal host Scientific name Countries References 
Cattle Bos taurus Mexico (242) 
Domestic water buffalo Bubalus bubalis Brazil (424) 
Goat Capra aegagrus hircus Brazil (528) 
Common opossum Philander marsuplialis Peru (277) 




Table 2.36 Animal host range of Leptospira weilii from non-human animals published prior to 28-31 August 2015 
 Animal host Scientific name Countries References 
Savile's bandicoot rat Bandicota savilei Cambodia (491) 
Cattle Bos taurus Australia (487) 
Bandicoot Not stated Australia (488) 
 
 
Table 2.37 Animal host range of Leptospira wolfii from non-human animals published prior to 28-31 August 2015 
 Animal host Scientific name Countries References 
Domestic dog Canis lupus familiaris Iran (507) 
Sheep Ovis aries Iran (507) 
 
 
Table 2.38 Animal host range of Leptospira biflexa from non-human animals published prior to 28-31 August 2015 
 Animal host Scientific name Countries References 
Cattle Bos taurus Malaysia (529) 
Armadillo Chaetophractus villosus Argentina (174) 






 Figure 2.3 Countries with published reports of Leptospira isolated 






Figure 2.4 Countries within which there have been reports of 




Figure 2.5 Countries within which there have been reports of 
Leptospira interrogans detection from animals, until August 2015  
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Figure 2.6 Countries within which there have been reports of 




 Figure 2.7 Countries within which there have been reports of 





 Figure 2.8 Countries within which there have been reports of 
Leptospira santarosai detection from animals, until August 2015 
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2.4 DISCUSSION 
This systematic review has confirmed that Leptospira are geographically 
widespread, and specific serovars or species have been detected from a 
large range of animal hosts, including amphibians, mammals, and reptiles. 
We have identified serovars and species with limited geographic and 
perhaps animal host range that will have important implications for 
leptospirosis control. Although our review is limited, in that we have not 
recorded studies that have attempted but been unable to detect 
Leptospira, our review does identify knowledge gaps where further 
leptospirosis research is needed. For example, we have identified many 
countries that have a high incidence of human leptospirosis (530), that 
have minimal or absent data on which animal hosts carry specific 
Leptospira serovars or species, as well as pathogenic serovars for whom 
no animal host has been identified.  
 
2.4.1 Host range of Leptospira 
Our review supports the view that Leptospira can infect almost any non-
human animal species (2). We identified isolation of Leptospira from 173 
animal species and while these were predominantly mammals, they also 
included reptiles and amphibians. We did not identify any reports of 
adequately typed isolation of Leptospira from birds or fish, although there 
have been reports of sero-positivity (531), and at least one report of 
isolation of Leptospira from birds (532). There have been reports that 
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Leptospira were unable to be isolated from adult birds during experimental 
infection (533).  It may be that fish can be carriers for Leptospira, and the 
absence of typed isolates is due to insufficient study (32).  
 
2.4.2 Host specificity of serovars or species 
We did find evidence of some degree of host specificity among some 
serovars, such as Hardjo, which has been isolated from only a small 
number of animal species. These have been predominantly ruminant 
livestock, and it is notable that neither L. borgpetersenii serovar 
Hardjobovis, nor L. interrogans Hardjo prajitno have been isolated from 
Rattus species. Other serovars, such as Icterohaemorrhagiae do not 
appear to have host specificity and have been isolated from a large 
number of animal species. There are data indicating that L. borgpetersenii 
has a reduced genome that results in a reduced ability to persist in the 
environment when compared to L. interrogans (11). Our findings show 
host restriction of serovars of L. interrogans and L. borgpetersenii. We did 
not investigate the causes for host specificity with our review. There are 
marked genetic differences between species that influence transmission 
and pathogenicity (11, 28), and whole genome sequencing may further 
elucidate genetic differences among serovars with a limited host range 
from those with a broad host range. 
 
Of the >250 pathogenic serovars of Leptospira recorded, we identified 
reports of isolations of 154 serovars from animal hosts. For many of these 
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serovars there has been a single report of isolation or detection in an 
animal host. The scarcity of data on a large number of pathogenic 
Leptospira subtypes may have several explanations. Explanations could 
include highly localised epidemiology of particular serovars, occasional 
exposure of animals to serovars for which soil is the reservoir, or 
insufficient study and reporting of animal leptospirosis in many areas. 
However, the complex serovar classification scheme, that has undergone 
multiple revisions may also contribute to serovars with a single reported 
isolation (6). 
 
2.4.3 Geographic distribution of Leptospira 
We have confirmed that Leptospira are geographically widespread, with 
typed isolates from every continent except Antarctica. Despite this, there 
are many countries for which there have been few, or no Leptospira typed 
to serovar or species, that have been isolated or detected by PCR in 
animals. Many of these countries are thought to have a high incidence of 
human leptospirosis (530), and it is therefore likely that the absence of 
information reflects a lack of research, rather than an absence of animal 
leptospirosis. As can be seen in Figure 2.3 countries in Africa comprise 
many of those from which data are needed. The data available from our 
review, and that of Allan and colleagues (21), indicates that Leptospira 
infection is common among humans and animals in Africa, and that there 
are many novel serovars. Other regions with a paucity of typed Leptospira 
detections include Central Asia, Scandinavia, and Eastern Europe. 
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2.4.4 Geographically restricted serovars and species 
There are several serovars, serogroups and species for which published 
reports indicate restricted geographical range. For example, all serovars 
from the Louisiana serogroup have been isolated from animals only within 
the United States of America, and Trinidad. Similarly, all serovars from 
within the Panama serogroup have been isolated only in Central America 
or South America. Among Leptospira species, L. noguchi and L. 
santarosai have rarely been reported outside of the Americas. The animal 
species infected with L. noguchi and L. santarosai include several, such as 
livestock, that are not indigenous to the Americas. The ability of even 
geographically restricted species to infect non-indigenous hosts suggests 
that Leptospira may have the ability to spread beyond their current 
geographic range. 
 
One limitation of the Leptospira species distribution we have documented 
is that our knowledge of species distribution is limited to only the period 
after genetic determination of Leptospira species, as serologic 
determination of serovar cannot determine species. As a large proportion 
of the literature included in our review pre-dates common use of PCR, the 
distribution tables must be interpreted cautiously. 
2.4.5 Potential application of host specificity and geographical 
restriction 
Our review indicates some serovars and serogroups have either restricted 
geographical or host range. MAT is not fully reliable for determining the 
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serogroup of the infecting serovar (22). However, marked MAT reactivity 
to serogroups with limited geographic or host range could inform 
epidemiologic investigation to determine source attribution. Serogroups 
with a limited documented host range include Celledoni, and Djasiman. 
Serogroups with a limited host and geographic range include Panama and 
Shermani. When human MAT sero-reactivity is to serogroups with a wide 
host range, epidemiologic investigations to investigate the potential 
reservoir hosts should be correspondingly broad.  Our data indicate that 
most serogroups, including those that are most commonly implicated in 
severe human disease have a broad geographic and host range, implying 
that patterns of MAT sero-reactivity among human leptospirosis cases 
provide only broad guidance into potential sources of infection. Reliable 
data relating to which Leptospira serovar was infecting human cases 
would increase the precision in predicting potential sources of infection, as 
the host range for individual serovars appears to often be more limited. 
Therefore, isolation of Leptospira from human cases, and determination of 
serovar could guide investigation of relevant animal reservoirs of 
leptospirosis, more precisely than MAT data. 
 
The geographical restriction of serovars is useful for clinicians to inform 
management of patients with symptoms compatible with leptospirosis and 
reference laboratories in their epidemiological monitoring. Our study may 
be useful when knowledge of serovars that are present in other locations 
is needed.  An example of such use is in choosing which serovars to 
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include in an MAT antigen panel when diagnosing returning travellers 
unwell with possible leptospirosis. In New Zealand, only six serovars have 
been isolated from animals (L. borgpetersenii serovar Balcanica, L. 
borgpetersenii serovar Ballum, L. Interrogans serovar Copenhageni, L. 
borgpetersenii serovar Hardjobovis, L. Interrogans serovar Pomona, and 
L. borgpetersenii serovar Tarassovi), with a further two serovars isolated 
only from humans (L. interrogans serovar Australis and L. interrogans 
serovar Canicola). The panel of antigens used during MAT at New 
Zealand’s Leptospira reference laboratory, the Institute of Environmental 
Science and Research Limited (ESR), contains only those serovars 
isolated from New Zealand (personal email communication, 26 Oct 17, 
Karen Cullen, ESR, New Zealand). Best practice when performing MAT is 
to use as antigens, a panel of serovars that represent locally circulating 
strains (22). Although we have recorded only typed Leptospira from non-
human animals, results of our systematic review could identify which 
serogroups should be represented in MAT antigen panels used to 
diagnose people whose leptospirosis was acquired overseas.  
 
2.4.6 Implications of our review for leptospirosis research in northern 
Tanzania 
In 2007-2008 the serogroups containing the serovar to which humans 
most frequently had the highest reactive titre were Mini and Australis.  Our 
review has identified the known host range for serovars from within these 
serogroups. For Mini this includes cattle and dogs, but not other livestock 
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such as goats, pigs, or sheep. It also includes wild animals including 
rodents, as well as animal species such as opossums that are not found in 
Tanzania. Serovars from serogroup Australis have been found in a wide 
range of animal species including multiple species of livestock, rodent and 
other livestock. Our review indicates the need to maintain broad lines of 
inquiry when investigating leptospirosis in Tanzania. 
 
The serovars and species detected in Africa have been documented 
previously (21), and our results are comparable. As we included only 
reports that used robust identification of Leptospira serovar or species, 
reports of detection of Leptospira from animals in Africa, such as 
mongoose (534), which have been recorded by Allan et al, were excluded 
from our review. 
 
Our review has the ability to inform which serovars are included in 
Leptospira microscopic agglutination test (MAT) panels. Subsequent to 
our systematic review search, there has been a publication describing the 
optimal MAT panel in Tanzania (20). Although our review does not include 
reports from humans, it identifies several serovars, not included in the 
panel suggested by Mgode and colleagues (20) that have been isolated 
from animals in Africa and could be included in an expanded serovar 
panel. 
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2.4.7 Study limitations 
Our systematic review has limitations that influence interpretation. It is 
likely that we have not recorded every isolation of Leptospira from every 
animal host. This could be due to the failure of our search terms to identify 
reports, or our failure to complete a full-text review of identified articles 
because we could not either obtain or translate the article.  It is likely that 
there are unpublished reports in reference collections, and reference 
collections with strains for which the source animal has not been reported. 
 
It is also likely that there has been misclassification of reported isolates. 
Leptospira serovar and species classification has undergone several 
major changes, with addition and subtraction of species, the genesis and 
alteration in the definition of serovar, and renaming of serovars (6, 29, 30). 
Early serotype determinations were not standardised, and the reference 
standard for most of the 20th century, cross-agglutination absorption 
testing, is a complex test to perform. As evidence of the difficulties such 
complexity produces, we identified published reports where authors 
identified errors in their own earlier classification of isolates (144, 535). 
The tables of serovar-animal host associations that we have summarised 
are likely to be insensitive for determining host range. Potential reasons 
include the difficulties of culturing Leptospira (536) and, the intermittent 
shedding of bacteria by host animals (537). We have been unable to 
identify adequately all negative cultures, there is likely to be a reporting 
bias, and some animal species have been rarely studied. Therefore, the 
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lack of documented isolation of a serovar from a particular animal host 
does not necessarily indicate that an animal is protected from infection. 
Loss of provenance of isolates is also a limitation of our data. Detailed 
typing of isolates by reference laboratories may be performed without 
citing the origin of the isolate. One notable example of this, is the first 
description of L. kirschneri, which includes several field isolates from New 
Zealand, but does not identify the host animal (538). 
 
We have recorded only studies that typed strains of Leptospira to serovar 
or species level. From our study it is not possible to determine if absence 
of a serovar or species from a location is due to the serovar or species not 
being present, or not being sought by researchers. Although we think that 
documentation of studies that did not find Leptospira would have been a 
useful addition to our study, it was not possible due to the insensitivity of 
culture and PCR at detecting Leptospira, and the challenge of defining 
what constitutes a sufficiently robust effort at detecting Leptospira. 
 
Only static tables are possible in a thesis. The data we have collected, 
may be relevant to researchers in many different formats, or with different 
filters than those presented in this thesis. Presenting the data in a flexible, 
searchable format would increase the utility of our study. We have plans to 
create an open-access database that allows researchers to search and 




Our systematic review indicates that Leptospira are broadly distributed 
geographically. They can infect a large number of mammals, and less 
commonly amphibians and reptiles. We identified several serovars, most 
notably serovar Hardjo that appears to have a limited host range, whereas 
many other serovars have been isolated from a much broader range or 
host animals. Serovars within one serogroup commonly have disparate 
documented animal hosts, and geographic ranges. This means that 
human MAT sero-reactivity patterns that are in most circumstances 
serogroup specific, give only very broad guidance about leads for 
epidemiologic investigation. 
 
In Tanzania, there is extremely sparse data on hosts of Leptospira. 
Conversely, on a global scale, there is a broad range of potential animal 
hosts for serogroup Mini and Australis, the serogroups to which humans 
with leptospirosis have the highest MAT titres. Investigation of both 
livestock and wild animals as potential reservoirs of human leptospirosis is 
needed. Isolation of Leptospira and serovar determination of human cases 
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Chapter 3. Prevalence of 
leptospirosis in patients 
attending hospital with a fever 
in northern Tanzania 
3.1 INTRODUCTION  
3.1.1 Why determine the prevalence of acute leptospirosis? 
Determining the prevalence of acute leptospirosis is an important 
component of investigating its epidemiology and has several advantages 
over investigations of community seroprevalence. First, there are 
uncertainties about the correlation of seropositivity and disease as 
individuals may seroconvert without noticeable symptoms (1). Therefore, 
prevalence of acute leptospirosis provides a starting point for investigating 
burden of disease. Secondly, as infection with Leptospira is likely to have 
occurred from a specific exposure, comparing the characteristics of cases 
of acute leptospirosis with other acute febrile illnesses allows more robust 




3.1.2 Case identification 
Although leptospirosis is associated with Weil’s disease (the syndrome of 
fever, jaundice and acute kidney injury due to leptospirosis) and fever with 
pulmonary haemorrhage, leptospirosis most commonly causes a non-
specific febrile illness (1). There have been attempts to derive clinical 
prediction scores for leptospirosis (2-5), but these appear either 
insufficiently sensitive or specific outside the institutions in which they 
were derived. For example, Rajapakse and colleagues investigated a 
clinical prediction model in Sri Lanka, which had a sensitivity of 80.3% and 
a specificity of 60.0% when compared with a Leptospira microscopic 
agglutination test demonstrating either a single titre ≥400 or a 4-fold rise in 
antibody titre between acute and convalescent serum samples (2). In their 
model, need for dialysis was the most discriminative variable. However, 
this finding was heavily influenced by their site of recruitment within a 
tertiary dialysis unit. In northern Tanzania, dialysis is not readily available 
and so the Rajapakse score is unlikely to perform well in our setting. In the 
absence of reliable clinical detection, we considered that a study to 
estimate the prevalence of acute leptospirosis should do so among all 
patients with a fever seen at hospital. 
 
3.1.3 Choice of surveillance sites 
The Tanzanian health system contains multiple levels of healthcare 
facilities. Patients with serious febrile illness who present to first level 
health care centres can be referred to secondary or tertiary referral 
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hospitals, but patients may also choose to present direct to secondary or 
tertiary hospitals (6).  Advantages of determining prevalence at tertiary 
referral hospitals include determining prevalence among the most severely 
ill patients and maximising our ability to draw conclusions across northern 
Tanzania. The disadvantage is that many patients who present at tertiary 
hospitals may be later in their illness, and have already received 
antimicrobial drugs (6), which has made leptospiraemia less likely, and 
diagnosis more difficult by molecular or cultural methods (7). In addition, 
as discussed in detail in Chapter 4 of this thesis, some patients with 
severe or fatal disease are unable to access hospital care. 
 
3.1.4 Aim 
I hypothesised that within Tanzania the prevalence of leptospirosis varies, 
as there is variation in exposure to it in different ecological settings. We 
aimed to determine the prevalence of leptospirosis in patients with fever 
who attended two Tanzanian tertiary hospitals in the city of Moshi and at 
Endulen Hospital in the Ngorongoro Conservation Area.  
 
3.2 METHODS 
3.2.1 Study sites 
Moshi, Kilimanjaro Region: We studied patients at two referral hospitals in 
Moshi: Kilimanjaro Christian Medical Centre (KCMC) and Mawenzi 
Regional Referral Hospital (MRRH). The hospitals’ locations are marked in 
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Figure 3.1. Moshi is the administrative centre for the Kilimanjaro Region 
that has a population of 1.6 million. The city is at approximately 890m 
above sea level. It has a tropical climate with rainy seasons from October 
through December and March through May. Aside from urban Moshi, the 
Region is rural with inhabitants practising cultivation and small-holder 
farming. KCMC is a 450-bed hospital and the zonal referral centre for 
several regions in Northern Tanzania. MRRH is a 300-bed hospital and 
the referral centre for the Kilimanjaro Region.  
 
Endulen, Ngorongoro Conservation Area, Arusha Region: We recruited 
participants at Endulen Hospital, also marked on Figure 3.1, in the 
Ngorongoro Conservation Area (NCA) in northern Tanzania. Endulen 
hospital is an 86-bed hospital and the only hospital in the southern NCA. 
The NCA has a tropical climate, with a single rainy season from November 
through May. The elevation of the NCA ranges from approximately 
1,000m-3,600m above sea level. Almost all inhabitants of the NCA are 





Figure 3.1 Satellite photograph of Tanzania indicating the location of 
Endulen and Moshi. Satellite photograph courtesy of the National 
Aeronautics and Space Administration Goddard Space Flight Center and 
U.S. Geological Survey. The trimmed image has been obtained from 
maplibrary.org (8)  
 
3.2.2 Study procedures 
3.2.2.1 Moshi  
From 20 February 2012 through 28 May 2014 the study team approached 
all adult patients with a febrile illness who were admitted to KCMC and all 
adult or paediatric patients who were admitted at MRRH.  In addition, we 
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approached every second patient who presented with fever to the 
outpatient department at MRRH. Hospitalized participants were eligible for 
enrolment if they had a history of fever within the previous 72 hours, an 
axillary temperature of >37.5°C or a tympanic, oral, or rectal temperature 
of ≥38.0°C at admission. Non-hospitalized patients were eligible if they 
had an axillary temperature of >37.5°C or a tympanic, oral, or rectal 
temperature of ≥38.0°C. All adult study participants provided written 
informed consent. For those under 18 years, a parent or guardian 
provided written informed consent. In addition, written assent was 
provided for those aged 12 to 18 years. Enrolment occurred only on 
weekdays. Enrolled patients underwent a standardised clinical history and 
examination, and phlebotomy. Blood was allocated for acute leptospirosis 
serology and culture, only if there was a sample available after blood 
parasite microscopy and standard aerobic blood culture. 
 
3.2.2.2 Endulen 
From June 2016 through April 2017 the study team approached all 
patients admitted to Endulen Hospital. Patients were eligible to enrol if 
they had a history of fever with 72 hours, or a measured tympanic 
temperature of ≥38.0°C. All adult study participants provided written 
informed consent. For those under 18 years of age, a parent or guardian 
provided written informed consent. In addition, written assent was 
provided for those aged 12 to 18 years. Maa (the first language of the 
Maasai tribe) speaking study personnel then undertook a standardized 
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clinical history and physical examination. Enrolment occurred only on 
weekdays. Enrolled patients underwent phlebotomy, with blood allocated 
for acute leptospirosis serology only if there was sample available after 
blood parasite microscopy and blood culture. Study team members visited 
participants at their homes 4-6 weeks after enrolment for collection of a 
convalescent serum sample.  
 
3.2.3 Laboratory techniques 
3.2.3.1 Serology 
Serology for leptospirosis was performed on acute and convalescent 
serum samples using the standard microscopic agglutination test (MAT) 
with a panel of 20 Leptospira serovars belonging to 17 serogroups at the 
US Centers for Disease Control and Prevention (CDC). These included 
serogroups: Australis (represented by L. interrogans serovar Australis, L. 
interrogans serovar Bratislava), Autumnalis (L. interrogans serovar 
Autumnalis), Ballum (L. borgpetersenii serovar Ballum), Bataviae (L. 
interrogans serovar Bataviae), Canicola (L. interrogans serovar Canicola), 
Celledoni (L. weilii serovar Celledoni), Cynopteri (L. kirschneri serovar 
Cynopteri), Djasiman (L. interrogans serovar Djasiman), Grippotyphosa (L. 
interrogans serovar Grippotyphosa), Hebdomadis (L. santarosai serovar 
Borincana), Icterohaemorrhagiae (L. interrogans serovar Mankarso, L. 
interrogans Icterohaemorrhagiae), Javanica (L. borgpetersenii serovar 
Javanica), Mini (L. santarosai serovar Georgia), Pomona (L. interrogans 
serovar Pomona), Pyrogenes (L. interrogans serovar Pyrogenes, L. 
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santarosai serovar Alexi), Sejroe (L. interrogans serovar Wolffi), and 
Tarassovi (L. borgpetersenii serovar Tarassovi). MAT was performed 
beginning at a dilution of 1:100, with subsequent two-fold dilutions. 
Positive controls were performed with every run, using known anti-sera. 
Negative controls were performed with every run. 
 
3.2.3.2 Culture 
We cultured the blood of participants enrolled at KCMC and MRRH for 
Leptospira. Leptospira blood culture was performed by inoculating 
Ellinghausen-McCullough-Johnson-Harris (EMJH) media with 3 drops of 
whole blood. The EMJH media was modified by inclusion of 5-fluorouracil. 
The inoculated EMJH was stored at room temperature for up to six weeks. 
Inoculated media was batch shipped to the US Centres for Disease 
Control and Prevention, Atlanta, Georgia, where it was maintained at 30°C 
and was checked weekly for a period of 6 months. 
 
3.2.4 Case definitions 
We defined acute leptospirosis as any one of the following: 
1. Serology:  
a. A four-fold rise in antibody titre between the acute and the 
convalescent serum samples, or  
b. any single reciprocal titre ≥800. 
2. Culture: Growth of Leptospira spp.  
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We defined Leptospira seropositivity as a single reciprocal antibody titre 
≥100.  
 
We defined the predominant reactive serogroup for cases and seropositive 
participants as the serogroup containing the serovar with the highest titre. 
 
3.2.5 Data management and statistical methods 
Data were collated in Microsoft Excel (Microsoft Corporation, Redmond, 
WA, USA), and analysed using Stata, version 13.1 (StataCorp, College 
Station, TX, USA). Differences in prevalence were calculated using a two-
sample test of proportions. P values are two sided, and significance was 
set at 0.05. 
3.2.6 Research ethics 
3.2.6.1 Moshi fever surveillance study 
We conducted this study in accordance with the Declaration of Helsinki. It 
was approved by the KCMC Research Ethics Committee (#295), the 
Tanzania National Institutes for Medical Research National Ethics 
Coordinating Committee (NIMR1HQ/R.8cNo1. 11/283), Duke University 
Medical Center Institutional Review Board (IRB#Pro00016134), and the 
University of Otago Human Ethics Committee (Health) (H15/055). We 
obtained written informed consent from all participants or their guardians. 
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3.2.6.2 Endulen fever surveillance study 
We conducted this study too in accordance with the Declaration of 
Helsinki. It was approved by the Tanzania National Institutes for Medical 
Research National Ethics Coordinating Committee (NIMRlHQ/R.8cIV01 
11/708), Glasgow University, College of Medical, Veterinary and Life 
Sciences Ethics Committee (200150140), and the University of Otago 
Human Ethics Committee (Health) (H17/052). Written informed consent 




3.3.1 Moshi serology  
Of 15,305 patients admitted and 30,413 presenting to the outpatient 
department, 2,962 (6.5%) met eligibility criteria. Of those, 1,398 (47.2%) 
were enrolled with 1,294 (92.5%) having serum tested for leptospirosis. Of 
the 1,294, 767 (59.3%) had paired serum samples collected, 381 (29.4%) 
had only acute serum collected, and 146 (11.2%) had only convalescent 
serum collected. Overall, 24 (1.9%, 95% confidence intervals 1.1-2.7%) 
met the study criteria for acute leptospirosis and 252 (19.5%, 95% 
confidence intervals 17.3-21.7%) were seropositive. The predominantly 
reactive serogroup for participants with acute leptospirosis and 
seropositive participants are listed in Tables 3.1 and 3.2 respectively. 
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Table 3.1 Serogroup to which participants with acute leptospirosis 
predominantly reacted, northern Tanzania, 2012-2014 and 2016-2017 
Serogroup Moshi Study (N=24)  Endulen study (N=6) 
 n % (95% CI)  n % (95% CI) 
Australis 9 37.5 (18.8-59.4)  1 6.7 (0.4-64.1) 
Autumnalis 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Ballum 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Bataviae 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Canicola 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Celledoni 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Cynopteri 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Djasiman 3 12.5 (2.7-32.4)  2 33.3 (4.3-77.8) 
Grippotyphosa 2 8.3 (1.0-27.0)  0 0.0 (0.0-45.9) 
Hebdomadis 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Icterohaemorrhagiae 3 12.5 (2.7-32.4)  1 16.7 (0.4-64.1) 
Javanica 0 0.0 (0.0-14.2)  1 16.7 (0.4-64.1) 
Mini 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Pomona 0 0.0 (0.0-14.2)  0 0.0 (0.0-45.9) 
Pyrogenes 2 8.3 (1.0-27.0)  0 0.0 (0.0-45.9) 
Sejroe 4 16.7 (4.7-37.3)  0 0.0 (0.0-45.9) 




Table 3.2 Serogroup to which Leptospira seropositive participants 
predominantly reacted, northern Tanzania, 2012-2014 and 2016-2017 
Serogroup Moshi Study (N=271)  Endulen study (N=45) 
 n % (95% CI)  n % (95% CI) 
Australis 66 24.4 (19.3-29.9)  8 17.8 (8.0-32.1) 
Autumnalis 3 1.1 (0.2-29.9)  0 0.0 (0.0-7.9) 
Ballum 0 0.0 (0.0-1.4)  0 0.0 (0.0-7.9) 
Bataviae 4 1.5 (0.4-3.7)  0 0.0 (0.0-7.9) 
Canicola 3 1.1 (0.2-29.9)  1 2.1 (0.1-11.8) 
Celledoni 1 0.4 (0.0-2.0)  1 2.2 (0.1-11.8) 
Cynopteri 0 0.0 (0.0-1.4)  0 0.0 (0.0-7.9) 
Djasiman 13 4.8 (2.0-7.1)  9 20.0 (9.6-34.6) 
Grippotyphosa 2 0.7 (0.1-2.6)  3 6.7 (1.3-18.3) 
Hebdomadis 2 0.7 (0.1-2.6)  0 0.0 (0.0-7.9) 
Icterohaemorrhagiae 151 55.7 (49.5-61.7)  9 20.0 (9.6-34.6) 
Javanica 0 0.0 (0.0-1.4)  2 4.4 (0.5-15.1) 
Mini 7 2.6 (1.0-5.2)  2 4.4 (0.5-15.1) 
Pomona 0 0.0 (0.0-1.4)  0 0.0 (0.0-7.9) 
Pyrogenes 4 1.5 (0.4-3.7)  1 2.2 (0.1-11.8) 
Sejroe 11 4.1 (2.0-7.1)  3 6.7 (1.3-18.3) 
Tarassovi 4 1.5 (0.4-3.7)  6 13.3 (5.0-26.8) 
 
Footnote: In the Moshi study, there were 17 participants who had equal 
titres to 2 serogroups (1 Australis and Sejroe, 7 Australis and 
Icterohaemorrhagiae, 1 Australis and Djasiman, 1 Australis and 
Pyrogenes, 1 Australis and Tarassovi,  1 Australis and Autumnalis, 2 
Sejroe and Icterohaemorrhagiae, 1 Sejroe and Djasiman, 1 
Icterohaemorrhagiae and Djasiman, and 1 Hebdomadis and Bataviae) and 
1 participant who had equal titres to 3 serogroups (Australis, 
Icterohaemorrhagiae and Canicola). In the Endulen study, there were 3 
participants with equal titres to 2 serogroups: (Djasiman and Javanica, 
Tarassovi and Wolffi, and Icterohaemorrhagiae and Tarassovi), and 1 
participant who had equal titres to 6 serogroups (Celledoni, Mini, 
Icterohaemorrhagiae, Javanica, Pyrogenes, Wolffi.) 
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3.3.2 Moshi culture  
Of 1,398 participants enrolled in the study, 1,342 (96.1%) had blood 
cultured for Leptospira. Leptospira was not isolated from the blood of any 
participant. 
 
3.3.3 Endulen serology  
We screened 2,463 patients presenting to the outpatient department at 
Endulen Hospital. Of 129 eligible patients, we enrolled 104 (80.6%) 
participants. We collected both acute and convalescent serum samples 
from 60 (57.7%) participants, an acute serum sample only from 40 
(38.5%), and a convalescent serum sample only from 4 (3.8%). 
 
We identified 6 (5.8%, 95% confidence intervals 2.1-12.1%) cases of 
acute leptospirosis. The leptospirosis cases comprised six (10.0%, 95% 
confidence intervals 3.8-20.5%) of 60 participants for whom we tested 
paired serum samples, and 0 (0.0%, 95% confidence intervals 0-3.5%) of 
44 participants for whom we tested a single serum sample. In total, 37 
(35.6%, 95% confidence intervals 26.4-45.6%) participants (including 6 
cases of acute leptospirosis) were seropositive to Leptospira. The 
predominant reactive serogroups of participants with acute leptospirosis 




3.3.4 Demographic characteristics of participants at the two sites 
The clinical and demographic characteristics of participants are included in 
Table 3.3.  From the Moshi hospitals, the median duration of fever was 4.0 
days at the time of enrolment. Of those diagnosed with leptospirosis in 
Moshi, the median (range) age was 37 (2-69) years, the median duration 
of fever (range) was 7 (1-90) days, 19 (79.2%) reported headache, 12 
(50.0%) reported myalgia and 1 (4.2%) had conjunctival suffusion. None 
were jaundiced. 
Table 3.3 Clinical and demographic characteristics of participants 
with fever, at Moshi, Tanzania, 2012-2014, and Endulen, Tanzania 
2016-17 
 Moshi Hospitals (N=1294) Endulen Hospital (N=104) 
 N % (95% CI) N % (95% CI) 
Age, median in years 
(range) 
23.6  (0.3-77.2) 27.0  (0.0-77.2) 
Fever duration, median 
in days (range)  
4.0  (1.0-68.5) Not available  
Conjunctivitis 56 4.3 (3.3-5.6) Not available  
Headache 767 59.3 (56.6-62.0) Not available  
Jaundice 39 3.0 (2.2-4.1) Not available  
Myalgia 381 37.2 (34.6-39.9) Not available  
Taken antibacterial 
drugs 
1171 90.5 (88.8-92.1) Not available  
Occupations       
Farmer 235  18.1 (16.0-20.3) 0 0.0 (0.0-3.4) 
Merchant 217 16.8 (14.8-18.9) 5 4.8 (1.5-10.9) 
Office worker 166  12.8 (11.0-14.8) 5 4.8 (1.5-10.9) 
Rancher/ livestock 
keeper 
73 5.6 (4.4-7.0) 43 41.3 (31.8-51.4) 
Other 610 46.9 (44.3-49.9) 51 49.0 (39.1-59.0) 
Male 595 46.0 (43.2-48.7) 50 48.0 (38.1-58.1) 
Ethnic group       
Chagga 651 50.4 (47.5-53.1) 5 4.8 (1.5-10.9) 
Pare 190 14.7 (12.8-16.7) 1 1.0 (0.0-5.2) 
Samba 66 5.1 (3.9-6.4) 0 0.0 (0.0-3.4) 
Maasai 15 1.2 (0.6-1.9) 66 63.5 (53.3-72.7) 
Other 371 28.7 (26.2-31.2) 32 30.7 (22.0-40.6) 
Abbreviations: CI= Confidence interval 
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3.3.5 Comparison between study sites 
Participants enrolled at the Moshi hospitals were more likely to be small-
holder farmers or merchants, and of Chagga or Pare ethnicity, whereas 
those enrolled at Endulen Hospital were more likely to be livestock 
keepers and of Maasai ethnicity. The prevalence of acute leptospirosis at 
Endulen Hospital was higher than at the two Moshi Hospitals (p=0.01). 
The prevalence of seropositivity at Endulen Hospital was also higher than 
at the two Moshi hospitals (p=0.001). We did not identify any difference in 
patterns of serogroup reactivity among cases of leptospirosis. Seropositive 
participants in Moshi were more likely to have their highest antibody titre to 
serogroup Icterohaemorrhagiae, while those at Endulen were more likely 
to have their highest antibody titre to serogroup Djasiman.  
 
3.4 DISCUSSION 
We conducted systematic surveillance for leptospirosis in two centres in 
northern Tanzania and found it to be an important cause of fever in both.  
The centres include an urban, agro-pastoralist, smallholder farm, and 
extensive pastoralist farming systems areas, which suggest that 




3.4.1 Comparison of the prevalence among participants in Endulen 
and Moshi 
The prevalence of acute leptospirosis was higher at rural Endulen hospital 
than at hospitals in urban Moshi. The study design at both sites was very 
similar, and so it is likely that either the epidemiology of leptospirosis was 
temporally dynamic, or that behavioural or environmental risk factors were 
different between the sites. There are few data, and no longitudinal data 
on the prevalence of acute leptospirosis among febrile patients in Africa 
(9, 10).  In Moshi, 8.4% of patients admitted with fever to KCMC or MRRH 
had either confirmed or probable acute leptospirosis during 2007-2008 
(11). Using current case definitions from the CDC (12), the probable cases 
of leptospirosis would all be considered confirmed cases. The data 
collected from two hospitals in Moshi over two separate time periods 
indicate a changing prevalence. This could be due to changes in the 
incidence of infection or changes in either population or healthcare 
seeking behaviours. In Chapter 4 of this thesis, we investigate the 
incidence of leptospirosis in the Moshi Urban and Rural Districts.  
 
As discussed in detail in Chapter 10, the sensitivity of MAT has been 
estimated as <10% when performed on an acute serum sample and >80% 
when performed on paired serum. As approximately 40% of participants at 
each site provided a single serum sample for MAT it is likely that we have 
underestimated the prevalence among patients with fever. As decedents 
are unable to provide a convalescent serum sample, we will have under-
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diagnosed fatal cases. As we did not determine the duration of fever 
among participants attending Endulen Hospital, the possibility that varied 
duration of illness may have influenced the observed prevalence cannot 
be discounted. 
 
3.4.2 Analysis of patterns of predominantly reactive serogroups 
We identified 24 participants in the Kilimanjaro Region with acute 
leptospirosis, who were most frequently sero-reactive to serovars from the 
Australis and Sejroe serogroups, with smaller numbers of cases showing 
dominant sero-reactivity to serovars within the Icterohaemorrhagiae, 
Djasiman, Grippotyphosa, Pyrogenes, and Tarassovi serogroups.  In the 
Endulen Hospital catchment area, we identified 6 cases, and they were 
sero-reactive to serovars from 5 separate serogroups including Australis, 
Djasiman, Icterohaemorrhagiae, Javanica, and Tarassovi. While it has 
been shown that MAT is an imperfect predictor of infecting serovar (13), 
dominant reactive serogroups may give some indication as to serovars 
circulating the regions. It is therefore of interest that there is a 
considerable overlap between the two studies areas as it may indicate 
similar reservoir hosts.   
 
Our systematic review of the host range of Leptospira serovars (Chapter 
2) provides insights into possible reservoir hosts of Leptospira from the 
serogroups to which patients with fever were most commonly seroreactive. 
We identified that Australis serogroup serovars, isolated in Africa until 
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2015, were from brown field rats (Arvicanthus niloticus) in Nigeria and 
from cattle in Zimbabwe. Subsequent to the date we performed our 
systematic database search, Mgode and colleagues have reported that 
they isolated serovar Lora from serogroup Australis from multi-mammate 
rats (Mastomys sp.) (14). Our systematic review identified reports that 
serovars from serogroup Sejroe have been isolated in Nigeria, South 
Africa, and Zimbabwe.  We were unable to identify any serovars from the 
Djasiman serogroup that have been isolated from animals in Africa. 
Worldwide, we identified that serovars from the Djasiman serogroup have 
been isolated from dogs, and opossums (Didelphis marsupialis) in South 
America, as well as palm civets (Paradoxurus hermaphroditus) and rats 
(Rattus bowersi) in Asia, and ground squirrels (Spermophilus citellus) in 
Europe. Serovars from the Icterohaemorrhagiae serogroup have been 
isolated from cattle and Norwegian rats (Rattus norvegicus) from Algeria, 
South Africa, Tanzania, and Zimbabwe. In addition, Mgode and colleagues 
have subsequently reported the isolation of serovar Sokoine, a member of 
serogroup Icterohaemorrhagiae, from cattle and the giant African pouched 
rat (Cricetomys sp.) in Tanzania (14).  
 
3.4.3 Variation in prevalence of seropositivity among participants in 
Endulen and Moshi 
We found differences in ethnicity and occupation of participants between 
our study sites in Moshi and Endulen consistent with recent census data 
(15). Our Moshi sites enrolled participants who predominantly were either 
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urban residents, or small-holder farmers with mixed cropping and small 
numbers of livestock. At Endulen Hospital, where we enrolled 
predominantly pastoralist farmers of Maasai ethnicity, we identified 35.6% 
of participants as seropositive, with a reciprocal titre of ≥100 against at 
least one serovar. In the two Moshi hospitals we identified 19.5% as 
seropositive using the same criteria. Both these prevalence estimates are 
high by global standards.  Recent systematic reviews highlight that the 
estimates of seroprevalence in our studies are higher than many other 
sites in East Africa (9, 10).  Within Tanzania, there have been marked 
variations in seroprevalence. Machangu and colleagues found a 
seroprevalence of only 0.3% among healthy cane-cutters from Kilombero, 
Zanzibar who were tested using MAT with two serovars 
(Icterohaemorrhagiae and Grippotyphosa) included in the antigen panel 
(16). This can only partly be explained by variations in study design, 
including the choice of participants and the number of serovars included in 
the MAT panel. It is plausible that there is a difference in prevalence 
between the healthy workers studied by Machangu and patients with 
fever. A difference in prevalence could relate to non-specific cross 
reactivity among febrile patients mounting an immune response (17). 
Alternatively, participants presenting with fever are at increased risk of 
being seropositive for leptospirosis because of a correlation in acquisition 
of multiple infectious disease through shared risk factors for leptospirosis 
and other infections. For example, living with an open sewer near the 
house, may be a risk factor for both typhoid fever (18) and leptospirosis 
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(19).  There was potential underestimation of the true prevalence of 
Leptospira seropositivity in the Machangu study through use of a limited 
panel of two serovars, Icterohaemorrhagiae and Grippotyphosa. They did 
not include serovars such as Djasiman and Australis, for which 
participants in our study were frequently seropositive. Notably 
Icterohaemorrhagiae was the most common serovar to which participants 
were seropositive at both the Endulen Hospital and the Moshi sites. 
Therefore, it seems likely that at least part of the difference between 
reported prevalence is due to a combination of variation of risk behaviours 
and livestock keeping practices between locations and changes in 
epidemiology over time.  
 
That there was a difference in serogroup reactivity patterns between 
participants who were seropositive and those who had leptospirosis is 
notable. Possible explanations include serologic cross-reaction, variations 
in disease severity by serogroup and changing epidemiology over time. 
The suggestion of changing seroprevalence over time is also supported by 
longitudinal data from febrile illness surveillance in Moshi in 2007-2008 
(11), in which the prevalence of seropositivity at 36.4% was higher than 
during our study in 2012-14.  
 
3.4.4 Universally negative Leptospira cultures  
Determining circulating serovars of Leptospira through isolation by culture 
is an important component of epidemiological investigations. However, the 
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sensitivity of Leptospira culture is low, around 10% (20), and isolation is 
uncommon. The universally negative culture results in our study likely 
reflect the low sensitivity of the test, as well as our methods and 
characteristics of our patients’ illness.  The duration of symptoms appears 
particularly important for successful isolation, with isolation rarely 
successful after 5 days of illness (21). In our cohort, the median duration 
of fever was 4.0 days, which means that for many participants the period 
of leptospiraemia may have passed by the time blood was drawn for 
culture. In addition, in our study, as in previous studies of patients with 
fever in Tanzania, there was widespread use of antibacterials prior to 
presentation at hospital (7). Recent use of an antibacterial is likely to 
decrease the viability of Leptospira, and the sensitivity of Leptospira 
culture. While alternative media, including Kortkoff’s and Stuart’s media, 
are available there is no evidence that they are more sensitive than EMJH 
media (21, 22). Finally, the transport of early Leptospira cultures from 
Moshi to the CDC in Atlanta, may have also adversely affected the 
sensitivity of culture. 
 
3.4.5 Conclusions 
In summary, we have identified that leptospirosis was an important cause 
of fever at two tertiary hospitals in Moshi, Kilimanjaro Region, and at a 
rural secondary level hospital in Endulen, Ngorongoro Conservation Area. 
We identified that the prevalence of leptospirosis was higher among 
patients with fever at Endulen than in Moshi during the time periods we 
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studied, providing evidence that the prevalence of leptospirosis varies 
geographically and temporally within northern Tanzania.  
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Chapter 4. Estimation of the 
incidence of acute human 
leptospirosis in the Moshi 
Urban and Moshi Rural 
Districts, Tanzania, 2012-14 
 
4.1 INTRODUCTION 
A recently published systematic review estimated leptospirosis caused 
1.03 million cases, 59,000 deaths annually (1).  The systematic review 
identified tropical countries, which includes Tanzania, as having among 
the highest incidence. Empiric data are needed to support these estimates 
and ensure appropriate resources for diagnosis, treatment, and 
prevention.  
4.1.1 Previous estimates of the incidence of leptospirosis in Tanzania 
Reports that estimate the incidence of leptospirosis from locations in 
continental Africa are scarce. That scarcity may be caused by the 
unavailability of diagnostic tests (2), low clinician awareness (3), and non-
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specific clinical presentation of leptospirosis (4).  Prior to our study, there 
were just two estimates of the incidence of leptospirosis in Tanzania (1, 5) 
with important differences between them, both in overall incidence and the 
structure of incidence with respect to age. Costa and colleagues published 
an estimate of the annual incidence of leptospirosis in Tanzania among 
global estimates of leptospirosis morbidity and mortality (1). This estimate 
was based on a prediction model derived from a systematic review of 
studies of reported leptospirosis incidence performed between January 
1970 and October 2008. The authors assessed study quality against four 
domains (methods for identifying the study population, methods for 
measuring incidence, sources of bias, and data analysis). They developed 
a meta-regression model that utilised data from the medium and high-
quality studies to estimate country specific leptospirosis incidence based 
on distance from the equator, percentage urbanisation of the population, 
life expectancy at birth, and location on a tropical island. This systematic 
review identified only a small number of studies: eight considered high 
quality and 72 medium-quality, which altogether were obtained mostly 
from five regions: 15 (19%) from Western Europe, 14 (18%) from the 
Caribbean, 10 (13%) from South-East Asia, 10 (13%) from tropical Latin 
America, 8 (10%) from Oceania. They included only two (3%) studies from 
Africa. Costa and colleagues estimated that the incidence of leptospirosis 
in Tanzania was 20·89 (95% confidence intervals [CI] 7·27 – 38·34) 
annual cases per 100,000 people. The highest incidence was among 
adults, and the incidence estimates for males and females under the age 
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of 5 years were 4.13 (95% CI 1.41-7.24) and 0.86 (95%CI 0.31-1.49), 
respectively. 
 
There is a single estimate of incidence based on empiric data for 
Tanzania. This estimate was for the Moshi Rural and Moshi Urban 
Districts of the Kilimanjaro Region of Tanzania for the period September 
2007 through August 2008 (5). Biggs and colleagues estimated the 
incidence of acute leptospirosis from hospital surveillance data by 
multiplying the prevalence of leptospirosis at surveillance sites both by the 
factors to account for the proportion of patients attending the surveillance 
hospitals who were tested for leptospirosis and those derived from a 
health-care utilisation survey that accounted for the proportion of those 
with a compatible illness seeking care at a surveillance site. They 
estimated the incidence of leptospirosis in the Moshi Rural and Moshi 
Urban Districts to be 75-102 annual cases per 100,000 people. This 
estimate was notable because it was one of the highest global annual 
incidences reported and substantially higher than that predicted by the 
model of Costa and colleagues. Additionally, Biggs found that children had 
a higher estimated incidence than adults, with an estimated annual 
incidence of 175-288 cases per 100,000 people for those aged under 5 
years, 149-161 cases per 100,000 people for those aged 5-15 years and 
33-59 cases per 100,000 people for those aged over 15 years. This is an 
inversion of the age specific incidence estimates of Costa.  
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4.1.2 Factors that may account for the variation in published 
estimates of leptospirosis incidence 
There are several factors that may explain the variation in the published 
estimates of incidence, including study methodology, and spatial and 
temporal variations in incidence. As illustrated above, there were major 
differences in the methodology of the studies of Biggs and Costa that may 
account for the different estimates. Regional variation in incidence might 
also explain a difference between a national estimate and that for a 
specific district.  Determinants of leptospirosis transmission including 
environmental factors, such as climate, presence of standing water and 
whether the location is rural or urban, and population factors, such as 
socio-economic status and predominant industries, could all vary 
according to location and could thus influence incidence (6). For example, 
Hawaii, which has markedly different environmental conditions, with a 
tropical island climate, from the mainland United States of America, has a 
markedly higher incidence of leptospirosis (7, 8). Similarly leptospirosis 
incidence varies between cities in Brazil (9).  
 
The incidence of leptospirosis may also vary in a single location over time. 
Leptospirosis is a zoonotic disease that can have stable transmission 
among reservoir hosts. Human beings are accidental hosts infected 
through contact with the urine of infected animal hosts or through contact 
with water contaminated by urine of infected animal hosts. Changes in 
epidemiology among reservoir and source species, distribution of surface 
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water, or human behaviour might all influence the incidence of human 
leptospirosis. In addition to endemic disease, there have been many 
epidemics of leptospirosis internationally, including in Nicaragua (1995) 
(10), Brazil (1996) (11), India (1999) (12), Indonesia (2002), Guyana 
(2005) (13), and the Philippines (2009) (14). Flooding or other extreme 
weather events can be precipitants, and these may be increasing with 
global warming (15).  As such, data gathered from the same location over 
time can provide insights into the dynamics of disease incidence, 
distinguish periods of endemic and epidemic transmission, and help 
determine more a representative burden of disease estimates. 
 
Although active, population-based surveillance is an ideal method for 
accurately determining incidence, resource and logistic challenges often 
preclude its use. Although there are many health facilities in northern 
Tanzania, where there are currently few resources to manage many 
pressing public health problems, most health facilities do not have the 
capacity to diagnose leptospirosis. The lack of resource prevents the use 
of a population-based approach. Estimating disease incidence by applying 
multipliers to account for the proportion of the community who may 
present at a surveillance hospital and be tested for the disease have been 
termed multiplier methods (5). Multiplier methods have been used 
successfully to estimate the incidence of acute infectious diseases in 
resource-limited settings by extrapolating from sentinel health facility data 
(16-18).   
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4.1.3 Study Aim 
We sought to estimate the incidence of acute human leptospirosis in 
northern Tanzania from 2012 until 2014 using a similar methodology to the 
2007-08 estimate in the same region in order to describe trends over two 
time periods.  
 
4.2 METHODS 
4.2.1 Estimation of incidence 
We calculated the incidence of acute leptospirosis using a multiplier study 
design. Briefly, we combined a healthcare utilisation survey performed in 
two districts within the Kilimanjaro Region with a hospital-based 
surveillance involving systematic evaluation for leptospirosis in febrile 
patients at the two major referral hospitals in the Kilimanjaro Region. We 
multiplied the number of identified cases of acute leptospirosis by a 
number of factors designed to account for incomplete data using the 
surveillance pyramid model (Figure 4.1) to estimate the incidence of acute 
leptospirosis for the Moshi Urban and Moshi Rural Districts, shown in 
Figure 4.2. (5). 
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Figure 4.1. Surveillance pyramid showing multipliers used to account 
for incomplete case identification 
Modified from Biggs HM, Hertz JT, Munishi OM, Galloway RL, Marks F, 
Saganda W, et al. Estimating leptospirosis incidence using hospital-based 
surveillance and a population-based health care utilization survey in 






Figure 4.2 Map of Kilimanjaro Region showing 2012 Census 
boundaries of Moshi Urban and Moshi Rural Districts. Map designed 
using QGIS Geographic Information System. Open Source Geospatial 
Foundation Project. http://qgis.osgeo.org 
 
4.2.2 Fever surveillance 
Study Site:  We studied patients at two referral hospitals in Moshi. Moshi is 
the administrative centre for the Kilimanjaro Region that has a population 
of 1.6 million. Moshi is situated at an elevation of approximately 890m and 
has a tropical climate with rainy seasons from October through December 
and March through May. Aside from urban Moshi, the region is rural with 
inhabitants practising cultivation and small-holder farming. Kilimanjaro 
Christian Medical Centre (KCMC) is a 450-bed hospital and the zonal 
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referral centre for several regions in Northern Tanzania. Mawenzi 
Regional Referral Hospital (MRRH) is a 300-bed hospital and the referral 
centre for the Kilimanjaro Region.  
Enrolment procedures: From 20 February 2012 through 28 May 2014 the 
study team approached all adult patients who were admitted to KCMC with 
a febrile illness as well as all adult or paediatric patients who were 
admitted at MRRH.  In addition, we approached every second patient who 
presented with fever to the outpatient department at MRRH. Hospitalized 
participants were eligible for enrolment if, on admission, they had a history 
of fever within the previous 72 hours or an axillary temperature of >37.5°C 
or a tympanic, oral or rectal temperature of ≥38.0°C. Non-hospitalised 
patients were eligible if they had an axillary temperature of >37.5°C or a 
tympanic, oral or rectal temperature of ≥38.0°C. All adult study participants 
provided written informed consent. For those under 18 years, a parent or 
guardian provided written informed consent. In addition, written assent 
was provided for those aged 12 to 18 years. This study differed from the 
previous Kilimanjaro Region incidence study in its enrolment of outpatients 
and the enrolment of children at MRRH rather than at KCMC. 
 
Enrolment occurred only on weekdays. Enrolled patients underwent 
phlebotomy, with blood allocated for acute leptospirosis serology only if 
there was a sample available after blood parasite microscopy and blood 
culture. Participants were asked to return for collection of convalescent 
serum 4-6 weeks after enrolment. We attempted to contact those who did 
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not attend the scheduled follow up and encourage attendance. 
Additionally, we recorded inpatient death. Unlike the previous study 
estimating leptospirosis incidence in the Kilimanjaro Region, we did not 
record inter-hospital transfer.  
 
4.2.3 Laboratory methods:  
Serology for leptospirosis was performed at the United States Centers for 
Disease Control and Prevention on acute and convalescent serum 
samples using the standard microscopic agglutination test (MAT) with a 
panel of 20 Leptospira serovars belonging to 17 serogroups. These 
included serogroups: Australis (represented by L. interrogans serovar 
Australis, L. interrogans serovar Bratislava), Autumnalis (L. interrogans 
serovar Autumnalis), Ballum (L. borgpetersenii serovar Ballum), Bataviae 
(L. interrogans serovar Bataviae), Canicola (L. interrogans serovar 
Canicola), Celledoni (L. weilii serovar Celledoni), Cynopteri (L. kirschneri 
serovar Cynopteri), Djasiman (L. interrogans serovar Djasiman), 
Grippotyphosa (L. interrogans serovar Grippotyphosa), Hebdomadis (L. 
santarosai serovar Borincana), Icterohaemorrhagiae (L. interrogans 
serovar Mankarso, L. interrogans Icterohaemorrhagiae), Javanica (L. 
borgpetersenii serovar Javanica), Mini (L. santarosai serovar Georgia), 
Pomona (L. interrogans serovar Pomona), Pyrogenes (L. interrogans 
serovar Pyrogenes, L. santarosai serovar Alexi), Sejroe (L. interrogans 
serovar Wolffi), and Tarassovi (L. borgpetersenii serovar Tarassovi).  
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4.2.3.1 Case definitions:  
We defined confirmed acute leptospirosis as participants who 
demonstrated a four-fold rise in agglutinating antibody titres between 
acute and convalescent serum samples. Cases were defined as probable 
if a participant’s serum had a single agglutinating titre of at least 1:800. 
These definitions were identical to those used to obtain the previous 
incidence estimate (5, 19). The predominant reactive serogroup for 
confirmed cases was defined as the serogroup containing the serovar with 
the largest rise in titres between acute and convalescent sera. For 
probable cases we used the serovar with the highest titre to define the 
serogroup. 
 
4.2.4 Derivation of multipliers 
A time multiplier of 1.40 was used to account for enrolment occurring only 
on weekdays (5 of every 7 days). Additionally, a study duration multiplier 
of 0.44 was included to calculate annual incidence from a study that 
enrolled for 27 months (20 February 2012 through 28 May 2014). We 
applied enrolment and blood draw multipliers to account for eligible 
patients either who did not enrol or for whom blood was not available for 
leptospirosis serology. Calculations of these multipliers are presented in 
the results. We were unable to include a transfer multiplier in the current 
study as details of inter-hospital transfer of participants were not recorded. 
For the estimation of incidence based solely on confirmed cases, a paired 
sera multiplier was applied to account for those patients who did not have 
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paired sera drawn. Diagnostic test multipliers were used to account for the 
sensitivity and specificity of MAT serology. The sensitivity was estimated 
at 100% for paired sera, 48.7% for participants with solely acute sera and 
93.8% for those with solely convalescent sera. The specificity was 
estimated at 93.8%. The estimates are based on a published evaluation of 
diagnostic tests (5, 20) and matched those used in the 2007-08 study.  
 
4.2.5 Healthcare utilisation survey 
A healthcare utilisation survey was carried out in the Moshi Urban 
(population 184,292) and Moshi Rural (population 466,737) Districts of 
Kilimanjaro Region between 13 June and 22 July 2011 as previously 
reported (5, 21).  In brief, 30 (66.7%) of the 45 wards within the two 
districts were selected randomly using a population-weighted approach. A 
study member collected data from the heads of the first 27 households 
encountered within the ward. A total of 810 households were sampled, 
comprising 3,919 household members. All households had at least one 
member >15 years of age, 361 had at least one member aged between 5 
and 15 years of age, and 198 households had at least one member aged 
below 5 years. The demographic characteristics from the healthcare 
utilisation survey have been previously compared to the 2002 Tanzanian 
Census (5). Age-specific population data has not yet been released from 
the 2012 Census (21). Questions relating to health-care seeking behaviour 
in the event of febrile illness were used to identify participants likely to 
present to KCMC or MRRH. These questions included, ‘what is the name 
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of the health care facility with an inpatient ward where you/your family 
would go if you/your family had fever?’ and ‘what will you do if a 
[household member subdivided by age bracket] has a fever for ≥ 3 days?’. 
The hospital multipliers are presented in Table 4.1.  Each multiplier is the 
reciprocal of the proportion of survey participants who responded that they 
would attend KCMC or MRRH as their first or second choice healthcare 
provider. 
 
Table 4.1. Multipliers based on responses to relevant questions in 












What will you do if a [household member] has a fever for ≥ 3 days? 
<5 198 17 67 8.6 33.8 11.6 3.0 
5 to 15 361 10 137 2.8 38.0 36.1 2.6 
≥15 810 35 299 4.3 36.9 23.1 2.7 
What is the name of the health care facility with an inpatient ward where you/your 
family would go if you/your family had fever? 
<5 198 10 68 5.1 34.3 19.8 2.9 
5 to 15 361 28 133 7.8 36.8 12.9 2.7 
≥15 810 50 313 6.2 38.6 16.2 2.6 
Key: KCMC = Kilimanjaro Christian Medical Centre; MRRH = Mawenzi 
Regional Referral Hospital; Mult. = multiplier 
 
 
4.2.6 Population denominators 
We used population totals from the 2012 census (21). As age specific 
population data were not available from that census, we multiplied age 
specific proportions from the 2002 census by the 2012 population total to 
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estimate age-specific populations. The 2007-2008 Kilimanjaro Region 
incidence estimate used population totals from the 2002 census.  
 
4.2.7 Comparison of incidence between study periods 
We compared incidence by using the estimate of incidence derived from 
confirmed and probable cases from each of the study periods and the 
estimated population sampled as the denominator. As shown in Table 4.2, 
the estimated population sampled was calculated by multiplying the total 
population by the proportion of participants in the healthcare utilization 
survey that identified KCMC or MRRH as hospitals they would attend in 
the event of febrile illness. We compared the highest estimates of 
incidence in each of the study periods.  
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Table 4.2 Estimated population of Moshi Urban and Moshi Rural 
District that reported that they would attend KCMC or MRRH if they 






















<5 68,680 82,016 0.09 0.34 6,212 27,613 
5 to 15 150,218 179,387 0.03 0.38 4,138 67,703 
≥15 326,270 389,625 0.04 0.37 134,536 160,660 
Total 545,168 651,028   144,887 255,976 
KCMC = Kilimanjaro Christian Medical Centre; MRRH = Mawenzi 
Regional Referral Hospital 
 
4.2.8 Sensitivity Analysis 
We repeated all calculations using both probable and confirmed cases of 
leptospirosis and then using confirmed cases only. Additionally, we 
performed a one-way sensitivity analysis by varying hospital multipliers 
according to answers to alternative relevant questions in the healthcare 
utilisation survey that might also reflect the behaviour of participants and 
diagnostic test multipliers by using a range of alternative plausible 




4.2.9 Statistical analysis  
Data was entered using the Cardiff Teleform system (Cardiff, Inc., Vista, 
CA, USA) into an Access database (Microsoft Corporation, Redmond, WA, 
USA). Incidence calculations were carried out using Microsoft Excel 2010 
(Microsoft Corporation. Redmond, WA, USA) spreadsheets. Other 
analyses were performed using Stata, version 13.1 (Stata-Corp, College 
Station, TX, USA). We used a test of proportions to compare the 
difference in prevalence between outpatients and inpatients. The p values 
are 2-sided and statistical significance was set at p<0.05. 
 
4.2.10 Research ethics 
This study was approved by the KCMC Research Ethics Committee 
(#295), the Tanzania National Institutes for Medical Research National 
Ethics Co-ordinating Committee (NIMR1HQ/R.8cNo1. 11/283), the 
Institutional Review Board of Duke University Medical Center 
(IRB#Pro00016134), and the University of Otago Human Ethics 
Committee (Health) (H15/055).  
4.3. RESULTS 
4.3.1 Fever surveillance 
There were 1,115 participants enrolled from within the study districts. Of 
participants, 409 (37.7%) were aged <5 years, 111 (10.0%) were aged 5-
14 years, 595 (53.4%) were aged ≥15 years, 593 (46.9%) were male and 
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758 (74.6%) reported having a fever for at least 3 days.  There were 1,017 
(91.2%) who had blood drawn for leptospirosis testing. 
 
Of 1,017 participants tested for leptospirosis, 12 (1.2%) met the case 
definitions for confirmed leptospirosis and an additional 7 (0.7%) met the 
case definitions for probable acute leptospirosis. The predominant reactive 
serogroups among confirmed and probable cases of leptospirosis are 
summarised in Table 4.3 
 
Of both confirmed and probable cases, there were seven (1.7%, 95% 
confidence interval [CI] 0.4 – 2.9%) cases among 416 outpatients and 12 
(1.9%, 95% CI 0.8 – 3.1%) cases among 601 inpatients. There was no 
statistically significant difference in the prevalence of leptospirosis 




Table 4.3 Frequency of confirmed and probable acute leptospirosis 
defined by predominant reactive Leptospira serogroup, Moshi Rural 
and Moshi Rural Districts, Tanzania, 2007-8 and 2012-14 
Leptospira serogroup Study Year 
2007-08 (n=41)  2012-14 (n=19) 
 N (%)  N (%) 
Mini 15  (36.6)  0 (0) 
Australis 14 (34.1)  8 (42.1) 
Celledoni 4  (9.8)  0 (0) 
Autumnalis 3  (7.3)  0 (0) 
Icterohaemorrhagiae 1 (2.4)  2 (10.5) 
Tarassovi 1 (2.4)  1 (5.3) 
Djasiman 1 (2.4)  1 (5.3) 
Hebdomadis 1 (2.4)  0 (0) 
Sejroe 0 (0)  3 (15.8) 
Pyrogenes 0 (0)  2 (10.5) 





Because the residence of those who declined to participate was not 
recorded, the enrolment multiplier was calculated for participants residing 
in both study and non-study districts. As 1,420 (59.3%) of 2,394 eligible 
patients were enrolled, we applied an enrolment multiplier of 1.69. Age 
was also not recorded among those who did not participate so age-
specific enrolment multipliers were not calculated.  Of the 1,115 
participants enrolled, 1017 (91.2%) were tested for leptospirosis and age-
specific blood draw multipliers were calculated as shown in Table 4.5.  A 
paired sera multiplier of 1.60 was applied to incidence calculations 
involving confirmed cases only, as 637 (62.6%) of 1,017 patients who had 
serum drawn had paired sera tested for leptospirosis. Of the 380 who 
were lost to follow up or were otherwise unable to provide both acute or 
convalescent sera, 173 (45.5%) were aged <5 years, 21 (5.5%) were aged 
5-14 years, 186 (49.6%) of 380 were aged ≥15 years and 180 (47.4%) 
were male.  
 
Table 4.5 Calculation of blood-draw multipliers, Moshi Rural and 
Moshi Urban Districts, Tanzania, 2012-14 
 
Age,  Enrolled Blood Drawn Multiplier 
years N        N   (%)  
<5 431 350 (82) 1.2 
5-15 111 109 (98) 1.0 
≥15 573 558 (97) 1.0 
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4.3.2 Incidence calculation 
The annual incidence of acute leptospirosis in the Moshi Urban and Rural 
Districts (2012-2014) was 11-18 cases per 100,000 population using 
hospital multipliers derived from the question ‘To which facility would you 
go if you were unwell with a fever lasting ≥3 days?’ When using responses 
to the question, ‘What is the name of the health care facility with an 
inpatient ward where you/your family would go if you/your family had 
fever?’ the incidence was 9-18 cases per 100,000 people. The annual 
incidence was highest in adults, ranging from 13 to 29 cases per 100,000 
people.  Details of the calculation and age-specific incidences are included 
in Table 4.6.  
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Based on the question: To which facility would you go if you were unwell with a fever lasting ≥3 days? 
Confirmed and probable cases          
<5 N/A N/A 2 6 6 N/A 1.4 2.1 0.4 7 82,016 9 
5 to 15 N/A N/A 0 0 0 N/A 1.4 1.7 0.4 0 179,387 0 
≥15 3 67 14 57 62 N/A 1.4 1.4 0.4 67 389,625 17 
Overall          75 651,028 11 
Confirmed only            
<5 N/A N/A 1 3 3 1.6 1.4 2.1 0.4 6 82,016 7 
>=5 to <15 N/A N/A 0 0 0 1.6 1.4 1.7 0.4 0 179,387 0 
≥15 3 67 8 33 50 1.6 1.4 2.2 0.4 111 389,625 28 
Overall          117 651,028 18 
Based on the question: What is the name of the health care facility with an inpatient ward where you/your family would go if you/your family had fever? 
Confirmed and Probable 
<5 N/A N/A 2 5 5 N/A 1.4 2.1 0.4 7 82,016 9 
5 to 15 N/A N/A 0 0 0 N/A 1.4 1.7 0.4 0 179,387 0 
≥15 3 47 14 45 46 N/A 1.4 1.4 0.4 50 389,625 13 
Overall 3         57 651,028 9 
Confirmed only     
<5 N/A N/A 1 2 2 1.6 1.4 2.1 0.4 7 82,016 8 
5 to 15 N/A N/A 0 0 0 1.6 1.4 1.7 0.4 0 179,387 0 
≥15 3 47 8 40 44 1.6 1.4 2.2 0.4 113 389,625 29 
Overall          120 651,028 18 
Key: KCMC: Kilimanjaro Christian Medical Centre; MRRH: Mawenzi Regional Referral Hospital, N/A: Not applicable
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Estimates of annual incidence in six monthly time blocks is summarised in 
Table 4.7. These data show a higher incidence during the first few months 
of the study. 
Table 4.7. Incidence of acute leptospirosis in six months intervals, 
Moshi Rural and Moshi Urban Districts, Tanzania, 2012-14 
Time Period Participants 
N  
Crude Cases 
    N   (%) 
Annual Incidence 
per 100,000 
18 Feb - 30 Jun 2012* 256 8 (3.1) 24 
1 Jul – 31 Dec 2012 222 2 (0.9) 6 
1 Jan – 30 Jun 2013 285 4 (1.4) 8 
1 Jul – 31 Dec 2013 218 5 (2.3) 9 
1 Jan – 30 Jun 2013 116 0    (0) 0 
* 4-month time interval 
4.3.3 Incidence calculation sensitivity analysis 
The results of the one-way sensitivity analysis are presented in Table 4.8. 
When we derived hospital multipliers from alternative questions from the 
healthcare utilisation survey that might also reflect the behaviour of 
participants, the estimated annual incidence ranged from 8-37 cases per 
100,000 people.  When we varied the estimated sensitivity of MAT from 
the lowest to highest plausible values (2, 20, 23, 25, 26), the estimated 
annual incidence varied from 10-25 cases per 100,000 people.  
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Table 4.8 Sensitivity analysis of leptospirosis incidence, Moshi Rural 
and Moshi Urban Districts, Tanzania, 2012-14 
Variable Cases per 
100,000 
population) 
Variation in multipliers based on varying the question from the 
healthcare utilisation survey 
 
Question: What will you do if a [household member subdivided by age 
bracket] has a fever lasting <3 days? 
25-37 
Question: What will you do if a [household member subdivided by age 
bracket] has a fever [duration not specified]? 
32-49 
Variations in estimation of sensitivity of MAT  
Lowest plausible estimate 
Paired sera: 75% 
Solely acute sera: 6% 
Solely convalescent sera: 70%  
17-25 
Highest plausible estimate 
Sensitivity paired sera: 100% 
Sensitivity acute sera only: 95% 




This study highlights the dynamic nature of leptospirosis epidemiology in 
the Kilimanjaro Region. Our study shows that both incidence and 
serogroup predominance among human cases have changed. The overall 
annual estimate of 11-18 cases of acute leptospirosis per 100,000 people 
is substantially lower than the estimated incidence of 75-102 cases per 
100,000 people per year from 2007-08 (5). In addition, the age-specific 
incidence appears to have changed, with children estimated to have a 
lower incidence than in the 2007-08 study. Despite the lower incidence 
during 2012-14, leptospirosis still appears to be an important cause of 
fever in our region. 
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The annual incidence of 11-18 cases per 100,000 persons is similar to 
estimates from Asian countries such as India, where the incidence is 20 
per 100,000 persons, Bangladesh where the incidence is 19 per 100,000 
people, and Myanmar where the incidence is 11 per 100,000 persons (1). 
If the incidence that we have estimated for the Moshi Urban and Moshi 
Rural Districts were extrapolated across Tanzania’s 2012 population of 45 
million people (21), between 4,950 and 8,100 patients would require 
hospitalisation per year.  
 
The explanation for the wide variation in incidence is uncertain, but may 
reflect changes in climatic conditions, transient presence of an infected 
reservoir host, changes in human-animal interactions, or changes in 
rodent-livestock interactions. Regarding climate, leptospirosis is 
recognised as an important public health problem following extreme 
weather events in other parts of the world such as Malaysia, Philippines, 
and Thailand (15). The strong El Niño conditions of 2006-07 were 
associated with flooding and epidemics of other diseases, such as Rift 
Valley Fever (27). Thus, El Niño conditions may have influenced 
leptospirosis incidence during 2007-08 (28-30). Urbanisation or reduced 
livestock ownership are unlikely to explain the change in incidence, 
because, first census data show a population increase in rural areas 
between the 2002 and 2012 and secondly livestock numbers are thought 
to have increased over the study period (21, 31). Livestock vaccination 
coverage to any disease remains low in Tanzania, and increased 
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vaccination against leptospirosis is unlikely to account for the reduced 
incidence (31).  
 
There has also been a change in the most common predominant reactive 
serogroup between study periods. Mini was the most commonly implicated 
serogroup during 2007-08, whereas it was not the predominant serogroup 
in any cases during 2012-2014 (4). Our findings are consistent with an 
interpretation of unstable serogroup transmission dynamics, with 
increased transmission of a serovar from within the Mini serogroup during 
2007-08. Changing incidence and rapid emergence of infections from new 
serovars has been seen in many settings and is a plausible explanation for 
our findings (8, 57, 58). Research to understand the reservoir hosts, 
sources, and risk factors for serogroup Mini in northern Tanzania may help 
to explain the apparent unstable transmission. Aside from the fever 
surveillance work at KCMC and MRRH in 2007-08, there are no reports of 
Leptospira serovars belonging to the Mini serogroup causing human 
disease in mainland East Africa, although Mini serovars have been 
isolated from people and small mammals in the western Indian Ocean 
islands of Mayotte and Madagascar (32-35). Elsewhere, although Mini is 
an uncommonly tested serogroup, serological reactivity to Mini has been 
shown in cattle (36-39), wild game animals (40, 41), and rodents (42). In 
Mayotte, a serovar from serogroup Mini is also thought to be the 
predominant infecting serogroup of cattle (43). The relevance to the 
epidemiology in Tanzania is that cattle are frequently exported to Comoros 
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and Mayotte from Tanzania (44, 45). Hence cattle may be a host for 
Leptospira from the Mini serogroup in Tanzania. Pilot serological study of 
cattle slaughtered for meat in Moshi Municipal District in 2014 found 
seroreactivity to L. borgpetersenii serovar Mini in 14 (24.1%) out of 58 
animals tested (46). This study of slaughtered cattle in the Moshi 
Municipal District also found that the majority of cattle sampled came from 
outside the Kilimanjaro Region, with 384 (84.8%) of 453 cattle sampled 
originating from the Manyara Region. This is consistent with other reports, 
that indicate that livestock owned by pastoralists are transported over 
large distances within the country and trans-nationally (47). The presence 
of cases due to Mini serogroup indicates that livestock may be a source 
for human leptospirosis in the area. Changes in either the origin of 
imported cattle between 2007-08 and 2012-14 or, changes in the 
epidemiology of leptospirosis in Manyara Region could influence the 
incidence of human leptospirosis in the Moshi Urban and Rural Districts. In 
addition, our data from both humans and livestock suggest that a 
representative of the Mini serogroup should be included in future MAT 
panels in East Africa. 
 
In 2012-14, the most common predominant serogroup was Australis, 
which was the second most commonly identified predominant reactive 
serogroup during 2007-08. Agglutination was observed against both test 
serovars (L. interrogans serovar Australis and L. interrogans serovar 
Bratislava) in 2007-08 and 2012-14. Continued identification of this 
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serogroup suggests that at least one serovar from the Australis serogroup 
is endemic in the region. Serovars from the Australis serogroup have been 
isolated from rodents in Tanzania (48), a human being in Kenya (49), an 
African grass rat in Nigeria (50), and cattle in Zimbabwe (51). Serologic 
studies of animals in East Africa have reported infrequent sero-reactivity to 
Australis serogroup in sheep, goats and pigs (52), and cattle (53). 
Seroreactivity against serogroup Australis serovars was also observed in 
cattle slaughtered for meat in the Moshi area in 2014 (46). Rural residence 
has previously been identified as a risk factor for acute leptospirosis in 
northern Tanzania (4). These findings raise the possibility of livestock as 
an important source of infection. However, care is needed in interpreting 
infecting Leptospira strains from serological data as cross-reactions 
between Mini, Sejroe, and Hebdomadis serogroups are common and 
using serological data to infer infecting serovars is unreliable (54, 55). 
Therefore, Leptospira spp. isolates from humans and animals, and studies 
investigating risk factors are needed. 
 
One of our study’s strengths is that the estimate of incidence used the 
same hospital surveillance system and the same healthcare utilisation 
survey within the same districts as the earlier study, allowing a direct 
comparison of discrete time periods. Estimates of incidence from multiplier 
methods may be sensitive to changes in multipliers. Differences in 
enrolment practices and multipliers between the 2007-08 incidence 
estimate and the current study may have influenced the difference in 
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estimated incidence. The 2012-14 study enrolled both those hospitalised 
and those treated as outpatients, whereas the 2007-08 study enrolled only 
inpatients.  However, in our study, the incidence did not vary by admission 
status. Other minor alterations in multipliers include the addition of a 
blood-draw multiplier and the omission of a transfer multiplier as these 
data were not collected. These multipliers ranged from 0.7-1.2 and if 
applied, would have widened the apparent difference between incidence 
estimates from 2007-08 and 2012-2014.  We used the 2012 census to 
estimate the population of Moshi Rural District and Moshi Urban District 
during our study. In comparison, Biggs and colleagues estimated the 
populations living in the same districts from the 2002 census. The 
combined total population of the two districts rose from 545,168 to 
651,028 between 2002 and 2012 (21). It is likely therefore that by using 
2002 population totals, the 2007-08 study underestimated the true 
population at the time of the study, and consequently will have 
overestimated the incidence by a small margin.  
 
There are other limitations in our study that influence interpretation of the 
results. We chose to estimate incidence using multiplier methods as 
resource limitations precluded active surveillance in the entire population. 
Although it is an accepted method of incidence estimation, it means that 
our estimate is based on a small number of cases, and some of the 
variation may be due to random error. In addition, multiplier methods rely 
on many assumptions. In particular, we assumed that those who 
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presented to the two tertiary referral hospital study sites were 
representative of the community sampled in the healthcare utilisation 
survey and that the care seeking behaviour of those surveyed is 
representative of the population. Income increased from US$651 in 2008 
to US$950 in 2014, which may have improved access to healthcare (56). 
However, we are unaware of any substantial changes to the health system 
or health seeking behaviour from 2007 through 2014, and hence any 
healthcare utilisation survey error is likely to be consistent between the 
studies. In the 2007-08 study, Biggs et al identified differences between 
the age and sex distribution of the 2002 census population and those who 
participated in the healthcare utilisation survey (5). We were unable to 
compare the demographics of the population in the 2012 census to those 
who took the healthcare utilisation survey but it is possible that the survey 
respondents are not representative of the wider community. In order to 
understand the effect that changes in care-seeking behaviour would have 
on our estimate, we have performed a sensitivity analysis to provide a 
range of estimates. In this sensitivity analysis we varied the multipliers 
according to different questions from the healthcare utilization survey 
asking about fever shorter than 3 days. The larger multipliers derived by 
these questions reflect the fact that patients with shorter durations of fever 
are less likely to present to tertiary hospitals. We think that these 
estimates are less accurate than our final estimate as three quarters of our 
participants reported a fever of at least 3 days. 
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We are likely to have underestimated the incidence of disease through our 
use of serological diagnosis and enrolment from referral hospitals and may 
have biased inclusion towards those with severe disease.  First, we 
assumed that those who provided serum for testing were similar to those 
who did not. Secondly, we used test multipliers to attempt to account for 
the insensitivity of MAT in the acute phase of illness. We performed 
calculations using a sensitivity of 100% for MAT on paired serum samples 
and 48% for MAT on those providing only acute serum samples to ensure 
comparability with the 2007-08 incidence estimate. However, there is 
increasing evidence that MAT is less sensitive than the values of 100% for 
paired sera and 48.7% for solely acute serum that we used. It is therefore 
likely that the true incidence is towards the upper end of the estimate in 
our sensitivity analysis (23, 25, 26). 
 
In conclusion, our study demonstrates substantial variation in leptospirosis 
incidence between time periods at the same site in continental Africa. 
Leptospirosis incidence appears to have declined from 2007-08 to 2012-
14, although it remains an important cause of fever. This appears partly 
due to unstable transmission of a serovar from within the Mini serogroup. 
Our findings indicate the value of leptospirosis surveillance over multiple 
year time periods to understand the epidemiology of the disease. Our 
findings also highlight that much more work is needed to identify the 
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Chapter 5. Estimation of the 
burden of human leptospirosis 
in the Moshi Urban and Moshi 
Rural districts, Tanzania, 2007-
08 and 2012-14 
 
5.1 INTRODUCTION 
5.1.1 Assessing burden of disease: disability-adjusted life years lost 
Estimation of disease burden is critical for appropriate allocation of 
resources for diagnosis, treatment, and prevention. Disability Adjusted Life 
Years Lost (DALYs) is a metric used to estimate the burden of disease (1, 
2). DALYs consider both premature death as well as the non-fatal health 
consequences to provide a single measure of the burden of disease (2) 
and are calculated as shown in Figure 5.1. Years of life lost (YLL) are 
estimated from the age-specific incidence of fatal cases of a given disease 
and a standardised measure of life expectancy that is considered the 
mean achievable life expectancy regardless of cultural, health or 
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socioeconomic factors (3). Years of life lived with disability are estimated 
from the incidence, duration, and severity of disease. The severity of 
disease is measured through disability weights that measure the 
magnitude of health loss associated with specific diseases. Disability 
weights were derived from an internet survey, and population-based 
surveys in five countries (4). The surveys ask participants to assess the 
equivalence of health states using pairwise comparisons. The disability 
weights are measured on a scale from 0 to 1, where 0 equals a state of full 
health and 1 equals death (5).  
 
 DALYs = YLL + YLD 
 
YLL = N x LE   YLD = I x DW x LE 
Key: YLL = years of life lost; YLD = years lived with disability; N = number 
of deaths per year; LE = life expectancy at age of death; I = incidence; DW 
= disability weight 
Figure 5.1 Formula for calculating Disability Adjusted Life Years 
(DALYs) 
 
5.1.2 Estimates of the global burden of leptospirosis 
While global or country specific burden of disease estimates are not 
completely aligned with global health development assistance, they are 
broadly aligned and there are efforts to align assistance and burden of 
disease more closely (6). Similarly, although there was an imperfect 
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correlation, Gillum and colleagues found that the magnitude of the burden 
of disease in the United States of America and globally was the strongest 
predictor of disease-specific research funding (7).  Leptospirosis has not 
been a unique illness included in global burden of disease metrics (1, 8). 
Despite its lack of inclusion, there is evidence that leptospirosis is a major 
cause of illness worldwide. A recent paper, by Torgerson and colleagues, 
sought to estimate the global burden of leptospirosis in DALYs (3). The 
paper was based on a systematic review, which is reviewed in detail in 
Chapter 4, and estimated the global incidence of leptospirosis (9). DALYs 
were estimated by the addition of YLL from fatal disease to YLD for non-
fatal disease (Figure 5.1). Torgerson and colleagues estimated YLL by 
applying a case fatality ratio of 6.95% to age-specific estimates of 
incidence and a standardised life expectancy of 86 years. They included 
YLL from miscarriage, because they estimated that 54% of pregnant 
women who develop leptospirosis will miscarry.  Torgerson and 
colleagues estimated YLD by applying disability weights for acute 
infectious illness to all, and weights for serious complications of 
leptospirosis to a proportion of cases. The disability weights used were 
based on those of acute infectious disease from the GBD 2010 study (10). 
The disability weights and durations of illness used by Torgerson were 
0.053 for two months for acute mild disease, 0.210 for two months for 
acute moderate disease and a composite 0.562 for two weeks, 0.510 for 
two weeks and 0.210 for one month for acute severe disease.  
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5.1.3. Recent publications that may influence estimates of the burden 
of leptospirosis 
Since the work by Torgerson there have been refinements of the 
estimated case-fatality ratio of acute leptospirosis (11), and the disability 
weights assigned by the Institute of Health Metrics and Evaluation (IHME) 
to infectious diseases (5). Since these are both factors in the calculation of 
DALYs, they may influence estimates of disease burden. The case fatality 
ratio used by Torgerson was 0.057 for all ages and was derived from a 
systematic review of leptospirosis morbidity and mortality by Costa and 
colleagues (9). Costa found that data on case-fatality ratios was sparse, 
with 35 studies identified between 1970 and 2008, which had case-fatality 
ratios ranging from 0.001 to 0.143. Since the Torgerson review, Taylor and 
colleagues have published a systematic review of case-fatality ratios for 
acute untreated leptospirosis (11). Of note, they excluded those who 
received dialysis and other intensive supportive care, thereby excluding 
reports of the sickest cohort of patients. Taylor and colleagues identified 
41 eligible studies and estimated the overall case-fatality ratio as 0.022. 
They also identified that increasing patient age was associated with an 
increasing case-fatality ratio, with those aged under five years having 
negligible mortality and those over 60 years having a case-fatality ratio of 
0.600.  
 
As stated earlier, leptospirosis does not have disease specific disability 
weights. However, other diseases that cause febrile illness, including 
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malaria, dengue, and yellow fever do have assigned disability weights. In 
the 2015 Global Burden of Disease study they shared common disability 
weights of 0.006 (95% CI 0.002-0.012) for acute mild disease, 0.051 (95% 
CI 0.032-0.074) for acute moderate disease and 0.133 (0.088-0.190) for 
acute severe disease. These are somewhat lower than those used by 
Torgerson and colleagues. Both case-fatality ratio and disability weights 
will influence calculation of DALYs, with 96.4% of the DALYs estimated by 
Torgerson were due to mortality. 
 
5.1.4 The importance of data driven estimates of leptospirosis 
burden 
The estimates of leptospirosis incidence and burden in Tanzania are 
based on modelling and extrapolate data that mostly originates outside of 
Tanzania (3, 9, 10). It is possible that the assumptions implicit in the 
models of incidence and burden are not valid in Tanzania due to variation 
in ecosystems and transmission pathways. Further, as there have been 
refinements in the case-fatality ratio and disability weights, the prior 
estimates may no longer be accurate. There is a need for up to date 
estimates of the burden of leptospirosis that are based on local data. 
 
5.1.5 Study Aim 
We aimed to estimate the burden of leptospirosis in the Moshi Urban 
District and Moshi Rural District, Tanzania for the years 2007-08 and 
2012-14 
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5.2 METHODS 
5.2.1 Overview 
We estimated and report our estimates of the human disease burden from 
leptospirosis in keeping with the standards of the Guidelines for Accurate 
and Transparent Health Estimates Reporting (GATHER) (12). We 
estimated disease burden in DALYs using the formula in Figure 5.1, which 
sums the number of years of life lost (YLL) due to leptospirosis mortality 
and the number of years lived with disability (YLD) related to leptospirosis. 
We conducted our research using data from the study described in 
Chapter 4, which estimated annual leptospirosis incidence during 2012-14, 
and a study by Biggs et al which estimated the annual incidence in 2007-
08 (13). We used established estimates of the case fatality ratio (11), 
disability weights (1), and life expectancy (1) in order to estimate DALYs 
lost. 
5.2.2 Estimates of case fatality ratio 
We used a case fatality adjusted for age that has been estimated by a 
systematic review of the case fatality ratio of untreated leptospirosis (11), 
as shown in Table 5.1.  
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Table 5.1 Age adjusted case fatality ratios of acute leptospirosis (11) 
Age in years Case Fatality Ratio  (95% CI) 
0-15 0.0% (0-25.0) 
16-45 16.3% (0-34.1) 
45-59 36.7% (16.7-66.7) 
>60 60.0% (33.3-60.0) 
 
5.2.3 Disability weights 
Acute disability weight: Leptospirosis was not disease listed as a unique 
condition in the 2015 Global Burden of Disease (5). As such it did not have 
disability weights assigned. Other diseases that cause febrile illness, 
including malaria, dengue, and yellow fever shared common disability 
weights of 0.006 (95% CI 0.002-0.012) for acute mild disease, 0.051 (95% 
CI 0.032-0.074) for acute moderate disease, and 0.133 (0.088-0.190) for 
acute severe disease. The definitions for these disease states were (5): 
 
“Infectious disease: acute episode, mild has a low fever and mild 
discomfort, but no difficulty with daily activities. 
Infectious disease: acute episode, moderate has a fever and aches, 
and feels weak, which causes some difficulty with daily activities. 
Infectious disease: acute episode, severe has a high fever and pain, 




We classified hospitalised cases of leptospirosis as: infectious disease, 
acute disease, severe. In contrast to assumptions made by Torgerson 
when assessing the global burden (3), neither fatal cases nor severe non-
fatal cases were assumed to have received one month of dialysis, as 
dialysis is not readily available in northern Tanzania. 
 
Post-acute disability weight: The Global Burden of Disease Study defines 
this disease state as (5): 
 
“Infectious disease, post-acute consequences (fatigue, emotional lability, 
insomnia): The person is always tired and easily upset. The person 
feels pain all over the body and is depressed.” 
 
A review of the literature, identified two papers reporting post-acute 
sequelae of leptospirosis. The first reported symptoms of 11 individuals, 
22 years after the diagnosis of acute leptospirosis (14). They identified 2 
(18.2%) of 11 participants reported persisting visual disturbance and 4 
(36.4%) reported on-going headaches. The second study assessed the 
post-acute consequences of leptospirosis (3) and found that 68 (30.2%) of 
225 individuals diagnosed with acute leptospirosis in the Netherlands 
reported suffering chronic symptoms (15). For the 57 (83.8%) who 
reported duration of symptoms, the median duration of symptoms was 
between six and eight months. We applied the disability weight for 
Infectious disease, post-acute consequences (fatigue, emotional lability, 
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insomnia) of 0.210 (95% CI 0.148-0.308) to 30.2% of cases for a duration 
of 7 months.   
 
5.2.4 Population estimates 
We used population totals from the 2012 census (16). As age specific 
population data were not available from the 2012 census, we multiplied 
age specific proportions from the 2002 census by the 2012 population total 
to estimate age-specific populations. The 2007-2008 Kilimanjaro Region 
incidence estimate used population totals from the 2002 census (13).  
 
5.2.5 Life expectancy 
Life expectancy was estimated using Global Burden of Disease 2015 
Reference Life Tables (17). These life tables were constructed based on 
the lowest estimated age-specific mortality rates from all locations with 
populations over 5 million. Age standardised DALYS were calculated 
using the Global Burden of Disease world population 2015 age standard 
(8). 
 
5.2.6 Time discounting and age-weighting 
It is possible to adjust the estimate of burden of disease by age-weighting 
where more weight is given to years of life lost by young adults, and by 
time discounting where future losses are estimated at present day values. 
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We did not use time discounting nor age-weighting, in keeping with recent 
Global Burden of Disease studies (1). 
5.2.7 One-way sensitivity analysis 
We varied the incidence of disease, to the highest and lowest values 
plausible as shown in Chapter 3 of this thesis. We also varied the 
estimated case-fatality ratio to 0.07 for all ages, and separately, the 
disability weight structure to match that used by Torgerson and 
colleagues. Their disability weight structure assigned 50% of cases a 
disability weight of 0.053 for two months of illness, 40% a disability weight 
of 0.21 for two months of illness and, 10% a disability weight of 0.562 for 
two weeks of illness, 0.510 for two weeks of illness and 0.210 for one 
month of illness. 
 
5.2.8 Statistical Analysis 
Calculations were carried out using Microsoft Excel 2010 (Microsoft 
Corporation. Redmond, WA, USA) spread sheets. A one-way sensitivity 
analysis was performed varying incidence, case-fatality ratio and disability 
weights to the highest and low plausible alternative values. 
 
5.3 RESULTS 
We estimated that, during 2007-08, there were 1,989.1 DALYs lost 
annually, and during 2012-14, 364.9 DALYs lost annually in the Moshi 
Urban and Moshi Rural Districts of Tanzania. Details of the calculation are 
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shown in Tables 5.2 and 5.3. YLL made up 98.4% of the total in 2007-08 
and 99.5% in 2012-14. Using the population structure of Tanzania, this 
equates to an annual burden of 364.9 DALYs per 100,000 people during 
2007-08 and 104.4 DALYs per 100,000 people during 2012-14. Using 
age-standardisation, there were 495.0 DALYs per 100,000 people 
annually during 2007-08 and 169.4 DALYs per 100,000 people annually 
during 2012-14. 
 
5.3.1 One-way sensitivity analysis 
The one-way sensitivity analysis of this estimate is shown as Table 5.4.  
Adjusting the case fatality ratio increased the estimate of annual DALYs 
lost due to leptospirosis during 2007-08 but lowered the estimate for 2012-
14. Adjusting the incidence to the highest plausible value increased the 
estimated annual DALYs lost. Adjusting the disability weight structure had 
little influence on the estimated annual DALYs lost during both time 
periods. 
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Years of life lived 
with disability 
Disability adjusted 
years of life lost 
Age-standardised 
DALYs/ 100,000 people 
0-4 89,408 177 158.3 0.0 0.0 158.3 9.3 9.3 1.1 
5-9 81,230 161 130.8 0.0 0.0 130.8 7.7 7.7 0.8 
10-14 70,327 161 113.2 0.0 0.0 113.2 6.7 6.7 0.8 
15-19 56,697 59 33.5 5.5 391.8 28.0 1.6 393.5 56.2 
20-24 49,610 59 29.3 4.8 319.2 24.5 1.4 320.7 50.5 
25-29 44,159 59 26.1 4.2 263.2 21.8 1.3 264.4 45.3 
30-34 35,436 59 20.9 3.4 194.3 17.5 1.0 195.4 40.0 
35-39 26,168 59 15.4 2.5 131.1 12.9 0.8 131.9 34.6 
40-44 21,262 59 12.5 2.0 96.5 10.5 0.6 97.1 29.1 
45-49 15,810 59 9.3 3.4 145.0 5.9 0.3 145.3 53.8 
50-54 14,174 59 8.4 3.1 115.3 5.3 0.3 115.7 43.0 
55-59 9,268 59 5.5 2.0 66.0 3.5 0.2 66.2 33.4 
60-64 9,813 59 5.8 3.5 98.3 2.3 0.1 98.4 40.7 
65-69 5,997 59 3.5 2.1 50.5 1.4 0.1 50.6 28.3 
70-74 5,997 59 3.5 2.1 41.2 1.4 0.1 41.3 18.1 
75-79 3,816 59 2.3 1.4 20.6 0.9 0.1 20.7 10.3 
80+ 5,997 59 3.5 2.1 24.3 1.4 0.1 24.4 8.9 
Total 545,168    1957.4  31.8 1989.2 495.0 
Abbreviations: DALYs= Disability adjusted life years lost 
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Years of life lived 
with disability 
Disability adjusted 
years of life lost 
Age-standardised DALYs/ 
100,000 people 
0-4 105,505 9 9.5 0.0 0.00 9.5 0.6 0.56 0.1 
5-9 96,633 0 0.0 0.0 0.00 0.0 0.0 0.00 0.0 
10-14 83,955 0 0.0 0.0 0.00 0.0 0.0 0.00 0.0 
15-19 66,657 17 11.3 1.8 132.72 9.5 0.6 133.28 19.3 
20-24 57,172 17 9.7 1.6 106.00 8.1 0.5 106.48 17.4 
25-29 49,140 17 8.4 1.4 84.38 7.0 0.4 84.79 15.6 
30-34 42,195 17 7.2 1.2 66.67 6.0 0.4 67.03 13.8 
35-39 35,354 17 6.0 1.0 51.04 5.0 0.3 51.33 11.9 
40-44 27,464 17 4.7 0.8 35.92 3.9 0.2 36.15 10.0 
45-49 21,690 17 3.7 1.4 57.31 2.3 0.1 57.45 18.5 
50-54 17,498 17 3.0 1.1 41.03 1.9 0.1 41.14 14.8 
55-59 11,213 17 1.9 0.7 23.01 1.2 0.1 23.08 11.5 
60-64 11,179 17 1.9 1.1 32.26 0.8 0.0 32.30 14.0 
65-69 7,182 17 1.2 0.7 17.43 0.5 0.0 17.45 9.8 
70-74 6,955 17 1.2 0.7 13.77 0.5 0.0 13.80 6.2 
75-79 4,284 17 0.7 0.4 6.67 0.3 0.0 6.69 3.5 
80+ 6,949 17 1.2 0.7 8.12 0.5 0.0 8.14 3.1 
Total 651,028    676.32  3.36 679.68 169.4 
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Table 5.4 One-way sensitivity analysis of annual DALYs lost due to 
leptospirosis, Moshi Urban and Rural Districts, Tanzania during 
2007-08 and 2012-14 
 




Main estimate of annual DALYs 1,989.1 679.7 
Case fatality ratio set to 0.07 3,027.3 298.5 
Disability weights calculated the same as Torgerson 
(3) 
2,097.7 691.2 
Incidence set to lowest plausible 1,456.0 679.7 
Incidence set to highest plausible  9,697.7 3,196.6 
Abbreviations: DALYs= Disability adjusted life years lost 
5.4 DISCUSSION 
The burden of leptospirosis in humans in the Moshi Urban and Rural 
Districts during both 2007-08 and 2012-14 periods was high.  The 2015 
Global Burden of Disease study estimated that there was a total of 
31,643.8 DALYs lost per 100,000 people in 2010 and 23,575.1 DALYs lost 
per 100,000 people in Tanzania in 2015 due to communicable, neonatal, 
maternal, and nutritional causes (1). Assuming the total annual DALYs lost 
in Tanzania during 2007-08 were similar to the total lost in 2010, our 
estimate for the burden of leptospirosis approximate 1.6% of the total. 
Similarly, assuming the total annual DALYs lost during 2012-14 was 
similar to 2015, our estimate of the burden of leptospirosis in 2012-14 
would be 0.7% of the total. For both periods, leptospirosis would be placed 
among the 20 leading causes of lost DALYs in Tanzania (18). In 
comparison to Tanzania age-standardised DALYs from the 2015 Global 
Burden of Disease study (19), our estimates of leptospirosis burden were 
approximately one tenth that of malaria (2262.2 DALYs per 100,000 
 269 
people), but greater than other, more high-profile diseases such as 
dengue (3.4 DALYs per 100,000 people), rabies (3.9 DALYs per 100,000 
people) and yellow fever (7.6 DALYs per 100,000 people). In addition, our 
estimated burden of leptospirosis is similar to the estimate for all neglected 
tropical diseases (279.8 DALYs per 100,000 population) in Tanzania. 
Given the large number of diseases encompassed within the neglected 
tropical diseases, it suggests that the Global Burden of Disease Study has 
underestimated the burden of neglected tropical diseases in Tanzania. 
 
5.4.1 Disproportionate burden of leptospirosis on working age adults 
During both time periods the largest burden of disease was borne by 
adults between 15-65 years of age, despite the higher incidence in 
children during 2007-08. This was due to the lower estimated case-fatality 
ratio for children. A disproportionate burden on working age adults, is in 
keeping with other reports including case series (20-22), studies on sero-
conversion (23), and global estimates of morbidity and mortality (9).  
Diseases affecting adults have important economic consequences that are 
not measured by the DALY metric. Infection with leptospirosis is most 
likely to occur during a person’s economically productive years, 




5.4.2 Contribution of YLL to DALYs 
Almost all of the DALYs lost due to leptospirosis were due to years of life 
lost from fatal illness. There were few DALYs accrued from non-fatal acute 
infectious disease. Leptospirosis is an acute infectious disease, and the 
greatest symptoms are present for only a few weeks. The low number of 
DALYs reflects the short duration of illness, and the low disability weight 
assigned to severe infection. Although disability weights are well 
established in DALY measurement, the weights for acute infectious 
disease appear surprisingly low. For example, the disability weight for 
acute life-threatening infection is lower than that for the chronic sequelae 
of infection such fatigue, emotional lability, insomnia (5). That the 
overwhelming proportion of leptospirosis DALYs are due to YLL suggests 
that in addition to prevention, strategies aimed at improving survival during 
the acute illness would have a greater effect in reducing DALYs than 
strategies aimed at mitigating the long-term sequelae of leptospirosis. 
These might include early diagnosis, prompt use of antimicrobials for 
severe infection and appropriate supportive care.  
 
5.4.3 Implications of the one-way sensitivity analysis 
The one-way sensitivity analysis identifies that our estimate of the burden 
of leptospirosis is most influenced by incidence and the case-fatality ratio. 
Limitations in our understanding of these two parameters are therefore the 
most importance sources of uncertainty in our DALY estimates. The two 
measurements of incidence in northern Tanzania vary substantially (13, 
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25). In the context of unstable incidence, repeated surveillance is 
important to establish a baseline incidence and identify epidemics. A 
surveillance platform with measurements at multiple time points would 
allow a more reliable estimate of the baseline burden and the effect of 
epidemics on estimates of the burden of disease.  
 
Estimates of the case-fatality ratio vary substantially between reports (9, 
11, 21). Our choice of the estimated case-fatality ratio of untreated 
leptospirosis may be considered high. However, we think these are the 
most appropriate case-fatality ratio estimates as there is no established 
age-specific estimate for treated leptospirosis. We consider age-specific 
estimates of the case fatality ratio to be important as age has been a 
strong risk factor for mortality in studies of inpatients with leptospirosis (21, 
26). In addition, the effect of treatment on the case fatality ratio is 
uncertain, as data on whether antimicrobials reduce mortality is currently 
inconclusive (27, 28), and supportive care is limited in northern Tanzania. 
Improving the precision of estimates of the case-fatality ratio would require 
improved detection of both fatal and non-fatal cases. Leptospirosis is 
under-diagnosed because clinicians lack awareness of its symptoms (29). 
Therefore, surveillance systems should be designed to systematically test 
those with compatible symptoms, including all those with non-specific 
febrile illness. Under diagnosis can also be partly attributed to imperfect 
diagnostic tests. Microscopic agglutination test serology is the reference 
standard diagnostic test (30), with a case defined as either a single high 
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titre or, a four-fold rise in titre between acute and convalescent samples 
(31). The microscopic agglutination test has poor sensitivity on a single 
serum sample (32), and therefore estimates of case-fatality ratio will be 
biased through excluding those who do not survive long enough to have 
convalescent serology drawn. Therefore, tests that are both sensitive and 
specific during the acute phase are needed to improve the precision of 
case-fatality estimates. We explore the accuracy of diagnostic tests during 
the acute phase of leptospirosis in Chapters 10 and 11 of this thesis.  
 
5.4.4 Limitations 
Limitations in our study will have influenced the estimated DALY lost. Most 
importantly we were unable to stratify incidence by age for those aged ≥15 
years. There are also gaps in our knowledge that limit the precision of our 
estimate of the leptospirosis burden in northern Tanzania. These include 
gaps regarding the impact of acute and sub-acute sequelae of life-
threatening infectious illness including respiratory failure and renal failure. 
Both of these can occur with severe leptospirosis (30, 33), and are 
associated with impaired function and quality of life (34-37). Neither has 
been assigned a disability weight. These sequelae are particularly relevant 
in the context of resource-limited health systems where treatment of 
respiratory failure and renal failure is not readily available and recovery 
may be prolonged and incomplete. Similarly, the longer-term health effects 
of leptospirosis may be underestimated and have been incompletely 
studied.  Very severe infectious illness has been shown to be associated 
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with chronic psychological and physical complaints (38). Goris and 
colleagues identified that 21.1% of those with chronic complaints lasted 
over 24 months (15). The actual duration is uncertain, and work in a small 
number of patients with leptospirosis identified that symptoms can last 
many years (14). Further work is needed to prospectively identify the 
evolution and persistence of symptoms. 
 
5.4.5 Conclusions 
Our study identifies leptospirosis as having a high burden of disease 
relative to other causes of fever in Tanzania. This burden fluctuates due to 
variations in incidence. Its greatest impact is on working age adults, which 
suggests an effect on productivity with potential additional impact on the 
family unit. Our research suggests a larger share of resources is 
warranted for leptospirosis control. The greatest uncertainties of our 
estimates are due to uncertainty about case-fatality ratio and incidence. 
Improved acute phase diagnostic tests and regular incidence surveillance 
would reduce the uncertainty of our estimates. 
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Chapter 6. Risk factors for 
acute leptospirosis in northern 
Tanzania 
 
6.1 INTRODUCTION  
In northern Tanzania, leptospirosis has been identified previously as an 
important cause of febrile illness (1). As well as being prevalent in hospital 
cohorts, we estimated in Chapter 5 that the burden of acute leptospirosis 
during 2007-08 was 495.0 annual disability life years lost (DALYs), and 
during 2012-14 the burden was 169.4 annual DALYs. Because of the high 
burden of disease caused by leptospirosis in this region, control efforts are 
warranted. Control activities require understanding of the locally important 
animal reservoirs, sources, and modes of transmission to humans. 
 
Figure 6.1 illustrates the chain of infection for leptospirosis (2). Reservoirs 
can be defined as epidemiologically connected populations or 
environments in which a pathogen can be permanently maintained and 
from which infection is transmitted to the target population (3). Sources of 
human infection include reservoir hosts as well as hosts that are not 
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reservoirs but are transiently excreting Leptospira. In addition, reservoir 
animals excrete Leptospira in their urine leading to environmental 
contamination. Leptospira are able to persist in soil and water (4). For 
leptospirosis, animal species may be reservoir hosts for some serovars, 
but not others (5). Humans are incidental hosts, who may be infected 
when their mucous membranes or broken skin are exposed to the urine of 
infected animals or contaminated surface water or soil (6).   
 Figure 6.1 Chain of leptospirosis infection 
 
While the major reservoirs, sources of human infection, and modes of 
transmission of infection are established on a global scale, there is 
substantial variation by location reflecting the diverse ecology of 
leptospirosis. In many tropical countries, rodent species are considered 
the most important animal reservoir for human infection (7). As such, 
dominant risk factors for leptospirosis in many tropical countries include 
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activities that expose individuals to rodent urine, such as living in urban 
slums, proximity to sewers, and exposure to flood waters (7-9). In contrast, 
as discussed in Chapter 1 of this thesis, in northern Tanzania there is 
evidence that leptospirosis is more common in rural areas (10). Previous 
Leptospira exposure studies have identified livestock farmers as a high-
risk group for Leptospira seropositivity (11). Serogroup reactivity patterns 
of human cases have also suggested that livestock may be reservoirs for 
human infections (10), and studies of livestock have found high 
proportions seropositive or with leptospiruria (12-14).   
 
Climate and geography can affect people’s risk of acquiring leptospirosis 
(15). Epidemics of leptospirosis have been associated with floods. People 
may be exposed to flood waters during extreme rainfall or when their 
environment contains geographic features that favour accumulation of 
water during rain. Variations in soil type and climate may also influence 
survival of Leptospira in soil and water. In Canada, humus-rich colloidal 
clay surface soil, and bedrock composed of limestone and dolomite have 
been associated with increased detection of Leptospira (16). In northern 
Tanzania chromic luvisols are common. Chromic luvisols, which are rich in 




We aimed to determine risk factors for human leptospirosis in northern 
Tanzania and identify which animal or environmental sources are 
important in transmission of leptospirosis to people. 
 
6.2 METHODS  
6.2.1 Study setting 
We conducted a cross-sectional study at Kilimanjaro Christian Medical 
Centre (KCMC), a 450-bed zonal referral hospital and, Mawenzi Regional 
Referral Hospital (MRRH) a 300-bed regional referral hospital, both in 
Moshi. Moshi (population ~180,000) is the administrative capital of the 
Kilimanjaro Region (population ~1.6 million) of Tanzania. 
 
6.2.2 Enrolment 
From 20 February 2012 through 28 May 2014 the study team approached 
all adult patients who were admitted to KCMC with a febrile illness as well 
as all adult or paediatric patients who were admitted at MRRH.  In 
addition, we approached every second patient who presented with fever to 
the outpatient department at MRRH. Hospitalised participants were eligible 
for enrolment if they had a history of fever within the previous 72 hours or 
an axillary temperature of >37.5°C or a tympanic, oral, or rectal 
temperature of ≥38.0°C at admission. Non-hospitalised patients were 
eligible if they had an axillary temperature of >37.5°C or a tympanic, oral, 
or rectal temperature of ≥38.0°C. All adult study participants provided 
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written informed consent. For those under 18 years, a parent or guardian 
provided written informed consent. In addition, written assent was 
provided for those aged 12 to 18 years. Enrolment occurred only on 
weekdays. Participants were asked to return 4-6 weeks after enrolment for 
collection of a convalescent serum sample. 
 
6.2.3 Laboratory methods 
Blood was allowed to clot for between 30 and 60 minutes. It was then 
centrifuged for 15 minutes at 1,126-1,455 relative centrifugal force to 
separate serum. Serum was stored at -80°C. Serum specimens were 
batch shipped on dry ice from Moshi to Atlanta, GA, United States of 
America (USA) for testing. Serology for leptospirosis was performed at the 
US Centers for Disease Control and Prevention using the standard 
microscopic agglutination test (MAT) with a panel of 20 Leptospira 
serovars belonging to 17 serogroups (17). These included: Australis 
(represented by L. interrogans serovar Australis, L. interrogans serovar 
Bratislava), Autumnalis (L. interrogans serovar Autumnalis), Ballum (L. 
borgpetersenii serovar Ballum), Bataviae (L. interrogans serovar 
Bataviae), Canicola (L. interrogans serovar Canicola), Celledoni (L. weilii 
serovar Celledoni), Cynopteri (L. kirschneri serovar Cynopteri), Djasiman 
(L. interrogans serovar Djasiman), Grippotyphosa (L. interrogans serovar 
Grippotyphosa), Hebdomadis (L. santarosai serovar Borincana), 
Icterohaemorrhagiae (L. interrogans serovar Mankarso, L. interrogans 
Icterohaemorrhagiae), Javanica (L. borgpetersenii serovar Javanica), Mini 
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(L. santarosai serovar Georgia), Pomona (L. interrogans serovar 
Pomona), Pyrogenes (L. interrogans serovar Pyrogenes, L. santarosai 
serovar Alexi), Sejroe (L. interrogans serovar Wolffi), and Tarassovi (L. 
borgpetersenii serovar Tarassovi).  MAT was performed beginning at a 
dilution of 1:100, with subsequent two-fold dilutions. Positive and negative 
controls were included with each run. 
 
6.2.4 Case and control definitions 
We defined cases as participants with either a four-fold rise in 
agglutinating antibody titres between acute and convalescent serum, or a 
single reciprocal titre of ≥800 (18). Controls were participants with 
negative titres on both acute and convalescent serum. The predominant 
reactive serogroup for cases was defined as the serogroup containing the 
serovar with the highest titre. 
 
6.2.5 Risk factor questionnaire 
At enrolment we administered a standardised clinical questionnaire and a 
risk factor questionnaire to capture exposure to the major reservoirs and 
non-reservoir sources of leptospirosis. Our questionnaire (Appendix A) 
included sections asking questions about participants’ demographic 
characteristics, water use and exposure, home and land, contact with 
animals, and food, rodent and agricultural exposures. We considered 
rodents, other wildlife, and livestock as potential reservoirs of leptospirosis 
(5). The questionnaire was designed to include established risk factors for 
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leptospirosis from studies done in other settings (7-9, 19-21). We included 
questions to capture exposure to these animals. In addition, as moist soil, 
mud, and standing water can be sources of human leptospirosis (22), we 
included questions about exposure of participants to these. We translated 
our questionnaire with the help of professional Kiswahili translator, and 
piloted our questionnaire among hospitalised patients to refine questions. 
 
6.2.6 Geospatial and rainfall data 
For participants who lived in the Kilimanjaro Region, study personnel 
visited participant households to record Global Positioning System (GPS) 
coordinates of participants’ dwellings. For the purposes of analysis, we 
zoned the participants’ environment according to population density: urban 
villages had a population density of ≥10 inhabitants/km2, peri-urban 
villages had a population density ≥3 inhabitants/km2 and were ≤15km 
distance from urban areas, and rural villages had a population density of 
<3 inhabitants/km2 or were ≤15km distance from an urban area (23). 
Population density was calculated from the 2012 Tanzania Population and 
Housing Census (24). Georeferenced mean annual rainfall and soil type 
data were obtained from the 2002 Kenya International Livestock Research 
Institute report (25). Land use data were obtained from the 2010 National 
Geomatics Center of China report (26). Daily rainfall data were obtained 
from the Tanzania Production Company (TPC) rainfall stations located 
approximately 20km from Moshi. 
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6.2.7 Study power 
I assessed study power using a two-sample proportion chi2 test with 
continuity correction to estimate study power (27, 28). A sample size of 
616 participants, including 24 cases would have 80% power to detect an 
odds ratio of 5 assuming an exposure prevalence of between 10% and 
70% among controls.  
 
6.2.8 Data Management 
Data were entered using the Cardiff Teleform system (Cardiff, Inc., Vista, 
CA, USA) into an Access database (Microsoft Corporation, Redmond, WA, 
USA). I assessed data integrity by evaluating each variable for implausible 
values and values inconsistent with answers to other questions. Any 
implausible or inconsistent were verified against the paper teleforms. 
Analyses were performed using Stata, version 13.1 (Stata-Corp, College 
Station, TX, USA).  
 
6.2.9 Statistical analysis 
Logistic regression was used to investigate associations between 
independent variables acute leptospirosis.  Initially all associations 
between individual behaviour variables and our outcome variables were 
assessed by bivariable logistic regression. In addition, to understand the 
relationship between independent variables, we performed bivariable 
logistic regression between all independent variables. We then developed 
models to investigate the behavioural variables and the geospatial 
 289 
variables separately. Because of the high ratio of independent variables to 
cases of acute leptospirosis, we considered multivariable logistic 
regression models of the individual behaviour variables, and the 
georeferenced variables to be unstable. Therefore, to facilitate 
multivariable modelling we investigated methods of dimension reduction. 
That is, reducing the number, and summarising the independent variables. 
We investigated a knowledge-based approach and a purely statistical 
approach. 
 
6.2.9.1 Knowledge based dimension reduction: creation of cumulative 
exposure scales 
We created summary scales to estimate quantitatively overall patient 
exposure to each of the main modes and sources of infection that we 
identified from the published literature: urine of cattle, goats, pigs and 
rodents, and surface water (7). In addition to facilitating multivariable 
modelling, our scales assessed the cumulative exposure to potential 
sources of Leptospira infection. This allowed us to assess the effects of 
cumulative exposure to each source on the risk of human leptospirosis. 
We used an analytic hierarchy process to develop these scales (29). First, 
we identified relevant behaviours and living conditions from the risk factor 
questionnaire to be included in each scale.  We then identified locally 
experienced subject matter experts, including livestock field officers, 
physicians, rodent ecologists, veterinarians, water engineers, water and 
sanitation epidemiologists, and zoonotic disease epidemiologists. For 
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each potential source of infection, we asked experts to rank each relevant 
behaviour against every other behaviour in terms of the likelihood and 
intensity of exposure to the source using a 9-point bidirectional scale 
(Table 6.1). We then calculated weightings using a matrix that added, for 
each behaviour, reciprocals of the score from each pairwise comparison 
(30). We assessed precision and error in the judgment process through 
measuring an expert’s internal consistency in multiple pairwise 
comparisons. We excluded weightings by experts who provided internally 
inconsistent answers, as designated by a consistency ratio >0.2 (30), and 
then calculated the geometric mean of the weightings given by all included 
experts. To aid interpretation of exposure scores, we multiplied all weights 
within each scale by a constant, so that possible scores on each scale 
ranged from zero to five. Finally, we derived an overall score for each 
participant on each exposure scale based on their questionnaire answers, 
such that someone who had performed none of the exposure activities 
scored zero and someone who performed all of the activities scored five.  
 
6.2.9.2 Model building using exposure scales  
Relationships between exposure scores and log odds of acute 
leptospirosis and Leptospira seropositivity, were assessed using fractional 
polynomial transformations of the exposure scales (31). We allowed up to 
two degrees of freedom and utilised the function selection procedure of 
Stata’s multivariable fractional polynomial algorithm to select the best 
fitting transformation for each exposure scale. The correlation between 
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exposure scales was assessed using linear regression. Interactions 
between exposure scales were assessed using factor variables. Through 
use of directed acyclic graphs, we considered that all exposure scores 
might act as confounders, and our initial multivariable models included all 
exposure scales. Variables were examined for co-linearity using variance 
inflation factors. We used stepwise backwards elimination to arrive at the 
model that minimised the Akaike Information Criterion (AIC) (32), p values 
were two sided, and the significance level was set at 0.05.  
 
Table 6.1 Fundamental Scale: A scale of absolute numbers used to 








Equal exposure 1 1 Equal exposure 
 1/2 2  
A bit less exposure 1/3 3 A bit more exposure 
 1/4 4  
Quite a bit less exposure 1/5 5 Quite a bit more exposure 
 1/6 6  
Much less exposure 1/7 7 Much more exposure 
 1/8 8  
Vastly less exposure 1/9 9 Vastly more exposure 
Adapted from Saaty TL. Decision making with the analytic hierarchy 
process. Int J Services Sciences. 2008;1(1):83-98. 
 
 
6.2.9.3 Statistical dimension reduction: principal component analysis 
We undertook a principal component analysis with orthogonal (varimax) 
rotation (33, 34). We assessed the number of components based on scree 
plot inflection point. We assessed the loading of each variable with each 
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component. We assigned participants a score for each component based 
on their answers to questionnaire variables that had loadings >0.3 for a 
component. For binary variables, participants scored either 0 or 1. The 
rodent sighting variables were ordinal, with answers of never, less than 
once per week, and greater than once per week. We scaled these to 0, ½, 
and 1 in order to maintain proportionality with the other variables included 
in the scale. 
 
6.2.9.4 Assessing the relationships between the two methods of 
dimension reduction 
We compared the participants’ component derived scores with 
participant’s expert opinion derived scores using scatter-plots and linear 
regression. 
 
6.2.9.5 Assessing the relationship of leptospirosis to the exposure scales 
We assessed the relationships between acute leptospirosis and 
Leptospira seropositivity with the scales from each method of dimension 
reduction separately. Relationships between the scales and odds of acute 
leptospirosis and seropositivity were assessed using fractional polynomial 
transformation of the scales (31).  We assessed for interaction terms using 
factor variables. Multivariable models were built for each method of 
dimension reduction using initially all exposure scales. We allowed up to 
two degrees of freedom and utilised the function selection procedure of 
Stata’s multivariable fractional polynomial algorithm to select the best 
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fitting transformation for each variable. Variables were examined for co-
linearity using a correlation matrix. We used stepwise backwards 
elimination to arrive at the model that maximised the AIC (32). P values 
were two sided, and the significance level was set at 0.05. 
 
6.2.9.6 Handling of geospatial risk factors 
Spatial scan statistics were calculated using a Bernoulli model to assess 
evidence of spatial clustering of cases using SatScan version 9.0 
(www.satscan.org) (35). We assessed whether cases were randomly 
distributed and identified high risk and low risk clusters.  The spatial scan 
statistic was set to include a maximum of 50% of the data. Statistically 
significant clusters were identified using p<0.05.  
 
We also investigated whether georeferenced variables were risk factors 
for leptospirosis. Geospatial data were managed using QGIS, version 
2.8.3 (Free Software Foundation, Boston, MA, USA). When performing 
logistic regression, we condensed data of soil type other than chromic 
luvisol as very few participants lived on land of other soil types. 
Georeferenced mean rainfall were available in 200mm/year intervals. As 
there were few individuals in many of the rainfall intervals, we condensed 
these into three intervals of <1000mm/year, 1000-1600mm/year and 
>1600 mm/year. We built logistic regression models using Stata, version 
13.1 (Stata-Corp, College Station, TX, USA). Our initial models of 
geospatial risk factors included all variables with a p value <0.2 in 
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bivariable logistic regression. No variables were forced into the model as 
confounders. We performed backwards stepwise model selection to 
minimise the AIC.  
 
6.2.9.7 Assessment of attributable fraction 
We assessed the population attributable fraction for risk factors that 
showed a statistically significant association with leptospirosis by using 
maximum likelihood estimation of the attributable fraction from the logistic 
regression models (36). 
 
6.3 RESULTS 
6.3.1 Enrolment and participant characteristics 
Of 15,305 patients admitted and 30,413 presenting to the outpatient 
department during the study period, 2,962 met eligibility criteria and 1,416 
(47.8%) were enrolled. We did not collect detailed information about why 
eligible patients did not participate. Of 1,293 participants who completed 
the risk factor questionnaire and had serum tested, 24 (1.8%) met the 
study criteria for acute leptospirosis, and 592 (45.2%) were classified as 
controls (Figure 6.2). Of the remaining participants, 449 (34.7%) were 
seronegative but provided only a single serum sample and so were 
excluded from analysis, and 228 were seropositive. An analysis of risk 
factors for Leptospira seropositivity is reported separately (Chapter 7). 
Participant characteristics are shown in Table 6.2.  
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Fig 6.2 Study flow diagram for patients seeking care at Kilimanjaro 





Table 6.2 Demographic and clinical characteristics of study 
participants, among patients with febrile illness (N=616), northern 
Tanzania, 2012-14 
    Acute leptospirosis (N=24) Controls (N=592) 
    n (%) n (%) 
Demographic characteristics     
  Age, median (range) years 37.8 (2.4-67.7) 21.9 (0.2-84.2) 
 Female sex  13 (54.2) 313 (52.9) 
  Pastoralist tribe* 0 (0) 2 (0.3) 
  Residence in urban district 11  (45.8) 288  (48.7) 
Clinical history      
  Fever duration >7 days  14 (58.3) 160 (27.0) 
 Received prior antibiotics 9 (37.5) 219 (37.0) 
 Conjunctival suffusion 0 (0) 13 (2.2) 
 Haemoptysis 0 (0) 0 (0) 
  Jaundice 0 (0) 9 (1.5) 
  Neck stiffness 6 (25) 56 (9.5) 
Key: *Pastoralist tribe: Maasai, Barahaig. 
 
6.3.2 Description of reactive serogroups 
The frequency with which participants were predominantly reactive to 
various Leptospira serogroups is shown in Table 6.3. Of the 24 cases, 9 
(37.5%) reacted predominantly to Australis, 4 (16.7%) to Sejroe, 3 (12.5%) 
to Icterohaemorrhagiae, 3 (12.5%) to Djasiman, 2 (8.3%) to 
Grippotyphosa, 2 (8.3%) to Pyrogenes, and 1 (4.2%) to Tarassovi.  
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Table 6.3 Predominantly reactive serogroup of leptospirosis cases, 
northern Tanzania, 2012-14 
Serogroup Leptospira cases (N=24) 
 n (%) (95% CI) 
Australis 9 (37.5) (19.8-59.4) 
Sejroe 4 (16.7) (5.9-38.9) 
Icterohaemorrhagiae 3 (12.5) (3.7-34.5) 
Djasiman 3 (12.5) (3.7-34.5) 
Pyrogenes 2 (8.3) (1.9-30.2) 
Grippotyphosa 2 (8.3) (1.9-30.2) 
Tarassovi 1 (4.2) (0.5-27.4) 
Abbreviations: CI = confidence intervals 
6.3.3 Association of individual behavioural risk factors 
Bivariable logistic regression of individual risk factors are included in 
Appendix B. There was a strong association between behaviours involving 
a single livestock species. For example, having cleaned cattle waste was 
associated with having fed cattle with an OR 324.1 (95% confidence 
intervals [CI] 96.6-1087.0). There was some association between 
behaviours involving different livestock species. For example, having 
cleaned cattle waste was associated with having cleaned goat waste with 
an OR 28.8, CI 12.0-69.1. There was a small magnitude association 
between rodent contact variables and livestock related variables. For 
example, owning cattle was not associated with seeing rodents frequently 
in the house, compound or fields, and had a low magnitude association 
with seeing rodents in the kitchen or food store (OR 1.5, CI 1.1-2.1).  
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6.3.4 Logistic regression of acute leptospirosis and individual 
behaviours 
Results for the logistic regression analysis of individual behaviours are 
shown in Table 6.4. On bivariable regression several livestock-related 
variables, including feeding cattle (OR 3.9, 95% confidence intervals [CI] 
1.3-10.3) and cleaning up cattle waste (OR 4.3, CI 1.2-12.9), were 
associated with leptospirosis. In addition, working as a farmer (OR 3.3, CI 
1.3-8.2), and working in rice fields were associated with leptospirosis (OR 
14.6, CI 2.9-59.5). There were some variables, such as killing rodents (OR 
5.5, CI 0.94-21.5), for which we did not identify associations with 
leptospirosis that had odds ratio confidence intervals that included the 
possibility of a large increase in risk. In addition, for several variables there 
were broad confidence intervals that encompassed the possibility that the 
variable may convey a large increase in risk or a large decrease in risk. 
Examples of such variables included keeping cattle inside the house (OR 
8.5, CI 0.15-110) and keeping goats inside the house (OR 5.1, CI 0.10-
48.2). 
 
6.3.5 Estimation of population attributable fraction of individual 
behaviours 
The population attributable fraction for each of the variables that we 
identified as statistically significant using logistic regression are shown in 
Table 6.5. The attributable fraction for each variable in Table 6.5 is 
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estimated from bivariate logistic regression, and as discussed below must 
be interpreted cautiously. 
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Table 6.4 Bivariable logistic regression of individual risk factors for 
acute leptospirosis among patients with febrile illness (N=616), 






Bivariate logistic regression 
 
 n (%) n (%) OR (95% CI) p value 
Livestock exposure variables     
Cleaned cattle waste 5 (20.8) 34 (5.7) 4.3 (1.2-12.9) <0.01 
Cleaned goat waste 3 (12.5) 30 (5.1) 2.7 (0..48-9.7) 0.11 
Cleaned pig waste 1 (4.2) 17 (2.9) 1.5 (0.03-10.2) 0.71 
Fed cattle 7 (29.2) 57 (9.6) 3.9 (1.3-10.3) 0.02 
Fed goats 4 (16.7) 57 (9.6) 1.9 (0.45-5.9) 0.26 
Fed pigs 1 (4.2) 20 (3.8) 1.2 (0.02-8.5) 0.84 
Herded cattle 1 (4.2) 6 (1.0) 4.2 (0.49-36.7) 0.19 
Herded goats 1 (4.2) 13 (2.2) 1.9 (0.24-15.4) 0.53 
Kept cattle inside the house 1 (4.2) 3 (0.5) 8.5 (0.15-110) 0.29 
Kept goats inside the house 1 (4.2) 5 (0.8) 5.1 (0.10-48.2) 0.14 
Kept pigs inside the house 1 (4.2) 54 (9.1) 0.4 (0.01-2.7) 0.42 
Milked cattle 2 (8.3) 15 (2.5) 3.5 (0.36-16.5) 0.28 
Milked goats 0 (0.0) 1 (0.2) NA  
Owning cattle 9 (37.5) 128 (21.6) 2.2 (0.82-5.4) 0.12 
Own dogs 3 (12.5) 110 (18.6) 0.6 (0.12-2.2) 0.66 
Owned goats 8 (33.3) 143 (24.2) 1.6 (0.6-4.0) 0.31 
Own pigs 1 (4.2) 54  (9.1) 0.43 (0.1-3.3) 0.70 
Slaughtered cattle 3 (12.5) 51 (8.6) 1.5 (0.44-5.3) 0.51 
Slaughtered goats 2 (8.3) 14 (2.4) 3.8 (0.80-17.5) 0.09 
Slaughtered pigs 0 (0.0) 4 (0.7) NA  
Rodent exposure variables      
Worked as a farmer 10 (41.7) 106 (17.9) 3.3 (1.3-8.2) 0.01 
Killed rodents 3 (12.5) 15 (2.5) 5.5 (0.94-21.5) 0.06 
Freq. rodents seen in house 
  Less than once/week 



















Freq. evidence of rodents seen in house 
  Less than once/week 



















Freq. rodents seen in fields 
  Less than once/week 



















Freq. rodents seen in compound 
  Less than once/week 



















Freq. rodents seen in kitchen/ food store 
  Less than once/week 



















Surface water exposure variables     
Bathed in surface water 6 (25.0) 124 (20.9) 1.3 (0.40-3.4) 0.79 
Drank untreated surface water 4 (16.7) 69 (11.7) 1.2 (0.28-3.6) 0.97 
Had standing water in compound 9 (37.5) 154 (26.1) 1.7 (0.64-4.2) 0.31 
Walked barefoot 14 (58.3) 271 (45.8) 0.85 (0.33-2.1) 0.85 
Washed in surface water 5 (20.8) 132 (22.3) 0.91 (0.26-2.6) 1.00 




Table 6.5 Population attributable fraction estimates for risk factors of 
acute leptospirosis in northern Tanzania, 2012-14 
Variable Estimate (95% confidence interval) 
Cleaned cattle waste 0.16 (0.11-0.21) 
Fed cattle 0.21 (0.14-0.28) 
Worked as a farmer 0.29 (0.17-0.39) 
Worked in rice fields 0.16 (0.14-0.17) 
 
6.3.6 Knowledge based cumulative exposure scales 
6.3.5.1 Analytic hierarchy process and activity weights 
Nine (42.9%) of 21 experts surveyed provided consistent multiple pairwise 
rankings of the relative exposure to livestock urine individuals performing 
various activities would have. These included four (26.7%) of 15 livestock 
field officers, three (100%) of three veterinarians, and two (100%) of two 
zoonotic epidemiologists. Two (100%) of two water engineers, and two 
(100%) of two epidemiologists provided consistent multiple pairwise 
rankings of the relative exposure to surface water. Three (75%) of four 
rodent ecologists provided consistent pairwise rankings of relative 
exposure to rodent urine. The weights assigned to individual behaviours 




Table 6.6 Component risk factors and relative weights for exposure 
to multiple leptospirosis infection sources derived from an analytic 
hierarchy process conducted among East African subject matter 
experts, 2015 
Cattle or goat urine exposure Rodent urine exposure Surface water exposure 
Variable Weight Variable Weight Variable Weight 
Clean livestock waste 0.85 Subsistence farmer 0.70 Drink surface water 1.81 
Birth livestock 0.78 Sugar cane worker 0.68 Bathe in surface water 1.41 
Keep livestock inside 
house 
0.74 Handle rat carcasses 0.66 Work in rice field  0.73 
Milk livestock 0.72 See rats in kitchen 0.55 Wash in surface water 0.65 
Slaughter livestock 0.66 Plumber 0.54 Walk barefoot 0.22 
Veterinarian 0.48 See rats in house 0.47 
Have standing water 
in compound 
0.18 
Herd livestock 0.27 Kill rats 0.45   
Keep livestock around 
house 
0.26 
See evidence of rats in 
house 
0.40   
Feed livestock 0.23 
See evidence of rats in 
compound 
0.28   
  
See evidence of rats in 
fields 
0.28   
Total 5.00  5.00  5.00 
 
 
6.3.5.1 Participant exposure scores 
The distributions of participant’s exposure scores are shown in Figures 
6.3-6.7. On these scales, 70.1% of participants had no exposure to cattle 
urine, 31.7% had no exposure to rodent urine, and 33.9% had no 
exposure to surface water.  The mean exposure scores were: cattle urine 
exposure 0.16 points (95% confidence intervals 0.12-0.19), goat urine 
exposure 0.12 points (0.10-0.19), pig urine exposure 0.09 points (0.06-
0.12), rodent urine exposure 0.83 (0.77-0.90) and surface water exposure 
0.87 (0.76-0.98). 
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Scatter plots showing the relationship of various exposure scores are 
shown in Figures 6.8-6.11 For example, there was limited correlation 
between cattle urine exposure and both goat urine exposure (r2=0.21) and 
pig urine exposure (r2=0.04). In addition, there was little correlation 
between livestock exposure scores and rodent urine exposure (for 
example, cattle urine exposure and rodent urine exposure, r2=0.04), 
livestock exposure scores and surface water exposure (for example cattle 
urine and surface water (r2=0.02), and between rodent urine exposure and 
surface water exposure (r2=0.02) 
 
Legend: Density= frequency over class width and is scaled so that the 
sum of their areas = 1 
Figure 6.3 Histogram of participant scores on knowledge-based 
cattle urine exposure scale, among cases of acute leptospirosis 





Legend: Density= frequency over class width and is scaled so that the 
sum of their areas = 1 
Figure 6.4 Histogram of participant scores on knowledge-based goat 
urine exposure scale, among cases of acute leptospirosis (N=24) and 





Legend: Density= frequency over class width and is scaled so that the 
sum of their areas = 1 
Figure 6.5 Histogram of participant scores on knowledge-based pig 
urine exposure scale, among cases of acute leptospirosis (N=24) and 






Legend: Density= frequency over class width and is scaled so that the 
sum of their areas = 1 
Figure 6.6 Histogram of participant scores on knowledge-based 
rodent urine exposure scale, among cases of acute leptospirosis 





Legend: Density= frequency over class width and is scaled so that the 
sum of their areas = 1 
Figure 6.7 Histogram of participant scores on knowledge-based 
surface water exposure scale, among cases of acute leptospirosis 






Figure 6.8 Scatterplot of participants’ cattle urine and goat urine 
exposure scores among patients with febrile illness (N=616), 






Figure 6.9 Scatterplot of participants’ cattle urine and pig urine 
exposure scores among patients with febrile illness (N=616), 








Figure 6.10 Scatterplot of participants’ cattle urine and rodent urine 
exposure scores among patients with febrile illness (N=616), 








Figure 6.11 Scatterplot of participants’ cattle urine and surface water 
exposure scores among patients with febrile illness (N=616), 







Figure 6.12 Scatterplot of participants’ goat urine and pig urine 
exposure scores among patients with febrile illness (N=616), 






Figure 6.13 Scatterplot of participants’ goat urine and rodent urine 
exposure scores among patients with febrile illness (N=616), 






Figure 6.14 Scatterplot of participants’ goat urine and surface water 
exposure scores among patients with febrile illness (N=616), 






Figure 6.15 Scatterplot of participants’ pig urine and rodent urine 
exposure scores among patients with febrile illness (N=616), 






Figure 6.16 Scatterplot of participants’ pig urine and surface water 
exposure scores among patients with febrile illness (N=616), 






Figure 6.17 Scatterplot of participants’ rodent urine and surface 
water exposure scores among patients with febrile illness (N=616), 





6.3.4.1.3 Logistic regression of acute leptospirosis and exposure 
scales 
Results for the logistic regression analysis of the exposure scales are 
shown in Table 6.7. All exposure scales had a linear relationship with log 
odds of acute leptospirosis (as determined by the best fitting fractional 
polynomial) and there were no significant interactions. Table 6.7 shows 
the interaction terms explored. Increasing exposure to cattle urine and to 
rodents were each associated with acute leptospirosis on bivariable 
analysis (p=0.02 for each). In the multivariable analysis, the odds ratios for 
both cattle urine exposure and rodent exposure remained the same but 
neither was statistically significant.  The logistic regression of the final 
multivariable model was bootstrapped using 1,000 repetitions, as smaller 
number of repetitions gave unstable results. On the bootstrapped 
multivariable logistic regression (Table 6.7), neither cattle urine exposure 
nor rodent urine exposure had a statistically significant association with 
acute leptospirosis (cattle urine exposure OR 1.9 per point, 95% 
confidence intervals 0.91-4.0, p = 0.09, rodent urine exposure OR 1.6 per 
point (95% confidence intervals 0.98-2.6, p= 0.06).  To put these odds 
ratios in context, one point on the cattle urine exposure score was 
approximately equivalent to cleaning up livestock waste, or the combined 
exposure from both keeping cattle inside the house and herding cattle 
(Table 6.6). One point on the rodent urine exposure scale was 
approximately equivalent to, for example the combined total exposure 
from both seeing rodents in the kitchen and killing rodents (Table 6.6).
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Table 6.7 Bivariable and multivariable logistic regression models of 
association between exposure scales among patients with acute 
leptospirosis (n=24) and controls (n=592) in northern Tanzania, 2012-
14 
 Bivariable  Multivariable 
Variable OR (95% CI) p-value  OR (95% CI) p-value 
Cattle urine exposure 2.3 (1.1-4.7) 0.02  1.9 (0.91-4.0) 0.09 
Goat urine exposure 2.0 (0.82-4.7) 0.13    
Pig urine exposure 1.0 (0.32-3.3) 0.97    
Rodent urine exposure 1.7 (1.1-2.8) 0.02  1.6 (0.98-2.6) 0.06 
Surface water exposure 1.1 (0.84-1.4) 0.48    
Abbreviations: OR= odds ratio; CI= confidence interval 
 
Table 6.8 Logistic regression of interaction terms and acute 
leptospirosis among patients with acute leptospirosis (n=24) and 
controls (n=592) in northern Tanzania, 2012-14 
Interaction Odds ratio (95% CI) P value 
Cattle urine exposure and goat urine exposure 1.9  (0.47-7.3) 0.38 
Cattle urine exposure and pig urine exposure NA NA NA 
Cattle urine exposure and rodent urine exposure 0.95 (0.38-2.4) 0.91 
Cattle urine exposure and surface water exposure 0.91 (0.57-1.5) 0.69 
Goat urine exposure and pig urine exposure NA  0.99 
Goat urine exposure and rodent urine exposure 0.42 (0.11-1.6) 0.20 
Goat urine exposure and surface water exposure 1.1 (0.56-2.1) 0.83 
Pig urine exposure and rodent urine exposure 1.4 (0.24-7.8) 0.73 
Pig urine exposure and surface water exposure NA NA NA 
Rodent urine exposure and surface water exposure 0.74 (0.54-1.0) 0.07 
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6.3.7 Statistically derived scales using principal component analysis 
We selected four components based on the inflection point of the scree 
plot shown in Figure 6.18. The component eigenvectors were greater than 
1.5 for each of the four components and together they explained 49.9% of 
variance in the data. The variables with a loading >0.30 to any component 
are shown in Table 6.9 
 
Figure 6.18 Scree plot of eigenvalues for principal component 
analysis of risk factor questionnaire among patients with febrile 




Table 6.9 Variables loading most strongly with principal components, 
among patients with febrile illness (N=616), northern Tanzania, 2012-
14 
 
# Variable (loading) Component name 
1 Fed cattle (0.37) 
Fed goats (0.35) 
Fed pigs (0.34) 
Cleaned cattle waste (0.34) 
Cleaned goat waste (0.30) 
Handling livestock 
2 Evidence of rodents in the house (0.47) 
Seen rodents in the house (0.44) 
Seen rodents in the kitchen or food store (0.45) 
Seen rodents in the compound (0.42) 
Seeing rodents 
3 Washing using surface water (0.50) 
Bathing in surface water (0.48) 
Drinking surface water (0.42) 
Contact with untreated surface water 
4 Herd cattle (0.55) 
Herd goats (0.55) 
Slaughtered cattle (0.39) 
Slaughtered goats (0.36) 
Herding or slaughtering ruminant livestock 
Key: # Component number 
6.3.7.1 Participant component scale scores 
Summary statistics of the scores of participants on the scales generated 
from the identified components are shown in Table 6.10.  There were 522 
(84.7%) participants with a score of zero on the handling livestock scale, 
207 (33.6%) with a score of zero on the seeing rodents scale, 355 (57.7%) 
participants with a score of zero on the contact with untreated surface 
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water scale, and 543 (88.2%) participants with a score of zero on the 
herding or slaughtering ruminant livestock scale. The distribution of 
participant scores is shown in Figures 6.19 – 6.22.  
 
Table 6.10 Summary statistics of participant scores on principal 
component derived scales, among patients with febrile illness 
(N=616), northern Tanzania, 2012-14 
Variable         N Mean Median Range 
Handling livestock 616 0.4 0.0 0-4 
Seeing rodents 616 1.6 1.0 0-4 
Contact with untreated surface water 615 0.6 0.0 0-3 





Figure 6.19 Histogram of participant scores for component 1: 
handling livestock, among cases of acute leptospirosis (n=24) and 





Figure 6.20 Histogram of participant scores for component 2: seeing 
rodents, among cases of acute leptospirosis (n=24) and controls 




Figure 6.21 Histogram of participant scores for component 3: contact 
with untreated surface water, among cases of acute leptospirosis 




Figure 6.22 Histogram of participant scores for component 4: herding 
and slaughtering ruminant livestock, among cases of acute 




6.3.7.2 Comparison of principal component analysis derived scales with 
knowledge based derived exposure scores 
I examined the correlation, through scatter plots and linear regression, of 
the principal component analysis derived scores with the expert opinion 
derived cumulative exposure scores that had similar biologic meaning. 
The scatter plots are shown as Figures 6.23 – 6.29 and Table 6.10 shows 





Figure 6.23 Scatterplot of knowledge-based cattle urine exposure 
score and principal component analysis derived livestock handling 





Figure 6.24 Scatterplot of knowledge-based goat urine exposure 
score and principal component analysis derived livestock handling 






Figure 6.25 Scatterplot of knowledge-based pig urine exposure score 
and principal component analysis derived livestock handling score 




Figure 6.26 Scatterplot of knowledge-based cattle urine exposure 
score and principal component analysis derived herding or 
slaughtering ruminant livestock score among patients with febrile 





 Figure 6.27 Scatterplot of knowledge-based goat urine exposure 
score and principal component analysis derived herding or 
slaughtering ruminant livestock score among patients with febrile 





Figure 6.28 Scatterplot of expert opinion derived rat urine exposure 
score and principal component analysis derived seeing rodent score 






Figure 6.29 Scatterplot of expert opinion derived surface water 
exposure score and principal component analysis derived contact 
with untreated surface water score among patients with febrile 
illness (N=616), northern Tanzania, 2012-14 
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Table 6.10 Linear regression of principal component analysis derived 
scores with knowledge-based exposure scores among patients with 
febrile illness (N=616), northern Tanzania, 2012-14 
PCA derived scores 
 Knowledge based 
scores 
Co-efficient 95% CI R2 
Handling livestock Cattle urine exposure  0.43 0.39-0.47 0.46 
Handling livestock Goat urine exposure 0.55 0.51-0.59 0.52 
Handling livestock Pig urine exposure 0.30 0.25-0.35 0.18 
Herding or slaughtering 
ruminant livestock 
Cattle urine exposure 0.14 0.11-0.16 0.21 
Herding or slaughtering 
ruminant livestock 
Goat urine exposure 0.13 0.10-0.15 0.13 
Seeing rodents Rodent urine exposure 0.42 0.40-0.44 0.81 
Contact with surface water Surface water exposure 0.19 0.19-0.19 0.97 
Abbreviations: PCA=principal component analysis 
6.3.7.3 Logistic regression of acute leptospirosis and principal component 
analysis derived scores 
The results of bivariate logistic regression are shown in Table 6.11. 
Handling livestock was the only score that showed a statistically significant 
association with acute leptospirosis (OR 1.4, CI 1.1-1.9).  The exploration 
of possible variable interactions is shown in Table 6.12. There were no 
statistically significant interaction terms, although we had low power to 
detect interactions. All exposure scales showed a linear relationship with 
the log odds of acute leptospirosis (as determined from fitting fractional 
polynomial models). A multivariate model was built using all exposure 
scales. The final model contained the single variable livestock handling 
(OR 1.4, CI 1.1-1.9, p=0.02).  We estimated bootstrapped confidence 
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intervals of the final logistic regression model using 1000 replications and 
found consistent results (livestock handling OR 1.4, CI 1.0-2.0, p=0.04). 
The population attributable fraction of livestock handling was 0.16 (CI 
0.09-0.25).  
 
Table 6.11 Bivariable logistic regression models of association 
between principal component derived scales among patients with 
acute leptospirosis (n=24) and controls (n=592) in northern Tanzania, 
2012-14 
Variable number and name Odds ratio 95% CI p value 
1 Handling livestock 1.4 1.1-1.9 0.02 
2 Seeing rodents 1.2 0.9-1.5 0.26 
3 Contact with surface water 1.0 0.7-1.5 0.84 
4 Herding or slaughtering ruminant livestock 1.7 0.9-3.1 0.12 
 
Table 6.12 Logistic regression of interaction terms and acute 
leptospirosis among patients with acute leptospirosis (n=24) and 
controls (n=592) in northern Tanzania, 2012-14 
Variable names Odds ratio P value 
Livestock handling and seeing rodents 0.95 0.66 
Livestock handling and contact with surface water 0.87 0.28 
Livestock handling and ruminant livestock herding 1.2 0.30 
Seeing rodents and contact with surface water 0.80 0.10 
Ruminant herding and contact with surface water 1.1 0.70 
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6.3.8 Geospatial and temporal analysis 
GPS co-ordinates were available for houses of 521 (84.6%) participants. 
There was no statistically significant clustering in the spatial distribution of 
cases. The spatial distribution, and identified clusters, are indicated in 
Figure 6.30. There was a spatial cluster of participants whose house 
location conferred a relative risk <1 (1 of 253, RR 0.07, p=0.08). This 
cluster contained the area higher on the slopes of Mount Kilimanjaro. 
There was also a cluster of participants whose house location conferred a 
relative risk >1 that contained the flatter area at the base of Mount 
Kilimanjaro (4 of 13, RR=12.0, p=0.43). No cluster was statistically 
significant. Results of the bivariable logistic regression analysis of geo-
referenced environmental risk factors and acute leptospirosis are shown in 
Table 6.13. There were no statistically significant associations but the 
number of cases in many categories was very small. 
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Table 6.13 Temporal and geo-referenced risk factors for acute 
leptospirosis and Leptospira seropositivity among patients with 
febrile illness, northern Tanzania, 2012-14 




Acute leptospirosis logistic 
regression 
 n (%) n (%) OR (95% CI) p-value 
Land use       
Cultivated 12 (70.6) 330 (65.5) REF  
Urban 4 (23.5) 148 (29.4) 0.74 (0.24-2.3) 0.61 
Natural 1 (5.9) 26 (5.2) 1.1 (0.13-8.5) 0.96 
Main soil type       
Chromic Luvisol 17 (100) 444 (88.1) REF  
Other 0 (0) 60 (11.9) NA NA 
Ward population density, 
median in people/ km2 (IQR) 
2052 (433-7296) 962 (131-6064) 1.1* (0.95-1.2) 0.32 
Elevation, median in MASL 
(IQR) 
803 (794-856) 840 (803-980) 0.97§ (0.96-1.0) 0.25 
Annual Mean Rainfall     
<1000mm  2 (11.8) 103 (20.4) 0.39 (0.09-1.8) 0.23 
1000-1600mm  13 (76.5) 264 (52.4) REF  
>1600mm  2 (11.8) 137 (27.2) 0.30 (0.07-1.3) 0.11 
Village zone designation     
Urban 10 (58.8) 281 (55.8) REF  
Peri-urban 3 (17.7) 104 (20.6) 0.81 (0.22-3.0) 0.75 
Rural 4 (23.5) 119 (23.6) 0.94 (0.29-3.1) 0.92 
Temporal Rainfall Variables N=24 N=592   
Total rainfall in preceding 30 
days, median in mm (IQR) 
25 (1-65) 22 (1-68) 1.0 # (0.67-1.8) 0.69 
Largest single day rainfall in 
preceding 30 days, median in 
mm (IQR) 
13 (1-27) 13 (1-34) 0.92 # (0.16-5.2) 0.93 
Abbreviations: IQR= interquartile range; MASL= meters above sea level; NA= not applicable; REF= 
reference value 
Key: *The odds ratio, is the increase in odds of leptospirosis for an increase in population density of 
100 people/ km2; § Odds ratio is the increase in odds of leptospirosis for an increase in population 
density of per 10m increase in elevation; ♯ OR is the increase in odds of leptospirosis for an 





Figure 6.30 Home location of participants with and without acute 
leptospirosis and clusters of risk among patients with patients with 





We identified multiple associations between exposure to cattle and acute 
leptospirosis, suggesting that cattle are important sources of human 
leptospirosis. We also identified work in rice fields as a risk factor for 
human leptospirosis, which may indicate that rice field water that has been 
contaminated by Leptospira shedding animals is the likely source. Both 
these findings have implications for control and prevention of leptospirosis 
in Tanzania. In addition, our results may help clinicians identify individuals 
at high risk of leptospirosis, aiding decision making in patient care. 
 
6.4.1 Multiple analyses suggest cattle are an important source of 
human leptospirosis 
Our data indicate that cattle may play an important role in the transmission 
of leptospirosis in northern Tanzania. On bivariate logistic regression, we 
found an association with behaviours that involved cattle, specifically 
feeding cattle and cleaning up cattle waste. Using two unrelated methods 
of data dimension reduction we found an association between cattle urine 
exposure and leptospirosis, as well as between livestock handling and 
leptospirosis.  Using multivariable models, we found an association 
between livestock handling and acute leptospirosis. These findings are 
consistent with other data from northern Tanzania that point to livestock as 
an important source of human leptospirosis. Seroreactivity to serogroups 
Australis and Sejroe, to which leptospirosis cases were frequently 
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seropositive, was frequently observed among cattle slaughtered for meat 
in the Moshi area in 2014 (14). Furthermore, 7.3% of live cattle tested 
were shedding Leptospira in their urine (14). Our findings are consistent 
with other studies examining risk factors for Leptospira seropositivity in 
Africa. For example, in rural Uganda seroreactivity among humans to 
Leptospira serovars often found in livestock was common, and livestock 
skinning was a risk factor for seroreactivity (37). Similarly, Leptospira 
seropositivity was common among abattoir workers in Kenya and 
Tanzania (13, 38). We did not find evidence of an association between 
having milked cattle, slaughtered cattle, or kept cattle inside the house, 
and acute leptospirosis. These are activities that have previously been 
found to be associated with leptospirosis (7). In our study the confidence 
intervals that surrounded our estimates of odds ratios were wide, as these 
activities were infrequently performed. This means that for many of the 
activities we may not have observed a true association. Alternatively, there 
are variations in how different tribes in Tanzania keep cattle, and it may be 
that the methods used by local tribes to milk or slaughter livestock are 
somehow protective compared to methods used in other cultures. 
 
6.4.2 Inconsistent associations of rodent contact and leptospirosis 
Rodent exposure is an important risk factor for leptospirosis in tropical 
areas of the Asia-Pacific region and South America (7, 39, 40). We did not 
identify any evidence of associations of individual rodent related variables 
and leptospirosis. However, in our study the odds ratios of many individual 
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rodent related variables had wide confidence intervals and include the 
possibility of a true association.  We created a knowledge-based summary 
scale of rodent urine exposure, which showed an association with 
leptospirosis on bivariate logistic regression. A key component of the 
rodent urine exposure scale was working as a farmer, which was itself 
associated with leptospirosis. The scale generated from the principal 
component analysis relating to rodent exposure was not associated with 
leptospirosis on bivariate or multivariate regression. To put our findings in 
context, Leptospira have been isolated from rodents in other parts of 
Tanzania, but not in Moshi, or the surrounding districts. A recent study of 
rodent carriage in Moshi found that none of 393 rodents was excreting 
Leptospira in their urine (14), (41). However, there were few individuals 
exposed to many individual risk factors, and few cases of leptospirosis. 
Inadequate study power is an alternative explanation for our findings. In 
addition, our study investigated the risk factors for human infection, but 
leptospirosis is a zoonotic disease, with potential for transmission cycles 
between non-human animal species such as rodents and livestock. The 
existing global body of evidence clearly documents the important role of 
rodents as reservoir hosts and so further evidence is needed before 




6.4.3 Rice farming as a risk factor for leptospirosis 
We found an association between working in rice fields and leptospirosis, 
but few participants in our study farmed rice so the estimates were not 
fully reliable. In some areas of northern Tanzania rice farming is practised 
intensively, and there are active efforts to increase irrigated, continuously 
flooded rice farming across Tanzania (42). In Asia, where rice farming is 
well established as a risk factor for leptospirosis, humans are infected 
through prolonged contact with water that may be contaminated by 
infected animal hosts (7, 39). We did not find an association with the 
surface water exposure score nor in individual behaviours that exposed 
participants to surface water, which perhaps indicates that exposure to the 
continuously flooded rice paddies is qualitatively different from exposure to 
moving stream water on the lower mountain slopes. Further work is 
needed to investigate this risk source and to identify which animal hosts 
may be responsible for rice paddy contamination in Tanzania. Identifying a 
pattern in the sero-reactivity in human cases might provide clues as to the 
responsible serovars, and hence animal host. However, there was no 
dominant reactive serogroup among cases of acute leptospirosis who 
farmed rice. 
 
6.4.4 Variation in behaviours among livestock owners 
We found that many participants had some exposure to each potential 
source of leptospirosis, but the amount of exposure frequently varied. For 
example, we identified that over 30% of participants had some exposure to 
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cattle, and that exposure was common in those who live in both urban and 
rural areas. However, among those who had some exposure to cattle, 
there was variation in the frequency and type of contact.  The implication, 
when considering target groups for disease prevention interventions, is 
that not all who own or have contact with livestock are at equal risk of 
zoonotic disease. 
 
6.4.5 Comparison of dimension reduction techniques   
One reason that we employed dimension reduction techniques was that 
we identified fewer cases than expected and had a large ratio of individual 
behaviour risk factors to cases of leptospirosis. Purely statistical methods 
of dimension reduction have been used in infectious disease epidemiology 
(43). In our analysis the groupings generated by the principal component 
analysis were not easily relatable to a single animal species, which 
illustrates the limitation of this technique for hypothesis-driven 
investigation.  
 
The use of knowledge-based scales that quantified cumulative exposure 
to well established potential sources of leptospirosis allowed us to test 
hypotheses regarding likely sources of infection and measured cumulative 
exposure. There was substantial correlation between the principal 
component derived scales and knowledge-based scales involving surface 
water and rodents but less so with the scales relating to livestock 
practices. The grouping of activities by potential source of leptospirosis 
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appeared an advantage of knowledge-based scales but there are also 
limitations relating to their construction. First, we may not have included a 
sufficiently comprehensive number of individual behaviours adequately to 
estimate total exposure. However, being more inclusive of variables risked 
cumbersome pairwise comparisons. Second, we identified substantial 
variability in the answers of experts in their comparisons of behaviours, 
and the weightings assigned to each behaviour will be sensitive to 
variations in comparisons. Thirdly combining high risk activites with 
activities that did not convey increased risk may have masked true 
associations. There is certainly scope to improve our cumulative exposure 
scales. Methods such as the Delphi process, which use expert consensus 
have been used in infectious disease epidemiology (44) and in the case of 
zoonotic disease may improve the ranking of behaviours with regard to 
how they expose an individual to potential zoonotic disease transmission.  
 
6.4.6 Geospatial analysis 
We did not identify statistically significant spatial clusters of participants 
with leptospirosis nor spatial risk factors for leptospirosis.  Factors that 
may have contributed to such a lack of association may include the limited 
resolution of our risk factor data and few cases of leptospirosis. 
 
6.4.7 Limitations 
The extent to which the identified risk factors reflect those of the 
community are affected by several aspects of study design and analysis. 
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Reliance on imperfect serologic tests for diagnosis may have misclassified 
some participants with leptospirosis as controls, potentially minimising 
association of risk factors with leptospirosis. We chose controls who had 
febrile illness, all of whom could have been identified as leptospirosis 
cases. However, the use of hospitalised controls may have influenced our 
results if hospitalised patients had different exposure to risk factors than 
the general population. Although diagnosis was performed prospectively, 
our risk factor questionnaire was based on recall of exposures and may be 
subject to bias. Additionally, the prevalence of acute leptospirosis was 
lower than earlier time periods, and we may not have observed important 
associations due to insufficient sample size. Conversely, although some 
associations of individual behaviours were statistically significant, they 
were based on only a few cases and should be interpreted with caution. 
The associations for acute leptospirosis were seen only on bivariate 
analysis, and these associations may be due to confounding from 
unobserved behaviours. Despite this, the consistency of the association of 
the livestock related variables strengthens our confidence in the 
interpretation of the importance of livestock as a reservoir for human 
leptospirosis in our region. Another important limitation is that the risk 
factors we identified may be relevant only at the time period studied, 
because changes in the incidence of leptospirosis in the study area might 
also reflect changes in predominant sources and modes of transmission 
over time (45). Further, as risk factors for leptospirosis may vary by 
serovar, a pan-serovar analysis may aggregate cases of leptospirosis 
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acquired from disparate sources and lead our not identifying true 
associations.   
 
We may have misclassified cases or controls. All currently available 
diagnostic tests for leptospirosis, including MAT (46), are imperfect and it 
is possible that there is misclassification of participant cases or control 
status. The sensitivity and specificity of MAT on paired serum samples is 
explored in detail in Chapters 10 and 11. In brief, MAT is thought to be 
approximately 80% sensitive and less than 100% specific (47). That is, not 
all participants with leptospirosis will seroconvert on MAT (47), and for 
some participants a single high MAT titre may be due to a prior illness 
(48). We chose MAT for our case definitions since MAT on paired serum 
samples, while imperfect, remains the reference standard (47). 
Furthermore, culture, nucleic acid amplification and point-of-care IgM 
serology lack sensitivity in our setting (14, 49, 50) and reports from other 
settings have been mixed (46, 51-53).  Our MAT panel of 20 serovars, 
covered the major Leptospira serogroups that cause human disease, and 
all those within which African isolates are grouped. We did not use locally 
isolated serovars and this may have influenced identification of cases. 
However, studies on the use of local isolates in MAT reference panels 
have shown that they do not necessarily perform better than other 
serovars from the same serogroup (54, 55).  
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6.4.8 Implications for disease control 
Our results have implications for control of leptospirosis. The estimated 
population attributable fractions indicate that several risk factors have 
substantial influence on the burden of leptospirosis in northern Tanzania, 
and that multiple interventions may be needed to control leptospirosis. Our 
estimation of attributable fraction is based on associations from logistic 
regression. These associations may not be causal and therefore 
interpretation of the attributable fractions must be done cautiously. The 
odds ratios associated with cattle related activities were relatively small, 
but as some of these activities were commonly performed they conferred a 
substantial population attributable fraction. Transmission of leptospirosis 
from livestock to people is amenable to control through personal protective 
equipment for those performing high risk activities (56). In addition, 
Leptospira vaccines are available for use in livestock. In some countries 
such vaccines have contributed to successful control of leptospirosis (56). 
Few participants reported working in the rice fields but it had a large odds 
ratio, and consequently a substantial attributable fraction. Japan has 
dramatically reduced leptospirosis incidence among rice farmers through 
personal protection measures and livestock vaccination (39). Methods of 
leptospirosis control that may have relevance in northern Tanzania are 
discussed in detail in Chapter 12. 
6.4.9 Implications for clinicians 
Our identification of risk factors also has implications for clinicians 
managing patients who present with fever. Leptospirosis is challenging to 
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diagnose due to diagnostic tests that perform poorly early in the illness 
(47). Development of an accurate probability of the disease prior to 
performing laboratory testing is therefore critical to test interpretation. No 
clinical features have been found that reliably differentiate leptospirosis 
from other febrile illnesses (10, 22). Therefore, defining high-risk groups 
can help identify febrile patients at particular risk. Our study suggests that 
clinicians should have a high index of suspicion of leptospirosis among 
rice field workers, and those who have contact with cattle. 
6.4.10 Conclusions 
In conclusion, we identified subsistence farming, contact with cattle and 
work in rice fields as risk factors for leptospirosis. Our findings are 
consistent with infected cattle transmitting leptospirosis to people. Further 
work to isolate infecting serovars from humans and livestock is needed to 
confirm the importance of these associations. Nonetheless, we suggest 
that control of Leptospira in livestock could play a role in preventing 
human leptospirosis in Africa. 
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Chapter 7. Risk factors for 
Leptospira seropositivity in 
northern Tanzania 
 
7.1 INTRODUCTION  
As illustrated in Chapter 6, identifying sufficient numbers of leptospirosis 
cases for a robust assessment for risk factors is challenging, even in 
endemic regions.  In patients presenting with a febrile illness who are 
seropositive to Leptospira but do not have acute leptospirosis, sero-
reactivity to Leptospira indicates prior infection (1, 2). Therefore, studies 
investigating risk factors for Leptospira seropositivity can give insights into 
risks factors and sources of leptospirosis (3, 4).  Patients attending 
hospital with fever may not be representative of the general population, 
which may influence which risk factors are found to be associated with 
Leptospira seropositivity. For example, recruitment may be enriched for 
those with financial and geographical access to hospital, and to those with 
risk factors for other febrile illnesses. Despite these limitations, in northern 
Tanzania there are few data, and an assessment of risk factors for 
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Leptospira seropositivity among febrile patients would provide useful 
information about important risk factors and sources of infection. 
 
There have been previous studies of Leptospira seropositivity in Tanzania, 
but few that have explored risk factors. As discussed in Chapter 3, 
Leptospira seroprevalence among patients with febrile illness in Moshi 
was high at 19.5% (95% confidence intervals [CI] 17.3-21.7%). The 
seroprevalence was similar to that found by Schoonman and colleagues in 
Tanga where 15.1% of abattoir workers in a cross-sectional study had 
antibodies to Leptospira (5). An analysis of risk factors in Tanga found that 
livestock farmers, meat inspectors, and abattoir workers were at highest 
risk (5). These findings are consistent with elsewhere in East Africa. In 
Uganda, Dreyfus and colleagues found that the seroprevalence among 
patients attending healthcare centres was 35%, with the highest risk 
groups those who skinned cattle, and those who lived in close proximity to 
monkeys (4).  The findings of Dreyfus and Schoonman, as well as our 
findings that cattle contact and farm work were risk factors for acute 
human leptospirosis, suggest that risk factors for Leptospira seropositivity 
in northern Tanzania might include occupational or other close contact 
with livestock. Additionally, as we identified work in rice fields as a risk 
factor for acute human leptospirosis (Chapter 6), it is likely that it may also 
be a risk factor for Leptospira seropositivity. An analysis of risk factors for 
Leptospira seropositivity may be better able to identify which aspects of 




We aimed to identify risk factors for Leptospira seropositivity among 
patients with fever in northern Tanzania 
 
7.2 METHODS 
7.2.1 Study setting 
We conducted a cross-sectional study at Kilimanjaro Christian Medical 
Centre (KCMC), a 450-bed zonal referral hospital and, Mawenzi Regional 
Referral Hospital (MRRH) a 300-bed regional referral hospital, both in 
Moshi. Moshi (population ~180,000) is the administrative capital of the 
Kilimanjaro Region (population ~1.6 million) of Tanzania. 
 
7.2.2 Enrolment 
From 20 February 2012 through 28 May 2014 the study team approached 
all adult patients who were admitted to KCMC with a febrile illness as well 
as all adult or paediatric patients who were admitted at MRRH.  In 
addition, we approached every second patient who presented with fever to 
the outpatient department at MRRH. Hospitalised participants were eligible 
for enrolment if they had a history of fever within the previous 72 hours or 
an axillary temperature of >37.5°C or a tympanic, oral, or rectal 
temperature of ≥38.0°C at admission. Non-hospitalised patients were 
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eligible if they had an axillary temperature of >37.5°C or a tympanic, oral, 
or rectal temperature of ≥38.0°C. All adult study participants provided 
written informed consent. For those under 18 years, a parent or guardian 
provided written informed consent. In addition, written assent was 
provided for those aged 12 to 18 years. Enrolment occurred only on 
weekdays. Participants were asked to return 4-6 weeks after enrolment for 
collection of a convalescent serum sample. 
 
7.2.3 Laboratory methods 
Blood was allowed to clot for between 30 and 60 minutes. It was then 
centrifuged for 15 minutes at 1,126-1,455 relative centrifugal force to 
separate serum. Serum was stored at -80°C. Serum specimens were 
batch shipped on dry ice from Moshi to Atlanta, GA, United States of 
America for testing. Serology for leptospirosis was performed at the US 
Centers for Disease Control and Prevention using the standard 
microscopic agglutination test (MAT) with a panel of 20 Leptospira 
serovars belonging to 17 serogroups (6). These included: Australis 
(represented by L. interrogans serovar Australis, L. interrogans serovar 
Bratislava), Autumnalis (L. interrogans serovar Autumnalis), Ballum (L. 
borgpetersenii serovar Ballum), Bataviae (L. interrogans serovar 
Bataviae), Canicola (L. interrogans serovar Canicola), Celledoni (L. weilii 
serovar Celledoni), Cynopteri (L. kirschneri serovar Cynopteri), Djasiman 
(L. interrogans serovar Djasiman), Grippotyphosa (L. interrogans serovar 
Grippotyphosa), Hebdomadis (L. santarosai serovar Borincana), 
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Icterohaemorrhagiae (L. interrogans serovar Mankarso, L. interrogans 
Icterohaemorrhagiae), Javanica (L. borgpetersenii serovar Javanica), Mini 
(L. santarosai serovar Georgia), Pomona (L. interrogans serovar 
Pomona), Pyrogenes (L. interrogans serovar Pyrogenes, L. santarosai 
serovar Alexi), Sejroe (L. interrogans serovar Wolffi), and Tarassovi (L. 
borgpetersenii serovar Tarassovi).  MAT was performed beginning at a 
dilution of 1:100, with subsequent two-fold dilutions. Positive and negative 
controls were included with each run. 
 
7.2.4 Case and control definitions 
We defined seropositivity as participants with Leptospira antibodies 
detected by MAT at a reciprocal titre ≥100 (7). Controls were participants 
with negative titres on both acute and convalescent serum. The 
predominant reactive serogroup for cases was defined as the serogroup 
containing the serovar with the highest titre. 
 
7.2.5 Risk factor questionnaire 
We used the standardised risk factor questionnaire described in Chapter 6 




7.2.6 Geospatial and rainfall data 
For participants who lived in the Kilimanjaro Region, study personnel 
visited participant households to record Global Positioning System (GPS) 
coordinates of participants’ dwellings. For the purposes of analysis, we 
zoned the participants’ environment according to population density: urban 
villages had a population density of ≥10 inhabitants/km2, peri-urban 
villages had a population density ≥3 inhabitants/km2 and were ≤15km 
distance from urban areas, and rural villages had a population density of 
<3 inhabitants/km2 or were ≤15km distance from an urban area (8). 
Population density was calculated from the 2012 Tanzania Population and 
Housing Census (9). Georeferenced mean annual rainfall and soil type 
data were obtained from the 2002 Kenya International Livestock Research 
Institute report (10). Land use data were obtained from the 2010 National 
Geomatics Center of China report (11). Daily rainfall data were obtained 
from the Tanzania Production Company (TPC) rainfall stations located 
near Moshi. 
 
7.2.7 Data Management 
Data were entered using the Cardiff Teleform system (Cardiff, Inc., Vista, 
CA, USA) into an Access database (Microsoft Corporation, Redmond, WA, 
USA). I assessed data integrity by evaluating each variable for implausible 
values and values inconsistent with answers to other questions. Any 
implausible or inconsistent were verified against the paper teleforms. 
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Analyses were performed using Stata, version 13.1 (Stata-Corp, College 
Station, TX, USA).  
 
7.2.8 Statistical analysis 
Logistic regression was used to investigate associations between 
independent variables and Leptospira seropositivity.  Initially all 
associations between individual behaviour variables and our outcome 
variables were assessed by bivariable logistic regression. We also 
investigated associations between behaviours and seropositivity to 
serogroup Icterohaemorrhagiae, which was the most commonly identified 
serogroup to which participants were seropositive. We developed 
multivariable logistic regression models to investigate the association of 
Leptospira seropositivity with behavioural variables and the geospatial 
variables separately. We investigated dimension reduction methods to 
assess the effects of cumulative exposure and help identify sources of 
human infection. We used a knowledge-based approach and a purely 
statistical approach of dimension reduction. 
 
7.2.8.1 Knowledge based dimension reduction: creation of cumulative 
exposure scales 
We created summary scales to estimate quantitatively overall patient 
exposure to each of the main modes and sources of infection that we 
identified from the published literature: urine of cattle, goats, pigs and 
rodents, and surface water (3). Our methods for creating the scales are 
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described in detail in Chapter 6. In brief, we used an analytic hierarchy 
process to develop these scales (12). We identified relevant behaviours 
and living conditions from the risk factor questionnaire to be included in 
each scale and asking subject matter experts to rank each relevant 
behaviour against every other behaviour in terms of the likelihood and 
intensity of exposure to the source using a 9-point bidirectional scale. We 
then calculated weightings using a matrix that added, for each behaviour, 
reciprocals of the score from each pairwise comparison (13). To aid 
interpretation of exposure scores, we multiplied all weights within each 
scale by a constant, so that possible scores on each scale ranged from 
zero to five. Finally, we derived an overall score for each participant on 
each exposure scale based on their questionnaire answers, such that 
someone who had performed none of the exposure activities scored zero 
and someone who performed all of the activities scored five.  
 
7.2.8.2 Model building using exposure scales  
Relationships between exposure scores and log odds of acute 
leptospirosis and Leptospira seropositivity were assessed using fractional 
polynomial transformations of the exposure scales (14). We allowed up to 
two degrees of freedom and utilised the function selection procedure of 
Stata’s multivariable fractional polynomial algorithm to select the best 
fitting transformation for each exposure scale. The correlation between 
exposure scales was assessed using linear regression. Interactions 
between exposure scales were assessed using factor variables. Through 
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use of directed acyclic graphs, we considered that all exposure scores 
might act as confounders, and so our initial multivariable models included 
all exposure scales. Variables were examined for co-linearity using 
variance inflation factors. We used stepwise backwards elimination to 
arrive at the model that minimised the Akaike Information Criterion (AIC) 
(15). P values were two sided and the significance level was set at 0.05.  
 
7.2.8.3 Statistical dimension reduction: principal component analysis 
We undertook a principal component analysis with orthogonal (varimax) 
rotation as described in Chapter 6 (16, 17). Briefly, we assessed the 
number of components based on scree plot inflection point. We assigned 
participants a score for each component based on their answers to 
questionnaire variables that had loadings >0.3 for a component.  
 
7.2.8.4 Assessing the relationship of leptospirosis to the exposure scales 
We assessed the relationships of Leptospira seropositivity with the scales 
from each method of dimension reduction separately. Relationships 
between the scales and odds of acute leptospirosis and seropositivity 
were assessed using fractional polynomial transformation of the scales 
(14). Multivariable models were built for each method of dimension 
reduction using initially all exposure scales. We allowed up to two degrees 
of freedom and utilised the function selection procedure of Stata’s 
multivariable fractional polynomial algorithm to select the best fitting 
transformation for each variable. Interactions between exposure scales 
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were assessed using factor variables. Variables were examined for co-
linearity using a correlation matrix. We used stepwise backwards 
elimination to arrive at the model that maximized the AIC (15). P values 
were two sided, and the significance level was set at 0.05. 
 
7.2.8.5 Handling of geospatial risk factors 
Spatial scan statistics were calculated using a Bernoulli model to assess 
evidence of spatial clustering of cases using SatScan version 9.0 
(www.satscan.org) (18). We assessed whether Leptospira seropositive 
participants were randomly distributed and identified high risk and low risk 
clusters.  The spatial scan statistic was set to include a maximum of 50% 
of the data. Statistically significant clusters were identified using p<0.05.  
 
We also investigated whether georeferenced variables were risk factors 
for leptospirosis. Geospatial data were managed using QGIS, version 
2.8.3 (Free Software Foundation, Boston, MA, USA). When performing 
logistic regression, we condensed data of soil type other than chromic 
luvisol as very few participants lived on land of other soil types. 
Georeferenced mean rainfall were available in 200mm/year intervals. As 
there were few individuals in many of the rainfall intervals, we condensed 
these into three intervals of <1000mm/year, 1000-1600mm/year and 
>1000 mm/year. We built logistic regression models using Stata, version 
13.1 (Stata-Corp, College Station, TX, USA). Our initial models of 
geospatial risk factors included all variables with a p value <0.2 in 
bivariable logistic regression. No variables were forced into the model as 
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confounders. We performed backwards stepwise model selection to 
minimize the AIC.  
7.3 RESULTS 
7.3.1 Enrolment and participant characteristics 
Of 15,305 patients admitted and 30,413 presenting to the outpatient 
department during the study period, 2,962 met eligibility criteria and 1,416 
(47.8%) were enrolled. Of 1,293 participants who completed the risk factor 
questionnaire and had serum tested, 252 (19.5%) were seropositive, and 
592 (45.8) were classified as controls (Figure 6.1). Participant 
characteristics are shown in Table 7.1. The frequency with which 
seropositive participants were predominantly reactive to different 
serogroups is shown in Table 7.2. 
 
Table 7.1 Demographic and clinical characteristics of study 
participants, northern Tanzania, 2012-14 
    Leptospira seropositive (N=252) Controls (N=592) 
Demographic characteristics n (%) n (%) 
  Age, median (range) years 33.5 (0.3-93.5) 21.9 (0.2-84.2) 
 Female sex  147 (58.3) 313 (52.9) 
  Pastoralist tribe* 6  (2.4) 2 (0.3) 
  Residence in urban district 112 (44.4) 288  (48.7) 
Key: *Pastoralist tribe: Maasai, Barahaig 




Table 7.2 Predominantly reactive serogroup of those Leptospira 
seropositive, among patients with febrile illness northern Tanzania, 
2012-14 
Serogroup Leptospira seropositive (N=271)* 
 n (%) (95% CI) 
Australis 66 (24.4) (19.6-29.9) 
Sejroe 11 (4.1) (2.3-7.2) 
Icterohaemorrhagiae 151 (55.7) (49.7-61.6) 
Djasiman 13 (4.8) (2.8-8.1) 
Pyrogenes 4 (1.5) (0.6-3.9) 
Grippotyphosa 2 (0.7) (0.2-2.9) 
Tarassovi 4 (1.5) (0.6-3.9) 
Mini 7 (2.6) (1.2-5.3) 
Bataviae 4 (1.5) (0.6-3.9) 
Canicola 3 (1.1) (0.4-3.4) 
Autumnalis 3 (1.1) (0.4-3.4) 
Hebdomadis 2 (0.7) (0.2-2.9) 
Celledoni 1 (0.4) (0.1-2.6) 
Key: *Of 252 seropositive participants, 17 individuals had equal titres to 2 
serogroups, and 1 individual had equal titres to 3 serogroups. 
 
 
7.3.2 Logistic regression of Leptospira seropositivity and individual 
behaviours  
A sample size of 844 participants, including 271 seropositive participants 
would have 80% power to detect an odds ratio of 2.0 assuming an 
exposure prevalence of between 10% and 85% among controls. Our 
bivariable logistic regression analysis for individual risk factors and 
Leptospira seropositivity are shown in Table 7.3. Slaughtering goats (OR 
2.3, CI 1.0-4.8), working as a farmer (OR 1.8, CI 1.3-2.5), frequently 
seeing rodents in the kitchen (OR 1.5, CI 1.1-2.1), or working in rice fields 
(OR 3.6, CI 1.5-9.0) were risk factors on bivariable regression. We 
assessed for the interactions shown in Table 7.4, and no interaction was 
significant.  In our final multivariable model, shown in Table 7.5, working 
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as a farmer (OR 1.6, CI 1.1-2.3), working in the rice fields (OR 2.7 CI 1.0-
7.2), or seeing rodents in the kitchen more than once per week (OR 1.5, 
CI 1.0-2.1) were all independent risk factors for Leptospira seropositivity. 
Walking barefoot (OR 0.7, CI 0.5-0.9) and owning dogs (OR 0.6, CI 0.4-
1.0) conferred reduced odds of Leptospira seropositivity.  
 
7.3.3 Logistic regression of Leptospira serogroup 
Icterohaemorrhagiae seropositivity and individual behaviours  
Table 7.6 shows the results of bivariate logistic regression for individual 
behaviours and seropositivity to serogroup Icterohaemorrhagiae. As with 
our pan-serogroup Leptospira seropositivity logistic regression, 
slaughtering goats (OR 2.8, CI 1.3-6.3) and seeing rodents in the kitchen 
or home food stores (OR 1.7, CI 1.1-2.4) were associated with 
seropositivity to serogroup Icterohaemorrhagiae. In addition, participants 
who reported having had standing water in the compound around their 
house within the previous thirty days were more likely to be seropositive to 
Leptospira serogroup Icterohaemorrhagiae (OR 1.6, CI 1.1-2.3). 
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Table 7.3 Logistic regression of risk factors Leptospira seropositivity 








 n (%) n (%) OR (95% CI) P value 
Livestock exposure variables       
Assisted cattle birth 2 (0.8) 2 (0.3) 2.4 (0.33-16.9) 0.39 
Assisted goat birth  3 (1.2) 8 (1.4) 0.9 (0.23-3.3) 0.85 
Assisted pig birth 0 (0.0) 0 (0.0) NA  
Cleaned cattle waste 18 (7.1) 34 (5.7) 1.3 (0.70-2.3) 0.44 
Cleaned goat waste 17 (6.8) 30 (5.1) 1.4 (0.73-25) 0.33 
Cleaned pig waste 7 (2.8) 17 (2.9) 1.0 (0.40-2.4) 0.94 
Fed cattle 30 (11.9) 57 (9.6) 1.3 (0.79-2.0) 0.32 
Fed goats 27 (10.7) 57 (9.6) 1.1 (0.69-1.8) 0.63 
Fed pigs 6 (2.4) 20 (3.4) 0.70 (0.28-1.8) 0.45 
Herded cattle 4 (1.6) 6 (1.0) 1.5 (0.44-5.6) 0.48 
Herded goats 10 (4.0) 13 (2.2) 1.8 (0.80-4.3) 0.15 
Kept cattle inside the house 4 (1.6) 3 (0.5) 3.2 (0.70-14.3) 0.13 
Kept goats inside the house 3 (1.2) 5 (0.8) 1.4 (0.33-6.0) 0.64 
Kept pigs inside the house 0 (0.0) 0 (0.0) NA  
Milked cattle 10 (4.0) 15 (2.5) 1.6 (0.70-3.6) 0.27 
Milked goats 2 (0.8) 1 (0.2) 4.7 (0.43-52.4) 0.21 
Owning cattle 64 (25.4) 128 (21.6) 1.2 (0.9-1.7) 0.23 
Owned dogs 35 (13.9) 110 (18.6) 0.71 (0.47-1.1) 0.10 
Owned goats 72 (28.6) 143 (24.2) 1.3 (0.90-1.8) 0.18 
Owned pigs 15 (5.9) 54 (9.1) 0.63 (0.35-1.1) 0.13 
Slaughtered cattle 22 (8.7) 51 (8.6) 1.0 (0.60-1.8) 0.95 
Slaughtered goats 13 (5.2) 14 (2.4) 2.3 (1.0-4.8) 0.04 
Slaughtered pigs 4  (1.6) 4 (0.7) 2.4 (0.59-9.6) 0.23 
Rodent exposure variables        
Worked as a farmer 70 (27.9) 106 (17.9) 1.8 (1.3-2.5) <0.01 
Killed at least one rodent 6 (2.4) 15 (2.5) 0.88 (0.36-2.4) 0.89 
Handled rodent carcasses 10 (4.0) 18 (3.0) 1.3 (0.60-2.9) 0.49 
Freq. rodents seen in house* 
  Less than once/week 



















Freq. rodents seen in kitchen* 
  Less than once/week 



















Freq. rodents seen in compound* 
  Less than once/week 



















Freq. rodents seen in fields* 
  Less than once/week 



















Surface water exposure variables     
Bathed in surface water 56 (22.2) 124 (20.9) 1.1 (0.75-1.5) 0.68 
Drank untreated surface water 41 (16.3) 69 (11.7) 1.1 (0.75-1.7) 0.56 
Had standing water in compound 81 (32.1) 154 (26.1) 1.3 (1.0-1.9) 0.07 
Walked barefoot 98 (38.9) 271 (45.8) 0.75 (0.56-1.0) 0.07 
Washed in surface water 60 (23.8) 132 (22.3) 1.1(0.77-1.5) 0.63 
Worked in rice fields 12 (4.8) 8 (1.4) 3.6 (1.5-9.0) 0.01 
Key: * Reference category is not having seen rodents in the kitchen.  
Abbreviations: OR= odds ratio; CI= confidence interval  
  
 374 
Table 7.4 Logistic regression of interaction terms and Leptospira 
seropositivity among seropositive patients (n=252) and controls 
(n=592) in northern Tanzania, 2012-14 
Interaction OR (95% CI) P value 
Standing water in the compound and owning cattle 0.9 (0.4-2.1) 0.89 
Standing water in the compound and owning goats 1.3 (0.6-2.8) 0.47 
Standing water in the compound and owning pigs 1.4 (0.3-5.6) 0.64 
Standing water in the compound and walking barefoot 0.8 (0.4-1.5) 0.41 
Walking barefoot and owning cattle 1.1 (0.5-2.2) 0.82 
Walking barefoot and owning goats 1.3 (0.6-2.5) 0.49 
Walking barefoot and owning pigs 2.4 (0.7-8.1) 0.15 
Working in rice fields and owning cattle 2.2 (0.3-33) 0.39 
Working in rice fields and owning goats NA  
Working in rice fields and owning pigs NA  
Working in rice fields and seeing rodents in the fields 1.2 (0.4-3.6) 0.4 
Abbreviations: OR= odds ratio; CI= confidence interval 
 
Table 7.5 Multivariable Logistic regression of individual risk factors 
Leptospira seropositivity in northern Tanzania, 2012-14 
Variable Bootstrapped multivariate logistic regression 
 OR (95% CI) P value 
Owned dogs 0.63 (0.40-1.0) 0.05 
Owned goats 1.4 (1.0-2.0) 0.08 
Owned pigs 0.65 (0.35-1.2) 0.16 
Worked as a farmer 1.6 (1.1-2.3) 0.02 
Had standing water in compound 1.4 (1.0-1.9) 0.06 
Walked barefoot 0.68 (0.49-0.9) 0.01 
Worked in rice fields 2.7 (1.0-7.2) 0.05 
Saw rodents in the kitchen more than once per week* 1.4 (1.0-2.1) 0.03 
Saw rodents in the kitchen less than once per week* 0.91 (0.56-1.5) 0.69 
Key: * Reference category is not having seen rodents in the kitchen 
Abbreviations: OR= odds ratio; CI= confidence interval 
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Table 7.6 Logistic regression of risk factors for seropositivity with 
Leptospira serogroup Icterohaemorrhagiae among patients with 
febrile illness in northern Tanzania, 2012-14 







 n (%) n (%) OR (95% CI) P value 
Livestock exposure variables       
Cleaned cattle waste 9 (6.0) 43 (6.2) 0.95 (0.45-2.0) 0.91 
Cleaned goat waste 7 (4.6) 40 (5.8) 0.79 (0.35-1.8) 0.58 
Cleaned pig waste 4 (2.7) 20 (2.9) 0.91 (0.32-2.7) 0.87 
Fed cattle 17 (11.3) 70 (10.1) 1.1 (0.64-2.0) 0.67 
Fed goats 15 (9.9) 69 (10.0) 1.0 (0.55-1.8) 0.99 
Fed pigs 2 (1.3) 24 (3.5) 0.37 (0.09-1.6) 0.19 
Herded cattle 2 (1.3) 8 (1.2) 1.1 (0.24-5.5) 0.86 
Herded goats 4 (2.7) 19 (2.7) 0.97 (0.32-2.9) 0.95 
Kept cattle inside the house 1 (0.7) 6 (0.9) 0.76 (0.09-6.4) 0.80 
Kept goats inside the house 0 (0.0) 8 (1.2) NA  
Kept pigs inside the house 8 (5.3) 60 (8.7) 0.59 (0.28-1.3) 0.17 
Milked cattle 3 (2.0) 22 (3.2) 0.62 (0.18-2.1) 0.44 
Milked goats 2 (1.3) 1 (0.1) 9.3 (0.84-103.1) 0.07 
Owning cattle 32 (21.2) 160 (23.1) 0.90 (0.58-1.4) 0.62 
Owned dogs 18 (11.9) 127 (18.3) 0.60 (0.36-1.0) 0.06 
Owned goats 41 (27.2) 174 (25.1) 1.1 (0.74-1.65) 0.60 
Owned pigs 9 (6.0) 142 (8.7) 0.67 (0.32-1.4) 0.28 
Slaughtered cattle 15 (9.9) 58 (8.4) 1.2 (0.66-2.2) 0.54 
Slaughtered goats 10 (6.6) 17 (2.5) 2.8 (1.3-6.3) 0.01 
Slaughtered pigs 3 (2.0) 5 (0.7) 2.7 (0.66-11.8) 0.16 
Rodent exposure variables        
Worked as a farmer 143 (20.6) 33 (22.0) 1.1 (0.7-1.7) 0.71 
Killed at least one rodent 3 (2.0) 18 (2.6) 0.76 (0.22-2.6) 0.66 
Handled rodent carcasses 8 (5.3) 20 (2.9) 1.9 (0.81-4.4) 0.14 
Freq. rodents seen in house* 
  Less than once/week 



















Freq. rodents seen in kitchen* 
  Less than once/week 



















Freq. rodents seen in compound* 
  Less than once/week 



















Freq. rodents seen in fields* 
  Less than once/week 



















Surface water exposure variables     
Bathed in surface water 34 (22.5) 146 (21.1) 1.1 (0.71-1.7) 0.69 
Drank untreated surface water 25 (16.6) 103 (14.9) 1.1 (0.71-1.8) 0.60 
Had standing water in compound 54 (35.8) 181 (26.2) 1.6 (1.1-2.3) 0.02 
Walked barefoot 39 (25.8) 153 (22.1) 0.91 (0.63-1.3) 0.59 
Washed in surface water 63 (41.7) 306 (44.2) 1.2 (0.82-1.8) 0.32 
Worked in rice fields 4 (2.7) 16 (2.3) 1.2 (0.38-3.5) 0.80 
 
Key: * Reference category is not having seen rodents in the kitchen 




7.3.4 Assessment of the relationship of Leptospira seropositivity with 
knowledge-based cumulative exposure to potential sources of 
transmission 
The composition of the scales, and weighting of the individual variables 
used in the analysis of Leptospira seropositivity was the same used in the 
analysis of risk factors for acute leptospirosis described in Chapter 6. 
 
7.3.4.1 Participant exposure scores 
The distributions of participants’ exposure scores, shown in Figures 7.1-
7.5, disclose that for each exposure score most participants had no 
exposure, but among those with exposure there is variability, with some 
participants engaged in multiple activities that generate exposure to 





Figure 7.1 Histogram of participant scores on knowledge-based 
cattle urine exposure scale, among Leptospira seropositive 







Figure 7.2 Histogram of participant scores on knowledge-based goat 
urine exposure scale, among Leptospira seropositive participants 




Figure 7.3 Histogram of participant scores on knowledge-based pig 
urine exposure scale, among Leptospira seropositive participants 




Figure 7.4 Histogram of participant scores on knowledge-based 
rodent urine exposure scale, among Leptospira seropositive 





Figure 7.5 Histogram of participant scores on knowledge-based 
surface water exposure scale, among Leptospira seropositive 
participants (N=252) and controls (N=592), northern Tanzania, 2012-
14 
 
7.3.4.2 Logistic regression of Leptospira seropositivity and exposure 
scales 
Results of the logistic regression of Leptospira seropositivity and the 
exposure scales are listed in Table 7.7. All exposure scales had a linear 
relationship with the log odds of Leptospira seropositivity, and there were 
no significant interactions. Table 7.8 shows the interaction terms 
investigated. Rodent exposure (OR 1.2 per point, CI 1.0-1.5) was 
associated with Leptospira seropositivity in the bivariable analyses. 
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However, no exposure scale remained statistically significant in the 
multivariable regression. 
 
Table 7.7 Bivariable and multivariable logistic regression models of 
association between exposure scales and Leptospira seropositivity 
(n=252) relative to controls (n=592) in northern Tanzania, 2012-14 
 Bivariable Multivariable 
Variable OR (95% CI) p-value OR (95% CI) p-value 
Cattle urine exposure 1.2 (0.86-1.8) 0.23   
Goat urine exposure 1.5 (0.96-1.3) 0.07 1.3 (0.86-2.1) 0.20 
Pig urine exposure 0.89 (0.56-1.4) 0.61   
Rodent urine exposure 1.2 (1.0-1.1.5) 0.03 1.2 (0.98-1.4) 0.07 
Surface water exposure 1.0 (0.93-1.1) 0.47   
 
Table 7.8 Logistic regression of interaction terms and Leptospira 
seropositivity among patients with Leptospira seropositivity (n=252) 
and controls (n=592) in northern Tanzania, 2012-14 
Interaction OR  (95% CI) P value 
Cattle urine exposure and goat urine exposure 1.1 (0.60-2.1) 0.70 
Cattle urine exposure and pig urine exposure 1.3 (0.63-2.7) 0.48 
Cattle urine exposure and rodent urine exposure 1.2 (0.72-1.9) 0.54 
Cattle urine exposure and surface water exposure 1.1 (0.85-1.4) 0.56 
Goat urine exposure and pig urine exposure 1.0 (0.51-2.1) 0.93 
Goat urine exposure and rodent urine exposure 0.94 (0.54-1.6) 0.84 
Goat urine exposure and surface water exposure 1.0 (0.76-1.3) 0.97 
Pig urine exposure and rodent urine exposure 1.0 (0.56-1.9) 0.90 
Pig urine exposure and surface water exposure 0.92 (0.68-1.2) 0.57 
Rodent urine exposure and surface water exposure 0.97 (0.86-1.1) 0.61 
Abbreviations: OR= odds ratio; CI= confidence interval 
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7.3.5 Investigation of the association of Leptospira seropositivity 
with scales derived statistically using principal component analysis 
We selected four components based on the inflection point on the scree 
plot shown in Figure 7.6. The component eigenvectors were greater than 
two for each selected component and together they explained 46.2% of 
the variation in the data. The variables with a loading of >0.30 to each 
component are shown in Table 7.9. 
 
 
Figure 7.6 Scree plot of eigenvalues for principal component analysis 
of risk factor questionnaire among patients with febrile illness 
(N=844), northern Tanzania, 2012-14 
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Table 7.9 Variables loading most strongly with principal components, 
among patients with febrile illness (N=844), northern Tanzania, 2012-
14 
# Variable (loading) Component name 
1 Fed cattle (0.38) 
Fed pigs (0.36) 
Fed goats (0.35) 
Cleaned cattle waste (0.34) 
Cleaned goat waste (0.32) 
Handling livestock 
2 Evidence of rodents in the house (0.48) 
Seen rodents in the house (0.46) 
Seen rodents in the kitchen or food store (0.44) 
Seen rodents in the compound (0.42) 
Seeing rodents 
3 Washing using surface water (0.53) 
Bathing in surface water (0.51) 
Drinking surface water (0.46) 
Contact with untreated surface water 
4 Herd cattle (0.55) 
Herd goats (0.55) 
Slaughtered cattle (0.37) 
Slaughtered goats (0.36) 
Herding or slaughtering ruminant livestock 
 
7.3.5.1 Participant component scale scores 
Summary statistics of the scores of participants on the scales generated 
from the identified components are shown in Table 7.10.  There were 712 
(84.4%) participants with a score of zero on the handling livestock scale, 
313 (37.1%) with a score of zero on the seeing rodents scale, 642 (76.1%) 
participants with a score of zero on the contact with untreated surface 
water scale, and 739 (87.6%) participants with a score of zero on the 
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herding or slaughtering ruminant livestock scale. The distributions of 
participant scores are shown in Figures 7.7-7.10.  
 
Table 7.10 Summary statistics of participant scores on principal 
component derived scales, among patients with febrile illness 
(N=844), northern Tanzania, 2012-14 
Variable         Mean Median Range 
Handling livestock 0.4 0.0 0-5 
Seeing rodents 1.6 1.0 0-4 
Contact with untreated surface water 0.6 0.0 0-3 






Figure 7.7 Histogram of participant scores for component 1: handling 
livestock, among Leptospira seropositive patients (n=252) and 




Figure 7.8 Histogram of participant scores for component 2: seeing 
rodents, among Leptospira seropositive patients (n=252) and 




Figure 7.9 Histogram of participant scores for component 3: contact 
with untreated surface water, among Leptospira seropositive 




Figure 7.10 Histogram of participant scores for component 4: herding 
and slaughtering ruminant livestock, among Leptospira seropositive 
patients (n=252) and controls (n=592) in northern Tanzania, 2012-14 
 
7.3.5.2 Logistic regression of Leptospira seropositivity and principal 
component analysis derived scores 
The results of bivariate logistic regression are shown in Table 7.11. None 
of the scores was associated with Leptospira seropositivity. All exposure 
scales showed a linear relationship with the log odds of acute 
leptospirosis. The exploration of possible variable interactions is shown in 
Table 7.12. None w associated with Leptospira seropositivity. A 
multivariate model was built using all exposure scales and the factor 
variable from the combination of livestock handling and ruminant livestock 
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herding or slaughtering. We were unable to construct a model with an 
association with Leptospira seropositivity.  
 
Table 7.11 Bivariable logistic regression between exposure scales 
among patients with Leptospira seropositivity (n=252) and controls 
(n=592) in northern Tanzania, 2012-14 
Variable OR (95% CI) p value 
Handling livestock 1.1 (0.9-1.2) 0.44 
Seeing rodents 1.1 (1.0-1.2) 0.30 
Contact with surface water 1.0 (0.9-1.2) 0.60 
Herding or slaughtering ruminant livestock 1.3 (0.9-1.7) 0.13 
 
Table 7.12 Logistic regression of interaction terms and Leptospira 
seropositivity among patients with Leptospira seropositivity (n=252) 
and controls (n=592) in northern Tanzania, 2012-14 
Interaction OR  (95% CI) P value 
Livestock handling and ruminant livestock herding 1.3 (1.0-1.7) 0.06 
Livestock handling and seeing rodents 1.0 (0.9-1.1) 0.99 
Ruminant livestock handling and seeing rodents 1.0 (0.8-1.3) 0.75 
Livestock handling and contact with surface water 1.0 (0.9-1.1) 0.85 
Ruminant herding and contact with surface water 1.0 (0.8-1.3) 0.81 
Seeing rodents and contact with surface water 1.0 (0.9-1.1) 0.40 
 
7.3.6 Geospatial and temporal analysis 
GPS co-ordinates were available for houses of 685 (81.2%) participants.  
There was no statistically significant clustering in the spatial distribution of 
Leptospira seropositivity. The spatial distribution, and identified clusters 
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are indicated in Figure 7.11. These include a single cluster with a relative 
risk <1 (7 of 73, RR 0.34, p=0.42) situated on the slopes of Mount 
Kilimanjaro, and two clusters with a relative risk >1 (23 of 49, RR 1.9, 
p=0.98; and 51 of 130, RR 1.7, p=0.70) located on the flatter areas of 
lower Moshi. No cluster was statistically significant.  
 
Results of the bivariable logistic regression analysis of geo-referenced 
variables, temporally referenced rainfall and Leptospira seropositivity are 
shown in Table 7.13. There were no statistically significant associations. 
The exploration of potentially relevant interaction terms is shown in Table 
7.14. There were not significant interactions. 
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 n (%) n (%) OR (95% CI) p-value 
Land use       
Cultivated 122 (67.4) 330 (65.5) REF  
Urban 51 (28.2) 148 (29.4) 0.93 (0.64-1.4) 0.72 
Natural 8 (4.4) 26 (5.2) 0.83 (0.37-1.9) 0.66 
Main soil type       
Chromic Luvisol 162 (89.5) 444 (88.1) REF  
Other 19 (11.5) 60 (11.9) 0.87 (0.50-1.5) 0.61 
Ward population density, median in people/ km2 (IQR) 1172 (310-7296) 962 (131-6064) 1.0 *(0.98-1.1) 0.26 
Elevation, median in MASL (IQR) 822 (796-945) 840 (803-980) 0.99§ (0.98-1.0) 0.05 
Annual Mean Rainfall     
<1000mm  46 (25.4) 103 (20.4) REF  
1000-1600mm  101 (55.8) 264 (52.4) 0.86 (0.56-1.3) 0.47 
>1600mm  34 (18.8) 137 (27.2) 0.56 (0.33-0.93) 0.02 
Village zone designation     
Urban 92 (50.8) 281 (55.8) REF  
Peri-urban 39 (21.6) 104 (20.6) 1.5 (0.74-1.8) 0.54 
Rural 50 (27.6) 119 (23.6) 1.3 (0.86-1.9) 0.23 
Temporal Rainfall Variables N=252 N=592   
Total rainfall in preceding 30 days, median in mm (IQR) 33 (2-72) 22 (1-68) 1.2♯ (1.0-1.5) 0.06 
Largest single day rainfall in preceding 30 days, 14 (1-35) 13 (1-34) 1.6♯ (0.88-2.9) 0.12 
 
Abbreviations: OR = Odds ratio IQR = interquartile range; MASL = Meters above sea level  




Table 7.14 Logistic regression of interaction terms and Leptospira 
seropositivity among Leptospira seropositive patients (n=181) and 




Rainfall in 30 days prior to admission and urban land use 1.0 0.21 
Rainfall in 30 days prior to admission and elevation 1.0 0.27 
Annual mean rainfall 1000-1600mm and rainfall in 30 days prior 
to admission 
1.0 0.70 
Annual mean rainfall >1600mm and rainfall in 30 days prior to 
admission 
1.0 0.96 




Figure 7.11 Home location of Leptospira seropositive (N=181) and 
controls (N=504) participants with and without acute leptospirosis 
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7.4 DISCUSSION  
We identified risk factors for Leptospira seropositivity that imply there may 
be several sources of human Leptospira infection in northern Tanzania 
during 2012-14. The independent risks factors included: having worked as 
a farmer, having worked in rice fields, and having seen rodents frequently 
around the kitchen or home food stores. Of note, seeing rodents around 
home food stores or in the kitchen, and slaughtering goats were risk 
factors for Leptospira seropositivity but not risk factors for acute 
leptospirosis. These risk factors suggest that rodents and goats may have 
been sources of human leptospirosis. When considered alongside the risk 
factors we identified for acute leptospirosis, our results suggest a complex 
Leptospira ecosystem with multiple sources, and modes of transmission 
for human infection. Our results present multiple possible interventions to 
reduce Leptospira infection. 
 
7.4.1 Farm work as a risk factor 
Reporting work as a farmer was an independent risk factor for Leptospira 
seropositivity. This was consistent with farming being identified as a risk 
factor for acute leptospirosis (Chapter 6). Whether the sources of infection 
leading to seropositivity of those engaged in farm work are livestock 
species or rodent species has not been determined by this study. On 
bivariate logistic regression slaughtering goats was the only variable 
relating to livestock contact that was associated with Leptospira 
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seropositivity, and in a multivariable model none was identified. As 
discussed in Chapter 6 of this thesis, recent data indicate that there is a 
high prevalence of Leptospira seropositivity and Leptospira shedding in 
multiple species of livestock in Tanzania (19-25).  We identified that 
owning dogs was associated with reduced odds of Leptospira 
seropositivity, however further work is needed to understand whether this 
finding is consistent and investigate possible underlying reasons for the 
association. 
 
7.4.2 Rodents as a source of Leptospira infection 
Participants who saw rodents around their food stores or kitchens had 
greater odds of Leptospira seropositivity. No other rodent related variables 
or scales showed an association with Leptospira seropositivity. Although 
we have found little evidence of Leptospira infection in rodents in the 
Kilimanjaro Region (25), they are considered important reservoirs of 
leptospirosis (26). Serovars Canicola (serogroup Canicola), Kenya 
(serogroup Ballum), Lora (serogroup Australis), Mwogolo (serogroup 
Icterohaemorrhagiae) and Sokoine (serogroup Icterohaemorrhagiae) have 
all been isolated from rat species in Tanzania (24).  
 
7.4.3 Rice field work as a risk factor for Leptospira infection 
Rice work was a risk factor for Leptospira seropositivity among 
participants in this study, which is consistent with the association we found 
between rice field work and acute leptospirosis. That we found an 
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association of rice field farming with each of acute leptospirosis and 
Leptospira seropositivity strengthen the case that rice farmers are at high 
risk for Leptospira infection. The serogroups to which those who worked in 
rice fields were most frequently seropositive were Australis and 
Icterohaemorrhagiae which, as discussed above, could indicate that rice 
fields are being contaminated by Leptospira from either rodents or 
livestock. Further work is needed to establish risk factors among rice 
farmers and the source of their Leptospira infection. 
 
7.4.4 Patterns of serogroup reactivity 
The serogroups to which participants were most frequently seropositive 
were Icterohaemorrhagiae and Australis. Our results are consistent with 
other studies from Tanzania showing seroreactivity was most commonly 
against serogroup Icterohaemorrhagiae among humans, livestock, and 
rodents species (24). These include serovars Lora, which has been 
isolated from multi-mammate rat, Mwogolo, which has been isolated from 
giant African pouched rats and Sokoine, which has been isolated from 
cattle and rodents (24). In addition, a high proportion of both cattle and 
goats were seropositive to these serogroups (24).  
 
7.4.5 Use of dimension reduction  
We used the two scales generated as part of our analysis of the risks for 
acute leptospirosis in order to explore the relationship of cumulative 
exposure to potential sources of Leptospira infection, and Leptospira 
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seropositivity. We did not find an association between any of the 
composite scales and Leptospira seropositivity in multivariable logistic 
regression models.  
 
7.4.6 Differences between risk factors for acute leptospirosis and 
Leptospira seropositivity  
We identified that risk factors for Leptospira seropositivity were different 
from those for acute leptospirosis. Noticeably, we did not identify exposure 
to cattle as a risk factor for Leptospira seropositivity. In contrast, we 
identified frequent sightings of rodents in the kitchen as a risk factor for 
Leptospira seropositivity. There are several potential explanations for the 
observed difference in risk factors. One potential explanation is that the 
source of human leptospirosis has changed over time. Antibodies against 
Leptospira can persist for years and seropositive individuals are likely to 
have been infected prior to the study period. The change in leptospirosis 
incidence between 2007-08 and 2012-14 as well as dynamic patterns of 
predominant serogroup reactivity also suggest that sources of human 
Leptospira infection may be changing over time (27). An alternative 
explanation is that there may have been multiple sources of infection 
present at the time of the study, but that some serovars caused sub-
clinical illness.  The most frequent predominantly reactive serogroups 
among those with Leptospira seropositivity were markedly different from 
those with acute leptospirosis and disease severity can vary according to 




As discussed above, infection and development of antibodies to 
Leptospira may have occurred well before the study period, and risk 
behaviours of individuals at the time of the study may be different from 
when they were infected. Therefore, extrapolating risk factors for 
seropositivity to identify sources or reservoirs of infection for disease 
control must be done cautiously, particularly as we found differences in 
risk factors and serogroup reactivity patterns for acute leptospirosis and 
seropositivity.  
 
The extent to which the risk factors for Leptospira seropositivity that we 
identified reflect the risk factors across the whole community is influenced 
by several factors. Our study recruited those with febrile illness, which may 
bias the results if patients presenting to hospital with fever had a different 
frequency of exposure to potential risk factors than the whole community. 
The SatScan analysis may also be influenced by use of controls who have 
febrile illness, particularly if the distribution of controls was not 
representative of the population. As risk factors for infection and factors 
associated with hospital access will have influenced the likelihood of a 
community member acting as a control, results of the SatScan analysis 
should be interpreted with caution. 
 
 400 
The limitations discussed in Chapter 6 also apply. These limitations 
include recall bias when completing our questionnaire and failing to detect 
serovar specific associations through use of a pan-serovar analysis. We 
explored the possibility of serogroup specific associations and found that 
behaviours associated with seroreactivity to serogroup 
Icterohaemorrhagiae, the serogroup to which participants were most 
commonly seropositive, were very similar to those identified in our pan-
serovar analysis. However, risk factors for less commonly infecting 
serovars may not have been identified. 
 
7.4.8 Conclusions 
We identified risk factors and patterns of serogroup reactivity among 
participants with Leptospira seropositivity, some of which were different 
from those of participants with acute leptospirosis. The risk factors for 
Leptospira seropositivity that we identified indicated an elevated risk for 
subsistence farmers, and rice farmers. Although these occupations appear 
to be at greater risk than the general population, we did not clearly identify 
an animal source of infection for participants from these groups. Overall, 
we did identify that those with higher exposure to rodents, especially 
rodents in food stores were at elevated risk of being seropositive to 
Leptospira. Our results indicate a complex ecology of Leptospira in the 
study area, and it is likely that there are multiple sources of human 
infection. Our results are also consistent with risks and sources of infection 
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that are changing over time.  This should be considered when planning 
interventions to prevent human leptospirosis. 
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Chapter 8: Estimation of the 
incidence of acute 
leptospirosis among healthy 
livestock keepers living in six 
Districts in northern Tanzania 
8.1 INTRODUCTION 
8.1.1 Sub-national estimates of leptospirosis incidence in Tanzania 
In Chapter 4 we estimated the incidence of leptospirosis in Moshi Rural 
District and Moshi Urban District. Our work represents one of very few 
estimates of the incidence of acute leptospirosis in Tanzania (1-3). 
Outside of Moshi Rural District and Moshi Urban District, leptospirosis 
incidence has only been estimated at a national scale. The national 
estimate comes from a study by Costa and colleagues that estimated the 
incidence of leptospirosis in Tanzania using country level risk factors (3), 
without consideration for sub-national variation in incidence. As described 
in detail in Chapter 4, Costa and colleagues estimate was based on a 
prediction model incorporating distal risk factors that have been 
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associated with increased incidence of leptospirosis. These distal risk 
factors included: distance from the equator, percentage urbanisation of the 
population, life expectancy at birth and whether the country was a tropical 
island. The model was derived from a systematic review of studies 
performed between January 1970 and October 2008 that reported 
leptospirosis incidence (3). The systematic review identified only two 
reports from Africa of leptospirosis incidence. The distal risk factors 
identified during the systematic review may not operate in African 
countries as they do in Asia, Europe, or South America where most 
reports of leptospirosis incidence originated. The authors identified that 
their estimates of incidence for African countries may not be reliable (3). 
Sub-national incidence was not estimated by Costa but would help to 
prioritise surveillance and control activities by establishing which 
communities within Tanzania have the greatest disease burden. 
 
8.1.2 Potential differences in leptospirosis incidence within northern 
Tanzania 
For administrative purposes, Tanzania is divided into 31 Regions (4). The 
two major regions in northern Tanzania are Arusha Region and 
Kilimanjaro Region. Regions are divided into Districts, with seven Districts 
in each of the Arusha and Kilimanjaro Regions. Each District is sub-
divided into wards, each containing up to 21,000 people. Wards are 
subdivided into villages, which are comprised of sub-villages, which are 
themselves comprised of ten-house units. Published data from the 2012 
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Tanzanian census is aggregated by Region, with some of the differences 
in human and animal population density between Arusha Region and 
Kilimanjaro Region shown in Table 8.1. The differences in the density of 
people and livestock suggest that there may be a difference in the 
incidence of leptospirosis. As shown in Figure 8.1, rainfall and pooling of 
rainfall varies substantially across the Arusha and Kilimanjaro Regions. 
 
Table 8.1. Human and livestock populations from the Arusha and 
Kilimanjaro Regions, northern Tanzania (data from 2012 census and 
2008 livestock census) 
 Arusha Kilimanjaro 
Area (km2) 37,576 13,250 
Human population 1,694,310 1,640,087 
Human population density (per km2) 45 124 
Cattle number 1,813,637 494,135 
Cattle density (per km2) 50 36 
Goat population 1,818,450 644,334 
Goat density (per km2) 55 50 
Sheep population 1,402,236 355,961 
Sheep density (per km2) 39 26 
Pig population 27,475 123,696 





Figure 8.1 Mean annual rainfall in the Arusha Region and Kilimanjaro 
Region, as per the 2002 Kenya International Livestock Research 
Institute report (5) 
Footnote: Other Regions in Tanzania are marked in grey, and Kenya is 
marked in white.  
 
8.1.2 Difficulties of population-based cohort studies and estimating 
incidence from Leptospira seroprevalence 
In population-based cohort studies, a population is followed longitudinally 
to assess disease occurrence. In such studies, febrile patients are actively 
sought, ideally in the home with regular household visits, and leptospirosis 
is confirmed among febrile persons using accepted diagnostic methods. A 
population-based cohort study would provide the most reliable estimates 
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of incidence but would require substantial resources in order to recruit 
participants and maintain participation through the duration of the study 
(6).  Population based cohort studies have not been performed for 
leptospirosis in Africa. Another approach to determining incidence would 
be to estimate the incidence of leptospirosis from the prevalence of 
Leptospira antibodies and estimates of antibody half-life (7).  For 
leptospirosis, the relationship between seropositivity and recent 
symptomatic leptospirosis is complex, with not all those who seroconvert 
doing so in the context of symptomatic infection (8). For Leptospira 
antibodies the half-life is not clearly defined, particularly where repeated 
exposure is possible, and the persistence of Leptospira antibodies is 
variable (9). Therefore, estimates of leptospirosis incidence that are 
derived from seroprevalence are not fully reliable and would need to be 
validated against other approaches of estimating incidence. 
 
8.1.3 Use of risk factors for leptospirosis to infer incidence 
In Chapters 6 and 7 we described research investigating risk factors for 
acute leptospirosis and Leptospira seropositivity among patients who 
presented to hospital with febrile illness. We identified risk factors for 
leptospirosis among patients presenting with fever, using individual 
behavioural risk factors, and cumulative scales of exposure to potential 
source animals. To extend this work, we would like to use the prevalence 
of the identified leptospirosis risk factors among different populations in 
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northern Tanzania to try to understand the incidence of leptospirosis in 
those populations.  
 
To estimate leptospirosis incidence based on the prevalence of risk factors 
over a given time period we must assume that a logistic regression model 
that predicts the probability that an individual presenting to hospital with 
fever has leptospirosis will also predict the probability that an individual in 
the community with fever has leptospirosis. For this assumption to be 
valid, the prevalence of Leptospira within the environment or animal hosts 
needs to be similar in different locations and the risk factors must operate 
in a similar fashion among community members as they do in patients with 
febrile illness. The prevalence of Leptospira infection in the environment 
and among animals is unknown, but as described below is under active 
investigation. Whether risk factors for leptospirosis are similar among 
hospitalised patients and community members is also unknown. Risk 
factors for Leptospira seropositivity among community members may 
provide some insight into the risk factors for leptospirosis. However as 
described above, the relationship between Leptospira seropositivity and 
acute leptospirosis is complex, and risk factors for acute leptospirosis in 
northern Tanzania differed from those for Leptospira seropositivity 
(Chapters 6 and 7).   
 
If we accurately predict the probability that individuals have had 
leptospirosis over a given time period, the mean of the probabilities of a 
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group of individuals represents the period prevalence. To draw an 
inference about the incidence of leptospirosis based on the period 
prevalence requires us to assume that episodes of illness reported during 
the time period predominantly reflected incident rather than prevalent 
episodes. 
 
8.1.4 Choosing an appropriate geographic scale for assessment of 
risk factors 
Kilimanjaro Region and Arusha Region each cover large geographic areas 
and have populations >1.5 million people. Within these Regions there is 
variation in human density, livestock density, and farming practice. 
Estimation of the prevalence of risk factors for leptospirosis by District 
allows comparison with prevalence of risk factors in Moshi Rural District 
and Moshi Urban District. In turn, this allows standardisation of the 
estimated leptospirosis incidence against the estimates of leptospirosis 




As described in Chapter 6, participants enrolled in the study that assessed 
risk factors for acute leptospirosis among patients presenting with febrile 
illness most frequently lived in Moshi Urban and Moshi Rural Districts. In 
Chapter 4, we estimated the annual incidence of leptospirosis in the Moshi 
Urban and Moshi Rural Districts as 11-18 cases per 100,000 people 
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during 2012-2014. We hypothesise that the prevalence of the risk factors 
for acute leptospirosis, and therefore the incidence of leptospirosis might 
be higher in Districts of northern Tanzania that have a higher density of 
livestock than the Moshi Urban District and Moshi Rural District. 
 
8.1.6 Study aims 
Specifically, we aimed: 
1. To determine the prevalence of individual risk factors for acute human 
leptospirosis among healthy livestock keepers living in Longido District 
and Monduli District of Arusha Region, and Hai District, Moshi Rural 
District, Moshi Urban District and Rombo District of Kilimanjaro Region. 
2. To assess exposure to potential sources and reservoirs of leptospirosis 
among livestock keepers living in Longido District and Monduli District, 
Arusha Region, and Hai District, Moshi Rural District, Moshi Urban District 
and Rombo District, Kilimanjaro Region. 
3. To estimate the incidence of acute human leptospirosis among livestock 
keepers living in Longido District and Monduli District, Arusha Region, and 





8.2.1 Study setting, sampling frame, and recruitment  
We conducted our analysis within a cross-sectional study among livestock 
owners in northern Tanzania that was designed to assess risk factors for 
Leptospira seropositivity among livestock and their owners (10). Within 
Arusha Region and Kilimanjaro Region, Wards were categorised into 
settings, designated as predominantly pastoral, agro-pastoral, or peri-
urban. Wards with a population density of 10 inhabitants/km2 were 
classified as urban; Wards ≤15km distance from urban areas with a 
population density ≥3 and < 10 inhabitants/km2 were classified as peri-
urban; and Wards ≥15km distance from an urban area with a population 
density of <3 inhabitants/km2 were classified as rural. Within each study 
setting, a multi-stage random sampling process was used to select Wards, 
Villages, and households for sample visits. Sub-village or ten cell unit 
leaders were asked to indicate which households own livestock and a 
sampling frame of livestock owning households was developed for 
household selection. Although the sampling frame was not performed by 
District, sampling occurred within six Districts. These are shown in Figure 
8.2 and included Longido District and Monduli Districts in Arusha Region, 
and Hai District, Moshi Rural District, Moshi Urban District, and Rombo 





Figure 8.2 Maps of Tanzania and northern Tanzania identifying the 
Districts sampled during cross sectional survey of livestock keepers, 
northern Tanzania, 2013-2015. Map designed using QGIS Geographic 
Information System. Open Source Geospatial Foundation 





8.2.2 Recruitment and procedures 
All members of selected households were approached for enrolment in the 
study. The sample size was determined to estimate accurately animal 
sero-prevalence of bacterial zoonoses, with sufficient households selected 
to achieve sampling of 750 animals of each target species: cattle, sheep, 
and goats in each setting. Human and livestock seroprevalence testing 
using Leptospira microscopic agglutination testing is ongoing and is not 
reported in this thesis. 
 
8.2.2.1 Surveys 
Trained study staff-members who were fluent in the participants’ first 
language, primarily Kiswahili or Maa, administered standardised 
questionnaires (Appendix C). Questionnaires were developed to 
investigate risk factors for and potential effects of zoonotic disease. These 
included a household questionnaire administered to an adult household 
representative, and an individual questionnaire, administered to all study 
participants. For children, the questionnaire was administered to their 
primary caregiver. The questionnaires were designed to include 
established risk factors for zoonotic disease from studies done in other 
settings (11-16), adapted for the circumstances in northern Tanzania, and 
were piloted prior to use. We also asked whether fever had been present 
during the two weeks prior to the interview. With relevance to investigating 
risk factors for leptospirosis, questions included contact, and specific risk 
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behaviours with cattle, goats, sheep, and pigs; use of surface water for 
activities of daily living; and contact with rodents. The questionnaires were 
developed in conjunction with those from the study of patients with acute 
febrile illness (described in Chapter 6) in order to harmonise analysis. 
However, there were differences between the questionnaire used for the 
assessment of risk factors for acute leptospirosis among patients with a 
febrile illness, and the questionnaires in the cross-sectional community 
study. Specifically, participants in the cross-sectional community study 
were not asked if they had fed livestock within the last month, worked in 
sugarcane fields or rice fields, or walked barefoot. 
 
8.2.3 Data Handling and statistical analysis 
Data were entered using the Cardiff Teleform system (Cardiff, Inc., Vista, 
CA, USA) into a Microsoft Access database (Microsoft Corporation, 
Redmond, WA, USA). Analyses were performed using Stata, version 13.1 
(Stata-Corp, College Station, TX, USA). Data were collated for each 
individual, with results of household surveys applied to each member of 
the household. Potential risk factors for leptospirosis were selected that 
were consistent with those identified in Chapter 6. The prevalence of 
potential risk factors was assessed within each census-defined District.  
 
8.2.3.1 Scales of cumulative exposure to sources of leptospirosis 
Scales of cumulative exposure to the main sources and reservoirs 
identified in the acute leptospirosis risk factor study and ascertained in the 
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cross-sectional survey were made using the weights developed in Chapter 
6. A cumulative exposure score was calculated for each individual the 
based upon answers given in either the household or individual 
questionnaires. The differences between the questionnaire used for the 
assessment of risk factors for acute leptospirosis among patients with a 
febrile illness, and the questionnaires in the cross-sectional community 
study meant that the weighting for feeding livestock within the last month 
was not included when aggregating livestock urine exposure, working in 
the sugarcane fields was not included when aggregating rodent urine 
exposure, and neither working in rice fields nor walking barefoot were 
included when aggregating surface water exposure.  
 
8.2.3.2 Prediction of leptospirosis risk 
We predicted the risk of leptospirosis during the two weeks prior to the 
interview for each participant in the cross-sectional community dataset 
using the logistic regression model developed in Chapter 6. The 
regression model estimated odds ratios and 95% confidence intervals for 
variables containing scores that estimated the exposure of participants to 
potential sources of leptospirosis: urine from cattle, goats, pigs, and 
rodents, and surface water. We calculated predicted probabilities of 
individuals acquiring acute leptospirosis by applying the bootstrapped 
coefficients from the final multivariate model of acute leptospirosis to the 
exposure scores of participants who reported symptoms of fever within the 
last two weeks. For those participants who did not report fever, we set the 
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probability of leptospirosis during the two weeks prior to the interview as 
zero.  
8.2.3.3 Estimation of incidence by District 
We aggregated the predicted probability of recent leptospirosis for 
individuals by District and calculated the mean. We assumed that the 
mean predicted probability of leptospirosis equated to the two-week period 
prevalence. To estimate incidence, we standardised the two-week period 
prevalence for each District to that of Moshi Urban District. We chose 
Moshi Urban District as the standard as, along with Moshi Rural District, 
we had established estimates for the incidence of leptospirosis. To 
standardise incidence, we multiplied the mean predicted probability of 
leptospirosis in each district by a constant that calibrated the annual 
incidence to 18 cases per 100,000 people in Moshi Urban District. The 
annual incidence in Moshi Urban was set at 18 cases per 100,000 people 
to match the figure estimated in Chapter 4 for Moshi Urban District and 
Moshi Rural District. 
 
8.2.3.4 Assessment of error 
The errors associated with the risk prediction were assessed among the 
patients with acute febrile illness in whom the model was developed 
(Chapter 6). We evaluated errors associated with the magnitude of 
association of risk factors in our model by assessing the difference in 
predicted risk among cases and controls at the estimated upper and lower 
95% confidence intervals of the odds ratio for each risk factor. We 
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estimated the predictive power of the model through use of a receiver-
operator-curve (ROC).  Out-of-sample error (also known as generalisation 
error) of the final exposure scale multivariate model was assessed using 
root mean square error (RMSE) evaluated through leave-one-out cross 
validation (17, 18).  
 
8.2.3.5 Statistical tests 
For categorical variables, proportions and 95% confidence intervals (CI) 
were calculated, and differences were assessed using the chi-squared 
test. For continuous data, differences in means were assessed using the 
student’s t-test. The difference in the distribution of heavily skewed 
continuous data, such as the scales of cumulative exposure, and the 





8.3.1 Demographic and clinical characteristics 
From 4 September 2013 through 20 March 2015, 286 persons consented 
to participate and completed questionnaires. The characteristics of 
participants, described by District are summarised in Table 8.2. Of 280 
who provided either a date of birth or an approximate age range, there 
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were 19 (6.8%) individuals aged under 12 years, 184 (65.7%) aged from 
12 through 55 years, and 77 (27.5%) aged >55 years.   
 
 In Moshi Rural District and Moshi Urban District participants reported 
predominantly Chagga ethnicity (32 [72.7%] of 44 and 87 [84.5%] of 103 
respectively) and in Hai District and Rombo District all participants 
reported Chagga ethnicity. The participants in Longido District and 
Monduli District all reported being Maasai. In Longido District and Monduli 
District, 57 (96.6%) of 59 and 55 (98.2%) of 56 of participants respectively, 
reported their highest educational achievements as either primary school 
or no formal education. This contrasts with the Districts within Kilimanjaro 
Region, particularly Moshi Urban District where 13.6% of participants 
reported no formal education, and 59.2% reported primary school as their 
highest level of education. As shown in Table 8.2 the mean numbers of 
cattle and goats kept per household in the Longido and Monduli Districts 
of Arusha Region, were higher than the mean numbers of cattle and goats 
in Hai District, Moshi Rural District, Moshi Urban District and Rombo 
District, Kilimanjaro Region. As shown in Table 8.2 there was a significant 
difference in the prevalence of reported fever by District (p<0.01). The 
proportion of participants reporting fever within the last two weeks was 
higher in Longido District (47.5, CI 34.2-60.9) and Monduli District (50.0, 
CI 36.3-63.7), Arusha Region, than those from Moshi Rural District (13.6, 
CI 5.2-27.4) and Moshi Urban District (20.4, CI 13.1-29.5). The point 
estimates of the proportion of participants with fever from Hai District 
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(27.3, CI 6.0-60.1) and Rombo District (30.8, CI 9.0-61.4) were also lower 
than those of Longido District and Rombo District, but due to the small 
number of participants the confidence intervals were wide.  
 
8.3.2 Prevalence of individual potential risk factors for leptospirosis 
The prevalence of individual potential risk factors for leptospirosis is 
shown in Tables 8.3-8.5. The cumulative exposure scores of participants 
are shown in Table 8.6 and Figures 8.3-8.6. The distribution of scores 
differed by District for cattle urine exposure (Kruskal-Wallis p value <0.01), 
goat urine exposure (p <0.01), rodent urine exposure (p=0.03), and 
surface water exposure (p<0.01). As shown in Table 8.6 there was greater 
exposure to cattle urine, goat urine, and surface water in the Longido and 
Monduli Districts of Arusha Region, than in the Moshi Rural or Moshi 
Urban Districts of Kilimanjaro Region. The exposure to cattle urine, goat 
urine, rodent urine and surface water in Rombo District or Hai District had 
confidence intervals that overlapped those of Longido District and Monduli 
District, as well as those of Moshi Rural District and Moshi Urban District. 
 423 
Table 8.2 Characteristics of cross-sectional community study participants by District, northern Tanzania, 2013-2015 
  Districts of Arusha Region Districts of Kilimanjaro Region 
 Longido Monduli Hai Moshi Rural Moshi Urban Rombo 
Age  N=59 % (95% CI) N=56 % (95% CI) N=11 % (95% CI) N=44 % (95% CI) N=92# % (95% CI) N=13 
(%) 
% (95% CI) 
Age <12 years 3 5.1 (0.0-10.6) 5 8.9 (1.5-16.4) 0 0.0 2 10.5 (0.0-10.7) 9 9.8 (3.7-15.9) 0 0.0 
Age 12-55 years 45 76.2 (65.4-87.1) 40 71.4 (59.6-83.3) 6 54.5 (23.4-83.3) 27 61.4 (47.0-75.8) 58 63.0 (53.2-72.9) 8 61.5 (35.1-88.0) 
Age >55 years 11 18.6 (8.7-28.6) 8 14.3 (5.1-23.5) 5 45.5 (16.7-76.6) 14 31.8 (18.1-45.6) 34 37.0 (27.1-46.8) 5 38.5 (12.0-64.9) 
Tribe N=59  N=56  N=11  N=44  N=103  N=13  
Chagga 0 0.0 0 0.0 11 100 32 72.7 (57.6-84.0) 78 75.7 (66.4-83.1) 13 100 
Pare 0 0.0 0 0.0 0 0.0 3 6.8 (2.1-19.4) 10 9.7 (5.3-17.2) 0 0.0 
Maasai 59 100.0 56 100 0 0.0 0 0.0 0 0.0 0 0.0 
Sambaa 0 0.0 0 0.0 0 0.0 0 0.0 2 1.9 (0.5-7.5) 0 0.0 
Other 0 0.0 0 0.0 0 0.0 9 20.5 (10.9-35.1) 13 12.6 (7.4-20.6) 0 0.0 
Education             
None 37 62.7 (49.6-74.2) 37 66.1 (52.6-7.73) 1 9.1 (11.3-46.6) 4 9.1 (3.4-22.1) 14 13.6 (8.2-21.7) 2 15.4 (3.6-46.7) 
Primary 20 33.9 (22.9-47.0) 18 32.1 (21.1-45.5) 9 81.8 (47.3-95.8) 34 77.3 (62.4-87.4) 61 59.2 (49.4-68.3) 8 61.5 (33.2-83.7) 
Secondary 1 1.7 (0.2-19.4) 1 1.8 (0.2-11.9) 1 9.1 (1.1-46.6) 3 6.8 (2.2-19.4) 20 19.4 (12.8-28.2) 1 7.7 (0.9-41.2) 
High school 1 1.7 (0.2-11.3) 0 0.0 0 0.0 0 0.0 2 1.9 (0.5-7.5) 0 0.0 
University 0 0.0 0 0.0 0 0.0 3 6.8 (2.1-19.4) 6 5.8 (2.6-12.4) 2 15.4 (3.6-46.7) 
Fever within last 
2 weeks 
28 47.5 (34.2-60.9) 28 50.0 (36.3-63.7) 3 27.3 (6.0-60.1) 6 13.6 (5.2-27.4) 21 20.4 (13.1-29.5) 4 30.8 (9.0-61.4) 
Stock numbers*  Mean (95% CI)  Mean (95% CI)  Mean (95% CI)  Mean (95% CI)  Mean (95% CI)  Mean (95% CI) 
Number of cattle kept 38  (23-70)  23 (15-29)  2 (2-3)  2 (0-2)  0 (0-2)  2 (1-3) 
Number of goats kept 62 (32-129)  26 (16-30)  0 (0-2)  0 (0-4)  4 (0-8)  9 (6-11) 
Number of pigs kept 0 (0-0)  0 (0-0)  0 (0-0)  0 (0-1)  0 (0-0)  0 (0-0) 
Key: # 92 (89.3%) provided information in Moshi Urban District about their age; *Stock numbers are per household; 
Abbreviations: CI= confidence intervals 
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Table 8.3 Livestock related risk factors for leptospirosis among livestock keepers, by District in Tanzania, 2013-2015 
















n (%) 95% CI n (%) 95 CI n (%) 95% CI n (%) 95% CI n  95% CI n (%) 95% CI p 
Owned cattle 59 (100) N/A 56 (100) N/A 11 (100) N/A 29 65.9 50.7-78.4 41 (39.8) 30.8-49.6 10 (76.9) 46.4-92.8 <0.01 
Milked cattle 27 (45.8) 33.4-58.6 30 (53.6) 40.4-66.3 7 (63.6) 32.4-86.5 10 22.7 12.6-37.6 13 (12.6) 7.4-20.6 5 (38.5) 16.3-66.8 <0.01 
Slept in the same 
room as cattle 
3 (5.1) 1.6-14.8 3 (5.4) 1.7-15.5 2 (18.2) 4.2-52.7 0 0.0 N/A 1 (1.0) 0.1-6.7 1 (7.7) 1.0-41.3 0.03 
Cleaned up cattle 
waste 
13 (22.0) 13.2-34.5 13 (23.2) 13.936.2 9 (81.8) 47.395.8 23 52.3 37.5-66.6 25 (24.3) 16.9-33.6 6 (46.2) 21.5-72.8 <0.01 
Herded cattle 38 (35.6) 24.4-48.7 15 (26.8) 16.7-40.0 0 (0.0) N/A 2 4.5 1.1-16.7 6 (5.8) 2.6-12.4 1 (7.7) 1.0-41.3 <0.01 
Handled cattle 
placenta 
14 (23.7) 14.5-36.4 9 (16.1) 8.5-28.3 2 (18.2) 4.2-52.7 1 2.3 0.3-14.8 9 (8.7) 4.6-16.0 0 (0.0) N/A <0.01 
Assisted with cattle 
birth 
13 (22.0) 13.2-34.5 10 (17.9) 9.8-30.3 2 (18.2) 4.252.7 1 2.3 0.3-14.8 3 (2.9) 0.9-8.7 2 (15.4) 3.-46.86 <0.01 
Handled aborted cattle 
products  
4 (6.8) 2.5-16.9 3 (5.4) 1.7-15.5 0 (0.0) N/A 0 0.0 N/A 0 (0.0) N/A 0 (0.0) N/A 0.05 
Slaughtered cattle 10 (16.9) 9.3-28.9 9 (16.1) 8.5-28.3 0 (0.0) N/A 2 4.5 1.1-16.7 3 (2.9) 0.9-8.7 1 (7.7) 1.0-41.3 0.01 
Handled carcasses of 
cattle 
4 (6.8) 2.5-16.9 7 1(2.5) 6.0-24.2 0 (0.0) N/A 0 0.0 N/A 0 (0.0) N/A 0 (0.0) N/A <0.01 
Owned goats 59 (100) N/A 56 (100) N/A 6 (54.5) 25.5-80.7 18 40.9 23.7-56.0 90 (87.4) 79.4-92.6 13 (100) N/A <0.01 
Milked goats 27 (45.8) 33.4-58.6 18 (32.1) 21.2-45.5 0 (0.0) N/A 4 9.1 3.4-22.1 4 (3.9) 1.5-10.0 4 (30.8) 11.5-60.4 <0.01 
Slept in the same 
room as goats 
6 (10.2) 4.6-21.0 11 (19.6) 11.1-32.3 0 (0.0) N/A 0 0.0 N/A 7 (6.8) 3.3-13.7 3 (23.1) 7.2-53.6 <0.01 
Cleaned up goat 
waste 
14 (10.2) 4.6-21.0 27 (48.2) 35.4-61.3 2 (18.2) 4.2-52.7 11 25.0 14.3-40.0 55 (53.4) 43.7-62.9 9 (69.2) 39.6-88.5 <0.01 
Herded goats 33 (55.9) 43.0-68.1 16 (28.6) 18.2-41.9 0 (0.0) N/A 4 9.1 3.4-22.1 21 (20.4) 13.6-29.3 0 (0.0) N/A <0.01 
Assisted with goat 
birth 
21 (35.6) 24.4-48.7 17 (30.4) 19.7-43.7 1 (18.2) 4.2-52.7 5 11.4 4.7-24.8 8 (7.8) 3.9-14.9 0 (0.0) N/A <0.01 
Handled goat placenta 17 (28.8) 18.6-41.7 14 (25.0) 15.3-38.1 1 (9.1) 1.1-46.6 5 11.4 4.7-24.8 10 (9.7) 5.3-17.2 1 (7.7) 1.0-41.3 0.01 
Handled aborted goat 
products  
9 (15.3) 8.1-27.0 5 (8.9) 3.7-19.9 1 (9.1) 1.1-46.6 0 0.0 N/A 2 (1.9) 0.5-7.5 0 (0.0) N/A <0.01 
Slaughtered goats 23 (39.0) 27.3-52.0 14 (25.0) 15.3-38.1 0 (0.0) NA 2 4.5 1.1-16.7 11 (10.7) 6.0-18.3 3 (23.1) 7.2-53.6 <0.01 
Handled carcasses of 
goats 
4 (6.8) 2.5-16.9 7 (12.5) 6.0-24.2 0 (0.0) N/A 0 0.0 N/A 0 (0.0) N/A 0 (0.0) N/A <0.01 
Abbreviations: CI= confidence intervals 
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Table 8.4 Rodent related risk factors by District among livestock keepers in northern Tanzania, 2013-2015 
Variable Districts of Arusha Region Districts of Kilimanjaro Region Chi2 
  
Longido Monduli Hai Moshi Rural Moshi Urban Rombo 
 
 
n (%) 95% CI n (%) 95% CI n (%) 95% CI n (%) 95% CI n (%) 95% CI n (%) 95 CI p 
Performed rodent 
control activities 
47 (79.7) 67.3-88.2 51 (91.1) 80.1-96.3 9 (81.8) 47.3-95.8 40 (90.9) 77.9-96.6 94 (91.3) 84.0-95.4 12 (92.3) 58.7-99.0 0.25 
Handled rodent 
carcasses 
4 (6.8) 2.5-16.9 1 (1.8) 0.2-11.9 0 (0.0) N/A 0 (0.0) N/A 3 (2.9) 0.9-8.7 0 (0.0) N/A 0.35 
Disposed of rodent 
carcasses by feeding 
them to other animals 
17 (28.8) 18.6-41.7 18 (32.1) 21.2-45.5 0 (0.0) N/A 0 (0.0) N/A 5 (4.9) 2.0-11.2 0 (0.0) N/A <0.01 
Saw rodents in the 
house 
23 (39.0) 27.3-52.0 6 (10.7) 4.8-22.1 8 (72.7) 39.7-91.5 14 (31.8) 19.7-47.1 28 (27.2) 19.4-36.7 4 (30.8) 11.5-60.4 <0.01 
Saw evidence of 
rodents in the house 
47 (79.7) 67.3-88.2 49 (87.5) 75.8-94.0 8 (72.7) 39.7-91.5 24 (54.5) 39.6-68.7 67 (65.0) 55.3-73.7 12 (92.3) 58.7-99.0 <0.01 
Saw evidence of 
rodents in the kitchen 
14 (23.7) 14.5-36.4 6 (10.7) 4.8-22.1 7 (63.6) 32.4-86.5 21 (47.7) 33.4-62.5 30 (29.1) 21.1-38.7 4 (30.8) 11.5-60.4 <0.01 
Saw evidence of 




27.3-52.0 20 (35.7) 24.2-49.2 8 (72.7) 39.7-91.5 22 (50.0) 35.4-64.6 37 (35.9) 27.2-45.7 8 (61.5) 33.2-83.7 0.07 
Saw evidence of 
rodents in their fields 
17 (28.8) 18.6-41.7 35 (62.5) 49.1-74.3 3 (27.3) 8.5-60.3 24 (54.5) 39.6-68.7 33 (32.0) 23.7-41.7 3 (23.1) 7.2-53.6 <0.01 
Abbreviations: CI= confidence intervals 
Table 8.5 Surface water related risk factors by District among livestock keepers in northern Tanzania, 2013-2015 
Variable Districts of Arusha Region Districts of Kilimanjaro Region Chi2 
  
Longido Monduli Hai Moshi Rural Moshi Urban Rombo 
 
 
n (%) 95 CI n (%) 95 CI n (%) 95 CI n (%) 95 CI n (%) 95 CI n (%) 95 CI p 
Drink surface water 33 (55.9) 43.0-68.1 54 (78.6) 65.8-87.5 0 (0.0) N/A 7 (15.9) 7.7-30.1 4 (3.9) 1.5-10.0 0 (0.0) N/A <0.01 
Drink untreated 
surface water 
33 (55.9) 43.0-68.1 44 (78.6) 65.8-87.5 0 (0.0) N/A 7 (15.9) 7.7-30.1 2 (1.9) 0.5-7.5 0 (0.0) N/A <0.01 
Bathe in surface water 35 (59.3) 46.3-71.2 54 (96.4) 86.6-99.1 0 (0.0) N/A 7 (15.9) 7.7-30.1 4 (3.9) 1.5-10.0 0 (0.0) N/A <0.01 
Wash clothes or 
dishes in surface 
water 
35 (59.3) 46.3-71.2 54 (96.4) 86.6-99.1 2 (18.2) 4.2-52.7 7 (15.9) 7.7-30.1 4 (3.9) 1.5-10.0 0 (0.0) N/A <0.01 
Abbreviations: CI= confidence intervals 
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Table 8.6 Participant scores on knowledge-based exposure scales by District among livestock keepers in northern 
Tanzania, 2013-2015 
Variable Districts of Arusha Region Districts of Kilimanjaro Region  
 
Longido Monduli Hai Moshi Rural Moshi Urban Rombo 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Cattle urine exposure score 1.1 (0.8-1.3) 1.0 (0.8-1.1) 1.0 (0.6-1.5) 0.5 (0.4-0.7) 0.4 (0.2-0.5) 0.6 (0.3-0.8) 
Goat urine exposure score 1.4 (1.1-1.6) 1.3 (1.0-1.5) 0.2 (0.0-0.4) 0.4 (0.2-0.6) 0.7 (0.5-0.8) 0.9 (0.6-1.2) 
Rodent urine exposure score 1.8 (1.5-2.0) 2.1 (2.0-2.3) 2.3 (1.8-2.8) 2.0 (1.8-2.3) 2.0 (1.8-2.1) 2.4 (1.9-2.8) 
Surface water exposure score 2.1 (1.6-2.5) 3.7 (3.4-3.9) 0.7 (0.0-1.7) 0.6 (0.2-1.0) 0.1 (0.0-0.2) 0.5 (0.0-1.0) 




Figure 8.3 Histogram of participant scores on knowledge-based 
cattle urine exposure scale by District among livestock keepers in 






Figure 8.4 Histogram of participant scores on knowledge-based goat 
urine exposure scale by District, among livestock keepers in 




Figure 8.5 Histogram of participant scores on knowledge-based 
rodent urine exposure scale by District, among livestock keepers in 





Figure 8.6 Histogram of participant scores on knowledge-based 
surface water exposure scale by District, among livestock keepers in 
northern Tanzania, 2013-2015 
 
8.3.3 Assessment of error 
8.3.3.1 Assessment of predictive power of the regression model 
We assessed the predicted probability of leptospirosis among controls and 
leptospirosis cases in the acute febrile illness study (described in Chapter 
6) in order to assess how well our logistic regression model predicted 
leptospirosis within the study group. The development of our logistic 
regression model is described in Chapter 6 and contained two cumulative 
exposure variables: exposure to cattle urine and exposure to rodent urine. 
The logistic regression co-efficient (95% confidence intervals) for cattle 
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urine exposure and rodent urine exposure were 0.16 (-0.05 to 0.37) and 
0.11 (-0.01 to 0.25). The constant was -3.82 (-4.59 to -3.05). The right-
hand box-and-whisker of Figure 8.7 shows the distribution of predicted 
probabilities of leptospirosis that are obtained when using the point 
estimate of coefficients obtained from logistic regression among those with 
laboratory confirmed leptospirosis and controls who did not have 
leptospirosis. The distribution of probabilities was higher among cases 
than controls (Kruskal-Wallis test p value 0.01). The ROC (Figure 8.8) 
indicates that the model has an area-under-the-curve of 0.64.  
 
Figure 8.7 Predicted probabilities of leptospirosis among controls 




Figure 8.8 Receiver-operator-curve for a logistic regression model 
including scores of the exposure to cattle urine and rodent urine, 
estimating the accuracy of the logistic regression model for the 
diagnosis of leptospirosis among patients with fever, northern 
Tanzania, 2012-14  
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8.3.3.2 Assessment of model selection errors 
We assessed the effect of model selection errors by assessing differences 
in the probability distributions of leptospirosis among controls and cases 
that were estimated by the initial logistic regression model and the final 
logistic regression model. The initial logistic regression model and the 
process for arriving at the final model are described in detail in Chapter 6. 
The initial model contained the variables exposure to cattle urine, 
exposure to goat urine, exposure to pig urine, exposure to rodent urine 
and exposure to surface water. The final model contained the variables 
exposure to cattle urine and exposure to rodent urine. As shown in Figure 
8.9, we found that the distribution of probabilities for cases and controls 






Figure 8.9 Predicted probabilities of leptospirosis among controls 
and leptospirosis cases using estimates derived from the initial 
multivariable model and the final multivariable model among 
participants in the acute febrile illness study, northern Tanzania, 
2012-14 
 
8.3.3.3 Magnitude of association errors 
We assessed the effect that plausible changes in the odds ratio of the 
variables in our final multivariable model would have on the predicted 
probability that participants would have leptospirosis. To do this we 
evaluated the predicted probabilities for participants that would be 
obtained by using the upper and lower bounds of the 95% confidence 
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intervals of the regression coefficients from the bootstrapped final 
multivariable model of exposure scores. For cattle urine exposure the CI 
were -0.05 and 0.37. For rodent urine exposure the CI were -0.01 and 
0.25. As shown in Figure 8.7 and Table 8.7 there were differences in the 
distribution of predicted probabilities between controls and cases at each 
of the upper and lower bounds. However, the distribution of predicted 
probabilities for cases using the lower limit of the 95% confidence bounds 
for the coefficients overlapped with the distribution of probabilities of 
controls at the upper bound. This indicates that the confidence intervals 
that surround predictions in other data-sets will be broad, and is discussed 
further in Section 8.3.4. 
Table 8.7 Predicted lower and upper bounds of predicted 
probabilities of leptospirosis among controls and leptospirosis 
cases in acute febrile illness study, northern Tanzania, 2012-14 
  Mean 95% confidence intervals 
 
Lower bound of predicted probability  
 Control 0.019 0.019 – 0.020 




Upper bound of predicted probability  
 Control 0.076 0.070 – 0.081 
 Case 0.118 0.070 – 0.166 
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8.3.3.4 Assessment of out-of-sample error 
Leave-one-out cross validation among febrile patients of the final 
multivariable model found the RMSE = 0.193. The RMSE is the standard 
deviation of the residuals, where residuals are the differences between 
predicted values and those observed. The RMSE has the same scale as 
the dependent variable, and therefore in our scenario, the maximum 
possible RMSE is 1. 
     
8.3.4 Estimated predicted risk of leptospirosis among livestock 
owning community members 
We estimated the predicted probability that participants in the cross-
sectional community study had had leptospirosis during the previous two 
weeks using the final logistic regression model from Chapter 6. The mean 
value of participants within each District is shown in Table 8.8. The model 
contained the variables: exposure to cattle urine and exposure to rodent 
urine. For each individual in each district we estimated three probabilities 
using the model coefficients, the lower 95% confidence limits for the 
coefficients, and the upper 95% confidence limits for the coefficients. The 
density of predicted probabilities for participants in each District (Figure 
8.10) indicate that for most participants the predicted probability of 
leptospirosis was zero, but in each District there was a subset of 
participants whose predicted probability of having had acute leptospirosis 
during the previous two weeks was greater than zero. Figure 8.10 shows 
that participants in Longido Districts and Monduli District had a greater 
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predicted probability of acute leptospirosis than those in Moshi Rural 
District and Moshi Urban District. The Kruskal-Wallis test (p<0.01) 
suggests that there is a difference in the distribution of probabilities by 
District. However, as the upper and lower bounds of the coefficient 
confidence intervals overlap, the difference in predicted probabilities 
should be interpreted cautiously. Additionally, as there were few 
participants from Hai District and Rombo District the histogram showing 
the density of predicted probabilities of acute leptospirosis should be 
interpreted cautiously for these Districts. 
 
Table 8.8 Predicted risk of leptospirosis by District among livestock 
owners in northern Tanzania, 2013-15 




Hai 11 0.029 0.005 0.095 
Longido 59 0.071 0.009 0.235 
Monduli 56 0.055 0.009 0.206 
Moshi Rural 44 0.014 0.002 0.049 
Moshi Urban 103 0.015 0.004 0.048 






Figure 8.10 Histogram of predicted probability of leptospirosis 
among livestock keepers by District in northern Tanzania, 2013-15 
 
8.3.5 Estimation of incidence 
The mean predicted probability and therefore the estimated two-week 
prevalence of leptospirosis in Moshi Urban District was 1.5%, which was 
two orders of magnitude greater than the estimated incidence for one 
year. The reasons for the difference between estimates is discussed 
below in Section 8.4.8. We sought to calibrate the District specific two-
week period prevalence in Moshi Urban District to the previously 
estimated annual incidence in the Moshi Urban District. Dividing the 
estimated two-week period prevalence of 1,500 cases per 100,000 people 
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by 83 calibrated the two-week period prevalence in Moshi Urban District to 
the annual incidence of 18 cases per 100,000 people (Chapter 4). We can 
apply the same calibration factor to each District if we assume that the risk 
factors for leptospirosis convey the same odds of risk in each district. Such 
calibration allows us to estimate annual incidence for each District. The 
limitations of this assumption are discussed below in Section 8.4.8. The 
estimates of annual incidence of leptospirosis for each District are shown 
in Table 8.9. 
 
Table 8.9 Estimated incidence of leptospirosis among livestock 
keepers by District in northern Tanzania, 2013-15 




Estimated annual incidence of 
leptospirosis per 100,000 people 
(upper - lower bounds) 
Hai 0.029 83 35 (6-114) 
Longido 0.071 83 85 (11-282) 
Monduli 0.055 83 66 (11-247) 
Moshi Rural 0.014 83 17 (2-59) 
Moshi Urban 0.015 83 18 (5-58) 
Rombo 0.031 83 47 (7-145) 
Key: CI= confidence intervals; * The calibration factor standardises 
incidence estimates to that of Moshi Urban where the incidence has been 
previously determined as 18 cases/100,000  
8.4 DISCUSSION 
We have explored the prevalence of risk factors among six Districts in 
northern Tanzania. We identified differences between Districts in ethnicity, 
highest level of education, the period prevalence of fever, livestock 
numbers, the aggregated amount of livestock and surface water exposure, 
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and the prevalence of related individual behaviours between the Longido 
District and Monduli District of the Arusha Region and the Moshi Rural 
District and Moshi Urban District within Kilimanjaro Region.  By applying 
coefficients from a logistic regression model that described the association 
of cumulative exposure to cattle urine and rodent urine with leptospirosis, 
to data from each participant in our study, we predicted the probability that 
each participant had been unwell with leptospirosis during the previous 
two weeks. We estimated the mean predicted probability of leptospirosis in 
each District and calibrated our estimates to the established incidence in 
the Moshi Urban District to estimate the incidence in each District. We 
found that Longido District and Monduli District of the Arusha Region had 
higher point estimates of incidence than the Districts within Kilimanjaro 
Region.  
 
8.4.1 Demographic differences between Districts 
The demographic data from our study are in keeping with census data, 
indicating marked ethnic differences between Districts in northern 
Tanzania (4). Of particular note, Longido and Monduli Districts in Arusha 
Region contain a high proportion of Maasai, who continue to practise 
traditional pastoralist farming and who keep large numbers of cattle and 
goats. In contrast Hai, Moshi Rural, and Rombo Districts, which lie within 
Kilimanjaro Region, are predominantly populated by people of Chagga 
tribal background who have smaller, more intensive mixed farming units. 
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Moshi Urban is an urban centre, with immigration influenced by strong 
educational and tourism sectors (4).  
8.4.2 Differences in livestock related risk factors between Districts 
The overall distributions of participant scores of cumulative exposure to 
cattle and goats were higher in the Longido District and Monduli District of 
the Arusha Region than Moshi Urban District and Moshi Rural District. The 
number of participants sampled in Hai District and Rombo District was 
small, and the confidence intervals for many variables overlapped with the 
Districts in Arusha Region and other Districts in the Kilimanjaro Region.  A 
large proportion of livestock owners in Longido District and Monduli District 
performed high-exposure tasks. For example, 55.9% of participants in 
Longido District reported herding goats, and 26.8% reported herding cattle 
in the previous 30 days. In comparison, 9.1% of participants living in Moshi 
Rural District reported herding goats, and 4.5% reported herding cattle. In 
addition, activities that might generate intense exposure to blood or urine 
of infected animals such as birthing, or handling products of abortion were 
extremely common in Longido District and Monduli District. For example, 
35.6% of participants reported birthing goats and 15.3% reported handling 
products of abortion from goats within the last 30 days in Longido. In 
contrast, in Moshi Rural District 11.1% of participants reported assisted 
with goat birth and none reported handling products of abortion.  
8.4.3 Differences in rodent related risk factors between Districts 
Although the Kruskal-Wallis test identified a difference in the mean rank-
sums of the cumulative rodent urine exposure scores, the size of the 
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difference between study Districts was small. The scales of cumulative 
rodent exposure, and individual behaviours suggested that sighting 
evidence of rodents around and within the house was common in all study 
Districts. Despite a high proportion of participants reporting that they had 
engaged in rodent control activities, handling of rodent carcasses was 
uncommon. In Longido District and Monduli District the practice of feeding 
rodent carcasses to domestic animals was common (28.8% and 32.1% 
respectively) compared to only 4.9% in Moshi Urban District and 0.0% in 
all other Districts, and could pose a risk of transmission of disease from 
wild to domestic animals.  
 
8.4.4 Differences in surface water related factors between Districts 
There were marked differences in the exposure to surface water in 
different Districts. Again, in comparison to Moshi Rural District and Moshi 
Urban District, a higher proportion of participants living in Longido District 
and Monduli District used surface water for bathing and washing. In 
addition, participants in Longido District and Monduli District reported 
drinking untreated water more often than the Districts within Kilimanjaro 
Region. The rainfall across both Longido District and Monduli District is 
low, and highly seasonal. For example, the total annual rainfall in 
Ketumbeine Ward, Longido District during 2010 was low at <200mm (19). 
Unsegregated surface water use by both human and livestock can lead to 
water quality degradation in arid environments (20). Figure 8.11 shows a 
photograph taken by the author of livestock wading in and drinking from a 
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stream used for human drinking water collection and bathing in the 
Longido District. The use of water supplies for livestock and humans, as 
well as the consumption of untreated surface water suggests residents of 
Longido and Monduli Districts are at heightened risk of multiple zoonotic 
waterborne and water-washed diseases.  
 
Figure 8.11 Cattle in a waterway near Lake Natron, Longido District, 
2016 
 
8.4.5 Increased prevalence of fever in Longido District and Monduli 
District, and the potential prevalence of zoonotic disease 
Recent symptoms of fever were more commonly reported by participants 
from Longido and Monduli Districts than by participants from Moshi Rural 
and Moshi Urban Districts. This suggests a higher incidence of infectious 
disease associated with fever. In Moshi Rural and Moshi Urban Districts, 
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major causes of fever include bloodstream infections, notably typhoidal 
and non-typhoidal Salmonella enterica, bacterial zoonotic infections (i.e., 
brucellosis, leptospirosis, Q fever, spotted fever group rickettsiosis), and 
arboviral infections (21). The aetiology of fever among pastoralist farmers 
in Longido and Monduli Districts is unknown, and the increased two-week 
period prevalence of fever may indicate increased prevalence of diseases 
prominent in Moshi, or additional diseases. Malaria is unlikely to account 
for differences in fever prevalence as the malaria atlas project indicates 
that the prevalence of Plasmodium parasitaemia in all study Districts is low 
(22). An increased prevalence of zoonotic diseases, including leptospirosis 
is a plausible contributor to the higher prevalence of fever and is 
supported by the higher prevalence of behaviours exposing participants to 
livestock and surface water in Longido and Monduli Districts compared 
with Moshi Rural District and Moshi Urban District. 
 
8.4.6 Variations in leptospirosis incidence by district 
We have estimated the incidence of leptospirosis by estimating the 
probability that participants recruited in the community have had 
leptospirosis during the past two weeks. We aggregated participants by 
District and calibrated our probability estimates to the leptospirosis 
incidence for Moshi Urban District and Moshi Rural District that we 
estimated in Chapter 4. Our estimates suggest that Longido District and 
Monduli District are likely to have a higher incidence of leptospirosis than 
Moshi Rural District and Moshi Urban District. In Longido District and 
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Monduli District the annual incidence was 85 (CI 11-282) and 66 (11-247) 
cases per 100,000 people. Our estimates contain considerable uncertainty 
due to the poor predictive power of the model that we used to estimate the 
probability of leptospirosis. 
 
8.4.7 Assumptions required for incidence estimation 
Our probability estimates rely on the assumption that the risk factors 
measured adequately account for leptospirosis risk, that the risk factors 
operate consistently between Districts, and that the proportion of fevers 
caused by leptospirosis is similar among both community members and 
hospitalised patients reporting fever. These assumptions are unlikely to be 
true. The assumption that our model adequately accounts for leptospirosis 
risk is flawed, as based on the area under the ROC (Figure 8.6), our 
model fits the data poorly and is likely to be a poor predictor of risk. The 
estimated RMSE (0.193 out of maximum value of 1) also suggests that our 
model is a relatively poor predictor of leptospirosis, particularly in out-of-
sample datasets. The wide range between the upper and lower bounds of 
our probability estimates reflect the poor prediction and uncertainty of our 
model. As the risk of any individual behaviour is influenced by the 
prevalence of Leptospira shedding by reservoir hosts, and the ability of 
Leptospira to persist in the environment it is likely that there is variation in 
the degree to which risk factors are important in different settings. We 
currently do not have data available on the prevalence of Leptospira 
infection among livestock, and wildlife hosts, or on the prevalence of 
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Leptospira in waterways and soil in northern Tanzania. Such data will be 
important to improve accuracy of leptospirosis risk estimation. The 
proportion of fevers caused by leptospirosis in the community are 
unknown in all Districts in northern Tanzania. It is plausible that in 
community members with fever the presence of other infections such as 
respiratory viral infection are more common than in those hospitalised, 
which may lower the proportion of fevers caused by leptospirosis (23). 
 
 Our results estimated the two-week period prevalence at approximately 
1,500 cases per 100,000 people in Moshi Urban District, which was 
approximately 83 times the previously estimated annual incidence for 
severe acute leptospirosis. While some of the difference between the 
estimates may reflect a difference in the incidence of all cases of 
leptospirosis and those severe enough to cause hospitalisation, it also 
suggests that the assumptions list above may not hold true. By 
standardising our incidence estimates to those of Moshi Urban District, we 
mitigated violations of our assumptions.   
 
8.4.8 Study limitations 
Our study has a number of limitations that influence interpretation. First, 
our study enrolled only livestock owners, and did not seek to determine 
the proportion of the population that owned livestock. We are therefore 
uncertain of the application of findings to the non-livestock owning 
population. Given that the number of livestock, and the ratio of livestock to 
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people in both Longido and Monduli Districts is higher than in Moshi Rural 
and Moshi Urban Districts (4), we might expect that difference in 
prevalence of risk factors is in fact greater than we have observed. 
Second, the questionnaire used in this cross-sectional community study 
had several small but important differences from the questionnaire used in 
the study of risk factors among patients with fever (Chapters 6 and 7). 
Importantly, we did not ask participants in the community study about rice 
farming, and questions related to pig farming were insufficiently detailed to 
generate a pig urine exposure score. Third, the size of the population 
sample in Hai and Rombo Districts was extremely small. The uncertainty 
estimates are correspondingly large, and limit interpretation of results from 
these Districts.  
 
8.4.9 Recommendations for future studies 
Our approach of estimating zoonotic disease incidence from locally 
relevant risk factors provides a useful tool for extrapolating data from 
sentinel sites across a wide geographic area. Studies that use locally 
relevant proximal risk factors for leptospirosis to estimate disease period 
prevalence add to studies such as those of Costa (3) that use distal 
country level risk factors. It would be useful to validate our approach by 
estimating leptospirosis incidence, using multiplier methods such as those 
in Chapter 4, in the districts studied here.  Further studies to improve 
estimates of leptospirosis incidence across northern Tanzania require a 
model with greater predictive power. Additional factors that would improve 
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the predictive power of the model include data that could estimate the 
prevalence of Leptospira in soil, waterways, and animal hosts. The parent 
study from which our were collected will provide some of this additional 
information from livestock, but further work is needed to test the relative 
power of local prevalence of Leptospira within these potential sources in 
northern Tanzania to predict acute leptospirosis. In addition, future studies 
should include representative sampling of the entire population. While the 
complexities of the relationship between Leptospira seropositivity and 
acute leptospirosis make determination of incidence solely through 
seroprevalence challenging (8, 9), seroprevalence data could provide 
additional supporting evidence to risk factor based estimates of incidence. 
Finally our choice of logistic regression to model leptospirosis may have 
negatively influenced the predictive accuracy of our model. Stochastic 
models have shown promise in complex systems and should be explored 
in future work (24). 
8.4.10 Conclusions 
In conclusion, among livestock owners in northern Tanzania there was 
marked variation in prevalence of potential risk factors for acute 
leptospirosis, particularly for those risk factors related to contact with 
livestock and surface water. While our study has several important 
limitations that mean that a cautious interpretation of incidence across 
each study District, our data suggest that the highest annual incidence of 
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Chapter 9. Molecular studies 
on the epidemiology of 
leptospirosis in northern 
Tanzania 
9.1 INTRODUCTION 
Identifying the Leptospira species and serovars responsible for human 
infection is critical for understanding the potential reservoir hosts. In 
northern Tanzania, there are limited data on common species and 
serovars of Leptospira infecting humans. Currently available data are 
limited to microscopic agglutination testing serology (MAT), that can 
identify predominant serogroups, rather than serovar or species (1, 2). 
 
9.1.1 Detection of Leptospira through culture and polymerase chain 
reaction 
Culturing Leptospira from patients with acute leptospirosis provides the 
most robust means for determining species, serovar, and molecular 
characteristics. However, the sensitivity of Leptospira culture is low (3). In 
Chapter 2 of this thesis, the limitations of culture are underscored by 
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uniformly negative Leptospira culture results despite strong serologic 
evidence of infection. Polymerase chain reaction (PCR) targeting single 
gene targets has been used to diagnose leptospirosis by detecting 
Leptospira DNA in patient samples. The sensitivity of this technique has 
been reported with variable results, but is considered more sensitive than 
culture (3, 4). Perhaps the most important reason for the variation in 
accuracy among published reports is in the selection of patients. PCR is 
most sensitive when performed on blood of patients who are within the 
first few days of illness, as this is the bacteraemic phase of leptospirosis, 
or on urine during the second week of illness (5). Studies that enrol 
patients after the first week are likely to find lower sensitivity of PCR. In 
addition, the volume of sample from which DNA is extracted and the 
choice of body fluid, as whole blood has been found to be less sensitive 
than serum, can influence assay sensitivity (6). 
 
There have been multiple gene targets of Leptospira identified. Some 
target sequences are present in all Leptospira, such as in the gyrB, rrs, 
and secY genes. Although specific for the genus Leptospira, they are not 
specific for pathogenic species as they also detect DNA of saprophytic 
Leptospira species (4).  Several PCR assays targeting genes that are 
found only in pathogenic Leptospira, including lig, LipL32 and lfb1, have 
been developed. The LipL32 gene sequence codes for a conserved outer-
membrane protein (7). A PCR assay targeting the LipL32 gene has been 
found to detect DNA to a lower limit of detection of 20 copies per reaction 
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and have 100% specificity (8). The US Centers for Disease Control and 
Prevention (CDC) have optimised this assay (9, 10), and use it routinely 
on serum, plasma, and urine for the diagnosis of leptospirosis. In addition, 
the assay has been shown to be useful for diagnosis of patients during the 
first week of illness at multiple countries (11, 12). There have been no 
studies that indicate whether assays targeting the lig or lfb1 genes or 
LipL32 are more sensitive (4, 13).   
 
9.1.2 Identifying Leptospira through PCR 
PCR techniques have also been used to determine the species of infecting 
Leptospira. This has been achieved using PCR products of amplified 
targets within the secY and ompL1 genes that show variation between 
Leptospira species (14).  The sensitivity of these assays has not been fully 
determined, but when used in a two-step algorithm with a LipL32 assay 
were able to identify four common disease-causing species (L. 
interrogans, L kirschneri, L. borgpetersenii, and L. noguchii) (14). Ferriera 
and colleagues used 85 references strains, as well as clinical samples to 
evaluate the assays. They estimated the limit of detection was 103 
leptospires/ml, which was the same as the LipL32 assay. They found that 
the species-specific assays correctly identified each reference strain and 
all five culture positive clinical samples.  
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9.1.3 Study aim 
The aim of this study was to use PCR to determine which Leptospira 
species were present among human patients with acute leptospirosis in 
northern Tanzania in order to draw inferences about which animals may 
be reservoir hosts. 
 
9.2 METHODS  
9.2.1 Study setting 
We studied patients at Kilimanjaro Christian Medical Centre (KCMC) and, 
Mawenzi Regional Referral Hospital (MRRH) in Moshi, and Endulen 
Hospital in Endulen, as described in Chapter 3. 
 
9.2.2 Study procedures and participants 
We enrolled paediatric and adult patients presenting with a febrile illness 
to KCMC and MRRH from February 2012 through May 2014, and 
paediatric and adult patients admitted to Endulen Hospital with a febrile 
illness from June 2016 through April 2017 as described in Chapter 3. 
Trained study personnel drew blood for Leptospira culture and serum, 
which was used for leptospirosis serology, and in a subset PCR. 
Participants were asked to return 4-6 weeks after enrolment for collection 
of a convalescent serum sample. The methods and results of serology 
testing and Leptospira culture have been reported in Chapter 3. 
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9.2.3 Selection of participants for Leptospira PCR testing 
PCR was performed on the acute serum sample of all participants who 
had acute leptospirosis diagnosed by MAT serology. That is, all 
participants who had a four-fold rise in Leptospira antibody titre between 
acute and convalescent serum samples, or a single reciprocal titre ≥800. 
Additionally, we tested all decedents.  
 
9.2.4 Laboratory methods 
PCR was performed using a validated assay targeting LipL32. To perform 
the assay, we extracted DNA from 200μL serum using the QIAamp blood 
mini kit (Qiagen N.V. Venio, Netherlands) according to manufacturer’s 
instruction, except that 100μL Buffer AE was used to elute DNA. We 
performed PCR using PerfeCTa® qPCR ToughMix®, Low ROX™ (Quanta 
Biosciences, Gaithersburg, MD, USA), and the primers and probe shown 
in Table 3.1 using the ABI 7500 RT-PCR system instrument (Waltham, 
MA, USA). Inhibition was evaluated using the Taqman® exogenous 
internal positive control. Each experiment included positive controls, using 
DNA extracted from both a Leptospira interrogans culture of 0.5 
McFarland standard concentration diluted 1 x 10-4, and an aliquot of pre-
extracted DNA of 10pg/μL from Leptospira interrogans serovar 
Icterohaemorrhagiae strain RGA, American Type Culture Collection 
(ATCC) number 43642.  As negative controls, each experiment also 
included two no-template controls: one from the DNA master-mix room, 
and one and from the DNA addition room. The protocol specified that a 
 459 
run should be repeated if a positive control had a cycle threshold (CT) 
value ≥40. 
 
In samples in which we detected Leptospira DNA using the LipL32 assay, 
we performed PCR using sets of species-specific probes, respective 
flanking primers (shown in Table 3.1), targeting secY gene sequences that 
identify L. interrogans, L. kirschneri, and L. noguchi, and an ompL1 
sequence that identifies L. borgpetersenii (14). In each experiment there 
were species-specific positive controls: L. kirschneri serovar Cynopteri 
strain 3522C, ATCC 49945; L. noguchi strain 2001034031; L. 
borgpetersenii strain Ballum Mus 127 DMSO 4/21/15; and L. interrogans 
strain Icterohaemorrhagiae RGA, ATCC 43462.  We also included 
negative controls in each experiment. 
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Table 8.1. Polymerase chain reaction methods used in this study to target genes of pathogenic Leptospira spp. 





LipL32 LipL32-45F AAG CAT TAC CGC TTG TGG TG 60 40 
LipL32-286R GAA CTC CCA TTT CAG CGA TT 
LipL32-189P FAM AA AGC CAG GAC AAG CGC CG-BHQ1 
L. interrogans secY PFLint2 CTT GAG-CCT GCG CGT TAY C 63 45 
PRLint2  CCG ATA ATT CCA GCG AAG ATC 
TaqLint2 TET CTC ATT TGG TTA GGA GAA CAG ATC A BHQ1 
L. kirschneri secY F_nery CTG GCT TAA TCA ATG CTT CTG 60 45 
R_nery CTC TTT CGG TGA TCT GTT CC 
TqM_nery Texas Red CAG TTC CAG TTG TAA TAG ATA AGA TTC BHQ2 
L. noguchii secY FLnog2 TCA GGG TGT AAG AAA GGT TC 63 45 
RLnog2 CAA AAT TAA AGA AGA AGC AAA GAT 
TaqLnog FAM CGA TTG GCT TTT TGC TTG AAC CAT C-BHQ1 
L. borgpetersenii ompL1 F_bpn GAT TCG GGT TAC AAT TAG ACC 65 45 
R_bpn1 TTG ATC TAA CCG GAC CAT AGT 




Among 1,540 who were tested for leptospirosis using MAT, we identified 
30 (1.9%) participants with acute leptospirosis. We tested all 30 (100%) 
and detected Leptospira LipL32 DNA in 3 (10.0%).  In addition, we tested 
27 decedents, and identified Leptospira LipL32 DNA in 1 (3.7%). 
Information on the duration of fever was available in 53 (93.0%) of the 57 
tested, all of whom were recruited at either KCMC or MRRH. The median 
(range) reported duration of fever was 7 (1-90) days with 19 (35.8%) 
reporting symptoms of fever for fewer than 7 days. Self-reported 
antibacterial use was available in 53 (93.0%), with 49 (92.5%) reporting 
prior use. Result of species specific PCR reactions are shown in Table 
8.2. We identified one participant with each of the species: L. 
borgpetersenii, L. kirschneri, and L. interrogans. We were unable to detect 
DNA with any of the species-specific PCR reactions in the serum of the 
decedent with a positive LipL32 PCR (identified in Tables 2 and 3 as 
participant 4).  Selected clinical and risk factor questionnaire data are 




Table 8.2 LipL32 and species-specific PCR cycle threshold values, 
and MAT predominant serogroup in participants with Leptospira DNA 
detected, Tanzania 2012-2014 
Participant number 1 2 3 4 
PCR     
     LipL32 CT value 38.6 36.3 32.3 38.4 
     L. borgpetersenii CT value ND 37.8 ND ND 
     L. interrogans CT value 37.4 ND ND ND 
     L. kirschneri CT value ND ND 37.8 ND 
     L. noguchii CT value ND ND ND ND 
MAT     
     Predominant MAT serogroup  Sejroe  Pyrogenes  Sejroe  Pyrogenes  
     Acute reciprocal titre 0 0 0 400 
     Convalescent reciprocal titre 200 800 12,800 NA 
Key: CT = cycle threshold; MAT = microscopic agglutination serology; NA 




Table 8.3 Selected clinical information and potential risk factors for 
acute leptospirosis among cases of acute leptospirosis with 
Leptospira DNA detected, Tanzania 2012-2014 
Participant number 1 2 3 4 
Age, years 38 38 59 39 
Sex Male Male Male Male 
Duration of fever, 
days 
7 14 14 
3 














Seen rats in house Never Never < 1x/ week < 1x/ week 
Seen rats in 
compound 
< 1x/ week Never ≥ 1x/ week 
Never 
Seen rats in fields < 1x/ week Never < 1x/ week Never 
Worked in rice fields Yes Yes Yes No 
Rainfall in 30 days 
prior to admission*, 
mm 
0 364.0 34.7 91.6 
Footnote: *Rainfall recorded at the Tanzania Production Company rainfall 
station in lower Moshi. 
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9.4 DISCUSSION  
We have identified three species of Leptospira from four individuals in 
whom Leptospira DNA was detected. Our results indicate complex 
Leptospira ecology, with multiple species and serovars circulating among 
a human population who have multiple risk factors for infection. 
 
The Leptospira species that we identified as causing human disease in 
northern Tanzania, are in keeping with those identified elsewhere in East 
Africa. In neighbouring Kenya, L. borgpetersenii, L. interrogans, and L. 
kirschneri have been identified in people with febrile illness (15). In south-
east Tanzania L. interrogans and L. kirschneri have been detected by 
PCR and sequenced from human blood during a cross-sectional 
community survey of healthy adults (16). Sequencing of PCR products are 
thought to be close to 100% specific, and so the finding of Leptospira DNA 
in the blood of healthy people is surprising and not fully explored in the 
published report (16). These published reports of multiple Leptospira 
species in East Africa and our data, which indicate that there are multiple 
species infecting humans in Kilimanjaro Region are consistent with 
complex Leptospira ecology. This contrasts with some other ecosystems, 
such as island ecosystems where a limited number of serovars, and a 
single species may predominate (17).  
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9.4.1 Potential animal sources of the identified Leptospira species  
For a limited number of people with leptospirosis we have identified the 
species of Leptospira with which they were infected, and the Leptospira 
serogroup to which they mounted the strongest antibody response. 
Although there is cross reactivity between serogroups using MAT, 
identifying the likely serogroup and the species of Leptospira infecting 
humans provides clues as to possible animal reservoirs responsible for 
human disease. Strains from serogroup Sejroe, that could be L. 
interrogans, have been isolated from cattle (Bos taurus) in South Africa 
(serovar Hardjo, species undetermined) (18), although in Tanzania, 
serovar Hardjo isolates from cattle have been L. borgpetersenii (19). 
There is no serovar of serogroup Sejroe in the species L. kirschneri, which 
suggests either cross-reactivity of the MAT, or an as yet undiscovered 
serovar. African isolates of serovars from within serogroup Pyrogenes, 
that were either identified as, or likely to be L. borgpetersenii, include 
serovars Nigeria and Kwale, isolated from cattle in Nigeria and Zimbabwe, 
and the Tatera gerbil (Tatera robusta) in Kenya (20-22). In addition, at 
abattoirs in Moshi L. borgpetersenii have been identified, with secY gene 
sequences that resemble those of serovars Kwale and Nyanza with a 98% 
match (19). Therefore, our results are consistent with cattle acting as a 
source for human leptospirosis infection in Tanzania. Sequencing the PCR 
products from participants in our study and comparing phylogeny with 




The potential risk factors reported for the three individuals characterised in 
this chapter were all participants in the study of risk factors for acute 
leptospirosis in Tanzania described in Chapter 6. There, we identify cattle 
and rice farming as possible sources of human infection. Each of the three 
individuals with Leptospira DNA detected report multiple risk factors that 
exposed them to livestock, rodents and surface water. Therefore, at an 




A limitation of our study, when considering the potential diversity of 
circulating Leptospira species, is the low numbers of participants with a 
positive PCR. The negative PCR in participants who met accepted case 
definitions for leptospirosis demonstrates the challenges of detecting 
Leptospira. The sensitivity of PCR to diagnose acute leptospirosis has 
varied between reports (3, 4). Our results are in keeping with other studies 
from northern Tanzania, where Leptospira DNA was not detected in either 
the urine or plasma of patients with confirmed leptospirosis (19).  The 
sensitivity of PCR has been higher, at 43% for the LipL32 assay and 56% 
for the rrs assay, in a published report from Thailand (11). It has also been 
higher in a report from Sri Lanka, where it was estimated at 51.0% (95% 
CI: 37.5%–64.4%) on serum when compared to MAT (6). The reason for 
low sensitivity of PCR in our setting is not certain. Factors that influence 
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the likelihood of leptospiraemia at the time of sample collection could 
plausibly influence test sensitivity.  In our study, the duration of illness prior 
to presentation may have influenced sensitivity. In addition, in this study 
and others, we have identified that a high proportion of participants 
consumed antibacterial drugs prior to presentation at hospital, which may 
also reduce assay sensitivity (2, 19). Our decision to preferentially test 
participants with serologically confirmed leptospirosis is likely to mean that 
we have missed some cases of leptospirosis, as PCR is most sensitive 
early in the illness and serology has low sensitivity during this period. 
Despite the possibility that we have selected mostly serologically 
confirmed cases for PCR testing, the implication of our results for clinical 
diagnostic testing, is that PCR is not sufficiently sensitive to be used alone 
as a diagnostic test for leptospirosis.  
 
9.4.3 Conclusions 
In conclusion, we have identified multiple serogroups and species of 
Leptospira causing leptospirosis in a small number of human cases in 
northern Tanzania. This suggests a complex Leptospira ecosystem in 
Tanzania. Our findings also highlight that further work is needed to isolate 
Leptospira from human cases and compare linked human and animal 
isolates and phylogenetic molecular data, in order to confirm the reservoirs 
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Chapter 10. Systematic review 
and meta-analysis of the 
diagnostic accuracy of point-
of-care tests for leptospirosis 
10.1 INTRODUCTION 
10.1.1 Under-diagnosis of leptospirosis 
As discussed earlier in this thesis, leptospirosis was among the most 
commonly retrospectively identified causes of severe febrile illness in 
northern Tanzania (1).  Despite frequently being the diagnosed 
retrospectively using Leptospira microscopic agglutination testing as the 
cause of illness in our studies at Kilimanjaro Christian Medical Centre, 
Mawenzi Regional Referral Hospital, and Endulen Hospital, none were 
diagnosed in real-time by clinicians (2-4).  As the symptoms and clinical 
signs of leptospirosis are non-specific, clinician diagnosis relies on 
accurate, accessible, and affordable diagnostic tests (5). 
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10.1.2 Laboratory based diagnostic tests for leptospirosis 
Currently available diagnostic tools for leptospirosis include dark field 
microscopy, culture, nucleic amplification tests (NAAT), and serological 
methods.  
10.1.2.1 Dark field microscopy 
Dark field microscopy on a body fluid can be used to detect Leptospira up 
to a lower limit of detection of 1-2 leptospires per high powered field (6). 
However, dark field microscopy has proven insufficiently sensitive for 
routine clinical practice (6), with a sensitivity in one study of 40.2% when 
compared to a reference standard of either a positive Leptospira culture, 
or seroconversion or a ≥4-fold rise in antibody titre on Leptospira 
microscopic agglutination testing (7).  
10.1.2.2 Leptospira culture 
Leptospira can be isolated from blood, urine and cerebrospinal fluid. The 
optimal body fluid for culture varies according to duration of illness. During 
the first week of illness the patient will be leptospiraemic, and blood is 
preferred. During the second and third weeks, Leptospira may be cultured 
from the urine or cerebrospinal fluid. Leptospira culture requires 
specialised media, such as Ellinghousen-McCullough-Johnson-Harris 
media. One to two drops of body fluid are inoculated, and then incubated 
for up to 13 weeks. The prolonged culture is needed due to a doubling 
time of Leptospira that ranges from 10 hours to several days (6). If 
Leptospira are cultured, the test is considered to diagnose leptospirosis 
with a specificity of approximately 100%. However, due to the low level of 
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leptospiraemia and leptospiruria, culture has been estimated to have a 
sensitivity under 10% in comparison to a ≥4-fold rise in MAT antibody titre 
(8).  For clinicians, the major limitation of culture, in addition to the low 
sensitivity, is the long period of incubation needed. 
 
10.1.2.3 Polymerase chain reaction 
Polymerase chain reaction (PCR) has been applied to a variety of genetic 
targets including housekeeping genes of pathogenic and saprophytic 
Leptospira, such as rrs, gyrB, or secY as well as genes limited to 
pathogenic Leptospira including lipL32, lig, or lfb1 (9). PCR of both blood 
and urine have shown variable sensitivity. Although it is considered to 
have greater sensitivity than dark field microscopy, typically PCR has often 
been shown to have lower sensitivity than immunoglobulin M (IgM) 
serologic assays (6, 8) with sensitivity values such as 36.2% (10) when 
compared to MAT.  
 
10.1.2.4 Serology assays 
MAT is considered the reference standard serological test (11). For clinical 
diagnosis MAT is limited by complex and expensive method and requires 
maintenance of multiple strains of live Leptospira. In addition, MAT relies 
on testing paired serum samples to detect seroconversion. Diagnosing 
leptospirosis using MAT to detect a high level of combined Leptospira IgM 
and IgG in a single serum sample taken during the first 10 days of illness 
has been found to have a sensitivity of only 6.3% among culture positive 
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patients, and imperfect specificity (8).  Detection of IgM using enzyme 
linked immunosorbent assay (ELISA) can be used for early diagnosis of 
leptospirosis. ELISA assays can be based either on detection of whole cell 
Leptospira antibodies, recombinant surface proteins, or lipoproteins (6). In 
some evaluations ELISA has been shown to be more sensitive than MAT 
on an acute serum sample (8, 12). However, in other evaluations the 
sensitivity of IgM ELISA has been reported as low as 36% when compared 
with MAT and culture (13). The variation may in part be due to antigen 
variation as ELISA assays based on recombinant proteins or lipoproteins 
have lower sensitivity than those based on whole cell Leptospira 
antibodies (14). The critical limitation of Leptospira culture, PCR, MAT, 
and ELISA is that the tests requires procedures, expertise, and 
instruments that are not readily available in most African hospital 
laboratories. Furthermore, a reliable supply of electricity, reagents, and 
consumables makes establishing and maintaining a service difficult (6).  
Even well-equipped research laboratories have documented that reliable 
supply of these items is challenging (15). 
 
10.1.3 Commercially available point-of-care tests 
Inexpensive and simple point-of-care tests have been developed that 
detect anti-Leptospira IgM.  These have the potential to be deployed at 
both the district hospital laboratory and health centres level in low-
resource settings for the diagnosis of leptospirosis among febrile patients. 
Currently commercially available point-of-care assays include DPP 
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Leptospirosis assay (Fiocruz, Rio de Janeiro, Brazil), Leptorapide 
(Linnodee Ltd., Doagh, Northern Ireland), Leptocheck WB (Zephyr 
Biomedicals, Goa, India) SD Bioline Leptospira (Alere, Waltham, MA, 
United States of America), and Test-It Leptospira IgM Lateral Flow Assay 
(Lifeassay Diagnostics Pty Ltd. Cape Town, South Africa).  
 
10.1.3.1 DPP Leptospirosis 
DPP Leptospirosis uses a proprietary dual-path platform to detect 
antibodies against Leptospira immunoglobulin-like (lig) proteins in human 
serum (16).  The assay is only available for purchase in South America 
(personal communication T. Sturiale, Fiocruz, 30 November 2015). The lig 
antigen in the assay is considered to have only limited ability to detect 
Leptospira serovars outside of the Icterohaemorrhagiae serogroup (17). 
 
10.1.3.2 Leptorapide 
Leptorapide is a latex agglutination test, in which latex beads are coated 
with proprietary antigens derived from pathogenic strains of Leptospira. 
When patient serum that contains antibodies that bind to the antigen is 
added to the latex beads, it will cause interlinking of the beads observed 
macroscopically as agglutination.  
10.1.3.3 Leptocheck WB 
Leptocheck WB is a lateral flow assay in which anti-Leptospira IgM, if 
present in patient serum, binds to anti-human IgM gold conjugate as it 
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passes through the device membrane assembly. Leptocheck WB uses 
whole cell leptospiral antigen from the saprophytic Leptospira biflexa 
serovar Patoc strain that is made by heating, washing, and centrifugation 
of a well-established Leptospira culture. The resulting antigen is fixed in a 
band in combination with a stabilised and stained anti-IgM conjugate onto 
a solid strip. The IgM anti-IgM gold conjugate will bind to the antigen and 
be visible as a coloured band. 
 
10.1.3.4 SD Bioline Leptospira 
SD Bioline is a lateral flow assay that can detect human anti Leptospira 
IgM and IgG (18). Information on the antigen included in the assay is not 
available on their website, nor was it found using web searches (search 
terms: SD Bioline Leptospira; SD Bioline Leptospira package insert; SD 
Bioline Leptospira antigen) on 1 June 2015 and 27 February 2018. In 
addition, we were unable to purchase the assay in northern Tanzania. 
 
10.1.3.5 Test-It Leptospira 
The Test-It Leptospira uses very similar technology and antigen as 
Leptocheck WB. It is a lateral flow assay in which patient Leptospira IgM 
binds to a whole-cell heat resistant lipopolysaccharide antigen prepared 
from a non-pathogenic Leptospira biflexa serovar Patoc strain by boiling, 
washing, and centrifugation of a concentrated bacterial culture. The bound 
IgM is then detected and stained by anti-human IgM gold conjugate. 
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10.1.4 Measures of diagnostic test accuracy 
Sensitivity and specificity are measures of diagnostic test accuracy. 
Sensitivity is the probability that a person with the disease of interest will 
have a positive test result. Specificity is the probability that a person 
without the disease of interest will have a negative test result.  Sensitivity 
and specificity are critical tools for determining which tests are useful in 
clinical practice (19). In contrast to other measures of test accuracy such 
as positive and negative predictive value, sensitivity and specificity are not 
influenced by disease prevalence, and should therefore be relatively 
consistent across populations (19). However, sensitivity and specificity are 
not a fixed property of a test and can vary between populations (20). 
 
10.1.5 Systematic review and meta-analysis as tools for determining 
diagnostic test accuracy 
10.1.5.1 Systematic search strategy 
Systematic reviews of diagnostic test accuracy summarise the sensitivity 
and specificity estimated through multiple studies. Guidelines exist to 
ensure systematic reviews are conducted using a reproducible and 
systematic method (21). The recommended method includes a 
transparent search strategy, that is designed to identify all relevant 
literature, as well as inclusion criteria that allows readers to identify why 
included studies were selected. Ideally systematic reviews should search 
at least two databases and have broad inclusive search terms (20).  All 
identified papers should then be assessed for relevance.  
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10.1.5.2 Assessing articles for relevancy 
Most systematic reviews assess relevancy using a two-stage process (20). 
First, one or two reviewers review the title and abstract of articles, to 
establish if there is a prima facie case for relevancy. In the second stage, 
the full text of all potentially relevant papers is reviewed by two 
investigators to establish relevancy and whether inclusion criteria have 
been met.  
 
10.1.5.3 Assessment of method quality 
In order to inform interpretation of the results, the method quality, and 
applicability to practise should be assessed.  Method quality is often 
assessed using the Quality Assessment of Diagnostic Accuracy Studies 
(QUADAS or the revised QUADAS-2) criteria (22). QUADAS-2 considers 
quality and risk of bias in four domains: patient selection, performance of 
the index test, choice and performance of the reference test and flow and 
timing (22).  Patient selection may be a source of bias in case-control 
studies or when patients who may be difficult to diagnose are excluded 
from the study. In addition, if the study participants differ from those who 
would be tested in clinical practice, the results may not be applicable to 
patient care. Performance of the index test may introduce bias if the 
diagnosis of patients is known in advance, or if the cut-off is different from 
that in standard use. The reference test may bias the results if it does not 
correctly classify disease. The assessment of flow and timing includes 
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assessing any variation in duration of illness between performance of the 
reference test and index test, and whether all participants were subjected 
to the same tests. Flow and timing also includes an assessment of the 
analyses, and particularly how indeterminate or intermediate results are 
classified.  
 
10.1.5.4 Data analysis 
Meta-analysis is a tool that can be used for summarising estimates of 
sensitivity and specificity.  The Cochrane Collaboration currently 
recommends two random-effects methods for meta-analysis: the 
hierarchical summary receiver-operator-curve (HSROC) and the bivariate 
model (23). The HSROC is recommended for continuous tests, and the 
bivariate model is recommended for binary tests (23). Either method can 
be used to investigate sources of heterogeneity. Publication bias occurs if 
studies with positive results are more likely to be published, and such bias 
can threaten the validity of a systematic review. Deeks' method for 
detecting publication bias is recommended when performing a meta-
analysis of diagnostic test evaluations (20). 
 
10.1.6 Aim 
We sought to estimate the sensitivity and specificity among patients with 
fever of IgM point-of-care leptospirosis assays. We focused our review on 
assays that are available for clinical use in Tanzania, specifically lateral 
flow assays that use antigen derived from heat treated whole cell 
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Leptospira serovar Patoc strain Patoc 1, hereafter called the Patoc antigen 
lateral flow assay, and the Leptorapide card agglutination assay that uses 
a proprietary antigen  
 
10.2 METHODS 
We conducted our systematic review in accordance with the 2009 
Preferred Reporting of Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines. The PRISMA checklist is included as Appendix D. We 
registered our review with the International Prospective Register of 
Systematic Reviews (PROSPERO). 
10.2.1 Search strategy and article winnowing 
I compiled and piloted search terms using a ‘PICOS’ worksheet (Appendix 
E) that is used for framing the aim and methods of a systematic review. A 
PICOS acronym stands for: 
P – Patient Population or Problem 
I – Intervention (treatment/test) 
C – Comparison (group or treatment) 
O – Outcomes 
S - Setting  
 
The search was completed on 4 July 2017 using the terms: 
“(Leptospirosis/*diagnosis OR Leptospirosis/*immunology OR (Leptospir* 
AND Immunoglobulin M)) AND Humans AND (Sensitivity and Specificity 
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OR *Reference Standards)” on the databases Medline, Web of Science 
and Scopus.  I reviewed all abstracts and titles to determine which articles 
may have relevant data. For those deemed potentially relevant, Professor 
John A. Crump and I independently reviewed the full text of each article. 
Articles were included in our study if they were an evaluation of test 
accuracy of either a Patoc antigen lateral flow assay or Leptorapide 
among humans.  
10.2.2 Data extraction 
10.2.2.1 Assessment of study quality 
I assessed study quality using the revised Quality Assessment of 




Table 10.1 Criteria for assessing bias in reports of performance 
evaluations of point-of-care tests for acute leptospirosis  
Abbreviations: MAT= Leptospira microscopic agglutination test; PCR= 
Polymerase chain reaction; IgM ELISA= Immunoglobulin M enzyme-linked 
immunosorbent assay 




-Prospective selection of patients with fever, with cases and controls 
coming from the same population.  
Grade II 
-Retrospective evaluation 
- Case-control selection from same population 
-Selection of cases or controls using a subset of symptoms.  
Grade III -Selection of cases and controls from different populations 
   
Index Test 
Grade I 
- Assessors blinded to results of reference test when performing point 
of care test 
- Threshold for positivity is defined a priori, and is in keeping with 
standard use of the test 
Grade II 
-  Threshold is not in keeping with standard usage of the test 
- Threshold is not determined a priori 
Grade III - Assessors are not blinded to the results of the reference test when 
performing the point of care test 




- Use of MAT on paired serum samples +/- PCR +/- culture as the 
reference standard 
Grade II - Use of a single titre MAT threshold, or an IgM ELISA assay as the 
reference standard 




- All patients subject to the same reference tests 
- Reference tests and index tests performed on samples taken at the 
same time in the illness 
- Data presented to allow calculation of sensitivity and specificity 
Grade II - Use of samples collected on different days for index and reference 
tests 
Grade III 
- Sensitivity and specificity not able to be calculated from available 
information 
- Variation of the reference test between patients 
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10.2.2.2 Extraction of data assessing performance of diagnostic tests 
I extracted data onto a standardised data extraction sheet, relating to the 
parameters shown in Table 10.2. 
 
Table 10.2 Data extracted from reports of performance evaluations of 
point of care tests for leptospirosis 
1. Study quality  
2. Study characteristics 
a. Country 
b. Year 
c. Study design 
d. Index test manufacturer 
e. Index test cut off 
f. Index test performed to manufacturer’s instructions 
g. Reference test 
h. Reference test case definition 
i. MAT panel 
j. Sample type 
k. Mean duration of illness 
l. Proportion receiving prior antibacterials 
3. Results 
a. Number eligible 
b. Number enrolled 
c. Number true positive 
d. Number false positive 
e. Number true negative 
f. Number false negative 
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10.2.3 Analysis 
I constructed forest plots displaying estimated sensitivity and specificity, 
with 95% confidence intervals (CI) for individual studies, from contingency 
tables where the reference test was assumed to be 100% sensitive and 
specific, using Open MetaAnalyst (24, 25). Meta-analysis was performed 
using Open MetaAnalyst and the user written programme ’midas’ in Stata 
13.1 (StataCorp, College Station, TX, USA) (26). Meta-performance 
characteristics were established using a random-effects bivariate model. 
Publication bias was assessed using Deeks’ funnel plot asymmetry test 
(23, 27). Deeks’ funnel plot asymmetry test uses linear regression of log 
odds ratios on inverse root of effective sample sizes. A non-zero slope 
coefficient is suggestive of significant publication bias, or small study bias 
(p value <0.10). Study heterogeneity was assessed using the I2 statistic 
(28). 
10.3 RESULTS 
10.3.1 Study flow and quality 
Our search identified 225 unique reports.  Of these, 32 (14.2%) were 
selected as potentially relevant on the basis of title and abstract, and 
underwent full text review. We determined that 11 (4.9%) articles were 
relevant.  
 
The 11 published reports contained data from seven studies evaluating 
the performance of Leptorapide, and 11 studies evaluating the 
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performance of a Patoc antigen lateral flow assay. Two studies, both 
evaluating Leptorapide, could not be included as data that allowed 
calculation of sensitivity and specificity was not presented. These include 
one study within the paper by Brownlow and colleagues (29), and one 
study presented only in abstract from by Chang and colleagues (30). The 
results of bias assessment are shown in Table 10.3. I considered a single 
study to be of grade 1 quality in each of the 4 domains. Five (25.0%) 
studies had a high risk (Grade 3) of bias in the flow and timing domain. I 
rated only one (5.0%) study as Grade 1 for the reference test domain. Bias 
in the reference test domain was most commonly due to use of a 
reference standard other than that recommended by the World Health 




Table 10.3 Bias assessment of studies evaluating the performance of 
Leptorapide and Patoc antigen lateral flow assay point-of-care tests 













Smits HL 1 (31) 2001 LFA Grade 2 Grade 1 Grade 2 Grade 1 
Smits HL 2 (31) 2001 LFA Grade 2 Grade 1 Grade 2 Grade 1 
Eapen CK (32) 2002 LFA Grade 2 Grade 1 Grade 2 Grade 1 
Sehgal SC (33) 2003 LFA Grade 1 Grade 1 Grade 1 Grade 1 
Kannan A (34) 2012 LFA Grade 3 Grade 1 Grade 2 Grade 1 
Limmathurotsakul D 
(35) 
2012 LFA Grade 2 Grade 1 Grade 2 Grade 1 
Goris MG 1 (36) 2013 LFA Grade 1 Grade 1 Grade 2 Grade 1 
Goris MG 2 (36) 2013 LFA Grade 1 Grade 1 Grade 2 Grade 1 
Brownlow T 1 (37) 2014 LPE Grade 2 Grade 1 Grade 2 Grade 1 
Brownlow T 2 (37) 2014 LPE Grade 2 Grade 1 Grade 2 Grade 1 
Brownlow T 3 (37) 2014 LPE Grade 2 Grade 3 Grade 2 Grade 1 
Brownlow T 4 (37) 2014 LPE Grade 2 Grade 1 Grade 2 Grade 3 
Brownlow T 5 (37) 2014 LPE Grade 2 Grade 1 Grade 2 Grade 1 
Brownlow T 6 (37) 2014 LPE Grade 1 Grade 1 Grade 2 Grade 3 
Brownlow T 7 (37) 2014 LPE Grade 2 Grade 1 Grade 2 Grade 3 
Chang CH (30) 2014 LPE Grade 3 Grade 1 Grade 2 Grade 3 
Niloofa R (38) 2015 LFA Grade 1 Grade 1 Grade 2 Grade 1 
Podgorsek D (39) 2015 LFA Grade 2 Grade 1 Grade 2 Grade 1 
Eugene EJ (40) 2015 LFA Grade 2 Grade 1 Grade 2 Grade 3 
Abbreviations: LFA= Patoc antigen lateral flow assay; LPE= Leptorapide; 
Footnote: Numbers refer to different datasets from within the same paper 
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Table 10.4 Case definitions used in studies evaluating IgM assays for the diagnosis of leptospirosis 
Study Identifier Index test Reference test Reference test leptospirosis case definition 
Smits HL 1 Patoc LFA MAT ≥ fourfold rise in MAT titre or single MAT titre >=160 
Smits HL 2 Patoc LFA ELISA Single antibody titre ≥1:80 
Eapen CK  Patoc LFA ELISA Single antibody titre ≥1:80 
Sehgal SC Patoc LFA MAT + culture Positive culture, or seroconversion to an MAT titre ≥100, or a fourfold rise in MAT titre, or a single MAT titre≥400 
Kannan A Patoc LFA MAT Single MAT titre≥100 
Limmathurotsakul D Patoc LFA MAT + culture Positive culture or single MAT titre ≥400 
Goris MG 1 Patoc LFA MAT + ELISA + 
culture 
(i) Single MAT titre with a pathogenic strain ≥1:160, (ii) single IgM-ELISA titre ≥1:160, (iii) positive culture or (iv) 
seroconversion/four-fold titre rise MAT or IgM ELISA (titre ≤1:20 to ≥1:80) in paired samples taken at least 2 days apart 
Goris MG  2 Patoc LFA MAT + ELISA + 
culture 
(i) Single MAT titre with a pathogenic strain ≥1:160, (ii) single IgM-ELISA titre ≥1:160, (iii) positive culture or (iv) 
seroconversion/four-fold titre rise MAT or IgM ELISA (titre ≤1:20 to ≥1:80) in paired samples taken at least 2 days apart 
Brownlow T 1 Leptorapide MAT or ELISA Single antibody titre ≥1:40 
Brownlow T 2 Leptorapide MAT or ELISA Not stated 
Brownlow T 3 Leptorapide MAT or ELISA Not stated 
Brownlow T 4 Leptorapide MAT or ELISA Single antibody titre≥100 
Brownlow T 5 Leptorapide ELISA All samples had MAT≥100. Cases required a ELISA IgM antibody titre ≥80 
Brownlow T 6 Leptorapide MAT Criteria for serological diagnosis of leptospirosis using MAT testing was; a) sero-conversion from a titre of < 1 in 20 in the first 
sample and ≥ 1 in 80 in the second sample. b) four-fold rise in titre, a titre of 1 in 80 in the first sample, 1 in 320 or above in 
the second sample. c) A titre of 1 in 80 or 1 in 160 was considered as a significant titre in the case where second sample is 
not available. The optimal cut-off titre for single MAT was assessed based on plotting the ROC curve for different MAT titre 
obtained on confirmed cases and controls. 
Brownlow T 7 Leptorapide MAT Single MAT titre ≥100 
Chang CH  Leptorapide MAT +/- PCR Not stated 
Eugene EJ Patoc LFA MAT Single MAT titre ≥400 
Niloofa R Patoc LFA MAT Seroconversion to an MAT titre ≥100, or a fourfold rise in MAT titre, or a single MAT titre≥400 
Podgorsek D Patoc LFA MAT + culture Positive culture or single MAT titre ≥100 
Abbreviations: LFA= lateral flow assay, MAT= microscopic agglutination test, ELISA= enzyme linked immunosorbent assay 
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10.3.2 Study characteristics 
Evaluations of the Patoc antigen lateral flow assay were performed using 
participants from Brazil, India, Italy, Malaysia, the Netherlands, Poland, 
Seychelles, Slovenia, Sri Lanka, Thailand, United Kingdom, and the 
United States of America. Eight (72.7%) of 11 studies were cross-sectional 
design, and 3 (27.3%) were case-control studies. Only 3 (27.3%) used 
case definitions consistent with either the World Health Organisation or the 
US Centers for Disease Control and Prevention (41). Ten (91%) of 11 
studies were performed among patients with a clinical suspicion of 
leptospirosis and one (9%) was performed among patients with uveitis and 
was not included in the meta-analysis. One study reported mean duration 
of symptoms, and one study reported the prevalence of use of 
antimicrobials prior to testing. Evaluations of Leptorapide were performed 
among participants from eight countries: Brazil, India, Italy, Malaysia, the 
Netherlands, Poland, United Kingdom, and the United States of America.  
Five (62.5%) studies were of cross-sectional design, and three (37.5%) 
were case-control studies. No studies used laboratory case definitions 
consistent with those of either the World Health Organization or US 
Centers for Disease Control and Prevention.  No study reported the 
prevalence of antimicrobial use nor the duration of symptoms.  
10.3.3 Sensitivity and specificity estimates for Leptorapide and Patoc 
antigen lateral flow assays 
The number of participants with, and without leptospirosis who tested 
positive by each index test is shown in Table 10.5 and 10.6. The meta-
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analysis of the individual studies is shown in Table 10.7. The sensitivity 
and specificity of each study, and the meta-estimate is shown in Figure 1 
and Figure 2.  The study Brownlow 6 was not included in the meta-
analysis because with zero true cases sensitivity was unable to be 
estimated. Although in the funnel plot for Leptorapide (Figure 3) the 
regression line has a negative slope, Deeks’ test does not indicate funnel 
plot asymmetry (p = 0.12). In the funnel plot for the Patoc antigen lateral 
flow assay (Figure 4) the regression line has a near vertical slope and 
Deeks’ test does not indicate funnel plot asymmetry (p = 0.12). For studies 
evaluating Leptorapide the I2= 99% indicating that almost all heterogeneity 
in estimated sensitivity and specificity was due to study design rather than 
chance. For studies evaluating the Patoc antigen lateral flow assay I2 
=45% indicating that a moderate amount of the heterogeneity in estimated 
sensitivity and specificity was due to study design. 
 
Table 10.5 Extracted data from studies evaluating sensitivity and 
specificity of Leptorapide published prior to 4 July 2017  








Brownlow T 1 (37) 25 1 2 27 
Brownlow T 2 (37) 9 0 5 38 
Brownlow T 3 (37) 78 21 11 110 
Brownlow T 4 (37) 55 11 20 37 
Brownlow T 5 (37) 122 50 87 279 
Brownlow T 6 (37) 0 0 4 92 





Table 10.6 Extracted data from studies evaluating sensitivity and specificity of Patoc antigen lateral flow assays 
published prior to 4 July 2017 




True positive False positive True negative False negative Sensitivity  Specificity  
N (%) N (%) N (%) N (%) (95% CI) (95% CI) 
Smits 1 (12) KIT 116 (27.8) 28 (6.7) 255 (61.0) 19 (4.5) 0.86 (0.79-091) 0.90 (0.86-0.93) 
Smits 2 (12) KIT 39 (43.3) 6 (6.7) 41 (45.6) 4 (4.4) 0.91 (0.78-0.97) 0.87 (0.74-0.94) 
Eapen (17) Organon 54 (27.6) 6 (3.1) 131 (66.8) 5 (2.6) 0.90 (0.80-0.95) 0.96 (0.92-0.99) 
Sehgal (13) KIT 37 (31.6) 3 (2.6) 44 (37.6) 33 (28.2) 0.53 (0.54-0.82) 0.94 (0.82-0.98) 
Kannan (10) Zephyr 28 (36.8) 11 (14.5) 25 (32.9) 12 (15.8) 0.70 (0.42-0.69) 0.69 (0.53-0.82) 
Limmathurotsakul (21) KIT 120 (32.3) 69 (18.6) 165 (44.5) 17 (4.6) 0.88 (0.81-0.92) 0.71 (0.64-0.76) 
Goris 1 (14) BioMérieux 74 (5.3) 57 (4.1) 1235 (88.2) 34 (2.4) 0.69 (0.59-0.77) 0.96 (0.94-0.97) 
Goris 2 (14) Zephyr 100 (3.7) 56 (2.0) 2495 (91.3) 83 (3.0) 0.55 (0.47-0.62) 0.98 (0.97-0.98) 
Eugene (18) Zephyr 34 (40.5) 12 (14.3) 32 (38.1) 6 (7.1) 0.85 (0.70-0.93) 0.73 (0.58-0.84) 
Niloofa (15) Zephyr 286 (32.2) 121 (13.6) 405 (45.6) 76 (8.6) 0.79 (0.75-0.83) 0.77 (0.73-0.80) 
Podgorsek (16) Zephyr 29 (4.9) 7 (1.2) 547 (92.7) 7 (1.2) 0.81 (0.65-0.90) 0.99 (0.97-0.99) 
 
Footnote: Numbers refer to different datasets from within the same paper 
Assay manufacturers: KIT: Royal Dutch Tropical Institute, Amsterdam, Netherlands; Organon, Oss, Netherlands; Zephyr 
Diagnostics, Goa, India; BioMérieux, Marcy-l'Étoile, France 
Abbreviation: CI – confidence intervals 
 493 
Table 10.7 Random effects bivariate meta-analysis of the diagnostic 
accuracy of leptospirosis point-of-care tests from studies published 
until 4 July 2017  
Assay Sensitivity (%) Specificity (%) 
 Estimate (95% CI) Estimate (95% CI) 
Patoc antigen lateral flow assay 79  (70-86) 92  (85-96) 
Leptorapide 84  (70-92) 85  (74-92) 
Abbreviations: 95% CI = 95% confidence intervals
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Key: The squares indicate the point estimate of sensitivity or specificity 
from each study, and the line indicates the 95% confidence intervals. The 
vertical dotted line indicates the point meta-estimate of sensitivity or 
specificity, and the diamond indicates the 95% confidence intervals 
 






Key: The squares indicate the point estimate of sensitivity or specificity 
from each study, and the line indicates the 95% confidence intervals. The 
vertical dotted line indicates the point meta-estimate of sensitivity or 
specificity, and the diamond indicates the 95% confidence intervals 
Figure 10.2 Forest plot of sensitivity and specificity of Patoc antigen 





Key:  1/root(ESS) indicates the inverse root of the effective sample size 
Figure 10.3 Deeks’ funnel plot asymmetry test for studies evaluating 




Key:  1/root(ESS) indicates the inverse root of the effective sample size 
Figure 10.4 Deeks’ funnel plot asymmetry test for studies evaluating 
Patoc antigen lateral flow assay for leptospirosis 
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10.4 DISCUSSION 
We systematically collated published literature on the accuracy of Patoc 
antigen lateral flow point-of-care tests and the accuracy of the Leptorapide 
card agglutination test. We identified that most evaluations were at risk of 
bias. Of the studies included in our analysis, there was substantial 
heterogeneity in estimated sensitivity and specificity. Much of this 
heterogeneity related to variations in study design. Within these limitations, 
we estimated the sensitivity and specificity of the Patoc antigen lateral flow 
assay to be 79% (CI 70-86%) and 92% (CI 85-96%) respectively.  
We estimated the sensitivity and specificity of Leptorapide card agglutination 
test as 84% (CI 70-92%) and 85% (CI 74-92%).  
 
10.4.1 Study quality 
Only one study achieved Grade 1 (low risk of bias) scores for all domains. 
There were few studies that employed a cross-sectional design. Outside of 
epidemics, leptospirosis has a relatively low prevalence among patients with 
febrile illness in most countries due to the large number of other conditions 
that cause fever (42, 43). Cross-sectional studies therefore require large 
numbers of participants in order to accrue sufficient cases of leptospirosis. 
Case-control studies have the advantage of reducing the number of 
participants required, but risk inflating estimates of sensitivity and specificity 
(20).  Few studies used a case definition of leptospirosis that was consistent 
with those of the World Health Organisation or the US Centers for Disease 
Control and Prevention. Use of a single leptospirosis MAT titre ≥40, or solely 
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on a positive IgM ELISA result are likely to be major causes of bias. Although 
the use of an unvalidated, non-standardised definition hampers interpretation 
of published estimates of point-of-care test accuracy, the published reference 
standards, using Leptospira microscopic agglutination testing, PCR, and 
culture have imperfect accuracy and are logistically challenging (8, 12, 44). 
 
10.4.2 Estimates of point-of-care test accuracy 
In performing this systematic review and meta-analysis of evaluations of 
point-of-care tests of the Patoc antigen lateral flow assay and the Leptorapide 
assay, we did not find evidence of publication bias. However, within the data 
are large variations in estimated accuracy. These variations may relate to 
variations in performance between countries, but the I2 statistic and the high 
number of studies at risk of bias suggest it is at least as likely that factors 
relating to study design account for the variation in apparent diagnostic 
accuracy.  The calculated estimates of sensitivity and specificity must 
therefore be interpreted cautiously, as they may well over-estimate the 
accuracy of the point-of-care tests when used in the clinical setting. 
 
10.4.3 Limitations 
Our meta-analysis has several important limitations. We may have missed 
studies that were published in journals not indexed by PubMed or Scopus, 
and studies that were not published. Combining all studies into a single 
estimate of sensitivity and specificity may be misleading as there was 
substantial variation in both study design and in the populations from which 
participants were drawn. Although there was a large degree of heterogeneity 
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observed due to study design, this does not invalidate our results, as the 
mixed effects bivariate model we used assumed heterogeneity (23). Perhaps 
the most critical limitation is that our meta-analysis considered the reference 
standard to have 100% sensitivity and specificity. Leptospira microscopic 
agglutination testing is often considered the reference serologic test, but even 
under optimum conditions, using paired acute and convalescent serum 
samples it has a sensitivity and specificity less than 100% (8). The case 
definitions used in most studies included in our meta-analysis used less 
robust reference standards for which the sensitivity and specificity have not 
been adequately determined. In the context of imperfect reference standards, 
other authors have used latent class analyses (discussed in detail in Chapter 
11) to estimate sensitivity and specificity (8). This was not possible in our 
meta-analysis as most studies did not include a sufficient number of 
diagnostic assays, and there was too much variation in chosen reference 
standards.   
 
10.4.4 Implications for practice 
The estimated sensitivity and specificity of Leptorapide and the Patoc antigen 
lateral flow assay are encouraging for clinical use. However, the small number 
of studies, the high risk of bias in many of the included studies, and the 
evidence that much of the heterogeneity of results is due to study design 
factors rather than chance suggests that additional research may alter the 
findings of subsequent meta-analyses. In addition, the prevalence of 
leptospirosis among the population must be considered when assessing the 
utility of diagnostic tests in practice.  Among patients with fever in northern 
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Tanzania where the prevalence of leptospirosis approximates 10%, each 
point-of-care test would detect the majority of cases and have high negative 
predictive values. For example, Patoc antigen lateral flow assay, the negative 
predictive value would be 97.6%, with 2.4% of leptospirosis cases missed. 
However, only 45.9% of those who tested positive on the Patoc antigen lateral 
flow assay would truly have leptospirosis. The negative and positive predictive 
values suggest that either Leptorapide or the Patoc antigen lateral flow assay 
may be suitable as a screening test for leptospirosis. The high negative 
predictive values indicate that if either point-of-care test was used by 
clinicians in northern Tanzania, most leptospirosis cases would be diagnosed. 
Given that in the two studies in Moshi no patients were diagnosed in real-time 
with leptospirosis, this would be a substantial improvement. However, the 
positive predictive value of 45.9%, suggests that confirmatory testing would 
be needed for reliable diagnosis. It would seem inadvisable to encourage 
clinicians to use the point-of-care tests assays without confirmatory testing, as 
the large proportion of false positive leptospirosis point-of-care test results 
may lead to misdiagnosis of other conditions that require specific treatment.   
 
10.4.5 Implications for research 
Further work is needed to determine adequately the sensitivity and specificity 
of the Leptorapide slide agglutination assay, and the Patoc antigen lateral flow 
assay. Future studies should employ a robust reference standard with 
optimised sensitivity and specificity. Analytic techniques that account for an 
imperfect reference standard should also be considered. The other aspect of 
study design that we identified as requiring close attention in future studies is 
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the inclusion of participants that truly represent the populations among whom 
the tests will be used in clinical practice. 
 
10.4.6 Conclusions 
The evidence base for determining the sensitivity and specificity of 
Leptorapide, and the Patoc antigen lateral flow assay is small, and most 
published studies are at moderate or high risk of bias. We expect that further 
well-conducted studies may alter these estimates of diagnostic accuracy.  
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Chapter 11. Evaluation of the 
sensitivity and specificity of 
three commercially available 
leptospirosis point-of-care tests 
to diagnose human acute 
leptospirosis among patients 
with fever in northern Tanzania 
11.1 INTRODUCTION 
11.1.1 Statement of the problem 
In studies from our site in Moshi, northern Tanzania, 94 participants enrolled 
in two studies were diagnosed with leptospirosis retrospectively through 
microscopic agglutination testing (MAT), but none was diagnosed in real-time 
by clinicians (1, 2).  Although there may be several reasons for leptospirosis 
misdiagnosis by clinicians (3), lack of accessible and affordable diagnostic 
tests that have been validated in a local context is a major barrier to clinical 
diagnosis (4). As discussed in Chapter 10, serologic assays that detect 
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patient anti-Leptospira immunoglobulin (Ig) M are the most promising 
diagnostic tests for lower level health facilities in most parts of Africa, but their 
accuracy among patients with febrile illness in Africa has not been 
determined. As such further work is needed to determine the accuracy of anti-
Leptospira IgM assays. 
11.1.2 Evaluation of leptospirosis point-of-care tests 
When planning evaluations of anti-Leptospira IgM point-of-care tests 
that are most relevant to patient care, critical factors that may affect test 
accuracy are: study design, inclusion criteria for participants such that 
they best reflect the patient population in which the test will be used, the 
ecology of Leptospira in the study area, and management of the 
imperfect reference standard Leptospira case definitions. These issues 
are discussed below. 
 
11.1.2.1 Effect of study design on estimates of leptospirosis test accuracy 
Whether the study has a cross-sectional or case-control (sometimes called 
‘two-gate’) design influences estimates of sensitivity and specificity. The ability 
of diagnostic assays to differentiate leptospirosis from another febrile illness, 
may be different from the assays ability to differentiate leptospirosis from a 
healthy state. Therefore case-control designs where controls are healthy or 
have differences from cases other than absence of the disease of interest can 
inflate estimates of sensitivity and specificity (5, 6). Although obtaining 
adequate power is challenging for cross-sectional studies of uncommon 
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diseases, cross-sectional studies provide the least biased estimates of test 
accuracy (7, 8). 
 
11.1.2.2 Participant factors that can influence leptospirosis test accuracy 
Factors such as duration of illness, and its severity can influence test 
performance. The duration of illness is an important consideration because 
the immune response lags several days behind the onset of symptoms. IgM is 
not detectable until 4-5 days after the onset of illness, although it is produced 
earlier than IgG and agglutinating antibodies (9). Hence, evaluations 
performed among patients who are early in their illness will report lower 
sensitivity than those performed in patients who are beyond the first week of 
illness. For example, Goris and colleagues demonstrated sensitivity for 
multiple IgM based assays that increased from days 0-4 to days 5-10 and 
again through days 11-20 (10).  Similarly, a lateral flow assay detecting anti-
Leptospira IgM has been evaluated in the Andaman Islands, where it had a 
sensitivity of 52.9% during the first week of illness, and 86.0% during the 
second through fourth weeks of illness (11). The corresponding specificity 
was 93.6% during the first week and 89.4% from the second through fourth 
weeks (11). Severity of illness can also influence test accuracy, with lower 




11.1.2.3 The influence of Leptospira ecology and epidemiology on diagnostic 
test accuracy 
Variation in infecting serovars, background exposure to leptospirosis, and 
other non-leptospirosis illnesses may also influence test performance 
between study sites. The effect of the local epidemiology of infecting 
leptospirosis serovars on test accuracy is illustrated by a study of a dual-
pathway platform lateral flow assay based on recombinant Leptospira 
immunoglobulin like (lig) proteins found within only pathogenic Leptospira that 
was done on samples from participants from two areas of Brazil.  The assay 
showed high sensitivity among patients from an urban slum in Salvador, 
Brazil, where >90% of cases were caused by a serovar from Leptospira 
serogroup Icterohaemorrhagiae but lower sensitivity in patients recruited from 
Recife, Brazil, where the infecting serovar was less often from Leptospira 
serogroup Icterohaemorrhagiae (12). Prior exposure to Leptospira in patients 
who do not have acute leptospirosis can also influence test performance 
through persistent or cross-reacting antibodies (9, 13). Finally, infectious 
diseases other than leptospirosis can stimulate Leptospira antibody 
responses causing false-positive results (14-16). If such infections are locally 
prevalent they may affect estimates of test accuracy. These factors dictate 
that evaluations of diagnostic assays are generalisable only to settings with 
infections caused by a similar pattern Leptospira serogroups, similar levels of 
Leptospira seropositivity, and similar prevalence of cross-reacting infections. 
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11.1.2.4 Use of Leptospira MAT as a reference standard against which to 
evaluate IgM point-of-care tests 
In situations where there is a reference standard test that always classifies 
disease state correctly, the sensitivity and specificity of novel tests can be 
calculated using a contingency table. Using such a  table, the calculations to 





 Acute leptospirosis Not leptospirosis 
Point-of-care test + a b 
Point-of-care-test - c d 
Sensitivity = a/(a+c) x 100% 
Specificity = d/(b+d) x 100% 
Positive predictive value = a/(a+b) x 100% 
Negative predictive value = d/(c+d) x 100% 
Figure 11.1 Contingency table used for calculation of test performance 
 
As discussed in Chapter 10, all diagnostic tests for leptospirosis are imperfect. 
MAT is considered to be the reference standard but an imperfect reference 
standard. The best estimate of sensitivity and specificity of MAT is that by 
Goris and colleagues using a case-control design including culture positive 
leptospirosis cases, healthy controls, controls with infections other than 
leptospirosis, and controls with an unknown disease. They used a positive 
culture, which is considered 100% specific, to define cases allowing a 
determination of MAT sensitivity. Key limitations of their study include 
potential misclassification of controls, and a two-gate case control design with 
controls that did not represent the population among whom the test is used in 
clinical practice (5). Therefore, the estimate may not be reliable among 
undifferentiated patients with febrile illness. Despite the limitations, the study 
is consistent with the widely held view that MAT is imperfect, and details in 
which ways the test accuracy can be optimised. In the same study, Goris and 
colleagues identified that paired samples with at least 10 days between acute 
and convalescent samples had the highest sensitivity, with values of 90.0% 
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and 87.7% for 10-19 and ≥20 days respectively. By comparison, the 
sensitivity of detecting culture positive leptospirosis by defining a case as an 
individual with a high titre from a single sample was low, at 6.3% within the 
first 10 days of illness. The specificity of defining leptospirosis as ≥4-fold rise 
in MAT antibody titre between acute and convalescent serum samples is 
considered to approximate 100% (17, 18). Defining leptospirosis as a single 
high (≥400 or ≥800) titre is less specific where leptospirosis is endemic 
because Leptospira antibodies can persist in serum for several years (19). 
 
In situations where the reference standard is imperfect, conventional methods 
of measuring sensitivity and specificity can underestimate the performance of 
the assays under evaluation (20). Researchers have attempted to overcome 
the lack of a single imperfect reference standard test by assigning a diagnosis 
of the true disease state through multiple tests, either by using a composite 
reference standard or by using discrepancy analysis. Composite reference 
standard approaches use a fixed transparent rule to determine disease status. 
During evaluations of leptospirosis assays researchers have used composite 
reference standards, defining cases as all participant defined as a case by 
MAT, PCR or culture.  However, composite reference standards can lead to 
simplistic classifications that ignore uncertainty in classification (21). With 
regards to leptospirosis, use of a single high MAT antibody titre is imperfectly 
specific when leptospirosis is endemic (19). Even when combined, PCR and 
culture are likely to have low sensitivity. In our study Leptospira culture had 
been universally negative (discussed in Chapter 3), and Leptospira PCR 
using the LipL32 gene was positive in only three (12.5%) of 24 cases 
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(discussed in Chapter 9) (22). Ignoring uncertainty, and the resultant 
misclassifications can lead to under-estimation of test accuracy. Discrepancy 
analysis involves subjecting specimens with discrepant results from two 
assays to a third ‘deciding’ assay. This approach is considered to provide 
biased assessments of test performance and is not recommended (23). 
Therefore, use of more than one of the currently available tests will not create 
a perfect reference standard for the diagnosis of leptospirosis. However, by 
limiting participation in a study evaluating novel diagnostic tests to those who 
provide paired serum samples at least 10 days apart, and by excluding 
participants who do not seroconvert but have a single high antibody titre, the 
sensitivity and specificity of MAT would be optimised. Such optimisation 
mitigates the problems of using a contingency table with MAT as a reference 
standard and limits under-estimation of accuracy of diagnostic tests being 
evaluated.  
 
11.1.2.5 Use of latent class analysis to evaluate diagnostic tests against an 
imperfect reference standard 
Because of the flaws of combined reference standards and discrepancy 
analysis, latent class analysis (LCA) is used increasingly to overcome the 
challenges of imperfect reference standards when assessing diagnostic 
assays (18, 24-28). LCA is a statistical method for identifying unobserved 
groups from multivariate categorical data. When used to assess diagnostic 
tests, LCA assumes that the true disease state is ‘latent’ or not observable, 
but that the available diagnostic methods are able to assess the disease state 
to some degree. Although LCA can evaluate models of any number of latent 
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classes (29), in diagnostic test evaluations there are usually assumed to be 
two states: ‘diseased’ and ‘not diseased.’ Another assumption is that of 
conditional independence, where the probabilities of events are independent 
within each latent state. When using LCA to evaluate the accuracy of 
diagnostic tests, conditional independence means that results of the 
diagnostic test are independent from each other within each latent 
(unobserved) disease state. LCA estimates disease prevalence, as well as 
sensitivity and specificity of each of the diagnostic assays. For LCA to identify 
a suitable model there should be fewer latent classes than diagnostic test 
patterns. Under frequentist inferences, if a model cannot be identified, one 
solution is to impose constraints on the parameters, such as fixing the 
sensitivity or specificity of one of the tests. As the sensitivity and specificity of 
the tests are often not known, Bayesian inference can be used to constrain 
the parameters, but still allow incorporation of the uncertainty of the existing 
scientific information through the use of probability distributions. A prior 
probability distribution is the probability distribution describing our belief about 
the test accuracy before the current data are examined. Frequentist and 
Bayesian analyses of latent class models give similar results without input of 
prior probability distributions (30).  
 
Published articles caution that the assumptions used for LCA must be 
considered carefully (31, 32). The assumption that the tests are conditionally 
independent can be difficult to assess if there are few (<10) diagnostic tests 
under investigation (32). Although conditional dependence can be specified 
through random-effects extensions to Bayesian LCA, if dependence 
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structures are misspecified, estimates of test accuracy will be biased (32). As 
stated earlier, the number of latent classes cannot exceed the number of 
unique diagnostic test patterns (24). In practical terms, this means that if the 
diagnostic accuracy characteristics for every test are unknown and therefore 
not fixed, at least five assays must be evaluated in order to detect greater 
than two states. In addition, how we interpret each identified state is critical to 
interpretation of the estimated test accuracy. When LCA is used for the 
evaluation of diagnostic tests, it is commonly assumed that there are two 
states representing those ‘diseased’ by the disease of interest and those ‘not 
diseased.’  Whether this assumption is valid, how dependent the results of 
LCA are on the correct specification of latent class number and whether this 
assumption should be critically considered in each evaluation has not been 
investigated. We hypothesise that misspecification of the number of latent 
classes, or misinterpretation of the biologic meaning of the class structure will 
have profound effects on the estimates of diagnostic tests accuracy.  
 
Limmathurotsakul and others performed a meta-analysis of primary data from 
previous leptospirosis diagnostic assay evaluations (18), using Bayesian LCA 
to estimate sensitivity and specificity of MAT, PCR, and IgM antibody assays. 
In their model, they used uninformative priors, except that the specificity of 
culture was fixed at 100%.  They estimated the sensitivity of MAT as 70.4% 
and the specificity as 98.8% (17, 18). In the analysis by Limmathurotsakul, as 
in subsequent leptospirosis diagnostic assay evaluations, it is assumed that 
there are two latent states and that these states are ‘acute leptospirosis,’ and 
‘not leptospirosis’. Limmathurotsakul and colleagues, and subsequent 
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publications by other authors have successfully fitted their data to a latent 
class model with two latent states and interpreted the states as ‘leptospirosis’ 
and ‘not leptospirosis’. While rarely considered, it is plausible that in data from 
leptospirosis diagnostic assays, the two latent states do not equate to 
‘leptospirosis and ‘not leptospirosis’ or that there are more than two latent 
states (5). For example, we can conceive that if the leptospirosis IgM assays 
non-specifically detected IgM, the two latent states may be more appropriately 
labelled ‘IgM response’ and ‘No IgM response’. We could also plausibly 
conceive the presence of three latent states that might be labelled, 
‘leptospirosis,’ ‘not leptospirosis and without a Leptospira IgM response,’ and 
‘a disease state other than leptospirosis, but with an IgM response similar to 
that seen in leptospirosis.’ The third state could plausibly occur in patients 
infected with another pathogen who have previously had leptospirosis and 
mount a non-specific IgM response or among patients infected with organisms 
such as other spirochaetes or gram-negative bacteria (33) with similar outer-
membrane protein antigens. Determining the appropriateness of the labels 
given to latent classes is challenging. One way to explore accurate 
categorisation of classes is to run simulation models to see if a two-class 
latent class model will fit a system in which we have specified a different 
number of true states. Goodness-of-fit tests evaluate how well the observed 
data fits the model. In a simulation we would be interested to know whether 
the latent class models, when well fitted, will correctly estimate the sensitivity 
and specificity that we have set for the tests within the simulation. If we 
consider that LCA may be the best statistical method for evaluating novel 
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diagnostics when the reference standard is imperfect, it is important that the 
assumptions we make in such an analysis are tested. 
 
11.1.3 Study aims and objectives 
We aimed to perform an evaluation of three commercially available point-of-
care tests for leptospirosis against an imperfect reference standard, MAT, in 
an unselected cohort of patients presenting with a febrile illness to two referral 
hospitals in northern Tanzania, in order to determine the accuracy of the 
point-of-care tests. The three point-of-care tests are Leptocheck WB lateral 
flow assay, Leptorapide latex card agglutination test, and Test-It Leptospira 
lateral flow assay 
 
Our specific objectives were: 
1. To compare estimates of the sensitivity and specificity of the point-of 
care tests obtained using a contingency table analysis and a two class 
LCA model. 
2. To investigate the effect on estimates of diagnostic test accuracy of 
misspecification of the number of classes within an LCA, and the ability 
of goodness-of-fit testing to identify such misspecification.  
11.2 METHODS 
We adhered to the Standards for the Reporting of Diagnostic Accuracy 
Testing (STARD) during this study, and the STARD checklist is included as 
Appendix F (34). Study funders were not involved in study design. We 
evaluated, among patients acutely unwell with a febrile illness, the 
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performance of three rapid point-of-care diagnostic tests in acute phase 
serum against MAT serology in paired serum samples. 
 
11.2.1 Study population 
Participants were enrolled from August 2007 through September 2008 and 
from February 2012 through May 2014 as part of febrile illness surveillance 
studies at Kilimanjaro Christian Medical Centre (KCMC) and Mawenzi 
Regional Referral Hospital (MRRH) in Moshi, Tanzania 
 
We enrolled adults, defined as age >13 years, and children aged 2 months to 
13 years. During 2007-08 adults were eligible for enrolment if they had been 
admitted to the adult medicine ward and had a fever, defined in this group as 
an oral temperature of ≥38.0°C. Infants and children were eligible for 
enrolment if they were admitted to the KCMC paediatric ward and they had a 
history of fever in the past 48 hours, an axillary temperature of ≥37.5°C or a 
rectal temperature of ≥38.0°C.  
 
From February 2012 through May 2014 we enrolled adults and children 
presenting to KCMC and MRRH. From Monday through Friday, we screened 
all patients in the adult medical ward at KCMC and the paediatric and adult 
medical wards at MRRH within 24 hours of admission, as well as patients 
presenting to the outpatient department at MRRH. We enrolled consecutive 
eligible inpatients and every second eligible outpatient. Patients were eligible 
to participate if they had an axillary temperature of >37.5°C or, a tympanic, 
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oral, or rectal temperature of ≥38.0°C at presentation. Inpatients were also 
eligible if they reported a history of fever within the past 72 hours.   
 
11.2.2 Sample size calculation 
We estimated sample size using the method of Flahault et al (35). Assuming 
85% sensitivity, with an acceptable lower confidence interval of 75% and a 
prevalence of leptospirosis of 5%, we would need 176 cases and 3,344 
controls to be sufficient to assess point-of-care test accuracy. Participants in 
our study had already undergone testing for other diseases, and many did not 
have serum samples available. As we had fewer participants with suitable 
samples than determined by our sample size calculation, we utilised samples 
from every available participant.   
 
11.2.3 Sample acquisition and storage 
We took blood samples for serum archiving on the day of enrolment in a 
single blood draw and requested that participants return 4-6 weeks later to 
provide a convalescent serum sample. In our evaluation, we included only 
those participants who provided both acute and convalescent serum samples 
and had serum available after performing reference tests for all the diseases 
of interest including brucellosis, leptospirosis, Q fever, and rickettsioses. 




Trained clinical officers obtained clinical and demographic data by 
administering a standardised questionnaire to participants on the day of 
enrolment.   
 
11.2.4 Personnel conducting the evaluation 
Qualified laboratory scientists from the Bacterial Special Pathogens Branch of 
the US Centers for Disease Control and Prevention (CDC) performed 
leptospirosis MAT, brucellosis MAT, Q-fever indirect IgG immunofluorescence 
antibody testing (IFA), typhus group rickettsiosis (TGR) IFA and spotted fever 
group rickettsioses (SFGR) IFA. Blood culture and parasite microscopy was 
performed by trained laboratory scientists at the Kilimanjaro Clinical Research 
Institute Biotechnology Laboratory. I performed the point-of-care assays in 
conjunction with trained laboratory scientists (Mr I. Afwamba, Certificate in 
Medical Laboratory Science, Assistant Laboratory Technician; Ms R. Ossio, 
Bachelor of Science, Laboratory Scientist; and Mr R. Swai, Bachelor of 
Laboratory Science, Laboratory Scientist) from the Kilimanjaro Clinical 
Research Institute Biotechnology Laboratory, according to package insert 
instructions. All personnel who performed the point-of-care assays were 
trained on assay technique by Mr P. Sakasaka, Master in Science, Senior 
Laboratory Scientist and Laboratory Manager. Personnel who performed the 
point-of-care assays were blinded to the results of MAT. 
 
 525 
11.2.5 Laboratory methods 
11.2.5.1 Microagglutination testing  
This was performed using the standard microscopic agglutination test (MAT) 
with a panel of 20 Leptospira serovars belonging to 17 serogroups. These 
included serogroups: Australis (represented by L. interrogans serovar 
Australis, L. interrogans serovar Bratislava), Autumnalis (L. interrogans 
serovar Autumnalis), Ballum (L. borgpetersenii serovar Ballum), Bataviae (L. 
interrogans serovar Bataviae), Canicola (L. interrogans serovar Canicola), 
Celledoni (L. weili serovar Celledoni), Cynopteri (L. kirschneri serovar 
Cynopteri), Djasiman (L. interrogans serovar Djasiman), Grippotyphosa (L. 
interrogans serovar Grippotyphosa), Hebdomadis (L. santarosai serovar 
Borincana), Icterohaemorrhagiae (L. interrogans serovar Mankarso, L. 
interrogans Icterohaemorrhagiae), Javanica (L. borgpetersenii serovar 
Javanica), Mini (L. santarosai serovar Georgia), Pomona (L. interrogans 
serovar Pomona), Pyrogenes (L. interrogans serovar Pyrogenes, L. 
santarosai serovar Alexi), Sejroe (L. interrogans serovar Wolffi), and 
Tarassovi (L. borgpetersenii serovar Tarassovi).  MAT was performed 
beginning at a dilution of 1:100, with subsequent two-fold dilutions.  
 
We defined a positive MAT result as a participant with a four-fold rise in 
agglutinating antibody titres between acute and convalescent serum (36). We 
did not consider high single antibody MAT titres to be sufficiently specific of an 
evaluation of novel diagnostic tests, as MAT detects both IgM and IgG a 
single high titre can last several years and might therefore be present in an 
individual who does not have acute leptospirosis at the time of enrolment in 
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our study (19, 37). Therefore, we excluded participants who had by a single 
reciprocal titre ≥800 (36). The predominant reactive serogroup for cases and 
seropositive participants was defined as the serogroup containing the serovar 
with the highest titre. 
 
11.2.5.2 Point-of-care test product handling 
Leptorapide (all Lot #:030516-01, expiry date November 2017), Leptocheck 
WB tests kits (all Lot #:51123, expiry date February 2018), and Test-It 
Leptospirosis (all Lot #:42013, expiry date September 2018) were airfreighted 
direct from the manufacturer in conditions that complied with the  
manufacturers’ instructions. All were stored in a climate-controlled storage 
facility, with Leptocheck WB and Test-It Leptospirosis kept at 18°C, and 
Leptorapide kept at 4°C. 
 
11.2.5.3 Leptocheck WB 
We performed the Leptocheck-WB (Zephyr Biomedicals, Goa, India) 
according to the manufacturer’s instructions. Briefly, 10μL of serum was 
transferred using a micropipette to sample port ‘A.’ Immediately, 5 drops of 
sample buffer were dispensed into buffer port ‘B.’ We read the test after 15 
minutes. We read a single coloured band in the control window as negative, 
an additional red-deep purple band in the test window as positive, and a 




11.2.5.4 Leptorapide  
We performed the Leptorapide (Linnodee Ltd., Doagh, Northern Ireland) 
assay according to the manufacturer’s instructions.  Briefly, we deposited 5μL 
of latex beads in each circle of the agglutination card followed by 5μL of 
participant serum. A positive control was used for each agglutination card.  
We then rocked the card for 2-3 minutes, then interpreted the result, giving a 
score of 1 to 5 using the score diagram on the package insert. A score of ≥3 
was considered positive. The test was considered invalid if the positive control 
did not cause agglutination.   
 
11.2.5.5 Test-It Leptospira IgM Lateral Flow Assay  
We performed the Test-It Leptospira IgM Lateral Flow Assay (Lifeassay 
Diagnostics (Pty) Ltd. Cape Town, South Africa) according to the 
manufacturer’s instructions. Briefly, we pipetted 5μL of participant serum into 
the sample port on the cassette. We immediately added 3 drops of running 
fluid to the sample port. We read the result after 15 minutes. The presence of 
a line at the test zone and a line at the control zone was read as positive and 
graded as 1+ to 4+ according to the intensity of the test band in keeping with 
the diagram included in the package insert. We interpreted the result as 
negative if there was a line in the control zone but no line in the test zone.  




11.2.5.6 Laboratory testing for infections other than leptospirosis 
Bacteraemia: Following cleansing of the skin with isopropyl alcohol and 
povidone iodine, blood was drawn for aerobic blood culture. Blood was 
inoculated directly into BacT/Alert blood culture bottles. Blood culture bottles 
were assessed for volume adequacy by comparing the weight before and 
after inoculation with blood. For paediatric participants, adequate volume was 
defined as 4ml ± 20%, and for adult participants adequate volume was 
defined as 5ml ± 20%. BacT/ALERT standard aerobic bottles were loaded into 
the BacT/ALERT 3D Microbial Detection system (BioMérieux, Marcy l’Etoile, 
France), where they were incubated for 5 days. Organisms were identified 
using standard techniques.  
Brucellosis: Brucellosis was diagnosed using the standard microagglutination 
test (MAT). Standardized Brucella abortus strain 1119-3 killed antigen 
(National Veterinary Services Laboratory, Ames, IA, USA) was used for MAT 
at a 1:25 working dilution. Results were read on a Scienceware Plate Reader 
(Bel-Art Products, Wayne, NJ, USA). Minor modifications were made to the 
CDC standard MAT, including the use of U-bottom plates, incubation at 26°C, 
and discontinued use of staining techniques. A case of brucellosis was 
defined as a ≥4-fold rise in reciprocal agglutination titres between acute and 
convalescent serum samples. 
Malaria: Giemsa stained thick and thin blood films were examined for blood 
parasites by oil immersion microscopy. 
Rickettsiosis: Serum samples were tested for SFGR and TGR by IFA to 
Rickettsia conorii (Moroccan strain) and R. typhi (Wilmington strain) 
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respectively. A case of SFGR or TGR was defined as a ≥4-fold rise in titre in 
reciprocal titres between acute and convalescent serum samples.  
Q fever: Convalescent-phase serum samples were screened using Coxiella 
burnetii IgG enzyme-linked immunosorbent assay (ELISA) against Phase II 
antigen (Inverness Medical Innovations). For samples that were either positive 
or equivocal by ELISA, paired serum samples were tested by IFA with the C. 
burnetii (Nine Mile strain) Phase I and Phase II antigens. Cases were defined 
as having a ≥4-fold rise in titre in reciprocal titres to Phase II antigen between 
acute and convalescent serum samples. 
 
11.2.6 Precision studies 
A total of 10 samples, 5 that resulted positive and 5 that resulted negative for 
each point-of-care test were run twice during the same day, and again the 
following day to assess for result repeatability. Laboratory personnel were 
blinded as to previous results. 
11.2.7 Accuracy studies 
We performed all three point-of-care tests simultaneously on each serum 
sample. We thawed up to 20 samples in batches, then working independently 
we performed the assays. All assays would be performed within 2 hours of 
thawing. Laboratory personnel were blinded as to the result of MAT and the 




11.2.8 Statistical analysis 
Results were entered using the Cardiff Teleform system (Cardiff, Inc., Vista, 
CA, USA) into an Access database (Microsoft Corporation, Redmond, WA, 
USA). A data clerk (Mr R. Chuwa) checked the accuracy of the scanned 
data at the time of entry. I interrogated the database to ensure logical 
values for each variable and checked any missing or illogical values 
against the paper teleforms. 
 
11.2.8.1 Comparison of the study population against the complete cohort 
When comparing the evaluated cohort to the entire enrolled cohort, I analysed 
the difference in means with the student’s t-test, and proportions with a two-
sample test of proportions. Analyses were performed using Stata, version 
13.1 (StataCorp, College Station, TX, USA). 
 
11.2.8.2 Investigating assay performance using the contingency table method 
Test performance in terms of sensitivity, specificity, positive predictive value, 
and negative predictive value were calculated, as shown in Figure 11.1, with 
MAT as the reference standard. We estimated 95% exact binomial confidence 
intervals. Analyses were conducted using Stata, version 13.1 (StataCorp, 




11.2.8.3 Investigating assay performance using LCA 
I performed a Bayesian latent class analysis using a web latent class analysis 
application (http://mice.tropmedres.ac/) (38) that processed statistics using R 
version 2.11.1 (39), RtoWinBUGS application version 2.1.16, and WinBUGS 
version 1.4.3 (Cambridge, UK) (40). We used the model ‘MODEL106: 4-tests 
in 1-population Model (Advance Interface)’ to fit models. For the latent class 
model, we applied the estimated prior probabilities of sensitivity and specificity 
for the point-of-care tests to encompass the range of values identified during 
the systematic review of published reports of point-of-care test performance 
(described in detail in Chapter 10). We applied estimates of sensitivity and 
specificity of MAT from those published by Goris and colleagues (17), and 
Limmathurotsakul and colleagues (18). Application of prior probabilities 
truncated the range of values for sensitivity and specificity that our model 
could estimate. Between the limited parameters we chose a beta distribution 
that gave a broad U-shaped distribution of probabilities that was relatively 
agnostic about the true values of sensitivity and specificity from within the 
specified range. We specified a correlation between Leptocheck WB and 
Test-It Leptospira among the diseased population as both assays use similar 
antigens. The detailed specifications for each model are shown in Table 11.1. 
Convergence of Markov Chains was assessed by inspecting trace plots. 
Model fit was determined by assessing the agreement between the frequency 
with which each combination of test outcomes (hereafter called a profile) was 
observed and the frequency with which each profile was predicted using the 
posterior predictive distribution of each profile and Bayesian p-values. Due to 
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concerns about the fit of our model, which is described in the results section 
of this chapter, we also performed a LCA with uninformative priors.   
 
Table 11.1 Specifications of latent class models of leptospirosis 
diagnostic test performance among patients with fever, northern 
Tanzania, 2007-08 and 2012-14 
Specification Value 
Prior Distributions (all beta distribution (0.5,0.5)) Range 
Prevalence 0.00-1.00 
Sensitivity Test-It Leptospira 0.44-0.98 
Sensitivity Leptocheck WB 0.44-0.98 
Sensitivity Leptorapide 0.34-0.98 
Sensitivity MAT 0.70-0.99 
Specificity Test-It Leptospira 0.46-0.99 
Specificity Leptocheck WB 0.46-0.99 
Specificity Leptorapide 0.52-0.99 
Specificity MAT 0.90-0.99 
Initial Values Chain 1/ Chain 2 
Prevalence 0.9/0.3 
Sensitivity Test-It Leptospira 0.9/0.7 
Sensitivity Leptocheck WB 0.9/0.7 
Sensitivity Leptorapide 0.9/0.7 
Sensitivity MAT 0.9/0.7 
Specificity Test-It Leptospira 0.9/0.99 
Specificity Leptocheck WB 0.9/0.99 
Specificity Leptorapide 0.9/0.98 
Specificity MAT 0.9/0.99 
Settings  
Burn in iterations 5,000 
Markov Chain Monte-Carlo iterations 20,000 
Thinning rate 10 
 
11.2.9 Simulation of three state data in a two state LCA  
In order to evaluate the effect on LCA estimates of sensitivity and specificity 
from misspecification of the number of latent classes, we carried out a 
simulation study. Here I present the initial evaluation, which examined the 
effect on the estimates when we attempted to fit an LCA with two latent 
classes to a system in which we specified three latent classes. Further work is 
being carried out but is not included in this thesis. The simulations were 
carried out by Dr. Matthew R. Schofield (Department of Mathematics and 
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Statistics, University of Otago). I had input to the design and interpretation.  
We simulated data designed to mimic data acquired by the evaluation of 
actual point-of-care tests described above. We created a system with three 
true classes and set probabilities of a positive test in each state for four 
diagnostic tests. Class 1 represented ‘leptospirosis,’ Class 2 represented ‘a 
disease state other than leptospirosis, but with an IgM response similar to that 
seen in leptospirosis,’ and Class 3 represented ‘not leptospirosis with a very 
different IgM response.’ Conceptually the four diagnostic tests represented 
similar diagnostic tests to those evaluated in our real-world dataset: three 
point-of-care tests, and MAT. The probabilities of each class and test 
accuracy were specified (Table 11.2) so that each diagnostic test in our three-
state system would have a sensitivity and specificity (Table 11.3) that would 
produce a frequency of test outcome profiles similar to those that we found in 
our real-world data. The frequency of test outcome profiles for the real-world 





Table 11.2 Probability of latent classes and test positivity by latent class 
in the three-state system used in simulations 
Disease state Probability 
of state  
Probability of a positive test by state 
  POCT 1 POCT 2 POCT 3 MAT 
State 1 ‘Leptospirosis’ 0.08 0.05 0.22 0.10 0.88 
State 2 ‘Not leptospirosis but 
similar IgM’ 
0.12 0.81 0.93 0.36 0.25 
State 3 ‘Not leptospirosis and 
different IgM’ 
0.80 0.05 0.10 0.15 0.01 
 Key: POCT = Point-of-care test; MAT = Microscopic agglutination test 
 
Table 11.3 Accuracy of diagnostic tests outcomes for simulated 
datasets in a three-state system 
Test name* Sensitivity (%) Specificity (%) 
POCT1 5.0 61.1 
POCT2 22.0 44.4 
POCT3 10.0 82.2 
MAT 88.0 95.9 
Key: *Conceptually we think of these tests as three point-of-care tests, and 
microscopic agglutination testing. The values of sensitivity and specificity 
illustrate our example and are do not indicate actual tests.  
POCT = point-of-care test; MAT = microscopic agglutination test 
 
We then simulated 500 datasets of 1,000 individuals for our three-class 
system and on each occasion fitted, using frequentist modelling, a two-class 
latent class model. We included 1000 observations in our simulated dataset 
as it was a plausible number of participants in a well-conducted real-world 
evaluation of diagnostic tests and it minimised the number of profiles with zero 
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outcome counts.  For each fitted model, we assessed goodness-of-fit using 
the multinomial test and rejected the model if p<0.05. 
11.3 RESULTS 
11.3.1 Precision studies 
For Leptocheck WB and Test-It Leptospirosis, all 10 (100%) samples returned 
identical results on all three runs over two days. For Leptorapide, there was 
one minor discrepancy where one sample was interpreted as 4+ (positive) on 
the first run, and 3+ (positive) thereafter.  
 
11.3.2 Cohort 
Of 53,225 patients screened, 4,292 (8.1%) were eligible and 2,266 (53.8%) 
enrolled. Among participants 1,220 (53.8%) had paired serum samples tested 
by MAT, of whom 252 (20.7%) had an aliquot of acute serum available and 
were included in the current study.  
11.3.3 Participant characteristics 
Participant clinical characteristics, comparing those included in this study with 
the entire cohort who enrolled in both febrile illness surveillance studies are 
displayed in Table 11.4 and Table 11.5. The mean age of participants in the 
point-of-care test evaluation was greater than among the complete cohort of 
patients with febrile illness.  With only a single (0.4%) seropositive participant 
included in the point-of-care test evaluation, the prevalence of Leptospira 
seropositivity was also lower than the 432 (19.1%) seropositive participants 
among the total enrolled cohort. The highest reciprocal titre of the seropositive 
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participant was 100, against serogroup Icterohaemorrhagiae. Among those 
included in our study, those with a positive MAT result had a longer duration 
of illness than those with a negative MAT result (Table 11.6). 
 
Table 11.4 Characteristics of participants within the entire cohort of 
those enrolled with febrile illness and those included in this study, 
northern Tanzania, 2007-08 and 2012-14 
 
 
Entire Cohort (N=2266)  
 
Those with serum used 
in this study (N=252) 
 p-value 
 Mean (95% CI) or n(%)  Mean (95% CI) or n(%)   
Age, years 21.6 (20.8-22.4)  36.7 (34.9-38.4)  <0.01 
Fever duration 10.6 (9.6-11.6)  8.9 (7.2-10.6)  0.29 
Female sex  1166 (51.5)  138 (54.8)  0.32 
Jaundice 49 (2.2)  6 (2.4)  0.84 
Antibacterial drugs used 
prior during current illness 
951 (42.0)  101 (40.2)  0.58 
Leptospira seropositive but 
not meeting case definition 
432 (19.1)   1 (0.4)  <0.01 
Abbreviations: 95% CI= 95% confidence intervals 
Table 11.5 Characteristics of leptospirosis cases within the entire cohort 
of those enrolled with febrile illness and those included in this study, 
northern Tanzania, 2007-08 and 2012-14 
 
 
Entire Cohort (N=65) 
 
 
Those with serum used 
in this study (N=24) 
 
p-value 
 Mean (95% CI) or n(%)  Mean (95% CI) or n(%)   
Age, years 28.9 (23.7-34.0)  31.2 (22.9-39.5)  0.93 
Fever duration 12.5 (7.8-17.2)  11.7 (4.3-19.1)  0.96 
Female sex  31 (47.7)  9 (37.5)  0.39 
Jaundice 2 (3.1)  0  (0.0)  0.38 
Antibacterial drugs used 
prior during current illness 
31  (47.7)  9 (37.5)  
0.39 




Table 11.6 Characteristics of participants with and without a ≥4-fold rise 
in Leptospira microscopic agglutination test antibody titre included in 









 Mean (95% CI) or n(%)  Mean (95% CI)   
Age, years 31.4 (23.3-39.1)  37.2  (35.5-39.0)  0.05 
Fever ≥7 days 15 (62.5)  83 (36.4)  0.01 
Female sex  9 (37.5)  130  (57.0)  0.07 
Jaundice 0  (0.0)  6  (2.6)  0.42 
Antibacterial drugs used 
prior during current illness 
9 (37.5)  92  (40.5)  0.80 
Abbreviations: 95% CI= 95% confidence intervals 
 
11.3.4 Laboratory diagnoses 
Among those included in our evaluation of point-of-care tests, there were 24 
(9.5%) who had a positive MAT result with at least a four-fold rise in MAT 
antibody titre. Of leptospirosis cases, nine (37.5%) were predominantly 
reactive to serogroup Mini, four (16.7%) to serogroup Australis, three (12.5%) 
to serogroup Sejroe, three (12.5%) to serogroup Icterohaemorrhagiae, one 
(4.2%) to serogroup Celledoni, one (4.2%) to serogroup Djasiman, one (4.2%) 
to serogroup Grippotyphosa, one (4.2%) to serogroup Hebdomadis, and one 
(4.2%) to serogroup Pyrogenes. Among controls 18 (8.3%) participants were 
diagnosed with brucellosis, seven (3.2%) with bacteraemia (Escherichia coli 
two, Enterobacter aerogenes one, Salmonella enterica serovar Typhi one, 
Streptococcus pneumoniae one, Streptococcus pyogenes one, non-lactose 
fermenting gram negative bacillus one), five (2.3%) with falciparum malaria, 
and two (0.9%) with SFGR. One (4.2%) leptospirosis case had an additional 
diagnosis of SFGR. 
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11.3.5 Accuracy characteristics of the point-of-care tests using a 
contingency table  
The results of the point-of-care tests are shown in Table 11.7. Estimates of 
the accuracy of the point-of-care tests, that assumed MAT is a perfect 
reference standard, are shown in Table 11.8. Using this method, we 
estimated that Leptocheck WB had the highest point estimate of sensitivity 
(45.8%) and Test-It Leptospirosis had the highest specificity (87.0%). 
However, 95% confidence intervals of sensitivity and specificity overlapped for 
all tests. We did not identify variation in test performance according to 
duration of illness (Table 11.8). As shown in Table 11.9, we did not identify 
variation in test performance by predominant reactive serogroup. The 
frequency with which each leptospirosis assay yielded positive results among 
participants who were diagnosed with non-leptospirosis illnesses are shown in 
Table 11.10.   
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Table 11.7 Test results of leptospirosis point-of-care tests among 












MAT ≥4-fold rise in titre 
 
Positive Negative Total 
Positive 4 36 40 
Negative 20 192 212 
Total 24 218 252 
 













 MAT ≥4-fold rise in titre 
 Positive Negative Total 
Positive 11 41 52 
Negative 13 175 188 
Total 24 223 247 
 
















  MAT ≥4-fold rise in titre 
 Positive Negative Total 
Positive 6 17 23 
Negative 17 188 217 
Total 23 205 240 
 
Key: MAT = Leptospira micro-agglutination testing 
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Table 11.8 Estimates of accuracy of leptospirosis point-of-care tests among patients with febrile illness, northern 
Tanzania, 2007-08 and 2012-14 
 Leptorapide  Leptocheck WB  Test-It Leptospirosis 
 Estimate (95% CI)  Estimate (95% CI)  Estimate (95% CI) 
Overall         
Sensitivity (%) 16.7 (4.7 - 37.4)  45.8 (25.6 - 67.2)  26.1 (10.2 - 48.4) 
Specificity (%) 83.5 (77.9 - 88.2)  81.6 (76.9 - 86.5)  86.6 (81.4 - 90.9) 
Positive predictive value (%) 10.0 (2.8 - 23.7)  21.2 (11.1 - 34.7)  17.2 (6.6 - 33.6) 
Negative predictive value (%) 90.1 (85.1 - 93.8)  93.3 (88.9 - 96.4)  91.7 (87.1 - 95.1) 
Positive likelihood ratio  1.1 (0.4 - 2.7)  2.5 (1.5 - 4.2)  2.0 (0.9 - 4.2) 
Negative likelihood ratio  1.0 (0.8 - 1.2)  0.7 (0.5 – 1.0)  0.9 (0.7 - 1.1) 
Duration of fever <7 days            
Sensitivity (%) 30.0 (6.7 - 65.2)  30.0 (6.7 - 65.2)  20.0 (2.5 - 55.6) 
Specificity (%) 83.2 (75.9 - 89.0)  80.0 (72.3 - 86.4)  84.0 (76.5 - 89.8) 
Duration of fever ≥7 days            
Sensitivity (%) 7.1 (0.2 - 33.9)  57.1 (28.9 - 82.3)  30.8 (9.1 - 61.4) 
Specificity (%) 83.8 (73.8 - 91.1)  87.0 (77.4 - 93.6)  92.0 (83.4- 97.0) 
Abbreviations: CI= confidence intervals 
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Table 11.9 Proportion of leptospirosis cases detected by point-of-
care tests by predominant reactive serogroup of leptospirosis cases, 
northern Tanzania, 2007-08 and 2012-14 
 
 









Mini 9 1 (11.1)  5 (35.7)  3 (33.3) 
Australis 4 1 (25)  3 (42.9)  1 (25) 
Sejroe 3 1 (33.3)  1 (25)  1 (33.3) 
Icterohaemorrhagiae 3 0 (0)  1 (25)  1 (33.3) 
Djasiman 1 0 (0)  1 (50)  0 (0) 
Grippotyphosa 1 0 (0)  1 (50)  0 (0) 
Pyrogenes 1 0 (0)  0 (0)  0* N/A 
Hebdomadis 1 0 (0)  0 (0)  0 (0) 
Celledoni 1 1 (100)  1 (50)  0 (0) 
Total 24 4 (16.7)  13 (35.1)  6 (26.1) 





Table 11.10 Frequency of diagnoses other than leptospirosis among 
participants with positive results of leptospirosis tests, Tanzania, 
2007-08 and 2012-14 
 Bacteraemia Brucellosis  Malaria SFGR  No additional 
diagnosis 
 n/N (%) n/N (%) n/N (%) n/N (%) n/N (%) 
Leptocheck 1/7 (14.3) 3/18 (16.7) 0/5 (0.0) 1/3 (33.3) 43/203 (21.2) 
Test-It Leptospira 1/6 (16.6) 3/16 (18.8) 0/4 (0.0) 1/3 (33.3) 28/201 (13.9) 
Leptorapide 2/7 (28.6) 4/18 (22.2) 0/5 (0.0) 1/3 (33.3) 33/209 (15.8) 
MAT 0/7 (0.0) 0/18 (0.0) 0/5 (0.0) 1/3 (33.3) 23/209 (11.0) 
Key: SFGR= Spotted fever group rickettsiosis 
11.3.6 Test Concordance  
Diagnostic concordance is shown in Table 11.11. There were 225 
participants in whom all four diagnostic tests were performed. Only three 
participants tested positive on all three point-of-care tests and MAT. An 
additional six participants were positive on all three point-of-care tests and 
negative on MAT. There were 131 participants who tested negative on all 




Table 11.11 Frequency of concordance among diagnostic tests for 
leptospirosis among patients with febrile illness (N=225), Tanzania, 












131 9 17 11 
- MAT 
+ Leptorapide 
25 0 3 6 
+ MAT 
- Leptorapide 
12 0 4 3 
+ MAT 
+ Leptorapide 1 0 0 3 
Key: 
 
No positive tests 
 
One positive test 
 
Two positive tests 
 
Three positive tests 
 Four positive tests 
MAT= Microscopic agglutination testing 
 
 
11.3.7 Estimates of test accuracy using LCA 
The frequency with each test outcome profile occurred is shown in Table 
11.12. The estimated sensitivity, specificity, positive predictive value, and 
negative predictive value of the diagnostic assays, as well as the 
estimated prevalence of leptospirosis from the Bayesian LCA model are 
shown in Table 11.13. The histograms of the distribution of probabilities, 
are shown in Figures 11.2-11.5. The distribution of probabilities indicates 
the range of values that the sensitivity, specificity or prevalence might 
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take, and the probability that each possible value is the true value.  The 
distribution of probabilities from our LCA indicate that there is stacking of 
probabilities against the upper bound (100%) for the estimated sensitivity 
of Leptocheck WB and Test-It Leptospira. There is also stacking of 
probabilities against the specified lower bound (70.0%) for MAT. The 
Markov Chain tracing plots, which demonstrate chain convergence, are 
shown in Appendix G.  
 
Table 11.12 Frequency of diagnostic test result combinations of 
leptospirosis tests among patients with febrile illness in northern 





Leptorapide MAT Frequency (%) 
1 + + + + 3 (1.3) 
2 + + + - 6 (2.7) 
3 + + - + 3 (1.3) 
4 + + - - 11 (4.9) 
5 + - + + 0 (0.0) 
6 + - + - 0 (0.0) 
7 + - - + 0 (0.0) 
8 + - - - 9 (4.0) 
9 - + + + 0 (0.0) 
10 - + + - 3 (1.3) 
11 - + - + 4 (1.8) 
12 - + - - 17 (7.6) 
13 - - + + 1 (0.4) 
14 - - + - 25 (11.1) 
15 - - - + 12 (5.3) 





Table 11.13 Diagnostic accuracy of leptospirosis point-of-care tests 
and microscopic agglutination testing, estimated using two state 
Bayesian latent class model among patients with febrile illness in 
northern Tanzania, 2007-08 and 2012-14 
Parameters* Estimate (95% credible interval) 
Prevalence 9.3 (4.4 - 15.8) 
Test-It Leptospira  
Sensitivity 85. 3 (56.4 - 97.5) 
Specificity 93.0 (87.9 - 96.6) 
PPV 55.1 (28.3 - 77.2) 
NPV 98.5 (93.3 - 99.8) 
Leptocheck WB  
Sensitivity 93.1 (67.2 - 97.8) 
Specificity 86.5 (80.6 - 91.7) 
PPV 41.0 (20.1 - 62.3) 
NPV 99.2 (95.2 - 99.8) 
Leptorapide  
Sensitivity 45.7 (34.5 - 72.8) 
Specificity 85.8 (80.4 - 90.2) 
PPV 25.2 (12.7 - 40.8) 
NPV 94.0 (88.4 - 98.1) 
MAT  
Sensitivity 71.9 (70.1 - 80.0) 
Specificity 92.8 (90.2 - 96.2) 
PPV 51.0 (30.2 - 73.6) 
NPV 97.0 (94.6 - 98.8) 
Key: *Model specifications are included as Table 11.1 
Abbreviations: PPV= positive predictive value; NPV= negative predictive 




Figure 11.2 Histogram of the prevalence of leptospirosis among patients with febrile illness, Tanzania, 2007-08 and 
2012-14 
Footnote: Prior distributions (all beta distribution (0.5,0.5)) with the following constraints: prevalence 0.00-1.00; sensitivity Test-
It Leptospira 0.44-0.98; sensitivity Leptocheck WB 0.44-0.98; sensitivity Leptorapide 0.34-0.98; sensitivity MAT 0.70-0.99; 




Figure 11.3 Histogram and tracing plot of the sensitivity and specificity of Test-It Leptospira among patients with 
febrile illness, Tanzania, 2007-08 and 2012-14 
Footnote: Prior probability distributions (all beta distribution (0.5,0.5)) had the following constraints: prevalence 0.00-1.00; 
sensitivity Test-It Leptospira 0.44-0.98; sensitivity Leptocheck WB 0.44-0.98; sensitivity Leptorapide 0.34-0.98; sensitivity MAT 
0.70-0.99; specificity Test-It Leptospira 0.46-0.99; specificity Leptocheck WB 0.46-0.99; specificity Leptorapide 0.52-0.99; 




Figure 11.4 Histogram and tracing plot of the sensitivity and specificity of Leptocheck WB among patients with febrile 
illness, Tanzania, 2007-08 and 2012-14 
Footnote: Prior probability distributions (all beta distribution (0.5,0.5)) had the following constraints: prevalence 0.00-1.00; 
sensitivity Test-It Leptospira 0.44-0.98; sensitivity Leptocheck WB 0.44-0.98; sensitivity Leptorapide 0.34-0.98; sensitivity MAT 
0.70-0.99; specificity Test-It Leptospira 0.46-0.99; specificity Leptocheck WB 0.46-0.99; specificity Leptorapide 0.52-0.99; 
specificity MAT 0.90-0.99 
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Figure 11.5 Histogram and tracing plot of the sensitivity and specificity of Leptorapide among patients with febrile 
illness, Tanzania, 2007-08 and 2012-14 
Footnote: Prior probability distributions (all beta distribution (0.5,0.5)) had the following constraints: prevalence 0.00-1.00; 
sensitivity Test-It Leptospira 0.44-0.98; sensitivity Leptocheck WB 0.44-0.98; sensitivity Leptorapide 0.34-0.98; sensitivity MAT 
0.70-0.99; specificity Test-It Leptospira 0.46-0.99; specificity Leptocheck WB 0.46-0.99; specificity Leptorapide 0.52-0.99; 
specificity MAT 0.90-0.99 
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Figure 11.6 Histogram and tracing plot of the sensitivity of Leptospira Microscopic Agglutination Testing among 
patients with febrile illness, Tanzania, 2007-08 and 2012-14 
Footnote: Prior probability distributions (all beta distribution (0.5,0.5)) had the following constraints: prevalence 0.00-1.00; 
sensitivity Test-It Leptospira 0.44-0.98; sensitivity Leptocheck WB 0.44-0.98; sensitivity Leptorapide 0.34-0.98; sensitivity MAT 
0.70-0.99; specificity Test-It Leptospira 0.46-0.99; specificity Leptocheck WB 0.46-0.99; specificity Leptorapide 0.52-0.99; 
specificity MAT 0.90-0.99 
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11.3.8 Estimates of test accuracy using LCA with uninformative prior 
probabilities 
The LCA of our model, which incorporated prior information about the 
accuracy of the diagnostic tests, had posterior probability distributions that 
stacked against the imposed lower bound for sensitivity of MAT and 
Leptorapide, and against the natural upper bound for sensitivity of 
Leptocheck WB and Test-It Leptospira. Because of these findings we 
considered it important to assess the sensitivity of our model to removal of 
our prior probabilities. To do this, we conducted LCA of a model in which 
sensitivity and specificity were unconstrained for all tests. The estimated 
sensitivity and specificity of the unconstrained model are shown in Table 
11.14. In our unconstrained model, MAT using paired serum samples was 




Table 11.14 Diagnostic accuracy of leptospirosis point-of-care tests 
and microscopic agglutination testing, estimated using two state 
Bayesian latent class model among patients with febrile illness in 
northern Tanzania, 2007-08 and 2012-14 
Parameters Estimate (95% credible interval) 
Prevalence 12.4 (7.1 - 24.3) 
Test-It Leptospira  
Sensitivity 83.7 (45.8 - 100) 
Specificity 95.3 (91.1 - 99.1) 
PPV 70.9 (50.3 - 94.7) 
NPV 97.7 (86.0 - 100) 
Leptocheck WB  
Sensitivity 97.1 (71.8 - 100) 
Specificity 89.7 (83.6 - 99.5) 
PPV 55.9 (34.5 - 97.7) 
NPV 99.6 (92.9 - 100) 
Leptorapide  
Sensitivity 35.1 (17.8 - 57.9) 
Specificity 85.6 (80.3 - 90.1) 
PPV 26.3 (13.2 - 42.8) 
NPV 90.5 (77.7 - 95.6) 
MAT  
Sensitivity 26.1 (11.6 - 46.6) 
Specificity 92.0 (87.4 - 95.5) 
PPV 32.2 (13.0 - 58.6) 
NPV 97.0 (94.6 - 98.8) 
Abbreviations: PPV= positive predictive value; NPV= negative predictive 
value; MAT= Leptospira microscopic agglutination test 
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11.3.9 Simulation results 
With four binary diagnostic tests, there are 16 possible profiles or 
combinations of test outcomes. Table 11.14 shows the count frequency 
with which each profile occurred during a single simulation, and is included 
to facilitate comparison with the real-world data in Table 11.12. 
 
In 500 datasets simulated from our specified three-class system, the 
probability that a model of two latent classes was rejected due to 
inadequately fitting the data was 0.304. In a two-state latent class model of 
our specified system, we deliberately incorrectly assume that we have two 
states: ‘disease’ and ‘not diseased.’  We can then estimate the sensitivity 
of each of our four tests for detecting the ‘diseased’ state. The estimates 
from our simulations for each of the four tests (specified to mimic three 
point-of-care tests and MAT) are shown in Figure 11.7, which indicates 
that an adequately fitted two state LCA can produce estimates for test 
sensitivity that are markedly different from those specified in the simulated 
system. The estimated values for sensitivity, specificity, and disease 
prevalence of rejected models were similar to those from in which the 
model fitted the data adequately. We take this as evidence that more than 
one LCA may adequately fit the data. Further, a two class LCA that 
adequately fits the data may produce erroneous estimates of test 
accuracy, but this may not be apparent unless LCA with varying numbers 
of classes are explored.  
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Table 11.14 Frequency of diagnostic test result combinations from a 













but similar IgM 
Not leptospirosis 
and different IgM 
Total (%) 
1 + + + + 0 8 0 8 (0.8) 
2 + + + - 0 24 1 25 (2.5) 
3 + + - + 1 15 0 15 (1.5) 
4 + + - - 0 43 3 47 (4.7) 
5 + - + + 0 1 0 1 (0.1) 
6 + - + - 0 2 5 7 (0.7) 
7 + - - + 3 1 0 4 (0.4) 
8 + - - - 0 3 30 34 (3.4) 
9 - + + + 2 2 0 4 (0.4) 
10 - + + - 0 6 11 17 (1.7) 
11 - + - + 13 3 1 17 (1.7) 
12 - + - - 2 10 64 76 (7.6) 
13 - - + + 5 0 1 6 (0.4) 
14 - - + - 1 0 102 103 (11.1) 
15 - - - + 47 0 6 53 (5.3) 
16 - - - - 6 1 576 583 (58.3) 
Total 
   
80 120    800 1000 (100) 
Abbreviations: POCT1= point-of-care test 1; POCT2= point-of-care test 2; 






Figure 11.7 Estimated sensitivity and specificity of four diagnostic 
tests, from a two-state latent class model in 500 simulations of 1000 
observations in a three-state system 
Footnote: Sensitivity refers to the proportion of simulated participants with 
state 1 ‘leptospirosis’ who test positive with a given test, and specificity 
refers to the proportion of simulated participants without state 1 
‘leptospirosis’ who test negative.  Abbreviations: POCT= Point-of-care test; 
MAT= Leptospira microscopic agglutination test  
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11.4 DISCUSSION 
We have performed an evaluation of the diagnostic accuracy of three 
commercially available point-of-care Leptospira IgM tests. We found that 
estimates of sensitivity and specificity determined by contingency table 
and latent class analysis are markedly different. Both methods are 
dependent on assumptions and we are not confident that the assumptions 
of each method are valid.  Despite inclusion criteria for our study that we 
think will have maximised the accuracy of MAT, we expect that it remains 
an imperfect reference standard (14, 17, 18, 41, 42). Through examining 
LCA models from our real-world data and through fitting two-state LCA 
models to data simulated from a three-state system, we found evidence to 
question the validity of the widely-used assumption in LCA of diagnostic 
tests; that the latent states identified in LCA represent ‘disease ‘and ‘no 
disease’. 
 
11.4.1 Representativeness of our sample compared to those 
presenting to hospital with fever 
We intended that the participants included in our assay evaluation would 
be representative of patients presenting with a fever to hospitals in 
Tanzania. This was achieved for many important characteristics. These 
included the prevalence of leptospirosis, the prevalence of alternative 
diagnoses, and characteristics of the illness such as duration of fever, and 
presence of jaundice. We were unable to assess the severity of illness 
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among participants in our study as these data had not been collected. We 
included fewer children in our study than in the entire cohort and think this 
was due to lower blood draw volumes from paediatric participants, and all 
their serum was prioritised to reference standard laboratory tests. 
Participants in our study were different from those in the larger study in 
that there was a lower prevalence of Leptospira seropositivity. We are 
uncertain why this difference occurred.  
 
11.4.2 Differences in characteristics between those with and without 
leptospirosis 
There were significant differences in age and duration of illness between 
leptospirosis cases and those without the disease. The greater age of 
leptospirosis cases is due to the increased prevalence of leptospirosis 
among adults compared to children (discussed in Chapter 3 of this thesis). 
The reason that leptospirosis cases had a greater duration of fever is 
unknown.  
 
11.4.3 Test concordance 
A striking feature of our evaluation is the lack of concordance between 
each of the three point-of-care tests. We expected to see a high degree of 
concordance, particularly for the two whole-cell heat-treated Patoc 
Leptospira lateral flow assays. One potential reason for inconsistency may 
be inter-manufacturer antigen variation, as previous reports have identified 
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variation in antigen production between batches even from the same 
manufacturer (10). 
11.4.4 Estimates of point-of-care test accuracy using contingency 
tables 
Using contingency tables, the estimated sensitivity of all three point-of-
care tests was low, ranging from 45.8% (95% confidence intervals 25.6-
67.2%) for Leptocheck WB, to 16.7% (95% confidence intervals 4.7-
33.4%).  As MAT is an imperfect reference standard, we anticipate that we 
have underestimated the sensitivity and specificity of the point-of-care 
tests. However, our use of only patients with paired serum samples, four 
to six weeks apart, will have maximised the sensitivity of MAT and 
therefore minimised the underestimate of accuracy of the point-of-care 
tests. The 95% confidence intervals of sensitivity overlapped for each test, 
and we do not have sufficient evidence to conclusively determine that one 
particular point-of-care test has superior sensitivity than another. The 
specificity of the point-of-care tests was better, with estimated specificity 
from 82.6% (95% confidence intervals 76.9-87.5%) for Leptocheck WB, to 
87.0 (95% confidence intervals 81.6-91.2%) for Test-It Leptospira. Again 
as 95% confidence intervals for all tests overlapped, we were unable to 
determine whether one test had superior specificity than another.  
 
11.4.5 Latent class analysis of point-of-care test performance 
The estimates of sensitivity and specificity from our LCA were markedly 
different from those determined using contingency tables. The results we 
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obtained are similar to those obtained in other evaluations, showing that 
the lateral flow assays have high sensitivity and specificity (14, 18, 27, 43).  
Our model also estimated that both Leptocheck and Test-It Leptospira 
performed on acute serum had higher sensitivity and similar specificity to 
MAT performed on paired serum samples. 
 
However, we think that our results should be interpreted cautiously. The 
posterior probability histograms (Figures 11.2-11.6) show a stacking of 
probabilities against the imposed lower boundary (MAT and Leptorapide), 
and the natural upper boundary (Leptocheck WB and Test-It Leptorapide) 
indicating that our model is trying to fit values outside the range of 
plausible values obtained through our systematic review (Chapter 10). If 
we accept the model as accurate, we must accept that MAT on paired 
serum samples is substantially less sensitive than previous estimates (17). 
An alternative explanation for the estimated accuracy parameters that we 
consider more likely, is that the latent classes identified do not equate to 
‘leptospirosis’ and ‘not leptospirosis’ but may differentiate participant 
serum on some other basis, for example the presence of similar IgM. 
 
A limitation of our study is that all tests diagnosed leptospirosis through 
detection of antibodies. LCA has been used to evaluate several serologic 
leptospirosis tests previously (14, 27, 28). Despite this, use of assays that 
are all based on a single method of diagnosis could invalidate 
assumptions of conditional independence. Although concordance between 
 560 
assays was not high, we attempted to account for correlation between the 
assays that used similar antigen through use of latent class models that 
specified some correlation between the two whole-cell heat-treated 
Leptospira biflexa serovar Patoc lateral flow assays.  
 
11.4.6 Analysis of test accuracy by subgroups 
Our study was insufficiently powered to identify variations in test accuracy 
by duration of illness, infecting Leptospira serogroup or in patients with 
other infections. Therefore, the interpretation of the absence in variation 
should be interpreted cautiously. Also, we identified that many participants 
had taken antimicrobials prior to study enrolment and this may have 
influenced accuracy. We did not assess whether prior consumption of 
antimicrobials influenced test accuracy as the small number of diagnosed 
cases precluded sub-group analyses. 
 
11.4.7 Simulation of fitting two-state latent class models to a 
specified three state system 
Our simulated data also indicates that we should interpret results from a 
LCA with caution. We specified a three-state system that was founded in 
biologic plausibility, with the three states representing ‘leptospirosis,’ ‘not 
leptospirosis but similar IgM,’ and ‘not leptospirosis and different IgM.’ The 
probability distributions of test result profiles that these states generated 
mimicked probability distributions of the profiles seen in our real-world 
data. We were able to fit a model with two latent classes that was not 
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rejected in more than two thirds of simulations. The diagnostic test 
sensitivity estimated by two-class models were markedly different from 
those specified in our three-class system. Our results indicate that 
estimates of sensitivity and specificity derived from LCA are sensitive to 
assumptions about the number and meaning of latent classes, and that 
statistical tests for model fit are inadequate for determining the validity of 
assumptions about the number and meaning of latent classes. Our 
criticism, that two-class LCA models can adequately fit a system with 
greater than two true classes, adds to concerns about the sensitivity of 
LCA to misspecification of dependence structures that have been well 
documented in the literature (30-32). In context, our results indicate that 
we should rely on our understanding of disease and the broader context of 
febrile illness, rather than purely statistical methods when considering the 
appropriate label to apply to each latent class when analysing diagnostic 
test accuracy with LCA.  
 
Bayesian LCA are often used for evaluations of diagnostic tests because 
the true values of conditional diagnostic test outcome probabilities and the 
disease prevalence are often not exactly known, which makes the use of 
fixed parameters invalid. A potential criticism of the LCA models that we 
fitted to our simulated data is that they were frequentist, rather than 
Bayesian, and this differs from published LCA of leptospirosis assays (18, 
28, 38). In our simulation the disease prevalence and accuracy 
parameters were specified, and Bayesian inference was unnecessary. We 
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chose frequentist LCA for pragmatic reasons, as running Bayesian LCA on 
500 simulated datasets required substantial computing power and time. 
The methods for determining goodness of fit in frequentist models are 
different from those that we performed for the Bayesian LCA of real-world 
data, which makes direct comparisons difficult. However, Bayesian fit 
testing is less likely to reject the fit of a model than fit testing using 
frequentist methods. Therefore, we do not think that our use of frequentist 
rather than Bayesian LCA models should change the interpretation of our 
results nor our criticism of the sensitivity of LCA to misspecification of the 
number of classes (44, 45). 
 
11.4.8 Study limitations 
11.4.8.1 Sample size and study power 
We did not have sufficient participants to reach the sample size we had 
calculated, particularly with regard to the number of leptospirosis cases. 
The large number of participants without available serum limited both the 
number of participants and the power of our study to determine precisely 
the accuracy of the point-of-care tests or identify which test was most 
accurate. A study that had sufficient cases would have required close to 
2000 participants, which few studies evaluating leptospirosis point-of-care 
tests have achieved (10, 28). Although a case-control study may be a 
more efficient method of increasing the number of participants with 
leptospirosis, we chose a cross-sectional study design, rather than a two-
 563 
gate case control design in order to mimic the likely practice of clinicians, 
and reduce bias (5). 
 
11.4.8.2 Exclusion of leptospirosis cases diagnosed by a single high titre 
Our study was also limited by exclusion of participants who had a single 
high Leptospira antibody titre. Our exclusion of these participants may 
have adversely affected the estimates of test accuracy of IgM assays by 
excluding patients with a strong IgM response. However, we think that our 
rationale that the disease state of patients with a single high Leptospira 
antibody titre is unknown remains valid, as participants with a single high 
Leptospira antibody titre might also have had high IgG from previous 
infection but been misclassified as a case. In addition, we do not think that 
our exclusion of participants with a single titre ≥800 explains the low 
prevalence of Leptospira seropositivity in our study population, as most 
seropositive participants in the complete cohort had Leptospira MAT titres 
<400. 
 
11.4.9 Implications for use of leptospirosis point-of-care tests 
We think that the results of the point-of-care assays that we assessed 
should be interpreted cautiously by clinicians. We consider the estimates 
of accuracy of the point-of-care tests derived from LCA to be unreliable. 
Although the estimates derived from the contingency table method will 
have under-estimated the true sensitivity and specificity of point-of-care 
tests, the degree of underestimation may not be large because we 
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maximised the accuracy of MAT by including only participants who had 
both acute and convalescent serum samples. Unless the criteria of a ≥4-
fold rise in MAT titre between serum samples four to six weeks apart is 
substantially less accurate than previously thought, the point-of-care tests 
are unlikely to have sufficient sensitivity and specificity to adequately 
diagnose leptospirosis among patients with an undifferentiated febrile 
illness.  In addition, the concordance between point-of-care assays was 
poor, meaning clinicians would likely receive conflicting diagnostic 
information depending on which point-of-care test was chosen. 
 
11.4.10 Improving evaluations of leptospirosis diagnostic tests 
Guidelines, such as Standards for Reporting Diagnostic Accuracy 
(STARD) provide guidance about features of study design, analysis and 
reporting to improve the of quality of the evidence for diagnostic tests (34). 
The STARD guidelines recommend use of contingency tables, and do not 
provide guidance for the evaluation of diagnostic tests when the reference 
standard test is imperfect. While LCA may be a useful method of analysis 
when the reference standard is imperfect, our results suggest that 
additional features in study design and analysis are needed to identify 
unbiased, accurate, and precise estimates of sensitivity and specificity for 
diagnostic tests. One such feature is data from additional tests that detect 
leptospirosis through methods other than serology, such as culture or 
nucleic acid amplification tests.  Additionally, evaluations that use LCA 
should investigate models with varied numbers of latent classes that 
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encompass biologically plausible scenarios. Finally, evaluations should 
occur among cohorts of patients in whom the presence of diseases other 
than leptospirosis have been investigated with reference diagnostic tests. 
Well characterised cohorts where most or all participants have a diagnosis 
would improve knowledge of each participant’s prior probability of 
leptospirosis and inform interpretation of the groups identified by LCA. 
Challenges in multi-disease characterisation of cohorts include assigning a 
diagnosis to patients with diagnostic tests that are positive for more than 
one disease, and handling patients in whom no diagnosis is reached. Both 
of these challenges have been present in the few studies in Africa that 
attempted to investigate multiple diseases in a single cohort of patients 
with febrile illness (46-49). It may be that evaluations of diagnostic tests 
may require complex LCA models that consider multiple disease classes 
and information from imperfect tests that diagnose a wide spectrum of 
possible infections.  
 
11.4.11 Conclusions 
Our evaluation of the diagnostic accuracy of three commercially available 
point-of-care Leptospira IgM tests found that there was poor concordance 
between point-of-care tests. We also found that our estimates of sensitivity 
and specificity vary substantially depending on the method of statistical 
analysis and the accepted assumptions within that method. Although it is 
widely accepted that MAT is an imperfect reference standard, we included 
in our evaluation only participants who provided serum samples from both 
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the acute and convalescent phases of their illness in order to minimise 
bias. We have found that the estimates of test accuracy calculated through 
LCA are dependent on the assumption that there are only two latent 
states, which correspond to ‘leptospirosis and ‘not leptospirosis,’ and 
goodness-of-fit is an inadequate tool to assess for misspecification of the 
number of latent classes. We conclude that none of the IgM point-of-care 
tests that we evaluated are likely to be sufficiently accurate for patient 
care, although their exact sensitivity and specificity remain uncertain. We 
think that future studies of leptospirosis diagnostic tests that use LCA to 
estimate test accuracy require careful characterisation of alternative 
disease states in addition to other STARD requirements. 
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Chapter 12. Conclusions, 
future directions of research, 
and possible strategies for 
leptospirosis prevention in 
northern Tanzania 
12.1 ONE HEALTH INVESTIGATION OF ZOONOTIC 
DISEASE 
My doctoral thesis is but one part of an investigation into the impact and 
ecology of endemic bacterial zoonoses in northern Tanzania. We are a 
multi-disciplinary team encompassing medical doctors, veterinarians, 
social scientists, laboratory scientists and ecologists, who have 
collaborated while conducting multiple studies in order to gain insights into 
the disease burden and transmission pathways.  Our studies have 
collected data from hospitalised patients, healthy community members, 
livestock, and wildlife. My thesis contains novel approaches that have 
allowed us to gain insights into Leptospira epidemiology in northern 
Tanzania. We have completed the first systematic collation of Leptospira 
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serovar distribution in 40 years. My thesis also contains novel insights into 
the dynamics of Leptospira epidemiology in northern Tanzania, and the 
first published attempt to use case data to estimate the burden of 
leptospirosis in Tanzania. The development of scales that accumulate 
exposure to potential sources of Leptospira infection has not previously 
been attempted and allowed us to gain insights into risk factors for 
Leptospira infection. The use of risk factor prevalence to estimate 
incidence across a wider area is also a new approach that may warrant 
further use once refinements have been made. Finally through careful 
consideration of the assumptions inherent in latent class analyses we 
have identified pitfalls for those evaluating diagnostic tests. 
 
12.2 THE BURDEN OF LEPTOSPIROSIS IN NORTHERN 
TANZANIA 
12.2.1 The burden of human leptospirosis in northern Tanzania 
We have estimated the prevalence of leptospirosis among febrile 
hospitalised patients from urban, small-holder farming, and pastoralist 
communities and found that leptospirosis prevalence varies across years, 
as well as physical and social environments. Among pastoralist farmers 
with fever attending Endulen Hospital, we diagnosed 5.8% (95% 
confidence intervals 2.1-12.1%) with confirmed acute leptospirosis. Among 
a population of predominantly urban dwellers, and small-holder farmers, 
we diagnosed 1.9% (95% confidence intervals 1.1-2.7%) with confirmed 
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acute leptospirosis. Our estimates are likely to underestimate the true 
prevalence due to the imperfect sensitivity of microscopic agglutination 
testing (MAT) serology, particularly when used solely on serum taken at 
the time of enrolment. Nevertheless, our estimates of the prevalence of 
leptospirosis are similar to those from Southeast Asia (1), where 
leptospirosis is established as a major cause of fever. 
 
We estimated the incidence and burden of severe human leptospirosis in 
Moshi Rural and Moshi Urban Districts in the Kilimanjaro Region of 
northern Tanzania and found that even in those years with relatively few 
cases, the incidence of acute human leptospirosis is as high as 11-18 
cases per 100,000 people per year.  During the same period, we 
estimated that leptospirosis caused the loss of 104.4 disability-adjusted life 
years (DALYs) per 100,000 people annually, with the burden of DALYs 
falling disproportionately on people of working age. We think that the 
incidence among communities practising pastoralist farming is likely to be 
higher than in the Moshi Rural and Moshi Urban Districts. This is because 
we found both a greater prevalence of risk factors for leptospirosis among 
Maasai pastoralist farming in Longido District and Monduli, and a higher 
prevalence of acute leptospirosis among Maasai pastoralist farmers with 
fever attending Endulen Hospital, than among urban residents and small-
holder farmers with fever at hospitals in Moshi. Our incidence estimates 
are subject to imprecision and uncertainty because we used healthcare 
utilisation survey-based multipliers and MAT, a diagnostic test with 
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imperfect accuracy. Our one-way sensitivity analysis suggested that our 
estimate of incidence may be an underestimate of the true value. The 
variation in annual incidence from 75-102 cases per 100,000 people 
during 2007-08 to 11-18 cases per 100,000 people during 2012-14 
indicates the longitudinal surveillance is needed to better determine the 
baseline incidence and to identify epidemics. However, multiplier methods 
are well established for estimating incidence of infectious diseases for 
which the burden is calculated using natural history approaches and have 
the added advantages of being inexpensive and affordable over years of 
surveillance.   
 
Improved estimates of the case fatality ratio of leptospirosis require better 
diagnostic tests. Current diagnostic methods for leptospirosis are 
imperfect; MAT using acute and convalescent serum remains the best 
diagnostic method. Patients who die of leptospirosis usually do so prior to 
providing a convalescent serum sample and are, therefore, most likely to 
be undiagnosed. The sensitivity of PCR and point-of-care IgM assays that 
we estimated suggests neither has sufficient accuracy to substantially 
improve our understanding of the case fatality ratio of leptospirosis.  An 
alternative approach that may be worth exploring is the use of imperfect 
but inexpensive IgM assays in combination with Bayesian statistical 




12.2.2 The burden of livestock leptospirosis in northern Tanzania 
Attempts to build a case for public health interventions to prevent 
leptospirosis based solely on the burden of human disease invariably 
involves comparing the burden of leptospirosis against other diseases. It is 
an incomplete comparison to compare leptospirosis, or in fact any 
zoonosis, to purely human pathogens such as Streptococcus pneumoniae 
without considering the impact of the disease on livestock and livelihoods. 
While there is evidence of production and economic losses of leptospirosis 
in high resource farming systems such as New Zealand (2), the 
application of such studies to Tanzania is uncertain. The economic and 
social effect of a single livestock death is likely to be greater for a 
subsistence farmer for whom a small number of animals provide cash 
income, and an important protein source for his family, than for a New 
Zealand dairy farmer with several hundred cows. Assessing the burden of 
leptospirosis in livestock is complex, due to multiple confounding factors 
such as availability of feed, resistance to disease, and trading or 
slaughtering of diseased livestock. In addition, the clinical effects of animal 
infection vary by host animal and infecting serovar, and different studies 
have reported varying clinical effects of a serovar in a single host animal 
species. Data acquired during the systematic review in Chapter 2 provide 
an example of clinical effects in cattle: serovars Canicola (3-6), Mozdok (7, 
8), and Pomona (3-5, 9-14) have been repeatedly isolated from diseased, 
aborted or dead cattle. In contrast, although serovar Hardjo bovis has 
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been isolated from diseased cattle (15, 16), it has also frequently been 
identified in the urine of asymptomatic animals (4, 17-19).  
 
Despite the challenges, we identify the assessment of the production and 
the economic burden of leptospirosis on livestock as a priority for future 
research. Studies linking livestock health outcomes, and human economic 
outcomes with Leptospira infection would provide strong evidence of the 
production, economic and social effects of livestock infection among 
subsistence farmers.  
 
12.2.3 Combined estimates of the livestock and human burden of 
disease 
Although not presented in this thesis, we are currently investigating the 
association of herd level Leptospira seropositivity with livestock abortion, 
death, infertility, and production loss to allow a combined estimate in 
economic terms of the leptospirosis burden. We aim to use the estimate of 
the burden to livestock from leptospirosis to produce an estimate of the 
combined human and livestock burden of leptospirosis. Future directions, 
may include studies to inform our understanding of the adverse effects 
that livestock leptospirosis has on farmers’ quality of life and the 
opportunities lost to them.  
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12.3 DIAGNOSTIC TESTS FOR LEPTOSPIROSIS SUITABLE 
FOR CLINICIANS WORKING IN TANZANIA 
We performed a systematic review and meta-analysis of the diagnostic 
accuracy of IgM point-of-care tests. We found that while estimates of 
sensitivity and specificity have been high, the estimates are unreliable as 
most studies were at moderate or high risk of bias. Our evaluation of point-
of-care-tests among Tanzanians with fever found that IgM assays are 
unlikely to have sufficient sensitivity or specificity for widespread 
deployment and use as stand-alone diagnostic tests in patients. 
 
12.3.1 Evaluations of novel diagnostics for diseases with reference 
tests that have imperfect accuracy 
We also investigated statistical tools for evaluating leptospirosis diagnostic 
tests, given that reference tests for leptospirosis including MAT have 
imperfect accuracy. Using both data collected through our evaluation of 
the IgM point-of-care tests and simulations, we found that estimates of 
diagnostic test accuracy determined through latent class analyses are 
dependent on the assumption that the latent classes within the data 
correspond to ‘disease’ and ‘no disease.’ Our studies also suggest that 
this assumption may not hold true, and that commonly used measures of 
fit do not reliably detect misspecified latent classes. We conclude that if 
latent class analyses are used, they should be used cautiously. We 
suggest that for diseases with imperfect reference diagnostic tests, 
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evaluations of novel diagnostic tests should occur in cohorts of patients for 
whom the prevalence alternative diagnoses have been well-characterised.  
 
12.4 IDENTIFYING ANIMAL RESERVOIRS OF 
LEPTOSPIROSIS AND SOURCES OF HUMAN DISEASE 
12.4.1 A complex Leptospira ecosystem 
Our data supports the hypothesis that there is a complex Leptospira 
ecosystem in northern Tanzania. We identified that in different locations 
and time-periods sero-reactivity among human cases of acute 
leptospirosis was strongest against several different serogroups including 
Mini, Australis, and Djasiman. In addition, we identified 3 species of 
Leptospira causing human disease in Moshi during 2012-14. Finally, we 
found that the serogroups to which seropositive individuals were reactive 
were different from those to which individuals with acute leptospirosis were 
sero-reactive. Our results suggest that there are multiple species and 
serovars circulating, with many potential reservoir and non-reservoir hosts 
acting as sources of human infection. The implication is that Leptospira 
control strategies will need to be multi-faceted and accompanied by 
ongoing surveillance as effectiveness may vary over time. 
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12.4.2 Sources of human leptospirosis 
We performed a case-control analysis of a cross-sectional study and 
identified contact with cattle and rice farming as risk factors for acute 
leptospirosis. In addition, work performed in parallel and led by Dr. Allan, 
has identified that cattle are frequently seropositive to Leptospira and have 
a high prevalence of shedding Leptospira in their urine (20). In contrast, 
trapped rodents, primarily of Rattus spp., were not shedding Leptospira 
(20). These findings support the hypothesis that cattle may be important 
sources of human leptospirosis in the Kilimanjaro Region, but do not prove 
causality. The small magnitude of the associations of cattle related 
behaviours to human leptospirosis, the lack of association in multivariable 
models, and the small number of cases on which the findings are based 
are all important weaknesses that must be considered when planning 
interventions. While the magnitude of association between rice farming 
and human leptospirosis was large, it was based on a small number of rice 
farmer cases, and we have no environmental or ancillary data to support a 
causal link. A concern with the livestock data implicating cattle as a source 
of human leptospirosis is the weak epidemiologic link between individual 
people with leptospirosis and the sampled animals. The livestock and 
rodent sampling performed during 2012-13 was in villages where people 
who were diagnosed with leptospirosis during 2007-08 had lived (21). 
There was no known exposure of the historic human acute leptospirosis 
cases to the sampled animals. The link to contemporaneous cases is 
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weaker still, with little overlap in villages of residence between sampled 
animals and human cases. 
 
12.4.3 Next steps to determine pathways of transmission 
12.4.3.1 Timely identification and investigation of cases 
An important limitation of our study design was the identification of 
leptospirosis cases two to three years after they first presented to hospital. 
This delay was due to the lack of locally available accurate diagnostic 
tests. Animal sampling was performed in a representative fashion from 
large geographical areas. Therefore, comparisons of seroreactivity 
patterns between people and animals, or comparison of Leptospira 
species identified in people and animals are disconnected in time and only 
broadly approximated in place. We were unable to investigate contact 
between sampled animals and cases of leptospirosis.  These loose 
connections severely weaken any causal inference.  To improve our 
understanding of leptospirosis transmission, future work should aim to 
identify cases in real-time and investigate the presence of Leptospira in 
livestock, wildlife, and the environment in the homes and workplaces of 
people with leptospirosis. A key component of this will be the development 
of diagnostic capacity in northern Tanzania. 
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12.4.3.2 Improved detection and typing of Leptospira 
Our assessment of sources of human leptospirosis and transmission 
pathways has been limited by low sensitivity of direct detection methods of 
culture and PCR (22), as well as the low resolution of microagglutination 
testing to identify sub-types of infecting Leptospira. MAT is unable to 
determine infecting serovar and is an unreliable method of determining 
infecting serogroup (23, 24). In addition, as shown in Chapter 2, the 
diverse range of potential hosts of serovars from within a single serogroup 
renders identification of likely sources difficult. We were able to identify 
dominant patterns of serogroup reactivity for all patients with leptospirosis, 
and in three patients, the identifying species. Comparison of strains found 
using direct detection methods, such as culture or PCR would be ideal. 
However, consistent with the published literature, Leptospira culture and 
PCR were insensitive in our studies (25-27). More sensitive means of 
culture or molecular diagnosis that allow typing are needed to improve our 
understanding of Leptospira epidemiology in northern Tanzania and 
elsewhere.  
 
One approach to improving sensitivity is to collect more samples. 
Leptospira is transiently present in blood and urine (28). Performing 
culture and PCR or multiple specimens from multiple time points is likely to 
increase detection. There have been few advances in Leptospira culture in 
recent years, although increased understanding of the genome may 
improve sensitivity through improved understanding of growth 
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requirements (29). However, there have been advances in the direct 
detection and typing of Leptospira using molecular methods. These 
include single gene sequencing, multi-locus sequence typing (MLST), and 
whole genome sequencing. Single gene PCR targets, and single gene 
sequencing have been used successfully to differentiate species of 
Leptospira (30, 31). Indeed, we used of several single gene targets to 
identify the infecting Leptospira species among patients with leptospirosis 
in northern Tanzania (Chapter 8). Discrimination of infecting Leptospira 
species has limited value in source attribution given the large host range 
of pathogenic Leptospira species (Chapter 2), unless there is an 
epidemiologic link between a potential source and the host. MLST 
schemes provide more granular data that separates strains and might 
have more value in source attribution. There have been three MLST 
schemes developed and many isolates classified (32). The ‘7L’ MLST 
scheme uses seven genes (glmU, pntA, sucA, tpiA, pfkB, mreA, caiB) to 
distinguish seven major Leptospira pathogenic species (33). The ‘6L’ 
MLST scheme includes six genes (adk, icdA, secY, lipL32, lipL42, rrs) (34) 
while the third uses the loci considered to be the most discriminatory (adk, 
glmU, icdA, lipL32, lipL41, mreA and pntA) from the other two schemes 
(35). MLST has been successfully used in source attribution models in 
readily cultured food borne pathogens such as Campylobacter (36), 
Listeria (37), and nontyphoidal Salmonella (38). The challenges in 
culturing Leptospira have limited the application of MLST to source 
attribution of leptospirosis. However, there are recent reports of successful 
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MLST typing of Leptospira directly from patient samples (39). In addition, 
there have been reports of Leptospira detection and typing directly from 
patient samples using next-generation whole genome sequencing (40, 
41), although the sensitivity of this approach has not been evaluated.   
 
In summary, future studies of leptospirosis transmission in northern 
Tanzania would be strengthened by redoubled efforts to detect Leptospira 
by culture and PCR by collecting multiple urine and blood specimens 
direct from the patient during the illness, and utilising the PCR, and typing 
techniques available. Maximising Leptospira DNA recovered from human 
cases would facilitate phylogenetic comparison with Leptospira DNA from 
animal hosts and contribute to understanding of source attribution. 
 
12.4.3.3 Bayesian modelling to integrate molecular and behavioural risk 
factor data 
Understanding transmission pathways of leptospirosis requires integration 
of phylogenetic analyses and epidemiologic analyses. Considering both 
behavioural risk factors and strain typing together has provided insights 
into the source of, and protection strategies for Escherichia coli diarrhoeal 
disease (42). In South-East Asia, phylogenetic studies have been 
integrated with habitat data to provide insights into Leptospira 
transmission (43).  Leptospirosis has complex ecology. Analyses that 
integrate human epidemiologic data, environmental data, and animal 
epidemiologic data with phylogenetic data from both humans and animals 
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may help determine the direction of transmission among multiple potential 
animal and environmental reservoirs, and in turn the mode of human 
transmission. Understanding the mode of transmission of leptospirosis to 
people is important as control of human leptospirosis need not involve the 
elimination of Leptospira from reservoirs, but merely identify and block the 
mode of infection. For example, in Japan pathogenic Leptospira are 
readily found in the environment (44) or when small mammals are 
investigated (45), but the incidence of human leptospirosis is low (46). 
 
Bayesian networks are graphical models that display variables as nodes, 
and their conditional dependencies on a directed acyclic graph. Directed 
acyclic graphs visually represent causal pathways. Conditional 
dependency, which is based on Bayes theorem of conditional probability, 
describes the relationship between more than two variables, where the 
occurrence of one will affect the probability of the others occurring. The 
addition of conditional dependence probabilities to directed acyclic graphs 
explicitly describes relationships between variables and facilitates 
modelling of the effects of interventions that would alter the probability of 
any variable. Bayesian networks are better suited to understanding 
complex eco-epidemiology than regression models as they are better able 
to incorporate uncertainties and model complex correlations between 
multiple variables (47). Bayesian networks also have limitations in that 
they must convert continuous variables to discrete variables, which loses 
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data resolution and renders them unable to manage dependencies with 
feedback loops (48).  
 
Bayesian networks can be constructed using experts’ prior knowledge. 
Learning Bayesian network, are Bayesian Networks where connections 
can be inferred from study data.  Learning Bayesian networks have been 
proposed for investigating influenza and HIV transmission, as well as for 
predicting disease outbreaks (49).  Within the last year, there have been 
reports in which Bayesian networks have been used to investigate factors 
associated with Leptospira interrogans serovar Pomona infection among 
New Zealand abattoir workers (48), and to model the relative importance 
of animal species as sources of human Leptospira transmission in Fiji. The 
study among New Zealand abattoir workers identified that workers at the 
beginning of the slaughter process were at greatest risk and demonstrated 
the ineffectiveness of personal protective equipment. The authors 
concluded that the advantages of Bayesian networks included the ability to 
capture and illustrate graphically the natural complexity of data more 
effectively than generalised linear models (48). The study in Fiji also 
concluded that Bayesian networks were an effective tool for modelling 
complex ecology and drivers of transmission. They found that Bayesian 
network models that took account for dependency structures, such as the 
correlation of one livestock species correlated with another, performed 
better than those that did not.  
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Bayesian networks may be useful in establishing causal pathways of 
transmission of Leptospira in Tanzania, determining which risk factors are 
most relevant under varied conditions, and modelling the effect of 
interventions. Analysing future studies with Bayesian networks, would 
allow existing knowledge, including that gained during the research for this 
thesis to inform nodal conditional dependency probabilities to and ensure 
synthesis of the expanding body of knowledge of leptospirosis in 
Tanzania.  
 
12.5 PREVENTION STRATEGIES 
12.5.1 Context of leptospirosis – causes of fever, multiple zoonoses 
The work presented in this doctoral thesis summarises investigations into 
leptospirosis in northern Tanzania during 2012 through 2017. It exists in 
the wider context of zoonoses as a cause of illness and impairment of 
livelihoods in Africa. The social and environmental factors that favour 
leptospirosis transmission also facilitate transmission of other zoonoses 
such as brucellosis and Q fever. In northern Tanzania zoonotic infections 
other than leptospirosis are also common and share risk factors. The 
shared behavioural, social, and environmental risk factors create 
overlapping burdens of illness on people and their livestock, but also 




12.5.2 Prevention of human disease by reducing the prevalence of 
infection in livestock 
We have identified that contact with cattle was a risk factor for 
leptospirosis among patients presenting to hospital with fever during 2012-
2014, and that contact with goats was a risk factor for Leptospira 
seropositivity among the same population group during the same time 
period. As discussed in Chapters 6 and 7, there remains substantial 
uncertainty about these relationships. Further research, including 
modelling of effectiveness, would be needed before widespread 
application of any intervention. Nevertheless, the human-livestock 
interface provides a potential target for preventing human leptospirosis.  
 
Transmission of leptospirosis from livestock to humans could be prevented 
through reducing the prevalence of livestock infection or modifying human 
behaviours. Control strategies for Leptospira infection in livestock must 
consider the infecting serovars, the maintenance hosts of infecting 
serovars, the mode of transmission between animals, and the control 
options available (50). In Tanzania, the serovars infecting livestock are not 
fully known, but appear to be numerous and vary over time (20, 51, 52). 
The maintenance hosts of many serovars are unknown and they have 
been isolated in only a few instances (51). Therefore, further research is 
needed before the effectiveness of any control strategy is known. The 
studies conducted by our multidisciplinary team aim to answer many of 
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these questions and develop the knowledge necessary to plan a control 
strategy.  
 
In some countries, notably including New Zealand, the incidence of human 
leptospirosis has been reduced by reducing the prevalence of Leptospira 
infection of livestock (53). In New Zealand too, vaccination against the 
serovars causing livestock infection has been an important component of 
controlling leptospirosis in livestock and has been possible due to the 
limited range of serovars infecting them (53). In Tanzania, vaccination of 
livestock may be more challenging due to the larger number of serovars 
circulating and the lack of stability in serovars causing disease. 
Antibacterial drugs may also have a role in leptospirosis control in 
livestock, where they may be given to all members of an infected herd 
prior to vaccination.  Culling of carrier animals is thought to have little 
value in animal leptospirosis as no test will reliably identify carrier animals 
(50). 
 
12.5.3 Preventing leptospirosis among rice field workers 
We identified that rice field workers were at greater risk of leptospirosis 
than the general population. It is likely that infection is occurring within rice 
fields, as rice field exposure is a well-documented risk factor elsewhere 
(54). Whether Leptospira are contaminating rice fields from rodents or 
cattle is unknown, and there is evidence for each in other countries (55-
57). Identifying the likely reservoir, and mode of transmission would be 
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important when considering control programs to prevent leptospirosis rice 
farmers.  
 
12.5.4 The role of rodent control in leptospirosis prevention  
Our studies did not find evidence that implicated rodents as a source of 
human leptospirosis. Despite this, measures to discourage rodents may 
reduce human Leptospira infection, as rodents may be maintenance hosts 
that infect livestock or contaminate rice fields, soil and water. Rodent 
control measures may include poisoning or trapping, building rodent-proof 
buildings and barns, denying them access to food and drinking water 
around human habitation, through rodent-proof warehouses, food depots 
and water reservoirs, and by installing adequate sanitation infrastructure 
(58). 
 
12.5.5 Preventing leptospirosis through personal protective 
measures 
Personal protective measures and changing behaviour allows individuals 
to reduce their risk of leptospirosis. Education among livestock keepers 
may be an important first step, to raise awareness of leptospirosis, 
potential risks, and methods of minimising exposure.  Although 
recommended, the effectiveness of personal protective clothing has varied 
in different studies and has not always been shown to be protective (48, 
54, 59). Other recommended measures include wearing protective 
clothing, covering skin lesions with waterproof dressings, washing after 
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exposure to animal urine, contaminated soil, or water, washing and 
cleaning wounds, disinfecting contaminated areas, and preventing access 
to areas known to be contaminated with animal waste (58). As many of 
these measures may prove expensive and challenging for subsistence 
farmers, efficacy studies and cost-effectiveness analyses are important 
prior to recommending widespread adoption of the measures.  
 
12.6 CONCLUSIONS 
We have estimated that leptospirosis has a prevalence of between 1.9% 
and 5.8%% among hospitalized patients with fever in northern Tanzania, 
and that the prevalence varies according to time and place. In the Moshi 
Urban and Rural Districts during 2012-14 when the prevalence of 
leptospirosis was the lowest, the incidence of leptospirosis was between 
12 and 20 cases per 100,000 people per year, equating to 679.7 (range 
298.5-3196.6) disability-adjusted life years lost annually. We identified that 
contact with livestock and working in the rice fields were risk factors for 
human leptospirosis. The reservoir hosts of leptospirosis have not yet 
been fully characterized in northern Tanzania. Despite our findings, rats 
may yet play an important role in the ecology of Leptospira in northern 
Tanzania. For clinicians in health centres and hospitals leptospirosis is 
challenging to diagnose. Currently available point-of-care tests are 
insufficiently accurate to warrant deployment in the health system for 
individual patient management. Better tests are needed, but such tests will 
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need careful evaluation due to the imperfect accuracy of all currently 
available leptospirosis tests.  
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Appendix A. Questionnaire for leptospirosis risk factor study, 































Appendix B Bivariate logistic regression of behaviours among patients with febrile illness, northern Tanzania, 2012-
14 
 
Cleaned cattle waste Cleaned goat waste Cleaned pig waste Fed cattle Fed goats Fed pigs 
  Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) 
Cleaned goat waste 28.8 (12.0-69.1) 
     
Cleaned pig waste 36.7 (18.3-73.6) 12.3 (5.1-30.0) 
    
Fed cattle 324.1 (96.6-1087) 18.4 (9.7-35.0) 11.9 (5.2-27.5) 
   
Fed goats 15.3 (8.3-28.2) 97.8 (41.4-230.7) 7.2 (3.1-16.8) 43.1 (24.3-76.5) 
  
Fed pigs 23.9 (10.4-55.3) 10.9 (4.5-26.0) 1141.0 (255.7-5090.5) 20.2 (8.7-47.0) 10.5 (4.7-23.6) 
 
Herded cattle 10.9 (2.9-39.9) 7.7 (1.9-30.8) 3.9 (0.48-32.2) 22.0 (5.6-86.7) 14.5 (4.0-52.6) 3.6 (0.44-29.5) 
Herded goats 2.4 (0.68-8.2) 6.7 (2.5-17.9) 1.6 (0.20-12.2) 6.1 (2.6-14.6) 25.3 (10.1-63-7) 1.4 (0.19-11.2) 
Kept cattle inside the house 6.3 (1.2-33.3) . . 12.1 (2.7-55.1) 3.7 (0.70-19.3) . 
Kept goats inside the house 2.2 (0.27-18.2) 2.5 (0.30-20.4) . 1.2 (0.15-10.2) 1.3 (0.16-10.7) . 
Kept pigs inside the house 5.7 (2.9-11.0) 3.4 (1.6-7.3) . 3.7 (2.0-6.7) 2.9 (1.6-5.4) . 
Milked cattle 98.4 (34.7-278.8) 9.4 (3.8-23.1) 1.4 (0.19-11.1) 35.0 (13.5-90.5) 8.0 (3.5-18.3) 2.9 (0.64-12.9) 
Milked goats 7.7 (0.69-86.8) 8.6 (0.77-97.1) . 17.8 (1.6-198.2) 18.5 (1.7-206.4) . 
Owning cattle . 6.3 (3.4-11.6) 7.3 (3.3-17.4) 258.2 (62.6-1064) 9.2 (5.6-15.0) 10.1 (4.2-24.5) 
Own dogs 2.5 (1.4-4.6) 2.4 (1.3-4.6) 3.6 (1.6-8.3) 2.9 (1.8-4.8) 2.9 (1.7-4.8) 3.7 (1.7-8.3) 
Owned goats 4.8 (2.7-8.7) . 3.0 (1.3-6.9) 7.6 (4.7-12.3) 193 (47.0-796.8) 4.2 (1.9-9.3) 
Own pigs 5.5 (2.8-10.7) 3.4 (1.6-7.1) . 3.6 (2.0-6.5) 2.8 (1.5-5.3) . 
Slaughtered cattle 0.87 (0.31-2.5) 1.6 (0.65-3.9) 0.96 (0.22-4.2) 0.76 (0.32-1.8) 1.9 (0.98-3.7) 0.88 (0.2-3.7) 
Slaughtered goats 2.0 (0.57-6.7) 3.1 (1.0-9.5) 2.9 (0.64-13.0) 3.2 (1.3-7.8) 4.1 (1.7-9.7) 4.3 (1.2-15.4) 
Slaughtered pigs 5.2 (1.0-26.6) 5.9 (1.2-29.9) 12.3 (2.4-64.6) 2.9 (0.59-14.8) 5.6 (1.3-23.8) 11.3 (2.2-58.8) 
Worked as a farmer 9.5 (5.2-17.4) 9.7 (5.1-18.3) 5.7 (2.5-13.0) 8.5 (5.3-13.7) 8.3 (5.1-13.5) 7.8 (3.4-17.9) 
 615 
Appendix B continued. Bivariate logistic regression of behaviours among patients with febrile illness, northern 
Tanzania, 2012-14 
 Cleaned cattle waste Cleaned goat waste Cleaned pig waste Fed cattle Fed goats Fed pigs 
  Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) 
Killed rodents 2.6 (0.75-9.2) 1.8 (0.41-8.0) . 2.1 (0.69-6.4) 2.9 (1.0-8.2) . 
Rodents seen in house 2.1 (1.2-3.3) 2.4 (1.4-4.5) 1.5 (0.66-3.4) 1.5 (0.99-2.4)  1.5 (0.95-2.3) 0.76 (0.32-1.78) 
Freq. evidence of rodents seen in house 2.3 (1.3-4.1) 3.0 (1.6-5.5) 1.5 (0.66-3.4) 1.7 (1.1-2.7) 1.8 (1.1-2.8) 0.91 (0.40-2.1) 
Freq. rodents seen in fields 2.0 (0.97-4.1) 4.8 (2.5-9.1) 2.8 (1.1-7.2) 2.3 (1.3-4.1) 3.4 (2.0-5.8) 2.4 (0.97-6.4) 
Freq. rodents seen in compound 1.8 (1.0-3.3) 2.0 (1.1-3.7) 1.6 (0.68-3.7) 1.4 (0.88-2.3) 1.4 (0.88-2.29) 0.95 (0.39-2.3) 
Freq. rodents seen in kitchen/ food store 1.3 (0.68-2.3) 2.0 (1.1-3.6) 2.0 (0.89-4.7) 1.2 (0.75-2.0) 1.3 (0.78-2.1) 1.0 (0.42-2.5) 
Bathed in surface water 5.4 (3.0-9.5) 3.2 (1.8-5.9) 5.5 (2.4-12.6) 3.8 (2.4-5.9) 3.0 (1.9-4.8) 4.6 (2.1-10.1) 
Drank untreated surface water 3.0 (1.6-5.5) 2.5 (1.3-4.9) 2.4 (0.96-5.9) 3.3 (2.0-5.4) 3.3 (2.0-5.4) 3.1 (1.4-7.1) 
Had standing water in compound 0.32 (0.13-0.75) 0.78 (0.39-1.6) 0.11 (0.01-0.81) 0.51 (0.28-0.90) 0.63 (0.36-1.1) 0.10 (0.01-0.73) 
Walked barefoot 1.3 (0.74-2.2) 1.0 (0.58-1.9) 1.3 (0.58-2.9) 1.2 (0.74-1.8) 1.4 (0.89-2.2) 0.80 (0.36-1.8) 
Washed in surface water 4.9 (2.7-8.6) 3.2 (1.8-5.9) 3.6 (1.6-8.0) 3.4 (2.1-5.4) 2.7 (1.7-4.4) 3.6 (1.6-7.8) 




Appendix B continued. Bivariate logistic regression of behaviours among patients with febrile illness, northern 
Tanzania, 2012-14 
 
Herded cattle Herded goats 
Kept cattle inside the 
house 
Kept goats inside 
the house 
Kept pigs inside the 
house Milked cattle 
 
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) 
Herded goats 527.1 (62.5-4446.7) 
     
Kept cattle inside the house 41.5 (7.0-246.2) 15.5 (2.9-84.7) 
    
Kept goats inside the house . . . 
   
Kept pigs inside the house 1.3 (0.16-10.2) 0.51 (0.07-3.9) . 1.6 (0.20-13.5) 
  
Milked cattle 15.8 (3.3-65.3) 5.4 (1.5-19.7) . 4.8 (0.57-40.8) 0.99 (0.23-4.3) 
 
Milked goats . . . . . 71.1 (6.2-812.8) 
Owning cattle . 4.7 (2.0-10.8) . 5.8 (1.4-24.4) 5.5 (3.3-9.1) . 
Own dogs 2.1 (0.53-8.2) 1.7 (0.67-4.5) 0.80 (0.10-6.7) 2.9 (0.69-12.4) 4.9 (2.9-8.2) 2.3 (0.99-5.5) 
Owned goats 27.4 (3.5-217.9) 33.9 (7.9-146.0) 4.0 (0.88-17.8) . 4.6 (2.8-7.6) 6.7 (2.8-15.7) 
Own pigs 1.3 (0.16-10.0) 0.50 (0.07-3.8) . 1.6 (0.20-13.3) . 0.98 (0.22-4.2) 
Slaughtered cattle 2.7 (0.56-12.9) 1.0 (0.23-4.4) . 1.5 (0.18-12.5) 0.83 (0.32-2.1) 0.92 (0.21-4.0) 
Slaughtered goats 14.5 (3.5-59.4) 5.0 (1.4-17.9) . . 2.0 (0.69-6.1) 1.3 (0.17-9.8) 
Slaughtered pigs . . . . 3.9 (0.77-19.6) 11.8 (2.3-61.5) 
Worked as a farmer 9.2 (2.3-35.8) 4.4 (1.9-10.1) 0.63 (0.08-5.3) . 1.8 (1.0-3.1) 10.7 (4.4-26.2) 
Killed rodents 4.5 (0.54-37.4) 1.8 (0.23-14.2) . 5.8 (0.68-49.6) 0.56 (0.07-4.3) 6.1 (1.7-22.1) 
Rodents seen in house 1.7 (0.50-6.1) 1.9 (0.84-4.4) 10.5 (1.2-88.2) 1.0 (0.25-4.4) 0.81 (0.48-1.4) 2.3 (1.0-5.0) 
Freq. evidence of rodents seen in house 1.7 (0.50-6.1) 1.6 (0.70-3.7) 4.4 (0.85-22.7) 1.1 (0.14-9.4) 0.94 (0.56-1.6) 2.3 (1.0-5.0) 
Freq. rodents seen in fields 0.89 (0.11-7.1) 1.7 (0.57-5.1) 1.3 (0.16-11.2) 0.86 (0.17-4.3) 1.4 (0.70-2.9) 0.33 (0.04-2.4) 
Freq. rodents seen in compound 0.64 (0.14-3.1) 1.4 (0.58-3.3) 6.6 (1.3-34.2) 1.7 (0.39-7.1) 1.3 (0.74-2.2) 1.8 (0.78-4.0) 
Freq. rodents seen in kitchen/ food store 0.69 (0.15-3.2) 0.77 (0.28-2.1) 2.1 (0.47-9.5) 1.2 (0.25-6.2) 1.2 (0.68-2.0) 1.1 (0.45-2.6) 
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 Herded cattle Herded goats 
Kept cattle inside the 
house 
Kept goats inside 
the house 
Kept pigs inside the 
house Milked cattle 
 Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) 
Bathed in surface water 2.5 (0.70-8.9) 1.6 (0.66-4.0) 1.5 (0.28-7.7) 0.80 (0.10-6.5) 2.5 (1.5-4.2) 5.0 (2.2-11.2) 
Drank untreated surface water 1.4 (0.30-6.7) 1.6 (0.57-4.3) 2.3 (0.43-11.8) 1.6 (0.37-6.6) 1.8 (1.0-3.3) 2.2 (0.02-5.5) 
Had standing water in compound 0.28 (0.04-2.3) 0.53 (0.18-1.6) 1.0 (0.20-5.4) 0.77 (0.18-3.2) 0.53 (0.28-1.0) 0.64 (0.24-1.7) 
Walked barefoot 1.9 (0.55-6,9) 3.0 (1.2-7.4) 0.51 (0.10-2.7) 2.1 (0.49-8.7) 1.2 (0.75-2.0) 1.4 (0.64-3.1) 
Washed in surface water 2.3 (0.64-8.2) 1.5 (0.61-3.7) 1.4 (0.26-7.1) . 2.3 (1.4-3.8) 4.6 (2.0-10.3) 
Worked in rice fields . . . 
 




Appendix B continued. Bivariate logistic regression of behaviours among patients with febrile illness, northern 
Tanzania, 2012-14 
 
Milked goats Owning cattle Own dogs Owned goats Own pigs Slaughtered cattle 
 
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) 
Owning cattle 6.9 (0.62-76.0) 
     
Own dogs 2.4 (0.22-26.9) 5.3 (3.6-7.8) 
    
Owned goats . 15.1 (10.3-22.1) 5.8 (3.9-8.4) 
   
Own pigs . 5.3 (3.2-8.8) 4.7 (2.8-7.9) 4.4 (2.7-7.3) 
  
Slaughtered cattle 5.3 (0.48-59.6) 0.58 (0.30-1.12) 1.0 (0.56-2.0) 1.1 (0.65-1.9) 0.81 (0.32-2.1) 
 
Slaughtered goats 15.7 (1.4-178.4) 2.4 (1.1-5.3) 1.1 (0.41-3.0) 2.8 (1.3-6.1) 2.0 (0.68-6.0) 16.4 (7.3-36.6) 
Slaughtered pigs . 1.1 (0.23-5.7) 0.69 (0.08-5.6) 1.8 (0.42-7.5) 3.8 (0.76-19.3) 18.8 (4.4-80.5) 
Worked as a farmer 7.7 (0.69-84.9) 3.7 (2.6-5.3) 1.6 (1.1-2.5) 3.0 (2.1-4.2) 1.7 (1.0-3.0) 1.1 (0.60-1.9) 
Killed rodents 20.5 (1.8-235.5) 1.1 (0.38-2.9) 0.80 (0.23-2.7) 1.5 (0.59-3.7) 0.55 (0.07-4.2) . 
Rodents seen in house 3.5 (0.31-38.5) 1.2 (0.90-1.7) 1.1 (0.84-1.5) 1.4 (1.0-1.9) 0.85 (0.51-1.4) 1.5 (0.91-2.4) 
Freq. evidence of rodents seen in house 3.5 (0.31-38.5) 1.3 (0.95-1.8) 1.1 (0.80-1.7) 1.5 (1.1-2.1) 0.98 (0.59-1.6) 1.3 (0.80-2.1) 
Freq. rodents seen in fields . 1.6 (1.0-2.6) 2.4 (1.5-3.9) 2.0 (1.3-3.1) 1.6 (0.80-3.1) 1.8 (0.97-3.5) 
Freq. rodents seen in compound 5.2 (0.47-57.8) 1.5 (1.0-2.1) 1.4 (0.96-2.0) 1.2 (0.86-1.7) 1.3 (0.79-2.2) 0.90 (0.52-1.6) 
Freq. rodents seen in kitchen/ food store 1.4 (0.12-15.5) 1.5 (1.1-2.1) 1.5 (1.0-2.2) 1.5 (1.1-2.2) 1.2 (0.73-2.1) 1.6 (0.97-2.7) 
Bathed in surface water 1.8 (0.17-20.5) 3.0 (2.1-4.3) 2.0 (1.3-2.9) 2.4 (1.7-3.5) 2.4 (1.5-4.1) 1.1 (0.64-2.0) 
Drank untreated surface water 2.8 (0.25-31.2) 3.1 (2.1-4.5) 1.7 (1.1-2.6) 3.0 (2.0-4.4) 1.8 (0.99-3.2) 1.5 (0.82-2.7)  
Had standing water in compound 1.3 (0.12-14.4) 0.66 (0.45-0.97) 0.87 (0.58-1.3) 0.70 (0.49-1.0) 0.58 (0.31-1.1) 1.5 (0.90-2.5) 
Walked barefoot 0.64 (0.06-7.1) 1.0 (0.74-1.4) 1.1 (0.76-1.6) 1.3 (0.92-1.7) 1.3 (0.78-2.1) 1.3 (0.79-2.1) 
Washed in surface water 1.7 (0.15-18.9) 3.0 (2.1-4.3) 1.9 (1.3-2.8) 2.3 (1.7-3.3) 2.2 (1.3-3.7) 1.0 (0.59-1.8) 
Worked in rice fields . 1.1 (0.4-3.2) 0.53 (0.12-2.3) 0.97 (0.34-2.7) 0.59 (0.08-4.4) 0.55 (0.07-4.2) 
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Slaughtered goats Slaughtered pigs Worked as a farmer Killed rodents 
Rodents seen in 
house 
Freq. evidence of 
rodents seen in house 
 
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) 
Slaughtered pigs 10.8 (2.1-56.3) 
     
Worked as a farmer 4.3 (2.0-9.4) 2.3 (0.54-9.7) 
    
Killed rodents . . 2.9 (1.2-7.1) 
   
Rodents seen in house 1.9 (0.88-4.1) 5.3 (1.1-26.3) 1.5 (1.1-2.2) 2.9 (1.2-7.1) 
  
Freq. evidence of rodents seen in house 1.6 (0.76-3.5) 2.9 (0.69-12.3) 1.6 (1.2-2.2) 4.5 (1.7-11.8) 136.1 (81.6-226.9) 
 
Freq. rodents seen in fields 2.4 (0.93-6.0) 2.7 (0.53-13.6) 3.9 (2.5-6.1) 1.9 (0.64-5.9) 5.2 (3.2-8.4) 7.1 (4.3-11.7) 
Freq. rodents seen in compound 1.1 (0.47-2.5) 2.6 (0.65-10.6) 1.5 (1.0-2.1) 3.0 (1.2-7.1) 15.0 (10.3-21.8) 16.1 (11.1-23.5) 
Freq. rodents seen in kitchen/ food store 1.7 (0.75-3.7) 4.7 (1.1-19.9) 1.7 (1.2-2.4) 2.6 (1.1-6.24) 26.7 (17.4-41.0) 38.7 (22.9-57.9) 
Bathed in surface water 3.1 (1.4-6.7) 2.2 (0.53-9.4) 2.9 (2.0-4.2) 2.9 (1.2-6.9) 1.2 (0.88-1.7) 1.3 (0.94-1.8) 
Drank untreated surface water 3.5 (1.6-7.8) 1.9 (0.37-9.4) 2.2 (1.5-3.3) 2.3 (0.87-6.0) 1.4 (0.94-2.0) 1.5 (1.0-2.2) 
Had standing water in compound 1.1 (0.47-2.5) 0.37 (0.04-3.0) 0.89 (0.61-1.3) 1.0 (0.40-2.7) 1.4 (1.1-2.0) 1.4 (1.1-2.0) 
Walked barefoot 0.88 (0.40-1.9) 1.3 (0.32-5.2) 1.2 (0.88-1.7) 1.7 (0.73-4.2) 1.6 (1.2-2.2) 1.3 (1.0-1.8) 
Washed in surface water 2.8 (1.3-6.2) 2.1 (0.49-8.7) 2.8 (1.9-4.0) 2.6 (1.1-6.3) 1.3 (0.92-1.8) 1.3 (0.95-1.8) 
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Freq. rodents seen in 
fields 
Freq. rodents seen in 
compound 
Freq. rodents seen in 
kitchen/ food store 




Had standing water in 
compound 
 
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) 
Freq. rodents seen in compound 7.6 (4.8-12.3) 
     
Freq. rodents seen in kitchen/ food store 6.7 (4.2-10.6) 15.4 (10.7-22.3) 
    
Bathed in surface water 1.4 (0.85-2.3) 0.96-0.66-1.4) 0.98 (0.67-1.4) 
   
Drank untreated surface water 1.4 (0.79-2.4) 1.1 (0.70-1.6) 1.2 (0.76-1.8) 192.5 (85.9-431-5) 
  
Had standing water in compound 2.2 (1.4-3.4) 1.4 (1.0-1.9) 1.4 (0.99-1.9) 1.2 (0.86-1.8) 1.3 (0.85-1.9) 
 
Walked barefoot 1.5 (1.0-2.4) 1.4 (1.0-1.9) 1.3 (0.98-1.8) 1.6 (1.2-2.3) 1.9 (1.3-2.8) 1.7 (1.2-2.2) 
Washed in surface water 1.2 (0.72-1.9) 0.98 (0.69-1.4) 1.0 (0.70-1.5) 1332.1 (484.7-3661.0) 187.6 (79.7-441.6) 1.4 (1.0-2.0) 
Worked in rice fields 3.6 (1.3-9.6) 1.8 (0.71-4.3) 1.5 (0.60-3.8) 1.6 (0.61-4.2) 1.9 (0.68-5.3) 1.8 (0.71-4.4) 
 




Washed in surface 
water 
 
Odds ratio (95% CI) Odds ratio (95% CI) 
Washed in surface water 1.6 (1.2-2.3) 
 
Worked in rice fields 3.1 (1.2-8.1) 1.9 (0.73-4.7) 
Abbreviations: CI = confidence intervals 
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Appendix C. Questionnaires used in the cross-sectional community 



















































Appendix D. Preferred Reporting of Systematic Reviews and Meta-
Analyses (PRISMA) checklist for a systematic review and meta-
analysis of leptospirosis point-of-care tests 




TITLE   
Title  1 Identify the report as a systematic review, meta-
analysis, or both.  
10.0 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as 
applicable: background; objectives; data sources; 
study eligibility criteria, participants, and 
interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and 
implications of key findings; systematic review 
registration number.  
N/A 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of 
what is already known.  
10.1.2 and 
10.1.3 
Objectives  4 Provide an explicit statement of questions being 
addressed with reference to participants, 
interventions, comparisons, outcomes, and study 
design (PICOS).  
10.1.5 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it 
can be accessed (e.g., Web address), and, if 
available, provide registration information including 




6 Specify study characteristics (e.g., PICOS, length of 
follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as 




7 Describe all information sources (e.g., databases 
with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last 
searched.  
10.2.1 
Search  8 Present full electronic search strategy for at least 
one database, including any limits used, such that it 
could be repeated.  
10.2.1 
Study selection  9 State the process for selecting studies (i.e., 
screening, eligibility, included in systematic review, 




10 Describe method of data extraction from reports 
(e.g., piloted forms, independently, in duplicate) and 
any processes for obtaining and confirming data 
from investigators.  
10.2.2 
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Data items  11 List and define all variables for which data were 
sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
10.2.2 
Risk of bias in 
individual 
studies  
12 Describe methods used for assessing risk of bias of 
individual studies (including specification of whether 
this was done at the study or outcome level), and 





13 State the principal summary measures (e.g., risk 




14 Describe the methods of handling data and 
combining results of studies, if done, including 




Risk of bias 
across studies  
15 Specify any assessment of risk of bias that may affect 
the cumulative evidence (e.g., publication bias, 




16 Describe methods of additional analyses (e.g., 
sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified.  
N/A 
RESULTS   
Study 
selection  
17 Give numbers of studies screened, assessed for 
eligibility, and included in the review, with reasons for 




18 For each study, present characteristics for which data 
were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
10.3.1 
Risk of bias 
within studies  
19 Present data on risk of bias of each study and, if 







20 For all outcomes considered (benefits or harms), 
present, for each study: (a) simple summary data for 
each intervention group (b) effect estimates and 






21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
Table 
10.7 
Risk of bias 
across studies  
22 Present results of any assessment of risk of bias 






23 Give results of additional analyses, if done (e.g., 
sensitivity or subgroup analyses, meta-regression [see 
Item 16]).  
N/A 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, 
users, and policy makers).  
10.4 
Limitations  25 Discuss limitations at study and outcome level (e.g., 
risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
10.4 
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Conclusions  26 Provide a general interpretation of the results in the 
context of other evidence, and implications for future 
research.  
10.4 
FUNDING   
Funding  27 Describe sources of funding for the systematic review 
and other support (e.g., supply of data); role of funders 
for the systematic review.  
N/A 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for 





Appendix E. PICOS Worksheet and Search Strategy for the 
systematic review and meta-analysis of leptospirosis point-of-care 
tests 
1. Define your question using PICOS by identifying: Patient 
Population or Problem, Intervention (treatment/test), Comparison 
(group or treatment), Outcomes, and Setting.  
Your question should be used to help establish your search strategy.  
Patient/Problem:  The sensitivity and specificity of IgM point of care tests 
for leptospirosis are unknown because results from individual evaluations 
vary substantially. 
Outcome: Sensitivity and specificity of IgM tests for leptospirosis 
Setting: Humans – adults and children 
Write out your question: What is the sensitivity and specificity of IgM tests 
for the diagnosis of leptospirosis? 
 
2. Type of question/problem: underline one: Therapy/Prevention, 
Diagnosis, Etiology, Prognosis  
 






4. List main topics and alternate terms from your PICOS question 
that can be used for your search  
Leptospirosis – subheadings: diagnosis, immunology, Immunoglobulin M 
Diagnostic test performance - Sensitivity and Specificity, Epidemiologic 
methods, reference standards 
List your inclusion criteria –gender, age, year of publication, language 
List irrelevant terms that you may want to exclude in your search  
No exclusion criteria 
5. List where you plan to search 
Ovid Medline 
Web of Science 
Scopus 
 
6. Search term development and testing 
Search terms: 
Step 1:  I examined a selection of articles on the topic to identify 
commonly used MESH terms. The articles evaluated were: 
Limmathurotskul 2012, Smits 2001 and Niloofa 2015. I identified that 
MESH terms were not uniform across studies. 
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Table E1: MESH terms identified from three articles evaluating 
diagnostic tests for leptospirosis 
MESH Term Limmathurotskul 
2012 
Smits 2001  Niloofa 
2015 
Leptospirosis/*diagnosis Yes Yes Yes 
Leptospirosis/*immunology No Yes Yes 
Immunoglobulin M No Yes Yes 
Reference Standards Yes No No 
Sensitivity and Specificity No Yes Yes 
Humans Yes Yes Yes 
 
I constructed search terms based on these results and used an iterative 
process to construct search terms that identified several articles that I 
knew addressed the question of the review.  Appendix Table 2 shows 




Table E2. Searches performed in PubMed, June 2017  
Search Terms Hits Did the search identify these articles, which are known to be 
relevant? 
  Eugene 
2015 
Goris 2013 Limmathurotsakul 
2012 
Effler 2002 
(Leptospirosis/*diagnosis OR Leptospirosis/*immunology OR (Leptospir* 
AND Immunoglobulin M)) 
2848 Yes Yes Yes Yes 
(Leptospirosis/*diagnosis OR Leptospirosis/*immunology OR (Leptospir* 
AND Immunoglobulin M)) AND (Sensitivity and Specificity OR *Reference 
Standards) 
317 Yes Yes Yes Yes 
(Leptospirosis/*diagnosis OR Leptospirosis/*immunology OR (Leptospir* 
AND Immunoglobulin M)) AND Humans AND (Sensitivity and Specificity 
OR *Reference Standards) 
249 Yes Yes Yes Yes 
(Leptospirosis/*diagnosis OR Leptospirosis/*immunology) AND Humans 
AND (Sensitivity and Specificity OR *Reference Standards) 
236 Yes Yes Yes Yes 
(Leptospirosis/*immunology OR (Leptospir* AND Immunoglobulin M)) 
AND Humans AND (Sensitivity and Specificity OR *Reference Standards) 
111 Yes No No Yes 
(Leptospirosis/*diagnosis OR Leptospirosis/*immunology OR (Leptospir* 
AND Immunoglobulin M)) AND Immunoassay/methods (Sensitivity and 
Specificity OR *Reference Standards) 
74 No Yes No Yes 
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Final Search Terms 
(Leptospirosis/*diagnosis OR Leptospirosis/*immunology OR (Leptospir* 
AND Immunoglobulin M)) AND Humans AND (Sensitivity and Specificity 





Appendix F. Standards for the Reporting of Diagnostic Accuracy 
Testing Checklist 
 Section & Topic No Item 
Reported in 
section 
     
 TITLE OR 
ABSTRACT 
   
  1 Identification as a study of diagnostic accuracy using at least 
one measure of accuracy 
(such as sensitivity, specificity, predictive values, or AUC) 
Title 
 ABSTRACT    
  2 Structured summary of study design, methods, results, and 
conclusions  
(for specific guidance, see STARD for Abstracts) 
N/A 
 INTRODUCTION    
  3 Scientific and clinical background, including the intended use 
and clinical role of the index test 
11.1 
  4 Study objectives and hypotheses 11.1.3 
 METHODS    
 Study design 5 Whether data collection was planned before the index test and 
reference standard  
were performed (prospective study) or after (retrospective 
study) 
11.2.3 
 Participants 6 Eligibility criteria  11.2.1 
  7 On what basis potentially eligible participants were identified  
(such as symptoms, results from previous tests, inclusion in 
registry) 
11.2.1 
  8 Where and when potentially eligible participants were 
identified (setting, location and dates) 
11.2.1 
  9 Whether participants formed a consecutive, random or 
convenience series 
11.2.1 
 Test methods 10a Index test, in sufficient detail to allow replication 11.2.5 
  10b Reference standard, in sufficient detail to allow replication 11.2.5.1 
  11 Rationale for choosing the reference standard (if alternatives 
exist) 
11.1.2.4 
  12a Definition of and rationale for test positivity cut-offs or result 
categories  
of the index test, distinguishing pre-specified from exploratory 
11.2.5 
  12b Definition of and rationale for test positivity cut-offs or result 
categories  
of the reference standard, distinguishing pre-specified from 
exploratory 
11.1.2.4 
  13a Whether clinical information and reference standard results 
were available  
to the performers/readers of the index test 
11.2.7 
  13b Whether clinical information and index test results were 
available  
to the assessors of the reference standard 
11.2.7 
 Analysis 14 Methods for estimating or comparing measures of diagnostic 
accuracy 
11.2.8 




  16 How missing data on the index test and reference standard 
were handled 
11.2.8 
  17 Any analyses of variability in diagnostic accuracy, 
distinguishing pre-specified from exploratory 
N/A 
  18 Intended sample size and how it was determined 11.2.2 
 RESULTS    
 Participants 19 Flow of participants, using a diagram 11.3.2 (no 
diagram) 
  20 Baseline demographic and clinical characteristics of 
participants 
11.3.3 
  21a Distribution of severity of disease in those with the target 
condition 
N/A 
  21b Distribution of alternative diagnoses in those without the target 
condition 
11.3.4 
  22 Time interval and any clinical interventions between index test 
and reference standard 
11.2.3 
 Test results 23 Cross tabulation of the index test results (or their distribution)  
by the results of the reference standard 
Table 11.7 
  24 Estimates of diagnostic accuracy and their precision (such as 
95% confidence intervals) 
Tables 11.8 
and 11.13 
  25 Any adverse events from performing the index test or the 
reference standard 
N/A 
 DISCUSSION    
  26 Study limitations, including sources of potential bias, statistical 
uncertainty, and generalisability 
11.4.8 
  27 Implications for practice, including the intended use and 




   
  28 Registration number and name of registry N/A 
  29 Where the full study protocol can be accessed N/A 
  30 Sources of funding and other support; role of funders 11.2 




Appendix G. Tracing plots of the prevalence of leptospirosis and the 
accuracy of diagnostic tests from a latent class analysis performed 




Appendix G continued. Tracing plots of the prevalence of 
leptospirosis and the accuracy of diagnostic tests from a latent class 
analysis performed among patients with febrile illness, Tanzania, 




Appendix G continued. Tracing plots of the prevalence of 
leptospirosis and the accuracy of diagnostic tests from a latent class 
analysis performed among patients with febrile illness, Tanzania, 
2007-08 and 2012-14 
 
Footnote: A= Prevalence of leptospirosis; B= Sensitivity of Test-It 
Leptospira; C=Specificity of Test-It Leptospira; D=Sensitivity of 
Leptocheck WB; E=Specificity of Leptocheck WB; F=Sensitivity of 
Leptorapide; G=Specificity of Leptorapide; F=Sensitivity of microscopic 





Appendix H. Abstracts of conference presentations 
Maze MJ, Shirima GM, Lukambagire A-H, Bodenham RF, Rubach MP, 
Cash-Goldwasser S, Mkenda N, Kazwala RR, Mmbaga BT, Buza JJ, 
Maro VP, Galloway RL, Haydon DT, Crump JA, Halliday JEB. 
Leptospirosis among febrile outpatients attending hospital in a 
pastoral area in northern Tanzania. 10th International Leptospirosis 
Society Meeting, Palmerston North, New Zealand, November 2017 
Background:  Leptospirosis is an important cause of fever in Tanzania (1-
3). Risk factors for leptospirosis identified in urban and small-holder 
farming areas include rural residence and contact with livestock (4). We 
sought to determine leptospirosis prevalence in a rural area where 
pastoralist Maasai livestock keepers who have intense livestock contact 
predominate. 
Methods: We conducted this study at Endulen Hospital, Tanzania. 
Individuals presenting to hospital from August 2016 through March 2017 
were approached. Patients with a history of fever within 72 hours, or a 
tympanic temperature of ≥38.0°C were eligible. Serum samples were 
collected at presentation and 4-6 weeks later. Sera were tested using the 
standard microscopic agglutination test (MAT) using 20 Leptospira 
serovars from 17 serogroups, representing the major human disease-
causing serogroups. We defined acute leptospirosis as a four-fold rise in 
antibody titre between the acute and convalescent serum samples, or a 
reciprocal titre ≥800 in either sample (5). We defined Leptospira 
seropositivity as a single reciprocal antibody titre ≥100 in either sample. 
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Results: We identified 6 (10.0%) cases of acute leptospirosis among 60 
participants providing paired serum samples, and 0 (0.0%) among 44 
participants providing only a single sample. In total, 31 (29.8%) of 104 
participants were seropositive to Leptospira. The predominant reactive 
serogroups of seropositive participants and those with acute leptospirosis 
included Australis, Djasiman, Icterohaemorrhagiae, Javanica and 
Tarassovi.  
 
Conclusions: These data indicate leptospirosis is a common cause of 
fever in this predominantly Maasai pastoralist population. Research is 
needed on the impact and risk factors for leptospirosis.  
REFERENCES 
1. Allan KJ, Biggs HM, Halliday JEB, Kazwala RR, Maro VP, 
Cleaveland S, et al. Epidemiology of leptospirosis in Africa: a systematic 
review of a neglected zoonosis and a paradigm for 'One Health' in Africa. 
PLoS Negl Trop Dis. 2015;9(9). 
2. Biggs HM, Bui DM, Galloway RL, Stoddard RA, Shadomy SV, 
Morrissey AB, et al. Leptospirosis among hospitalized febrile patients in 
northern Tanzania. Am J Trop Med Hyg. 2011;85(2):275-81. 
3. Zhang HL, Mnzava KW, Mitchell ST, Melubo ML, Kibona TJ, 
Cleaveland S, et al. Mixed methods survey of zoonotic disease awareness 
and practice among animal and human healthcare providers in Moshi, 
Tanzania. PLoS Negl Trop Dis. 2016;10(3):e0004476. 
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4. Maze MJ, Cash-Goldwasser S, Rubach MP, Biggs HM, Galloway 
RL, Sharples KJ, et al., editors. Risk factors for acute human leptospirosis 
in northern Tanzania. In: Program and abstracts of the American Society 
of Tropical Medicine and Hygiene 65th Annual Meeting; 2016 November 
13-17, 2016; Atlanta, Georgia, USA. 
5. Centers for Disease Control and Prevention. Leptospirosis 








Maze MJ, Cash-Goldwasser S, Carugati M, Rubach MP, Allan KJ, 
Cossic B, Demeter E, Gallagher S, German R, Galloway RL, Crump 
JA. The global distribution and host range of Leptospira species and 
serovars. 10th International Leptospirosis Society Meeting, 
Palmerston North, New Zealand, November 2017 
Aim: Knowledge of the host range of Leptospira is critical to understand 
the epidemiology of human and animal leptospirosis (Ellis, 2015; Terpstra, 
2003). While attempts were made to collate these data many decades 
ago, they have not been updated using contemporary systematic review 
methods (Galton, 1966; Kmetky & Dikken, 1993). We sought to establish 
the current evidence of animal hosts and global distribution of Leptospira.  
Methods: Between 17-19 August 2015 we searched 7 library databases 
using the terms “Leptospir* AND ((Animal*) OR (mammal) OR (reptile) OR 
(bird) OR (avian) OR (amphibian)) AND [complete list of serovars 
separated by a boolean OR]. We included reports of isolation or molecular 
detection of Leptospira from a non-human animal that used robust 
serologic or molecular methods to identify the serovar or species.  We 
created a searchable database that allows identification of known hosts for 
each serovar or species. 
Results: Our search identified 8,545 articles, of which 455 met inclusion 
criteria. Reports were published from 1927 through 2015, related to 11 
Leptospira species and 153 serovars, and from 164 animal species in 75 
countries. Serovars with isolations from ≥20 animal hosts included 
Grippotyphosa (37), Icterohaemorrhagiae (31), Pomona (28), Ballum (26), 
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Australis (25), and Canicola (20), whereas for 70 serovars we identified 
reports of isolation from only a single animal.  
Conclusions: We have compiled published data on the host and 
geographic range for each Leptospira serovar or species that serves as a 
resource for the global leptospirosis community to facilitate research and 
epidemiologic investigations.  
REFERENCES 
Ellis, W. A. (2015). Animal leptospirosis. Curr Top Microbiol Immunol, 387, 
99-137. doi:10.1007/978-3-662-45059-8_6 
Galton, M. M. (1966). Leptospiral serotype distribution lists according to 
host and geographic area. Atlanta, Georgia, United States of America: 
Center for Disease Control. 
Kmetky, E., & Dikken, H. (1993). Classification of the species Leptospira 
interrogans and history of its serovars. Groningen, Netherlands: University 
Press Groningen. 
Terpstra, W. (2003). Human leptospirosis: guidance for diagnosis, 





Maze MJ, Galloway RL, Rubach MP, Allan KJ, Biggs HM, Halliday 
JEB, Cleaveland S, Saganda W, Lwezaula BF, Kazwala RR, Mmbaga 
BT, Maro VP, Crump JA, Three species of Leptospira detected in 
blood of patients with fever in northern Tanzania. 10th International 
Leptospirosis Society Meeting, Palmerston North, New Zealand, 
November 2017 
Background: Leptospirosis is a common cause of fever in Tanzania (1), 
with cattle and rice fields previously identified as likely sources of human 
infection (2). The predominant species and serovars causing human 
infection are unknown. We report the identification of three Leptospira 
species causing human leptospirosis. 
Methods: We enrolled patients from two hospitals in Moshi, Tanzania from 
February 2012 through September 2014. We performed leptospirosis 
microscopic agglutination testing (MAT) on acute and convalescent serum 
using a panel of 20 serovars from 17 serogroups. Among persons with 
acute leptospirosis, defined as participants with either a four-fold rise in 
antibody titre, or a single reciprocal titre ≥800, we performed real-time 
polymerase chain reaction (PCR) on serum targeting LipL32 (3). From 
samples yielding Leptospira DNA, we performed species-specific PCR 
using ompL1 and secY primers (4). 
Results: Among 1,446 participants, we identified 24 (1.7%) acute 
leptospirosis cases using MAT. Of these 24 cases, we detected Leptospira 
DNA in 3 (12.5%).  In two participants with highest MAT titres to serogroup 
Sejroe, we detected, using PCR, L. interrogans in one, and L. kirschneri in 
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the other.  In one patient with highest MAT titres to serogroup Pyrogenes, 
we detected L. borgpetersenii. 
Conclusions:  Our results indicate complex Leptospira ecology. Multiple 
Leptospira species were detected in patients with reactivity to two 
serogroups. Locally, L. borgpetersenii and L. kirschneri have been 
detected in cattle, and L. kirschneri has been detected in sheep (5). This 
concordance suggests ruminant livestock may be an important source for 
human leptospirosis in northern Tanzania. 
REFERENCES 
1. Biggs HM, Bui DM, Galloway RL, Stoddard RA, Shadomy SV, 
Morrissey AB, et al. Leptospirosis among hospitalized febrile patients in 
northern Tanzania. Am J Trop Med Hyg. 2011;85(2):275-81. 
2. Maze MJ, Cash-Goldwasser S, Rubach MP, Biggs HM, Galloway 
RL, Sharples KJ, et al., editors. Risk factors for acute human leptospirosis 
in northern Tanzania. In: Program and abstracts of the American Society 
of Tropical Medicine and Hygiene 65th Annual Meeting; 2016 November 
13-17, 2016; Atlanta, Georgia, USA. 
3. Galloway RL, Hoffmaster AR. Optimization of LipL32 PCR assay for 
increased sensitivity in diagnosing leptospirosis. Diagn Microbiol Infect 
Dis. 2015;82(3):199-200. 
4. Ferreira AS, Costa P, Rocha T, Amaro A, Vieira ML, Ahmed A, et 
al. Direct detection and differentiation of pathogenic Leptospira species 
using a multi-gene targeted real time PCR approach. PLoS One. 
2014;9(11):e112312. 
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5. Allan KJ. Leptospirosis in northern Tanzania: investigating the role 
of rodents and ruminant livestock in a neglected public health problem 





Maze MJ, Rubach MP, Sakasaka P, Swai R, Afwamba I, Galloway RL, 
Maro VP, Schofield M, Sharples KJ, Crump JA. Evaluation of 
performance of three commercially available leptospirosis IgM point-
of-care tests to diagnose acute leptospirosis among patients with 
fever in northern Tanzania. 10th International Leptospirosis Society 
Meeting, Palmerston North, New Zealand, November 2017 
Background: Leptospirosis is a common cause of fever in Tanzania (Biggs 
et al., 2011). Tests that clinicians in district hospitals can use to diagnose 
leptospirosis at initial presentation are needed. Point-of-care IgM tests 
would be suitable, but their performance varies according to context 
(Brownlow et al., 2014; Chang et al., 2014), and none has been evaluated 
in Africa. We evaluated three point-of-care tests in patients from northern 
Tanzania presenting to hospital with fever.  
Methods: Patients with fever presenting to hospital in Moshi, Tanzania, 
were enrolled during 2007-08 and 2012-14, and provided acute and 
convalescent serum. We tested paired serum using a 20-member panel 
Leptospira microscopic agglutination test (MAT), defining leptospirosis as 
a four-fold rise in antibody titre (minimum reciprocal titre 200), and acute 
serum with Leptocheck WB, Test-It Leptospirosis, and Leptorapide point-
of-care tests. We compared agreement with MAT and are evaluating latent 
class models. 
Results: We tested serum from 242 (19.8%) of 1,220 participants who 
underwent MAT, including 24 (9.9%) with positive MAT. Of those with 
positive MAT, the proportion positive on the point-of-care assays were: 
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Leptocheck WB 45.8%; Leptorapide 16.7%; Test-It Leptospira 26.1%. For 
those with negative MAT, the proportions negative on the point-of-care 
assays were Leptocheck WB 82.9%; Leptorapide 83.5%; Test-It 
Leptospira 87.0%. 
Conclusion: IgM point-of-care assays had low agreement with MAT for 
leptospirosis diagnosis. Latent class models can estimate point-of-care 
test sensitivity and specificity, however these models are sensitive to 
assumptions. We will present estimates of sensitivity and specificity at 
presentation based on a plausible range of latent class models.  
REFERENCES: 
Biggs, H. M., Bui, D. M., Galloway, R. L., Stoddard, R. A., et al. (2011). 
Leptospirosis among hospitalized febrile patients in northern Tanzania. 
Am J Trop Med Hyg, 85(2), 275-281. doi:10.4269/ajtmh.2011.11-0176 
Brownlow, T., Kavanagh, O. V., Logan, E. F., Hartskeerl, R. A., et al. 
(2014). 'Leptorapide' - a one-step assay for rapid diagnosis of human 
leptospirosis. Epidemiol Infect, 142(6), 1182-1187. 
doi:10.1017/S0950268813002112 
Chang, C. H., Riazi, M., Yunus, M. H., Osman, S., & Noordin, R. (2014). 
Limited diagnostic value of two commercial rapid tests for acute 





Maze MJ, Biggs HM, Rubach MP, Galloway RL, Cash-Goldwasser S, 
Allan KJ, Halliday JEB, Hertz JP, Saganda W, Lwezaula BF, 
Cleaveland S, Mmbaga BT, Maro VP, Crump JA. Comparison of the 
estimated incidence of acute leptospirosis in the Kilimanjaro Region 
of Tanzania between 2007-08 and 2012-14. American Society of 
Tropical Medicine and Hygiene, 65th Annual Meeting. Atlanta, 
Georgia. 13-17 November 2016 
The sole report of annual leptospirosis incidence in continental Africa of 
75-102 cases per 100,000 population is from a study performed in August 
2007 through September 2008 in the Kilimanjaro Region of Tanzania. To 
evaluate the stability of this estimate over time, we estimated the 
incidence of acute leptospirosis in Kilimanjaro Region, northern Tanzania 
for the time period 2012-2014. Cases were identified among febrile 
patients at two sentinel hospitals in the Kilimanjaro Region. Leptospirosis 
was diagnosed by serum microscopic agglutination testing using a panel 
of 20 serovars belonging to 17 separate serogroups. Serum was taken at 
enrolment and patients were asked to return 4-6 weeks later to provide 
convalescent serum. Confirmed cases required a 4-fold rise in titer and 
probable cases required a single titer of ≥800. Findings from a healthcare 
utilization survey were used to estimate multipliers to adjust for cases not 
seen at sentinel hospitals. Among 1,115 patients presenting with fever, 19 
(1.7%) had confirmed or probable leptospirosis. Of cases, the predominant 
reactive serogroups were Australis 8 (42.1%), Sejroe 3 (15.8%), 
Grippotypphosa 2 (10.5%), Icterohaemorrhagiae 2 (10.5%), Pyrogenes 2 
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(10.5%), Djasiman 1 (5.3%), and Tarassovi 1 (5.3%). We estimated the 
annual incidence as 11-18 cases per 100,000 population. We estimated a 
much lower incidence of acute leptospirosis than previously, with a notable 
absence of cases due to the previously predominant serogroup Mini. Our 






Maze MJ, Cash-Goldwasser S, Biggs HM, Rubach MP, Galloway RL, 
Sharples KJ, Allan KJ, Halliday JEB, Cleaveland S, Shand MC, 
Muiruri C, Kazwala RR, Saganda W, Lwezaula BF, Mmbaga BT, Maro 
VP, Crump JA. Risk factors for acute leptospirosis in northern 
Tanzania. American Society of Tropical Medicine and Hygiene, 65th 
Annual Meeting. Atlanta, Georgia. 13-17 November 2016. 
Leptospirosis is increasingly recognized as a major cause of febrile illness 
in Africa but little is known about risk factors for human infection. Patterns 
of sero-reactivity in Tanzania have indicated that livestock may be 
important sources of human leptospirosis. To test this hypothesis, we 
conducted a prospective cohort study of acute leptospirosis in northern 
Tanzania. We enrolled pediatric and adult patients with fever from two 
referral hospitals in Moshi, Tanzania and performed Leptospira 
microagglutination antibody testing on acute and convalescent serum. 
Cases were patients who had either a four-fold rise in Leptospira antibody 
titers or a single reciprocal titer ≥800, seropositivity required a single titer 
≥100, and controls had titers <100 in both sera. We administered a 
standardized questionnaire to assess behaviors over the preceding month. 
We calculated odds ratios (OR) for individual behaviors, and combined 
behaviors to form exposure scales to livestock, rodents, and surface 
water. Of 1,446 patients enrolled from February 2012 through September 
2014 the analyzed cohort included 24 (1.7%) cases, 179 (12.4%) 
seropositive participants and 592 (40.9%) controls. Among cohort 
members the median (range) age was 26.0 (0.2, 95.3) years and 422 
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(54.7%) were female. On bivariate analysis, acute leptospirosis was 
associated with age >12 years (OR 7.7, p<0.01), high level of cattle 
contact (OR 3.3, p=0.05), feeding cattle (OR 3.9, p=0.02), cleaning cattle 
waste (OR 4.3, p=0.03), working in fields (OR 2.9, p=0.02) and rice fields 
(OR 14.4, p<0.01). Seropositivity was associated with age >12 years (OR 
2.2, p<0.01), Maasai ethnicity (OR 7.0, p=0.03), high level of cattle contact 
(OR 1.7, p=0.04), keeping cattle inside the house (OR 4.7, p=0.04), high 
level of goat contact (OR 1.9, p=0.03), slaughtering livestock (OR 1.7, 
p=0.02), and working in rice fields (OR 3.9, p=0.01). Behaviors and scales 
for exposure to rodents and surface water were not associated with either 
acute leptospirosis or seropositivity. Our findings suggest livestock contact 





Allan KJ, Halliday JEB, Maze MJ, Goris MGA, Hartskeerl RA, Uzzell C, 
Ladbury G, Shand M, Kazwala RR, Maro VP, Keyyu J, Sharp J, Crump 
JA, Cleaveland S. Livestock, livelihoods and leptospirosis: insights 
from East Africa. 9th International Leptospirosis Society Meeting, 
Semarang, Indonesia. 7-10 October 2015 
Background: Leptospirosis has been widely overlooked and neglected in 
Africa. In East Africa, few studies of human febrile disease have been 
performed in the region but epidemiological data from the region indicates 
that serological exposure to Leptospira is widespread [1-3]. The first report 
of acute disease in the region came from a Kenyan study performed in 
1967, where leptospirosis was diagnosed in 7 (17.9%) of 39 patients with 
non-specific febrile illness [4]. In Tanzania, recent study demonstrated 
acute leptospirosis in 8.4% of patients (n=870) presenting at hospital 
facilities with severe febrile disease [5]. From hospital data, district level 
incidence was estimated as 75-102 cases per 100,000 population per year 
[6]. Here, we summarise the results of field studies established to explore 
the epidemiology and ecology of human and animal leptospirosis in Kenya 
and Tanzania and discuss the relevance of these insights to rest of the 
East African region.  
Methods: Study methods aim to integrate quantitative epidemiological 
components with qualitative social science studies and geo-spatial 
analysis. Epidemiological studies included i) on-going hospital-based 
febrile disease surveillance, ii) observational cross-sectional prevalence 
studies of linked human, livestock and rodent populations and iii) abattoir 
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surveillance of ruminant livestock. Social science components focused on 
disease knowledge and risk perceptions in health-care workers and village 
communities as well as characterization of farming practices and health-
care seeking behaviour.  
Results: Prevalence data indicates that ruminant livestock, particularly 
cattle, are important carrier hosts of pathogenic Leptospira spp. in 
Tanzania. By real-time PCR (qPCR), cattle infection prevalence ranged 
from 7-15% in abattoir-sampled animals. Microscopic Agglutination Test 
(MAT) results showed a marked overlap in predominant reacting 
serogroup between hospital patients with acute disease and cattle. Sheep 
and goats were also confirmed as carriers of pathogenic Leptospira 
species by qPCR (prevalence ~ 1%). However, in contrast to results from 
elsewhere in Kenya and Tanzania [7-10], rodents trapped in households in 
villages in the hospital catchment areas were negative for Leptospira 
infection. Risk factor analysis demonstrated that rural residence was a 
significant risk factor for acute human illness in northern Tanzania (OR = 
3.4; p < 0.001). L. borgpetersenii serovar Hardjo prevalence was also 
significantly higher in pastoral areas than peri-urban or agro-pastoral 
settings.  
Discussion: Our results, combined with serological data from elsewhere in 
the region indicate that livestock appear to be important reservoirs of 
pathogenic Leptospira species in East Africa. Cattle are essential sources 
of food and income for many subsistence farmers particularly in pastoral 
communities. As well as posing a zoonotic disease threat to livestock-
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keepers, Leptospira infection in food-producing animals may reduce 
productivity with direct and indirect detrimental effects on livelihoods and 
well-being. Work is underway to describe the diversity of Leptospira 
infection in people and livestock, and characterise to dairy and meat value 
chains in northern Tanzania to assess the broader economic impact of 
Leptospira in farming communities. Furthermore, our research findings 
from Tanzania are being applied to gain insight into the epidemiology of 
human and animal leptospirosis in the East Africa region, with important 
application in public health and livestock policies. 
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